Professional Documents
Culture Documents
Development of Food Chemistry Natural Products and Nutrition Research
Development of Food Chemistry Natural Products and Nutrition Research
Food Chemistry,
Natural Products,
and Nutrition
Research
Edited by
Antonello Santini and Nicola Cicero
Printed Edition of the Special Issue Published in Foods
www.mdpi.com/journal/foods
Development of Food Chemistry,
Natural Products, and
Nutrition Research
Development of Food Chemistry,
Natural Products, and
Nutrition Research
MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade • Manchester • Tokyo • Cluj • Tianjin
Special Issue Editors
Antonello Santini Nicola Cicero
University of Napoli Federico II University of Messina
Italy Italy
Editorial Office
MDPI
St. Alban-Anlage 66
4052 Basel, Switzerland
This is a reprint of articles from the Special Issue published online in the open access journal
Foods (ISSN 2304-8158) (available at: https://www.mdpi.com/journal/foods/special issues/food
chemistry natural products nutrition).
For citation purposes, cite each article independently as indicated on the article page online and as
indicated below:
LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number,
Page Range.
c 2020 by the authors. Articles in this book are Open Access and distributed under the Creative
Commons Attribution (CC BY) license, which allows users to download, copy and build upon
published articles, as long as the author and publisher are properly credited, which ensures maximum
dissemination and a wider impact of our publications.
The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons
license CC BY-NC-ND.
Contents
Gyung-Rim Yong, Yoseph Asmelash Gebru, Dae-Woon Kim, Da-Ham Kim, Hyun-Ah Han,
Young-Hoi Kim and Myung-Kon Kim
Chemical Composition and Antioxidant Activity of Steam-Distilled Essential Oil and
Glycosidically Bound Volatiles from Maclura Tricuspidata Fruit
Reprinted from: Foods 2019, 8, 659, doi:10.3390/foods8120659 . . . . . . . . . . . . . . . . . . . . 27
Ping-Chen Tu, Chih-Ju Chan, Yi-Chen Liu, Yueh-Hsiung Kuo, Ming-Kuem Lin and
Meng-Shiou Lee
Bioactivity-Guided Fractionation and NMR-Based Identification of the Immunomodulatory
Isoflavone from the Roots of Uraria crinita (L.) Desv. ex DC
Reprinted from: Foods 2019, 8, 543, doi:10.3390/foods8110543 . . . . . . . . . . . . . . . . . . . . . 57
v
Jin-Woo Jeong, Seon Yeong Ji, Hyesook Lee, Su Hyun Hong, Gi-Young Kim, Cheol Park,
Bae-Jin Lee, Eui Kyun Park, Jin Won Hyun, You-Jin Jeon and Yung Hyun Choi
Fermented Sea Tangle (Laminaria japonica Aresch) Suppresses RANKL-Induced
Osteoclastogenesis by Scavenging ROS in RAW 264.7 Cells
Reprinted from: Foods 2019, 8, 290, doi:10.3390/foods8080290 . . . . . . . . . . . . . . . . . . . . 103
Agata Campisi, Rosaria Acquaviva, Giuseppina Raciti, Anna Duro, Milena Rizzo and
Natale Alfredo Santagati
Antioxidant Activities of Solanum nigrum L. Leaf Extracts Determined in In Vitro
Cellular Models
Reprinted from: Foods 2019, 8, 63, doi:10.3390/foods8020063 . . . . . . . . . . . . . . . . . . . . . 117
Gabriel López-Garcı́a, Antonio Cilla, Reyes Barberá, Amparo Alegrı́a and Marı́a C. Recio
Effect of a Milk-Based Fruit Beverage Enriched with Plant Sterols and/or
Galactooligosaccharides in a Murine Chronic Colitis Model
Reprinted from: Foods 2019, 8, 114, doi:10.3390/foods8040114 . . . . . . . . . . . . . . . . . . . . . 129
Wan-Sup Sim, Sun-Il Choi, Bong-Yeon Cho, Seung-Hyun Choi, Xionggao Han, Hyun-Duk
Cho, Seung-Hyung Kim, Boo-Yong Lee, Il-Jun Kang, Ju-Hyun Cho and Ok-Hwan Lee
Anti-Obesity Effect of Extract from Nelumbo Nucifera L., Morus Alba L., and Raphanus Sativus
Mixture in 3T3-L1 Adipocytes and C57BL/6J Obese Mice
Reprinted from: Foods 2019, 8, 170, doi:10.3390/foods8050170 . . . . . . . . . . . . . . . . . . . . 145
Alexandra Galetović, Francisca Seura, Valeska Gallardo, Rocı́o Graves, Juan Cortés, Carolina
Valdivia, Javier Núñez, Claudia Tapia, Iván Neira, Sigrid Sanzana and Benito Gómez-Silva
Use of Phycobiliproteins from Atacama Cyanobacteria as Food Colorants in a Dairy
Beverage Prototype
Reprinted from: Foods 2020, 9, 244, doi:10.3390/foods9020244 . . . . . . . . . . . . . . . . . . . . . 163
vi
About the Special Issue Editors
Antonello Santini Ph.D., is Professor of Food Chemistry and Analysis of Food and Nutraceuticals and of
Food Chemistry at the Department of Pharmacy and at the Department of Agriculture at the University of
Napoli Federico II, Napoli, Italy, respectively. He is also Visiting Professor at the Albanian University of
Tirana, Albania. He holds a Ph.D. in Chemical Sciences. His research areas of interest are supported by many
international collaborations, mainly in the fields of food; food chemistry, nutraceuticals, and functional food;
safety; supplements; recovery of natural bioactive compounds using eco-sustainable and environmentally
friendly techniques from agro-food by products; nanocompounds; nanonutraceuticals; food risk assessment,
safety, and contaminants; mycotoxins and secondary metabolites; food analysis; and chemistry and food
education. He is responsible for funded research projects and for general cultural agreements established
between the University of Napoli Federico II and many universities worldwide, and external evaluator of
funded research projects for Italian and International Institutions. His research activity is documented by more
than 200 papers published in reputed peer-reviewed international journals. He is a member of the European
Food Safety Authority EFSA, ERWG, Parma, Italy; of the Italian Authority for Food Safety (CNSA), Italian
Ministry of Health, Rome Italy; of the Managing Board, Italian Chemistry Society (SCI) Division of Teaching
(DD-SCI), Rome, Italy; and Expert Member for Chemistry, EurSchool, European Commission, Bruxelles,
Belgium.
Nicola Cicero is Senior Researcher in Food Chemistry with the Department of Biomedical Sciences,
Dental and Morphological and Functional images, section S.A.S.T.A.S., at the University of Messina,
Italy. He holds two Ph.D. degrees: Enogastronomical Sciences and Tourism, Territory, and
Environment. He is teaching Oil and Wine in Mediterranean Food Habits and Fermentation
Biotechnology at the University of Messina, Italy. He is an expert in the quality and safety of agro-
food products. He has published about 100 publications, all in relevant peer-reviewed internationally
reputed journals. His research interests mainly focus on food, their quality assessment and safety
including the food and agro-food chain products, contaminants of organic and inorganic origin, and
analysis of food matrices. He has a relevant background of participation in international congresses
in the food area as chair or organizing and scientific committee member. He is an external evaluator
for the assessment of the scientific research activity of the Italian research system and has a wide
structured network of international collaboration in the food and environment area of interest. He is
a funder member of the scientific and technical committee of the spin-off company named
Science4Life srl and is an active consultant in the food industry.
vii
foods
Editorial
Development of Food Chemistry, Natural Products,
and Nutrition Research: Targeting New Frontiers
Antonello Santini 1, * and Nicola Cicero 2
1 Department of Pharmacy, University of Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy
2 Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Polo
Universitario Annunziata, 98125 Messina, Italy; ncicero@unime.it
* Correspondence: asantini@unina.it; Tel.: +39-81-253-9317
Abstract: The Special Issue entitled: “Development of Food Chemistry, Natural Products, and
Nutrition Research” is focused on the recent development of food chemistry research, including
natural products’ sources and nutrition research, with the objectives of triggering interest towards new
perspectives related to foods and opening a novel horizon for research in the food area. The published
papers collected in this Special Issue are studies that refer to different aspects of food, ranging from
food chemistry and analytical aspects, to composition, natural products, and nutrition, all examined
from different perspectives and points of view. Overall, this Special Issue gives a current picture
of the main topics of interest in the research and proposes studies and analyses that may prompt
and address the efforts of research in the food area to find novel foods and novel applications and
stimulate an environmentally-friendly approach for the re-use of the by-products of the agro-food
area. This notwithstanding, the main challenge is currently addressed to achieve a full comprehension
of the mechanisms of action of food components, the nutrients, outlining their high potential impact
as preventive and/or therapeutic tools, not only as a source of macro- and/or micro-nutrients, which
are necessary for all the metabolic and body functions.
The complete understanding of food matrices encompasses the analytical aspects and the
composition analysis, both of which are of paramount importance considering that emerging
new technologies and techniques in food analysis, chemometric techniques, and methods for food
authentication can allow obtaining a great amount of accurate and precise data. This potentially affects
the changes in consumer preferences and expectations, as well as the analysis of food innovations and
their impact on the global market [1,2].
Nonetheless, the frontier of the food chemistry has impacts with new challenges, which range
from: (i) novel foods; (ii) how adequate food safety may be determined; (iii) how nutritional intakes
evolve over time and are influenced by global dynamics; (iv) the novel delivery systems of the food
containing health beneficial compounds, which can have a great impact on health conditions, besides
their nutritional value and importance; (iv) natural sources and their waste or by-products’ recovery
and re-use [3,4].
The challenge to understand the mechanism of action of food micronutrients and of the secondary
metabolites involved in the chemistry of the food, especially when it is ingested, is currently triggering the
interest of researchers worldwide. The complete understanding of the metabolic pathway of foodstuffs,
which are complex matrices formed by many different substances, as well as the complete comprehension
and assessment of the effects that food has on the body’s metabolism are still open challenges.
The analytical details and knowledge of all the minor food components and/or contaminants
of different origins at a very high resolution give important information, especially on food safety
and quality parameters. Nonetheless, the actual perspectives of the research in food chemistry reveal
an emerging interest in a new interdisciplinary approach that involves the contribution from different
disciplines both in the food and natural products areas. Natural products are and have been a primary
source in many cases, not only of nutrients, but also of remedies for millennia. An example is the growing
interest towards the re-use of by-products from industrial processing of food and foodstuff to recover
biologically-active substances to obtain derived products originating from food matrices and that may
be useful to support/supplement the diet. Nutraceuticals are an outstanding example of this emerging
trend in the food chemistry area. The use or re-use of food industry by-products, as well as the recovery
of biologically-active compounds are receiving growing attention in view of the great interest towards
the green economy and the optimization of the available resources. In this perspective, foodstuff and
agro-food industry by-products’ re-use can play a major role. A new challenging opportunity is to
explore and substantiate with detailed chemical composition data and clinical data the mechanisms and
modes of action of the active substances contained in food.
These aspects are relevant for maintaining well-being and preventing, by their use, the onset of
diseases due to poor diet/food habits [5–16]. Safety is also a major challenge, as well as obtaining the
complete or increased bioavailability of substances derived from food. From this perspective, the interest
towards nanomaterials is emerging. Due to their remarkable properties, these are currently considered
novel emerging tools to be used in the food area [17]. An interesting work has been reported recently
regarding nanomaterials’ application to foodstuff and outlining possible beneficial effects on health [18].
Nanopharmaceuticals can be considered as an illuminating example, which have led to a great
change in the pharmaceutical industry and have had a great impact also on nutraceuticals. There is
increasing growth in the study of nanocompounds including nutraceuticals derived from food matrices
as phytocomplexes to obtain improved delivery, bioavailability, and effects. As a consequence, many
recent research works are addressed towards the use of nanotechnologies applied to food-derived
nutraceuticals, building up the innovative area of new emerging products: nanonutraceuticals [19,20].
Nanotechnology could be used for the proficient delivery of bioactive substances contained in
food with the aim to improve their bioavailability, thereby increasing the possible health benefits.
The advantages of nanotechnology applied to nutraceuticals are efficient encapsulation, smart delivery
to the target, and release from a nanoformulation. For instance, research on the encapsulation of
nutraceuticals into biodegradable, environmentally-friendly nanocarriers is ongoing to increase their
absorption and therapeutic potential [21].
Nanonutraceuticals are a promising tool and a new frontier for the future research in the food area,
widening the horizon of foods to a new perspective, focusing on the active substances contained in food
matrices and on complete understanding of their mechanisms of action in the body. These food-derived
novel compounds should be assessed in order to maintain their properties at the nano level to target
better bioavailability and efficacy, naturally, notwithstanding the due attention to guarantee both
safety and efficacy. Follow-up studies, as well as clinical and nutritional studies to evaluate possible
unwanted effects would be necessary, and there is a long way to go in targeting the above-mentioned
points [22–27].
The papers that make up the Special Issue cover a wide range of topics. The application of an innovative
analytical technique based on Nuclear Magnetic Resonance (NMR) experiments called Multi-Assignment
Recovered Analysis (MARA)-NMR to extra-virgin olive oil allowed the quantitative assessment of the oil’s
chemical composition, opening a wide range of applications [28].
The study of the Fatty Acid (FA) profile of wild Theba pisana, Cornu aspersum, and Eobania
vermiculata land snail samples, examined by Gas Chromatography with a Flame Ionization Detector
(GC-FID), put into evidence a high content of Polyunsaturated Fatty Acids (PUFAs), indicating their
potential as functional food constituents [29].
Foods 2020, 9, 482
The study of the native carotenoid composition in kumquat (Fortunella margarita) from Brazil
determined for the first time by a HPLC-DAD-APCI/MS (High Performance Liquid Chromatography-Diode
Array Detector-Atmospheric Pressure Chemical Ionization/Mass Spectrometry) allowed identifying and
quantifying eleven carotenoids, some present in the free form and some in their esterified form [30].
The Special Issue includes studies addressing natural compounds and essential oils. In particular,
nutmeg (Myristica fragrans) has been studied with the aim of comparing the antioxidant, antimicrobial,
and anti-inflammatory activity of the hydrolats and essential oil obtained by hydrodistillation in the
presence and absence of magnesium aluminometasilicate as an excipient [31].
The essential oil obtained from Maclura tricuspidata fruit revealed the relevant antioxidant activities
of the steam-distilled essential oil and the glycosidically-bound aglycone fraction when studied with
the Gas Chromatography–Mass Spectrometry (GC–MS) technique [32].
Functional food ingredients were exploited in the study on Uraria crinita by screening its
metabolites using immunomodulatory fractions from the root methanolic extract in combination with
bioactivity-guided fractionation and NMR-based identification [33].
Other manuscripts published in the present Special Issue evaluated the capacity of Elderberry fruit
(EDB) extract to decrease the elevated production of reactive oxygen species in hypertrophied 3T3-L1
adipocytes, evidencing a crucial role in the development of obesity and accompanying metabolic
dysfunctions [34].
A study on the sea tangle (Laminaria japonica Aresch), a brown alga, used as a functional food
ingredient in the Asia-Pacific region, allowed assessing how fermented sea tangle extract was effective
on the receptor activator of the nuclear factor-κB (NF-κB) ligand using RAW 264.7 mouse macrophage
cells [35].
In addition, another interesting study contained in the Special Issue evaluated the antioxidant and
anti-adipogenic activities of another vegetal matrix, namely a mixture of Nelumbo nucifera L., Morus
alba L., and Raphanus sativus, with a complete updated in vitro and in vivo study [36].
The anti-inflammatory potential effect of plant sterols from enriched milk-based fruit beverages
(with or without galactooligosaccharides in an experimental mouse model of chronic ulcerative colitis)
was proposed, evidencing a great beneficial effect in mice against colitis [37].
Along the same lines, another interesting paper addressed foods in traditional medicine with
antioxidant potential, in particular the assessment of the antioxidant effect of leaf extracts of Solanum
nigrum L. [38].
The topics of the Special Issue expand the horizon of food research, also examining other
applications of vegetal matrices. An example is the paper dedicated to the study of Llayta, a biomass
of the colonies of Nostoc cyanobacterium grown in the wetlands of the Andean highlands, harvested,
sun-dried, and used as an ingredient for human consumption, which revealed great potential as
a functional food ingredient due to its relevant content of essential amino acids and polyunsaturated
fatty acids [39].
The collection of papers is completed with one study addressing also industrial food applications,
especially for industries interested in replacing artificial dyes with natural pigments; cyanobacterial
phycobiliproteins as water-soluble colored proteins to be used as natural eco-sustainable pigments
were shown to have great potential in this area of interest [40].
Author Contributions: All the authors contributed equally in the conceptualization, assessment, visualization,
and writing of the text.
Conflicts of Interest: No conflicts of interest, financial or otherwise, are declared by the authors.
References
1. Ferreira, S.L.C.; Silva, M.M.; Felix, C.S.A.; da Silva, D.L.F.; Santos, A.S.; Neto, J.A.; de Souza, C.T.; Cruz, R.A., Jr.;
Souza, A.S. Multivariate optimization techniques in food analysis—A review. Food Chem. 2019, 273, 3–8.
[CrossRef] [PubMed]
Foods 2020, 9, 482
2. Zederkop Ballin, N.; Laursen, K.H. To target or not to target? Definitions and nomenclature for targeted
versus non-targeted analytical food authentication. Trends Food Sci. Technol. 2019, 86, 537–543. [CrossRef]
3. Santeramo, F.G.; Carlucci, D.; De Devitiis, B.; Seccia, A.; Stasi, A.; Viscecchia, R.; Nardone, G. Emerging
trends in European food, diets and food industry. Food Res. Int. 2018, 104, 39–47. [CrossRef] [PubMed]
4. Santini, A.; Novellino, E. Nutraceuticals: Beyond the diet before the drugs. Curr. Bioact. Compd. 2014, 10,
1–12. [CrossRef]
5. Santini, A.; Novellino, E. To Nutraceuticals and back: Rethinking a concept. Foods 2017, 6, 74. [CrossRef]
6. Santini, A.; Tenore, G.C.; Novellino, E. Nutraceuticals: A paradigm of proactive medicine. Eur. J. Pharm. Sci.
2017, 96, 53–61. [CrossRef]
7. Abenavoli, L.; Izzo, A.A.; Milić, N.; Cicala, C.; Santini, A.; Capasso, R. Milk thistle (Silybum marianum):
A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother. Res.
2018, 32, 2202–2213. [CrossRef]
8. Daliu, P.; Santini, A.; Novellino, E. A decade of nutraceutical patents: Where are we now in 2018? Expert Opin.
Ther. Pat. 2018, 28, 875–882. [CrossRef]
9. Durazzo, A.; D’Addezio, L.; Camilli, E.; Piccinelli, R.; Turrini, A.; Marletta, L.; Marconi, S.; Lucarini, M.;
Lisciani, S.; Gabrielli, P.; et al. From plant compounds to botanicals and back: A current snapshot. Molecules
2018, 23, 1844. [CrossRef]
10. Durazzo, A. Extractable and Non-extractable polyphenols: An overview. In Non-Extractable Polyphenols and
Carotenoids: Importance in Human Nutrition and Health; Saura-Calixto, F., Pérez-Jiménez, J., Eds.; Royal Society
of Chemistry: London, UK, 2018; pp. 1–37.
11. Durazzo, A.; Lucarini, M. A current shot and re-thinking of antioxidant research strategy. Braz. J. Anal. Chem.
2018, 5, 9–11. [CrossRef]
12. Santini, A.; Novellino, E. Nutraceuticals-shedding light on the grey area between pharmaceuticals and food.
Expert Rev. Clin. Pharmacol. 2018, 11, 545–547. [CrossRef]
13. Santini, A.; Cammarata, S.M.; Capone, G.; Ianaro, A.; Tenore, G.C.; Pani, L.; Novellino, E. Nutraceuticals:
Opening the debate for a regulatory framework. Br. J. Clin. Pharmacol. 2018, 84, 659–672. [CrossRef]
[PubMed]
14. Daliu, P.; Santini, A.; Novellino, E. From pharmaceuticals to nutraceuticals: Bridging disease prevention and
management. Expert Rev. Clin. Pharmacol. 2019, 12, 1–7. [CrossRef] [PubMed]
15. Durazzo, A.; Lucarini, M. Extractable and Non-extractable antioxidants. Molecules 2019, 24, 1933. [CrossRef]
16. Durazzo, A.; Lucarini, M.; Souto, E.B.; Cicala, C.; Caiazzo, E.; Izzo, A.A.; Novellino, E.; Santini, A. Polyphenols:
A concise overview on the chemistry, occurrence and human health. Phytother. Res. 2019, 33, 2221–2243.
[CrossRef] [PubMed]
17. Jeevanandam, J.; Barhoum, A.; Chan, Y.S.; Dufresne, A.; Danquah, M.K. Review on nanoparticles and
nanostructured materials: History, sources, toxicity and regulations. Beilstein J. Nanotechnol. 2018, 9,
1050–1074. [CrossRef] [PubMed]
18. Farokhzad, O.C.; Langer, R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities.
Adv. Drug Deliv. Rev. 2006, 58, 1456–1459. [CrossRef] [PubMed]
19. Watkins, R.; Wu, L.; Zhang, C.; Davis, R.M.; Xu, B. Natural product-based nanomedicine: Recent advances
and issues. Int. J. Nanomed. 2015, 10, 6055–6074.
20. Pimentel-Moral, S.; Teixeira, M.C.; Fernandes, A.R.; Arráez-Román, D.; Martínez-Férez, A.; Segura-Carretero, A.;
Souto, E.B. Lipid nanocarriers for the loading of polyphenols—A comprehensive review. Adv. Colloid Interf. Sci.
2018, 260, 85–94. [CrossRef]
21. Assadpour, E.; Jafari, S.M. A systematic review on nanoencapsulation of food bioactive ingredients and
nutraceuticals by various nanocarrier. Crit. Rev. Food Sci. Nutr. 2019, 59, 3129–3151. [CrossRef]
22. Helal, N.A.; Eassa, H.A.; Amer, A.M.; Eltokhy, M.A.; Edafiogho, I.; Nounou, M.I. Nutraceuticals’ Novel
Formulations: The Good, the Bad, the Unknown and Patents Involved. Recent Pat. Drug Deliv. Formul. 2019,
13, 105–156. [CrossRef] [PubMed]
23. Jones, D.; Caballero, S.; Davidov-Pardo, G. Bioavailability of nanotechnology-based bioactives and
nutraceuticals. Adv. Food Nutr. Res. 2019, 88, 235–273. [PubMed]
24. He, X.; Deng, H.; Hwang, H.M. The current application of nanotechnology in food and agriculture. J. Food
Drug Anal. 2019, 27, 1–21. [CrossRef] [PubMed]
Foods 2020, 9, 482
25. Das, G.; Patra, J.K.; Paramithiotis, S.; Shin, H.S. The sustainability challenge of food and environmental
nanotechnology: Current status and imminent perceptions. Int. J. Environ. Res. Public Health 2019, 16, 4848.
[CrossRef]
26. Peters, R.J.B.; Bouwmeester, H.; Gottardo, S.; Amenta, V.; Arena, M.; Brandho, P.; Marvin, H.J.P.; Mech, A.;
Moniz, F.B.; Pesudo, L.Q.; et al. Nanomaterials for products and application in agriculture, feed and food.
Trends Food Sci. Technol. 2016, 54, 155–164. [CrossRef]
27. McClements, D.J.; Xiao, H. Is nano safe in foods? Establishing the factors impacting the gastrointestinal fate
and toxicity of organic and inorganic food-grade nanoparticles. NPJ Sci. Food 2017, 1, 6. [CrossRef]
28. Rotondo, A.; La Torre, G.; Dugo, G.; Cicero, N.; Santini, A.; Salvo, A. Oleic Acid is Not the Only Relevant
Mono-Unsaturated Fatty Ester in Olive Oil. Foods 2020, 9, 384. [CrossRef]
29. Galluzzo, F.; Cammilleri, G.; Ulrici, A.; Calvini, R.; Pulvirenti, A.; Lo Cascio, G.; Macaluso, A.; Vella, A.;
Cicero, N.; Amato, A.; et al. Land Snails as a Valuable Source of Fatty Acids: A Multivariate Statistical
Approach. Foods 2019, 8, 676. [CrossRef]
30. Pinheiro-Sant’Ana, H.; Anunciação, P.; Souza, C.; de Paula Filho, G.; Salvo, A.; Dugo, G.; Giuffrida, D.
Quali-Quantitative Profile of Native Carotenoids in Kumquat from Brazil by HPLC-DAD-APCI/MS. Foods
2019, 8, 166. [CrossRef]
31. Matulyte, I.; Jekabsone, A.; Jankauskaite, L.; Zavistanaviciute, P.; Sakiene, V.; Bartkiene, E.; Ruzauskas, M.;
Kopustinskiene, D.; Santini, A.; Bernatoniene, J. The Essential Oil and Hydrolats from Myristica fragrans
Seeds with Magnesium Aluminometasilicate as Excipient: Antioxidant, Antibacterial, and Anti-inflammatory
Activity. Foods 2020, 9, 37. [CrossRef]
32. Yong, G.R.; Gebru, Y.A.; Kim, D.W.; Kim, D.-H.; Han, H.A.; Kim, Y.H.; Kim, M.K. Chemical Composition
and Antioxidant Activity of Steam-Distilled Essential Oil and Glycosidically Bound Volatiles from Maclura
Tricuspidata Fruit. Foods 2019, 8, 659. [CrossRef] [PubMed]
33. Tu, P.; Chan, C.; Liu, Y.; Kuo, Y.; Lin, M.; Lee, M. Bioactivity-Guided Fractionation and NMR-Based
Identification of the Immunomodulatory Isoflavone from the Roots of Uraria crinita (L.) Desv. ex DC. Foods
2019, 8, 543. [CrossRef] [PubMed]
34. Zielińska-Wasielica, J.; Olejnik, A.; Kowalska, K.; Olkowicz, M.; Dembczyński, R. Elderberry (Sambucus nigra
L.) Fruit Extract Alleviates Oxidative Stress, Insulin Resistance, and Inflammation in Hypertrophied 3T3-L1
Adipocytes and Activated RAW 264.7 Macrophages. Foods 2019, 8, 326. [CrossRef]
35. Jeong, J.; Ji, S.; Lee, H.; Hong, S.; Kim, G.; Park, C.; Lee, B.; Park, E.; Hyun, J.; Jeon, Y.; et al. Fermented Sea
Tangle (Laminaria japonica Aresch) Suppresses RANKL-Induced Osteoclastogenesis by Scavenging ROS in
RAW 264.7 Cells. Foods 2019, 8, 290. [CrossRef] [PubMed]
36. Sim, W.; Choi, S.; Cho, B.; Choi, S.; Han, X.; Cho, H.; Kim, S.; Lee, B.; Kang, I.; Cho, J.; et al. Anti-Obesity Effect
of Extract from Nelumbo Nucifera L., Morus Alba L., and Raphanus Sativus Mixture in 3T3-L1 Adipocytes
and C57BL/6J Obese Mice. Foods 2019, 8, 170. [CrossRef]
37. López-García, G.; Cilla, A.; Barberá, R.; Alegría, A.; Recio, M. Effect of a Milk-Based Fruit Beverage Enriched
with Plant Sterols and/or Galactooligosaccharides in a Murine Chronic Colitis Model. Foods 2019, 8, 114.
[CrossRef]
38. Campisi, A.; Acquaviva, R.; Raciti, G.; Duro, A.; Rizzo, M.; Santagati, N. Antioxidant Activities of Solanum
nigrum L. Leaf Extracts Determined in In Vitro Cellular Models. Foods 2019, 8, 63. [CrossRef]
39. Rivera, M.; Galetović, A.; Licuime, R.; Gómez-Silva, B. A Microethnographic and Ethnobotanical Approach
to Llayta Consumption among Andes Feeding Practices. Foods 2018, 7, 202. [CrossRef]
40. Galetović, A.; Seura, F.; Gallardo, V.; Graves, R.; Cortés, J.; Valdivia, C.; Núñez, J.; Tapia, C.; Neira, I.;
Sanzana, S.; et al. Use of Phycobiliproteins from Atacama Cyanobacteria as Food Colorants in a Dairy
Beverage Prototype. Foods 2020, 9, 244. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Land Snails as a Valuable Source of Fatty Acids: A
Multivariate Statistical Approach
Francesco Giuseppe Galluzzo 1 , Gaetano Cammilleri 1,2, *, Alessandro Ulrici 2 , Rosalba Calvini 2 ,
Andrea Pulvirenti 2 , Giovanni Lo Cascio 1 , Andrea Macaluso 1,2 , Antonio Vella 1 , Nicola Cicero 3 ,
Antonella Amato 4 and Vincenzo Ferrantelli 1,2
1 Istituto Zooprofilattico Sperimentale della Sicilia, via Gino Marinuzzi 3, 90129 Palermo, Italy;
francescogiuseppe92@gmail.com (F.G.G.); giovanni.locascio71@gmail.com (G.L.C.);
andrea.macaluso@izssicilia.it (A.M.); laboratorio.residui@gmail.com (A.V.);
vincenzo.ferrantelli@izssicilia.it (V.F.)
2 Dipartimento di Scienze della Vita, Università degli studi di Modena e Reggio Emilia, Via Università 4,
41121 Modena, Italy; alessandro.ulrici@unimore.it (A.U.); rosalba.calvini@unimore.it (R.C.);
andrea.pulvirenti@unimore.it (A.P.)
3 Dipartimento SASTAS, Università degli studi di Messina, Polo Universitario dell’Annunziata,
98168 Messina, Italy; ncicero@unime.it
4 Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di
Palermo, Viale delle Scienze, 90128 Palermo, Italy; antonella.amato@unipa.it
* Correspondence: gaetano.cammilleri86@gmail.com; Tel.: +39-328-8048262
Abstract: The fatty acid (FA) profile of wild Theba pisana, Cornu aspersum, and Eobania vermiculata
land snail samples, collected in Sicily (Southern Italy), before and after heat treatment at +100 ◦ C
were examined by gas chromatography with a flame ionization detector (GC-FID). The results show
a higher content of polyunsaturated fatty acids (PUFAs) in all of the examined raw snails samples,
representing up to 48.10% of the total fatty acids contents, followed by monounsaturated fatty acids
(MUFAs). The thermal processing of the snail samples examined determined an overall reduction of
PUFA levels (8.13%, 7.75%, and 4.62% for T. pisana, C. aspersum and E. vermiculata samples, respectively)
and a species-specific variation of saturated fatty acid (SFA) contents. Oleic acid remained the most
abundant FA of all of the snails species examined, accounting for up to 29.95% of the total FA content.
A relevant decrease of Ñ3/Ñ6 ratio was found only for T. pisana samples. The principal component
analysis (PCA) showed a separation of the snail samples in terms of species and heat treatment.
The results of this work suggest land snails as a valuable source of MUFA and PUFA contents and
boiling as appropriate treatment, according to the maintenance of healthy properties.
Keywords: fatty acids; land snails; GC-FID; heat processing; principal component analysis
1. Introduction
Terrestrial gastropods, commonly named land snails, constitute a niche food product traditionally
appreciated by many European countries, especially France and Italy. The use of land snails as food
is still steadily growing, and 26,000 tons of snails were imported from Africa and countries in the
Middle East [1]. Cornu aspersum, Eobania vermiculata, and Theba pisana are the land snail species most
consumed in Italy [2]. Land snails are consumed in different ways all over the world, but the principal
cooking procedures recognized are roasting and boiling, according to the traditions of the countries.
According to Milinsk et al. [3], there is a correlation between land snails’ diet and their nutritional
values. Recently, increasing attention was paid to the fatty acid composition, due to nutritional and
health-related aspects [4–8]. However, few studies are available about the fatty acid (FA) profile in
land snails [3,9,10] and, as far as we know, no data have been reported regarding the fatty acid profile
of T. pisana. Snails are commonly consumed in different ways after boiling due to the risk posed by the
possible presence of potentially pathogenic microorganisms [2]. The cooking temperature can influence
the nutritional aspect of mollusks [11]. At present, there are too few studies about the influence of heat
processing (such as boiling) on the nutritional composition of land snails.
In this context, the present work aimed at evaluating the fatty acids content of wild C. apsersum,
T. pisana, and E. vermiculata samples collected in Sicily (Southern Italy). Furthermore, the effect of
boiling on the fatty acid composition was evaluated to have a comprehensive nutritional evaluation of
this product after processing.
Figure 1. Scheme of the cooking process of the land snails samples collected.
2.3. Extraction of Fatty Acids and Gas Chromatography with a Flame Ionization Detector (GC-FID) Analysis
An amount of 10 ± 0.1 g of each pool of samples was placed in a glass of polypropylene and
mixed with diatomaceous earth (Sigma-Aldrich, Amsterdam, Holland). The mixture was transferred in
Foods 2019, 8, 676
an accelerated solvent extraction (ASE) ASE 200 cell (Thermo Fisher, Waltham, Massachusetts,
USA). The ASE operating conditions were set up as follows: 20 mL of hexane/acetone, 70:30;
extraction temperature 120 ◦ C for 6 min with a pressure of 120 pound per square (PSI).
The extract was filtered (size 240 nm) and dehydrated in rotavapor (Büchi, Flawil, Switzerland) at
+40 ◦ C. For the preparation of FAME, 100 mg of the oil extracted was trans-esterified in a pyrex tube by
using 2 mL of HCl/MeOH (2:98 v/v) to obtain the fatty acid methyl esters (FAMEs). The solution was
mixed in a vortex for 1 min and put in the oven at 120 ◦ C for 1 h. After cooling, 2 mL of bidistilled water
and 1 mL of hexane were added, and the mixture was centrifuged at 300 rpm for 1 min. Approximately
1 mL of the upper n-hexane phase was transferred in a vial and injected in gas chromatography (GC)
with a flame ionization detector (FID).
Each pool of samples was examined in triplicate by GC-FID analysis. The analysis was carried
out by a Trace GC/ULTRA HP 5890 GC + 7673 A/S (Thermo Fisher, Waltham, Massachusetts, USA);
a Famexax column (30m × 0.25 mm i.d. × 0.25 μm df) was used for the separation. A flame ionization
detector (FID) and ChromQuest 4.2.1 software (Thermo Fisher Scientific, Waltham, Massachusetts,
USA)were used for the qualification and quantification of the analytes. The injector port and the
detector temperatures were 220 ◦ C and 230 ◦ C, respectively. The split ratio was 1:20. The flow rates of
compressed air and hydrogen were 350 mL min−1 and 35 mL min–1 , respectively. The carrier gas was
helium (1.5 mL min−1 ). The oven temperature was programmed at a rate of 6.0 ◦ C min−1 from 130 to
225 ◦ C, held for 15 s.
Individual FAME was identified by comparison with the chromatographic behavior of authentic
standards by the formula:
TR = TR st ± 0.5 (1)
where TR is the determined retention time (min), and TR st is the retention time for each FA standard.
The relative percentages of the fatty acids were also determined. Quantitation of individual FAs is thus
based on the comparison of their peak areas (Ai), and the peak area of a suitable standard. The relative
percentages of fatty acids (C) were determined by the formula:
A
C = 100 (2)
A
where Fa% is the variation (expressed as a percentage), Fab and Faraw are the fatty acid content in boiled
and raw samples, respectively (expressed as mg/100 g).
Before calculating the principal component analysis (PCA) model, the erucic acid variable was
removed from statistical analysis because its presence was found only in raw T. pisana samples. All of the
variables were pre-treated by Pareto scaling [18,19], in order to have a compromise between highlighting
Foods 2019, 8, 676
the contribution of the most abundant analytes and keeping at the same time the information brought
by the less abundant ones. The PCA model was calculated using the software PLS-Toolbox ver. 8.6
(Eigenvector Research Inc., Wenatchee, WA, USA), running in the MATLAB environment (ver. 9.3, The
Mathworks Inc., Natick, MA, USA).
3. Results
Table 1. Fatty acids contents (mean ± SD; g/100 g FA) in fat extracted from the land snails species
examined (n = 3 replicates of each pool of samples). SFA = Saturated fatty acids, MUFA = monounsatured
fatty acids, PUFA = polyunsaturated fatty acids.
Among the SFA, palmitic acid (C16:0) was the most abundant in all of the samples examined
(from 12.63 to 16.02 g/100 g), followed by stearic acid (5.41–7.66 g/100 g). The SFA profiles in all of
the species consisted of C14:0 (ranging from 0.73 to 0.81 g/100 g), C16:0 (12.63–16.02 g/100 g), C17:0
(1.02–1.36 g/100 g), C18:0 (5.41–7.72 g/100 g), C20:0 (0.63–0.81 g/100 g), and C22:0 (0.31–0.64 g/100 g).
The raw T. pisana samples showed the highest ω3/ω6 ratio (0.58), followed by E. vermiculata (0.55)
and C. aspersum (0.43).
Figure 2. PC1 vs. PC2 score (a) and loading (b) plots of FA contents of the land snail samples examined,
according to the species and treatment (raw vs. boiled).
The score plot shows differences related both to species and to heat treatment. PC1 describes a
decrease in the number of fatty acids for each species after boiling. The variation is more marked for
the T. pisana samples, which in general show the highest amount of unsaturated fatty acids (UFAs).
In fact, both raw and boiled T. pisana samples lie at positive values of PC1, whereas all E. vermiculata
and C. aspersum samples lie at negative values of PC1; this is due to the fact that, notwithstanding the
significant decrease of FA content, boiled T. pisana still has a UFA content higher than raw E. vermiculata
and raw C. aspersum. These last two samples have essentially the same overall amount of FAs and
boiling leads to a more marked decrease for C. aspersum than for E. vermiculata.
T. pisana shows an opposite trend compared to the two other species considering the position
along PC2 of the samples before and after boiling. Recalling that the percentage of variance explained
by PC2 (3.93%) is much lower than the percentage of variance explained by PC1 (93.89%), PC2 accounts
for the differences between the different species in the variations of the FA compositions after boiling,
beyond the overall decrease, explained by PC1.
These variations of the FA profile can be examined more in-depth by means of the corresponding
loading plot reported in Figure 2b. In this plot, the variables that are far from the origin contributed to
the systematic variability explained by the PCA model, whereas variables close to the origin (like, e.g.,
C17:1, C14:0, C20:2, C20:1, C22:6, etc.) did not show a systematic trend.
The significant variations after boiling for all of the three species examined are related to PUFA,
MUFA, oleic acid, SFA, and linoleic acid, which show higher PC1 values. PC2 showed a different
variation of the fatty acid contents between the T. pisana samples and the other two species. A more
considerable variation of eicosapentaenoic (C20:5) acid, MUFA, and oleic acid was found for T. pisana
samples, whereas E. vermiculata and C. aspersum showed a more significant variation of SFA, linoleic acid,
palmitic acid, and linolenic acid.
Foods 2019, 8, 676
4. Discussion
Fatty acids are ubiquitous molecules in biological systems. They play several roles in metabolism,
as structural components in membrane lipids, and as precursors of some molecules like prostaglandins
and eicosanoids [20]. The dietary intake in favor of PUFA and MUFA instead of SFA is correlated to a
significant minor risk of cardiovascular disease (CDV) and can lead to health benefits [21]. Fatty acids
are a minor nutritional parameter of snail meat [4,9,10]. However, all of the raw snail samples examined
in this work showed a low SFA content, in accordance to what was reported by Szkucik et al. [10] in
farmed C. aspersum samples from Poland, but in contrast to what was found in wild Helix pomatia
samples from Southern Turkey [9].
According to the literature, the factors of critical importance for the snail meat FA profile are
the snail genus and its collection site. Interspecies differences in fatty acid composition were also
confirmed in this work for the MUFA contents. In particular, the T. pisana raw meat samples showed
C20:5 contents up to 16 times higher than C. aspersum and E. vermiculata samples; these differences
could be due to the different ecological aspects of the species examined. It is well known that T. pisana
is an agricultural pest in many parts of the world [21,22], feeding on a wide range of agricultural
plants, including cereals with high UFA contents [14,23]. Differently from T. pisana, C. aspersum
and E. vermiculata appear to be selective polyphagous organisms, preferring plants of the Poaceae
family [12,24,25]. Other studies have confirmed how the feeding regimen would affect the fatty acid
composition [4], verifying significant variations of MUFA contents related to the increase of soybean
oil as feed supply in reared C. aspersum samples. Feeds that include corn, sunflower, or soybean rich in
ω6 acids were shown to increase the content of these FAs in meat.
Nevertheless, the wild snail samples examined in this work showed high contents of UFA,
constituting up to 79% of the total fatty acids. The level of PUFA in edible snails was found to be higher
than SFA and MUFA, according to what was found in Helix lucorum and Limax flavus [26]. Our results
are contrary to what was reported by Ekin et al. [27] in free-living Melanopsis praemorsa snails of
Anatolia (Turkey) that showed a lower level of UFA and higher SFA contents. Essential fatty acids such
as linoleic acid, α linolenic acid, docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) were
determined. These fatty acids show protection effects against cardiovascular disease [28,29]; however,
the current intakes of EPA and DHA in European populations appear to be below the recommended
daily allowance (RDA) [29].
The thermal processing of the snail samples analyzed determined an overall reduction of PUFA
levels and a species-specific variation of MUFA and SFA contents, in contrast to what was found by
Szkucik et al. [10] in farmed C. aspersum samples from Poland, verifying a significant increase of the SFA
levels. The PUFA amounts of the samples analyzed decreased up to 7.98%, with a significant decrease
of the C 20:5 contents in T. pisana samples. Nevertheless, PUFA remained the principal component,
accounting for 44% of the total fatty acid contents in all of the species examined.
Among the MUFA, oleic acid (C18:1) remained the most abundant fatty acid of all of the snails
species examined, even after heat processing.
Regarding the SFA contents, our results appear to comply with what was reported by
Purwaningsih et al. [11] in mollusk muscles, showing that the SFA composition depends primarily on
the snail species, rather than the way of cooking. The heat treatment of T. pisana samples determined a
decrease of Ñ3/Ñ6 ratio from 0.58 to 0.3, reaching a value lower than the minimal ratio recommended
by the WHO [30]. However, the heat treatment allowed obtaining a total degradation of toxic fatty
acid as the erucic acid. Animal tests showed that the ingestion of oils containing erucic acid could lead
to a heart disease called myocardial lipidosis. Other potential effects observed in animals (changes in
liver, kidney, and skeletal muscle weight) occur at slightly higher doses.
Contrary to what was found by Szkucik et al. [10], the C. aspersum samples examined in this work
showed a considerable decrease of the relative amounts of SFA after heat treatment, favoring an increase
of the relative amounts of MUFA. The E. vermiculata samples showed a similar behavior of C. aspersum
samples after heat treatment, showing a decrease of 8.72% for SFA and 4.66% for PUFA, and an increase
Foods 2019, 8, 676
of the amounts of MUFA. A reduced PUFA content could be caused by the autoxidation mechanisms
initiated by temperature rise in meat during it is cooking [10,31]. Furthermore, these modifications
appear to be related to the process temperature, the cooking time, and the internal temperature reached
by the meat [31–34].
Principal component analysis allowed to depict the significant sources of variability of the dataset
analyzed using two Principal Components (PCs), which showed a clear separation of the land snail
samples according to species and heat treatment. The high percentage of variance explained by PC1
(93.89%) reflects the fact that the investigated variables were highly correlated, showing a general
decrease due to heat treatment; this variation was much more pronounced for T. pisana than for the
species C. aspersum and E. vermiculata. The highest variation after heat treatment common to all the
three species was related to PUFA, MUFA, oleic acid, and linoleic acid.
5. Conclusions
To the best of our knowledge, this work reports, for the first time, the fatty acid composition
of T. pisana samples and their variation as a result of heat processing, and the first time of fatty acid
composition in E. vermiculata, T. pisana, and C. aspersum collected in Sicily (Southern Italy). The results
showed a species-specific variation of FA contents in the land snails samples examined after boiling,
showing the highest UFA decrease in T. pisana samples.
The results demonstrate that the land snail species examined could be a good source of MUFA and
PUFA and their contents are species-specific. Boiling could be an adequate cooking procedure for land
snail consumption according to retained nutritional and healthy criteria (PUFA contents and ω-6/ω-3
ratio). Furthermore, the boiling process can safeguard consumers against potentially pathogenic
microorganisms. Given that boiling losses seem to be related to cooking time and temperature,
further studies are needed to find the best cooking condition in order to preserve the best nutritional
composition criteria of land snails.
Author Contributions: Conceptualization, F.G.G. and G.C.; methodology, F.G.G., A.M. and G.C.; validation, A.M.,
A.A., N.C. and G.L.C.; formal analysis F.G.G. and G.C.; investigation, A.P., A.U. and N.C.; data curation, A.U., R.C.,
G.C. and F.G.G.; writing—original draft preparation, F.G.G. and G.C.; writing—review and editing N.C., A.P., A.A.,
V.F. and A.V.; visualization, V.F. and A.A.; supervision, V.F.; project administration, V.F.; funding acquisition, V.F.
Funding: This research was funded by MINISTERO DELLA SALUTE, grant number RC IZS SI 16/15.
Acknowledgments: The authors thank Barbara Randisi for the technical support.
Conflicts of Interest: The authors declare no conflicts of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to
publish the results.
References
1. Pellati, R. Lumache e Consumi. Available online: http://www.fosan.it/notiziario/31_lumache_e_consumi.html
(accessed on 4 November 2019).
2. Cicero, A.; Giangrosso, G.; Cammilleri, G.; Macaluso, A.; Currò, V.; Galuppo, L.; Vargetto, D.; Vicari, D.;
Ferrantelli, V. Microbiological and Chemical Analysis of Land Snails Commercialised in Sicily. Ital. J. Food Saf.
2015, 4, 2. [CrossRef] [PubMed]
3. Milinsk, M.C.; das Graças Padre, R.; Hayashi, C.; de Oliveira, C.C.; Visentainer, J.V.; de Souza, N.E.;
Matsushita, M. Effects of feed protein and lipid contents on fatty acid profile of snail (Helix aspersa maxima)
meat. J. Food Compos. Anal. 2006, 19, 212–216. [CrossRef]
4. Alasalvar, C.; Pelvan, E.; Topal, B. Effects of roasting on oil and fatty acid composition of Turkish hazelnut
varieties (Corylus avellana L.). Int. J. Food Sci. Nutr. 2010, 61, 630–642. [CrossRef] [PubMed]
5. Ayas, D.; Ozogul, Y.; Ozogul, İ.; Uçar, Y. The effects of season and sex on fat, fatty acids and protein contents
of Sepia officinalis in the northeastern Mediterranean Sea. Int. J. Food Sci. Nutr. 2012, 63, 440–445. [CrossRef]
6. Özogul, Y.; Özogul, F.; Çiçek, E.; Polat, A.; Kuley, E. Fat content and fatty acid compositions of 34 marine
water fish species from the Mediterranean Sea. Int. J. Food Sci. Nutr. 2009, 60, 464–475. [CrossRef]
Foods 2019, 8, 676
7. Tangolar, S.G.; Özoğul, Y.; Tangolar, S.; Torun, A. Evaluation of fatty acid profiles and mineral content of
grape seed oil of some grape genotypes. Int. J. Food Sci. Nutr. 2009, 60, 32–39. [CrossRef]
8. Tokuşoğlu, Ö. The quality properties and saturated and unsaturated fatty acid profiles of quail egg:
The alterations of fatty acids with process effects. Int. J. Food Sci. Nutr. 2006, 57, 537–545. [CrossRef]
9. Özogul, Y.; Özogul, F.; Olgunoglu, A.I. Fatty acid profile and mineral content of the wild snail (Helix pomatia)
from the region of the south of the Turkey. Eur. Food Res. Technol. 2005, 221, 547–549. [CrossRef]
10. Szkucik, K.; Ziomek, M.; Paszkiewicz, W.; Drozd, Ł.; Gondek, M.; Knysz, P. Fatty acid profile in fat obtained
from edible part of land snails harvested in Poland. J. Vet. Res. 2018, 62, 519–526. [CrossRef]
11. Purwaningsih, S.; Suseno, S.H.; Salamah, E.; Mulyaningtyas, J.R.; Dewi, Y.P. Effect of boiling and steaming
on the profile fatty acids and cholesterol in muscle tissue of molluscs. Int. Food Res. J. 2015, 22, 1087–1094.
12. Lazaridou-Dimitriadou, M.; Kattoulas, M.E. Energy flux in a natural population of the land snail Eobania
vermiculata (Müller) (Gastropoda: Pulmonata: Stylommatophora) in Greece. Can. J. Zool. 1991, 69, 881–891.
[CrossRef]
13. Nicolai, A. The Impact of Diet Treatment on Reproduction and Thermophysiological Processes in the Land
Snails Cornu Aspersum and Helix Pomatia. Ph.D. Thesis, Universität Bremen, Bremen, Germany, 2010.
14. Odendaal, L.J.; Haupt, T.M.; Griffiths, C.L. The alien invasive land snail Theba pisana in the West Coast
National Park: Is there cause for concern? Koedoe 2008, 50, 93–98. [CrossRef]
15. Bertino, E.; Giribaldi, M.; Baro, C.; Giancotti, V.; Pazzi, M.; Peila, C.; Tonetto, P.; Arslanoglu, S.; Moro, G.E.;
Cavallarin, L.; et al. Effect of prolonged refrigeration on the lipid profile, lipase activity, and oxidative status
of human milk. J. Pediatr. Gastroenterol. Nutr. 2013, 56, 390–396. [CrossRef] [PubMed]
16. Taverniers, I.; De Loose, M.; Van Bockstaele, E. Trends in quality in the analytical laboratory. I. Traceability
and measurement uncertainty of analytical results. TrAC Trends Anal. Chem. 2004, 23, 480–490. [CrossRef]
17. Pantano, L.; Cascio, G.L.; Alongi, A.; Cammilleri, G.; Vella, A.; Macaluso, A.; Cicero, N.; Migliazzo, A.;
Ferrantelli, V. Fatty acids determination in Bronte pistachios by gas chromatographic method. Nat. Prod. Res.
2016, 30, 2378–2382. [CrossRef]
18. Raimondi, S.; Luciani, R.; Sirangelo, T.M.; Amaretti, A.; Leonardi, A.; Ulrici, A.; Foca, G.; D’Auria, G.;
Moya, A.; Zuliani, V.; et al. Microbiota of sliced cooked ham packaged in modified atmosphere throughout
the shelf life: Microbiota of sliced cooked ham in MAP. Int. J. Food Microbiol. 2019, 289, 200–208. [CrossRef]
19. van den Berg, R.A.; Hoefsloot, H.C.; Westerhuis, J.A.; Smilde, A.K.; van der Werf, M.J. Centering, scaling,
and transformations: Improving the biological information content of metabolomics data. BMC Genom. 2006,
7, 142. [CrossRef]
20. Ekin, İ. A comparative study on fatty acid content of main organs and lipid classes of land snails Assyriella
escheriana and Assyriella guttata distributed in southeastern Anatolia. Ital. J. Food Sci. 2015, 27, 75–81.
21. Baker, G.H. The Biology and Control of White Snails (Mollusca: Helicidae), Introduced Pests in Australia;
Commonwealth Scientific and Industrial Research Organization: Melbourne, Australia, 1986.
22. Baker, G.H. Damage, Population Dynamics, Movement and Control of Pest Helicid Snails in Southern Australia;
Commonwealth Scientific and Industrial Research Organization: Melbourne, Australia, 1989; pp. 175–185.
23. Cowie, R.H. The Life-Cycle and Productivity of the Land Snail Theba pisana (Mollusca: Helicidae). J. Anim. Ecol.
1984, 53, 311–325. [CrossRef]
24. Chevalier, L.; Coz, M.; Charrier, M. Influence of inorganic compounds on food selection by the brown garden
snail Cornu aspersum (Müller) (Gastropoda: Pulmonata). Malacologia 2003, 45, 125–132.
25. Chevalier, L.; Desbuquois, C.; Le Lannic, J.; Charrier, M. Poaceae in the natural diet of the snail Helix aspersa
Müller (Gastropoda, Pulmonata). Comptes Rendus de l’Académie des Sci.-Series III-Sci. de la Vie 2001, 324, 979–987.
[CrossRef]
26. Ekin, I.; Şeşen, R. Investigation of the Fatty Acid Contents of Edible Snails Helix lucorum, Eobania vermiculata
and Non-Edible Slug Limax flavus. Rec. Nat. Prod. 2017, 11, 562–567. [CrossRef]
27. Ekin, İ.; Başhan, M.; Şeşen, R. Possible seasonal variation of the fatty acid composition from Melanopsis
praemorsa (L., 1758) (Gastropoda: Prosobranchia), from southeast Anatolia, Turkey. Turk. J. Biol. 2011, 35,
203–213.
28. Harper, P.C. Breeding biology of the fairy prion (Pachyptila turtur) at the Poor Knights Islands, New Zealand.
N. Z. J. Zool. 1976, 3, 351–371. [CrossRef]
Foods 2019, 8, 676
29. Givens, D.I.; Gibbs, R.A. Current intakes of EPA and DHA in European populations and the potential of
animal-derived foods to increase them: Symposium on ‘How can the n-3 content of the diet be improved?’.
Proc. Nutr. Soc. 2008, 67, 273–280. [CrossRef] [PubMed]
30. WHO. Diet, Nutrition, and the Prevention of Chronic Diseases: Report of A WHO-FAO Expert Consultation;
[Joint WHO-FAO Expert Consultation on Diet, Nutrition, and the Prevention of Chronic Diseases, 2002, Geneva,
Switzerland]; WHO technical report series; Expert Consultation on Diet, Nutrition, and the Prevention of
Chronic Diseases, Weltgesundheitsorganisation, FAO, Eds.; World Health Organization: Geneva, Switzerland,
2003; ISBN 978-92-4-120916-8.
31. Weber, J.; Bochi, V.C.; Ribeiro, C.P.; Victório, A.D.M.; Emanuelli, T. Effect of different cooking methods on the
oxidation, proximate and fatty acid composition of silver catfish (Rhamdia quelen) fillets. Food Chem. 2008,
106, 140–146. [CrossRef]
32. Alfaia, C.M.M.; Alves, S.P.; Lopes, A.F.; Fernandes, M.J.E.; Costa, A.S.H.; Fontes, C.M.G.A.; Castro, M.L.F.;
Bessa, R.J.B.; Prates, J.A.M. Effect of cooking methods on fatty acids, conjugated isomers of linoleic acid and
nutritional quality of beef intramuscular fat. Meat Sci. 2010, 84, 769–777. [CrossRef]
33. Domínguez, R.; Gómez, M.; Fonseca, S.; Lorenzo, J.M. Influence of thermal treatment on formation of
volatile compounds, cooking loss and lipid oxidation in foal meat. LWT-Food Sci. Technol. 2014, 58, 439–445.
[CrossRef]
34. Rasinska, E.; Rutkowska, J.; Czarniecka-Skubina, E.; Tambor, K. Effects of cooking methods on changes in
fatty acids contents, lipid oxidation and volatile compounds of rabbit meat. LWT 2019, 110, 64–70. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Quali-Quantitative Profile of Native Carotenoids in
Kumquat from Brazil by HPLC-DAD-APCI/MS
Helena Maria Pinheiro-Sant’Ana 1 , Pamella Cristine Anunciação 1 , Clarice Silva e Souza 1 ,
Galdino Xavier de Paula Filho 2 , Andrea Salvo 3, *, Giacomo Dugo 3 and Daniele Giuffrida 3
1 Departamento de Nutrição e Saúde, Universidade Federal de Viçosa, Avenida P.H. Rolfs, s/n,
Viçosa 36571-000, Brazil; helena.santana@ufv.br (H.M.P.-S.); nutripamella@gmail.com (P.C.A.);
cla_souzabio@yahoo.com.br (C.S.e.S.)
2 Departamento de Educação, Universidade Federal do Amapá, Rodovia Juscelino Kubitschek, Km 02,
Jardim Marco Zero, Macapá 68903-419, Brazil; galdinoxpf@gmail.com
3 Department, of Biomedical and Dental Sciences and Morphofunctional Imaging, University of
Messina (Italy), V.le Annunziata, 98168 Messina, Italy; dugog@unime.it (G.D.); dgiuffrida@unime.it (D.G.)
* Correspondence: asalvo@unime.it; Tel.: +39-090-676-6880
Abstract: In this study the native carotenoids composition in kumquat (Fortunella margarita) (peel +
pulp) from Brazil was determined for the first time by a HPLC-DAD-APCI/MS (high performance liquid
chromatography-diode array detector-atmospheric pressure chemical ionization/mass spectrometry),
methodology. Eleven carotenoids were successfully identified and quantified in kumquat: four
carotenoids in the free form and seven carotenoids in the esterified form. β-citraurin-laurate
was the carotenoid found in the highest content (607.33 μg/100 g fresh matter), followed by
β-cryptoxanthin-laurate (552.59 μg/100 g). The different esterified forms of β-citraurin and
β-cryptoxanthin represented 84.34% of the carotenoids found, which demonstrates the importance
of esterification in natural fruits. β-carotene and free xanthophylls (β-cryptoxanthin, lutein and
zeaxanthin) represented 5.50% and 14.96%, respectively, of total carotenoids in kumquat. The total
carotenoid content of kumquat from Brazil was very high (2185.16 μg/100 g), suggesting that this fruit
could contribute significantly to the intake of important bioactive compounds by the population.
1. Introduction
The citrus family is one of the first crops in the world, it is estimated that half of the marketed
production comes from the Americas and 12% comes from the Mediterranean basin. Citrus cultivation
is thought to date back at least 4000 years and is mainly from the Asiatic south-east territories.
The estimated global citrus traffic for 2017–2018 was around 6 million tons. The most representative
cultures were Citrus sinensis (61%), Citrus reticulata (22%), Citrus limon (11%) and Citrus paradisi (6%).
In the Americas, the primacy of citrus production lies with Brazil followed by the United States. Sweet
oranges are grown in Brazil, mainly in the state of São Paulo, over an area of about 584000 hectares,
but also in the Amazonas area of northern Brazil, over about 2.7 hectares. [1].
The Citrus japonica, known by the common names of kincan (from Japanese kinkan) or cunquate
(from Chinese kumquat), is a small citrus fruit of the Rutaceae family [2]. It has four major cultivated
types, including Fortunella japonica, Fortunella margarita, Fortunella crassifolia, and Fortunella hindsii [3].
In eastern countries, this fruit is a part of the regular food habits of the population [4], but in Brazil
it is considered exotic, in addition to being little known and commercialized. Among the Brazilian
states, São Paulo has the largest production and commercialization of this fruit [5].
Kumquats are native to Central China. They are oval or round fruits with peel and orange smooth.
Its flavor varies from acid to sweet. The fruit is rich in vitamins, carotene, pectin, calcium, phosphorus,
iron and flavonoids [6]. Kumquats are consumed preferably in natura, whole and in shell. It is also
used to make jellies, mousse, jams, marmalades, liqueurs and cachaça [7], preparation of syrups, sauces
and also, accompaniment in fruit salads and for landscaping purposes and ornamentation [8,9].
Citrus japonica has been used as a traditional folk medicine in Asian countries to reduce alcohol
intoxication and as antidepressants, so they are used either as medicines or as edible fruit [10]. Many
studies on antioxidant, antimicrobial and antitumor effects have been carried out on kumquats,
however identification of the bioactive compounds in the fruit has received little attention [11].
The most elucidated chemical components in kumquat described in the literature are phenolics
compounds and flavonoids. Different phenolic compounds and flavonoids are described in Fortunella sp.
by HPLC-MS [12,13]. These studies have shown a higher concentration of phenolics in fruit peels, with
luteolin and kaempferol being the main flavonoids found in Fortunella sp. [8,14–17].
Studies on carotenoids in kumquat are extremely limited [9,18–20]. Agócs et al. [18] studied the
qualitative and quantitative composition of carotenoids of kumquat and other citrus species. However,
the sample preparation of the carotenoids involved a saponification step, a procedure that does not
allow us to evaluate the native composition of the carotenoids.
Studies on the composition of carotenoids in foods are very important because they participate in
various biological processes in plants, such as photosynthesis, photomorphogenesis, photoprotection,
and development [21]. In animals, provitamin A carotenoids play an essential role in the synthesis
of retinol (vitamin A) [22], whereas the xanthophylls lutein and zeaxanthin have been associated in
humans with the prevention of age-ralated eye degenerations [23,24].
Carotenoids are molecules made up of a long chain of usually forty carbon atoms; they can by
divided into two classes: (a) non oxygenated one named carotenes [25] and (b) oxygenated one named
xanthophylls [26]. Moreover, the xanthophylls are usually esterified with fatty acids in nature.
The studies on the content of carotenoids in kumquats concern plants grown in Asia but data
are not available for fruits harvested in Brazil [18,19]. Therefore, this work aimed to determine the
complete qualitative and quantitative profile of the kumquat carotenoid native composition for fruits
collected in the rural area of Viçosa, Minas Gerais, Brazil, through liquid chromatography coupled to
the mass detector (HPLC-DAD-APCI-MS).
2.1. Chemicals
The standards of β-carotene, β-cryptoxanthin, lutein, zeaxanthin and physalein, Standard purity
was above 98% were purchased from Extrasynthese (Genay, France), and the solvents MeOH (Methanol),
MTBE (Methyl-t-butyl ether) and H2 O (Water) from Sigma-Aldrich (Milan, Italy).
The samples were transported from the harvest site to the laboratory protected in styrofoam
boxes with blocks of ice, within two hours after collection. In the laboratory, the samples were selected
for appearance, excluding those with any epidermis injury or mechanical damage due to transport.
The fruits were removed from the seeds (peel + pulp) were homogenized in a food processor (RI 7625,
Philips, São Paulo Brazil), lyophilized (Liotop-LP510, Liobras, São Carlos, Brazil) and stored in plastic
containers with screw caps, covered with aluminum foil stored at −18 ± 1 ◦ C until further analyses.
Figure 1. Kumquat (whole fruit and cross-section) from Viçosa, Minas Gerais, Brazil.
20AC column oven and an SPD-M20A photo diode array detector. The data were processed with the
Labsolution software. For MS analysis a mass spectrometer detector (LCMS-8040) was used, equipped
with an APCI (atmospheric pressure chemical ionization) interface, both in positive and negative
ionization mode.
The column used was YMC C30 (250 mm × 4.6 mm × 5 μm); the mobile phases: MeOH/MTBE/H2O
(81:15:4, solvent A), MeOH/MTBE/H2O (6:90:4, solvent B); the linear gradient used was: 0–100% B
from 0 to 140 min. The column temperature was maintained at 30 ◦ C. The flow was 0.8 mL/min and
the injection volume was 20 μL.
The UV-Vis spectra were acquired in the range 220–700 nm, while the chromatograms were
extracted at 450 nm (sampling frequency: 4.16 Hz, time constant: 0.64 s). The MS was set up as follows:
Scan, both APCI positive (+) and negative (-); atomized gas flow (N2): 2.0 L/min; drying gas flow:
5 L/min; Time of the event: 0.06 s; range m/z: 300–1200; interface temperature: 350 ◦ C; Desolvation line
(DL) temperature: 300 ◦ C; thermal block: 300 ◦ C. The samples were analyzed in triplicate.
Figure 2. Chromatographic profile of native carotenoids of kumquat from Brazil: peel + pulp.
Identification of the compounds are in Table 1.
Foods 2019, 8, 166
Table 1. Compounds identification for Figure 2 (kumquat from Brazil: peel + pulp).
Figure 3. UV-Vis (PDA) and mass spectrum (APCI negative) of β-citraurin-laurate (A) and β-citraurin-
myristate (B) of kumquat from Brazil.
Moreover, both the molecular ions [M]−• at respectively m/z 614 and m/z 642 relative to the
β-citraurin-laurate and β-citraurin-myristate esters, obtained in the negative APCI mode, are also
clearly shown in the same figure. Eleven different carotenoids were identified in kumquat from Brazil;
four different β-citraurin esters and three β-cryptoxanthin esters were identified.
The predominant carotenoids were β-citraurin-laurate and β-cryptoxanthin-laurate, both esterified
with lauric acid. The chemical structures of these carotenoids are shown in Figure 4. Interestingly, no
free β-citraurin was detected in the present study.
Foods 2019, 8, 166
Shirra et al. [9] detected only 4 carotenoids in kumquat from Italy without saponification
(β-carotene, β-cryptoxanthin, lutein and zeaxanthin), which were also detected in the present study.
In contrast to our study, Agos et al. [18] reported only β-citraurin and β-cryptoxanthin in the free form
in kumquat from Hungary. However, these researchers used saponification after the extraction process
and did not quantify the carotenoid esters. Saponification may result in destruction or structural
transformation of carotenoids [31]. Huyskens et al. [19] studied the qualitative composition of kumquat
carotenoids from Israel by thin-layer chromatography and reported several carotenoids, including
β-citraurin, β-cryptoxanthin, lutein, β-carotene and zeaxanthin which were, also determined in the
present study. In addition, Huyskens et al. [19] reported that violaxanthin was the predominant
component in kumquat from Israel, whereas in our study β-citraurin-laurate was the major component.
Esterification with saturated fatty acids improves the stability of xanthophylls such as β-citraurin
and β-cryptoxanthin against heat and UV light, but does not affect their antioxidant activity [32].
During the storage and processing of the fruits the xanthophyll esters were more stable than the free
xanthophyll [33]. The pigment β-citraurin is responsible for the citrus reddish color, it derives from
of β-cryptoxanthin or zeaxanthin and accumulates in some citrus varieties [34,35]. In these fruits,
the accumulation of β-citraurin is not a common event, it is observed only in the flavedos of some
varieties during fruit ripening [34]. Frutita, a tropical fruit from Panama, showed a very high content
of β-citraurin [36].
Recent studies have shown that β-cryptoxanthin and β-citraurin esterified with lauric acid,
myristic acid and palmitic acid are found in the Mandarin Satsuma, [35].
The dietary intake of β-cryptoxanthin has been shown to prevent and reduce some pathologies
such as: cancer, diabetes and rheumatism due to its antioxidant activity [37–39]. Breithaupt et al. [40]
have verified that in chili, papaya, peach and persimmon, β-cryptoxanthin is mainly esterified with
saturated fatty acids. Furthermore, the bioavailability of β-cryptoxanthin esters is comparable to
the non-esterified form, since fatty acids can be effectively hydrolyzed by β-cryptoxanthin esters
before intestinal absorption in the human body [40]. In several citrus varieties, the esterified form
β-citraurin is found [35]. As already observed in another study [41], we have found β-cryptoxanthin
and β-citraurin in both free and esterified forms.
found. The different forms of β-citraurin (4 components esterified with fatty acids) and β-cryptoxanthin
(1 component in free form and 3 in esterified form) represented 84.34% of the carotenoids found in
kumquat from Brazil. Forms of β-citraurin and β-cryptoxanthin esterified with fatty acids accounted
for 79.54% of the total carotenoids in kumquat. These results show the importance of the study of the
intact carotenoids composition in different matrices (Table 2).
β-carotene was found in smaller amounts (120.19 μg/100 g fresh matter), representing 5.50% of total
carotenoids in kumquat, as well as free xanthophylls (β-cryptoxanthin, lutein and zeaxanthin), which
represented 14.96% of total carotenoids (326.96 μg/100 g) (Table 2). β-carotene and β-cryptoxanthin
possess provitamin A activity, playing a key role in human health [42]. Differently from our results,
Wang et al. [20] reported that β-cryptoxanthin was the major carotenoid present in kumquat cultivated
in Taiwan, while Schirra et al. [9] found lutein to be the major carotenoid present in kumquat from Italy.
Schirra et al. [9] found a lower concentration, in fresh matter, of β-carotene (33 μg/100 g),
β-cryptoxanthin (26 μg/100 g), lutein (44 μg/100 g) and zeaxanthin (24 μg/100 g) in kumquat from
Italy when compared to the concentrations of these carotenoids in kumquat from Brazil, reported
here for the first time. Wang et al. [41] found contents in dry matter that were much lower than
reported here, for lutein (9.9 μg/100 g), zeaxanthin (10.4 μg/100 g), β-cryptoxanthin (183 μg/100 g) and
β-carotene (131 μg/100 g) in kumquat cultivated in Taiwan. Carotenoid composition and contents in
fruits can be influenced by genetic factors, geographical regions, fruit processing, storage methods
Giuffrida et al. [25] and environmental conditions Lu et al. [26], which can explain the differences
found in these studies. Besides the climatic factors, the irrigation, soil conditions, fertilizers and
herbicides may also affect the carotenoids accumulation [26]. Regarding the carotenoids content in
food, Britton [43] have proposed the following classification ranges: low: 0–0.1 mg/100 g; moderate:
0.1–0.5 mg/100 g; high: 0.5-2 mg/100 g; very high: >2 mg/100 g. Thus, the total carotenoid content of
kumquat from Brazil was very high (2185.16 μg/100 g).
4. Conclusions
In this study the native carotenoids composition in kumquat (Fortunella margarita) from Brazil was
determined for the first time. Eleven native carotenoids in kumquat from the rural area of Minas Gerais,
Brazil were successfully identified and quantified by HPLC-DAD-APCI-MS. Four carotenoids in the
free form (β-carotene, β-cryptoxanthin, lutein and zeaxanthin) and 7 carotenoids in the esterified form
were identified (β-citraurin-caproate, β-citraurin-laurate, β-citraurin-myristate, β-citraurin-palmitate,
β-cryptoxanthin-laurate, β-cryptoxanthin-myristate, β-cryptoxanthin-palmitate). β-citraurin-laurate
and β-cryptoxanthin-laurate were the most abundant native carotenoids in kumquat from Brazil. The
Foods 2019, 8, 166
total carotenoid content of kumquat from Brazil was high (2185.16 μg/100 g), suggesting that this fruit
can contribute significantly to the ingestion of important bioactive compounds.
References
1. Instituto Brasileiro de Geografia e Estatística. Pesquisa de Orçamentos Familiares; Ministério da Saúde: Rio de
Janeiro, Brasília, 2009.
2. The Plant List. Available online: http://www.theplantlist.org/tpl/record/kew-2724150 (accessed on 15 May 2019).
3. Ogawa, K.; Kawasaki, A.; Omura, M.; Yoshida, T.; Ikoma, Y.; Yano, M. 3 ,5 -Di-C-β-glucopyranosylphloretin,
a flavonoid characteristic of the genus Fortunella. Phytochemistry 2001, 57, 737–742. [CrossRef]
4. Pompeu Junior, J. Rootstocks and scions in the citriculture of the São Paulo State; In Proceedings of
International Congress of Citrus Nurserymen, Ribeirão Preto, Brasil, 2001; pp. 75–82.
5. Watanabe, H.S.; De Oliveira, S.L. Comercialização de frutas exóticas. Revista Brasileira de Fruticultura 2014,
36, 23–38. [CrossRef]
6. Barreca, D.; Bellocco, E.; Caristi, C.; Leuzzi, U.; Gattuso, G. Kumquat (Fortunella japonica Swingle) juice:
Flavonoid distribution and antioxidant properties. Food. Res. Int. 2011, 44, 2190–2197. [CrossRef]
7. Koller, O.L. Citricultura Catarinense; Epagri: Florianópolis, Brazil, 2013.
8. Kawaii, S.; Tomono, Y.; Katase, E.; Ogawa, K.; Yano, M. Quantitation of flavonoid constituents in citrus fruits.
J. Agric. Food Chem. 1999, 47, 3565–3571. [CrossRef]
9. Schirra, M.; Palma, A.; D’Aquino, S.; Angioni, A.; Minello, E.V.; Melis, M.; Cabras, P. Influence of postharvest
hot water treatment on nutritional and functional properties of kumquat (Fortunella japonica Lour. Swingle Cv.
Ovale) fruit. J. Agric. Food Chem. 2007, 56, 455–460. [CrossRef]
10. Liu, Y.; Liu, Y.; Liu, Y.; Liu, H.; Shang, Y. Evaluating effects of ellagic acid on the quality of kumquat fruits
during storage. Sci. Hortic. 2018, 227, 244–254. [CrossRef]
11. Lou, S.N.; Ho, C.T. Phenolic compounds and biological activities of small-size citrus: Kumquat and
calamondin. J. Food Drug Anal. 2017, 25, 162–175. [CrossRef] [PubMed]
12. Lou, S.N.; Lai, Y.C.; Hsu, Y.S.; Ho, C.T. Phenolic content, antioxidant activity and effective compounds of
kumquat extracted by different solvents. Food Chem. 2016, 197, 1–6. [CrossRef] [PubMed]
13. Lou, S.N.; Lai, Y.C.; Huang, J.D.; Ho, C.T.; Ferng, L.H.A.; Chang, Y.C. Drying effect on flavonoid composition
and antioxidant activity of immature kumquat. Food Chem. 2015, 171, 356–363. [CrossRef] [PubMed]
14. Chen, M.H.; Yang, K.M.; Huang, T.C.; Wu, M.L. Traditional small-size citrus from Taiwan: Essential oils,
bioactive compounds and antioxidant capacity. Medicines 2017, 4, 28. [CrossRef]
15. Salvo, A.; Bruno, M.; La Torre, G.L.; Vadalà, R.; Mottese, A.F.; Saija, E.; Mangano, V.; Casale, K.E.; Cicero, N.;
Dugo, G. Interdonato lemon from Nizza di Sicilia (Italy): Chemical composition of hexane extract of lemon
peel and histochemical investigation. Nat. Prod. Res. 2016, 30, 1517–1525. [CrossRef]
16. Salvo, A.; Costa, R.; Albergamo, A.; Arrigo, S.; Rotondo, A.; La Torre, G.L.; Mangano, V.; Dugo, G. An in-depth
study of the volatile variability of chinotto (Citrus myrtifolia Raf.) induced by the extraction procedure.
Eur. Food Res. Technol. 2019. [CrossRef]
17. Costa, R.; Salvo, A.; Rotondo, A.; Bartolomeo, G.; Pellizzeri, V.; Saija, E.; Arrigo, S.; Interdonato, M.; Trozzi, A.;
Dugo, G. Combination of separation and spectroscopic analytical techniques: Application to compositional
analysis of a minor citrus species. Nat. Prod. Res. 2018, 32, 2596–2602. [CrossRef] [PubMed]
18. Agócs, A.; Nagy, V.; Szabó, Z.; Márk, L.; Ohmacht, R.; Deli, J. Comparative study on the carotenoid composition
of the peel and the pulp of different citrus species. Innov. Food. Sci. Emerg. Technol. 2007, 8, 390–394. [CrossRef]
Foods 2019, 8, 166
19. Huyskens, S.; Timberg, R.; Gross, J. Pigment and plastid ultrastructural changes in Kumquat (Fortunella
margarita) «Nagami» during ripening. J. Plant. Physiol. 1985, 118, 61–72. [CrossRef]
20. Wang, Y.C.; Chuang, Y.C.; Ku, Y.H. Quantitation of bioactive compounds in citrus fruits cultivated in Taiwan.
Food Chem. 2007, 102, 1163–1171. [CrossRef]
21. Nisar, N.; Li, L.; Lu, S.; Khin, N.C.; Pogson, B.J. Carotenoid metabolism in plants. Mol. Plant 2015, 8, 68–82.
[CrossRef] [PubMed]
22. Krinsky, N.I.; Johnson, E.J. Carotenoid actions and their relation to health and disease. Mol. Aspects Med.
2005, 26, 459–516. [CrossRef] [PubMed]
23. Fiedor, J.; Burda, K. Potential role of carotenoids as antioxidants in human health and disease. Nutrients
2014, 6, 466–488. [CrossRef]
24. Johnson, E.J.; Krinsky, N.I. Carotenoids and coronary heart disease. In Carotenoids; Springer: Basel, Switzerland,
2009; pp. 287–300.
25. Giuffrida, D.; Dugo, P.; Salvo, A.; Saitta, M.; Dugo, G. Free carotenoid and carotenoid ester composition in
native orange juices of different varieties. Fruits 2010, 65, 277–284. [CrossRef]
26. Lu, Q.; Huang, X.; Lv, S.; Pan, S. Carotenoid profiling of red navel orange “Cara Cara” harvested from five
regions in China. Food Chem. 2017, 232, 788–798. [CrossRef]
27. Donadio, L.C. Dicionário das Frutas; UNESP: Jaboticabal, Brazil, 2007.
28. The Angiosperm Phylogeny Group. An update of the Angiosperm Phylogeny Group classification for the
orders and families of flowering plants: APG IV. Bot. J. Linn. Soc. 2016, 181, 1–20.
29. Association of Official Analytical Chemists (AOAC). Official Methods of Analysis of the Association of Official
Analytical Chemists, 18th ed.; Association of Official Analytical Chemists: Washington, DC, USA, 2010.
30. Rodriguez-Amaya, D. Food Carotenoids: Chemistry, Biology and Technology; John Wiley & Sons: Hoboken, NZ,
USA, 2015.
31. Amorim-Carrilho, K.; Cepeda, A.; Fente, C.; Regal, P. Review of methods for analysis of carotenoids. Trends.
Analyt. Chem. 2014, 56, 49–73. [CrossRef]
32. Fu, H.; Xie, B.; Fan, G.; Ma, S.; Zhu, X.; Pan, S. Effect of esterification with fatty acid of β-cryptoxanthin on its
thermal stability and antioxidant activity by chemiluminescence method. Food Chem. 2010, 122, 602–609.
[CrossRef]
33. Bunea, A.; Socaciu, C.; Pintea, A. Xanthophyll esters in fruits and vegetables. Not. Bot. Horti Agrobot. Cluj
Napoca 2014, 42, 310. [CrossRef]
34. Ma, G.; Zhang, L.; Iida, K.; Madono, Y.; Yungyuen, W.; Yahata, M.; Yamawaki, K.; Kato, M. Identification
and quantitative analysis of β-cryptoxanthin and β-citraurin esters in Satsuma mandarin fruit during the
ripening process. Food Chem. 2017, 234, 356–364. [CrossRef]
35. Ma, G.; Zhang, L.; Matsuta, A.; Matsutani, K.; Yamawaki, K.; Yahata, M.; Wahyudi, A.; Motohashi, R.;
Kato, M. Enzymatic formation of β-citraurin from β-cryptoxanthin and zeaxanthin by carotenoid cleavage
dioxygenase4 in the flavedo of citrus fruit. Plant Physiol. 2013, 163, 682–695. [CrossRef]
36. Murillo, E.; Giuffrida, D.; Menchaca, D.; Dugo, P.; Torre, G.; Meléndez-Martinez, A.J.; Mondello, L. Native
carotenoids composition of some tropical fruits. Food Chem. 2013, 140, 825–836. [CrossRef]
37. Iskandar, A.R.; Liu, C.; Smith, D.E.; Hu, K.Q.; Choi, S.W.; Ausman, L.M.; Wang, X.D. β-Cryptoxanthin
restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis
and emphysema in A/J mice. Cancer Prev. Res. 2012, 6, 309–320. [CrossRef] [PubMed]
38. Takayanagi, K.; Morimoto, S.I.; Shirakura, Y.; Mukai, K.; Sugiyama, T.; Tokuji, Y.; Ohnishi, M. Mechanism of
visceral fat reduction in Tsumura Suzuki obese, diabetes (TSOD) mice orally administered β-cryptoxanthin
from Satsuma mandarin oranges (Citrus unshiu Marc). J. Agric. Food Chem. 2011, 59, 12342–12351. [CrossRef]
[PubMed]
39. Yamaguchi, M. Role of carotenoid β-cryptoxanthin in bone homeostasis. J. Biomed. Sci. 2012, 19, 36. [CrossRef]
[PubMed]
40. Breithaupt, D.E.; Weller, P.; Wolters, M.; Hahn, A. Plasma response to a single dose of dietary β-cryptoxanthin
esters from papaya (Carica papaya L.) or non-esterified β-cryptoxanthin in adult human subjects: A comparative
study. Br. J. Nutr. 2003, 90, 795–801. [CrossRef] [PubMed]
41. Wada, Y.; Matsubara, A.; Uchikata, T.; Iwasaki, Y.; Morimoto, S.; Kan, K.; Ookura, T.; Fukusaki, E.; Bamba, T.
Investigation of β-cryptoxanthin fatty acid ester compositions in citrus fruits Cultivated in Japan. Food Nutr.
Sci. 2013, 4, 98.
Foods 2019, 8, 166
42. Mercadante, A.Z.; Rodrigues, D.B.; Petry, F.C.; Mariutti, L.R.B. Carotenoid esters in foods-A review and
practical directions on analysis and occurrence. Food Res. Int. 2017, 99, 830–850. [CrossRef] [PubMed]
43. Britton, G.; Khachik, F. Carotenoids in food. In Carotenoids; Britton, G., Pfander, H., Liaaen-Jensen, S., Eds.;
Springer: Basel, Switzerland, 2009.
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Chemical Composition and Antioxidant Activity of
Steam-Distilled Essential Oil and Glycosidically
Bound Volatiles from Maclura Tricuspidata Fruit
Gyung-Rim Yong, Yoseph Asmelash Gebru, Dae-Woon Kim, Da-Ham Kim, Hyun-Ah Han,
Young-Hoi Kim and Myung-Kon Kim *
Department of Food Science and Technology, Chonbuk National University, Jeonju 54896, Jeonbuk, Korea;
rudfla1226@naver.com (G.-R.Y.); holden623@naver.com (Y.A.G.); eodns3344@gmail.com (D.-W.K.);
dadaham@naver.com (D.-H.K.); hha208@Korea.kr (H.-A.H.); yhoi1307@hanmail.net (Y.-H.K.)
* Correspondence: kmyuko@jbnu.ac.kr; Tel.: +82-63-270-25512
Abstract: Essential oil obtained from Maclura triscuspidata fruit has been reported to have functional
properties. This study aimed at determining chemical compositions and antioxidant activities of
steam-distilled essential oil (SDEO) and glycosidically bound aglycone fraction (GBAF) isolated from
fully ripe M. triscuspidata fruit. SDEO was isolated by simultaneous steam distillation and extraction
(SDE). GBAF was prepared by Amberlite XAD-2 adsorption of methanol extract, followed by methanol
elution and enzymatic hydrolysis. Both fractions were analyzed by gas chromatography–mass
spectrometry (GC–MS). A total of 76 constituents were identified from both oils. Apart from fatty acids
and their esters, the SDEO contained p-cresol in the highest concentration (383.5 ± 17.7), followed by
δ-cadinene (147.7 ± 7.7), β-caryophyllene (145.7 ± 10.5), β-ionone (141.0 ± 4.5), n-nonanal (140.3 ± 20.5),
theaspirane A (121.3 ± 4.5) and theaspirane B (99.67 ± 9.05 μg/g). Thirteen carotenoid-derived
compounds identified in the SDEO are being isolated from M. triscuspidata fruit for the first time.
Out of the 22 components identified in GBAF, 14 were present only in the glycosidically bound
volatiles. Antioxidant activity of the GBAF was higher than that of SDEO. These results suggest that
glycosidically bound volatiles of M. triscuspidata fruit have a good potential as natural antioxidants.
Keywords: Maclura triscuspidata fruit; essential oil; glycosidically bound volatiles; gas chromatography-mass
spectroscopy (GC–MS); chemical composition; antioxidant activity
1. Introduction
Plant-derived essential oils are complex mixtures of volatile and semi-volatile organic compounds
characterized by diverse odors and chemical compositions depending on their origins. They are
traditionally obtained from various plant tissues including fruits, seed, leaves, flowers, roots, woods
and barks by means of hydrodistillation, steam distillation, solvent extraction or cold pressing [1,2].
Due to their organoleptic and biological properties, essential oils have been used as flavoring agents
and natural preservatives in foods since ancient times [3]. More recently, essential oils and some of
their isolated components are increasingly being used in various commercial products such as foods,
cosmetics, perfumes, household cleaning products and hygiene products, and medicinal applications [2].
These compounds have been reported to have various biological activities including antimicrobial,
antioxidant, antiviral, antiplatelet, antithrombotic, antiallergic, anti-inflammatory, antimutagenic, and
anticarcinogenic properties [4–6].
Lipid oxidation causes serious problems in foods by producing unpleasant flavors, discoloration,
decreasing nutritional quality and safety of foods through due to production of secondary oxidation
products that have harmful effects on human health [7]. The use of essential oils as natural antioxidants
is a field of growing interest because of the fact that synthetic antioxidants such as butylated
hydroxyanisole (BHA) and butylated hydroxyltoluene (BHT) have been suspected of causing liver
damage and carcinogenesis when used at high levels in laboratory animals [8–11]. For this reason,
their use in the food industry has recently declined owing to safety concerns and consumer demand
for natural products.
Maclura tricuspidata (Carr.) Bur. (formerly known as Cudrania tricuspidata) which belongs to the
Moraceae family is a thorny tree native to East Asia including China, Japan and Korea. The leaves, root,
stem and fruit of this plant have been used in traditional herbal medicines to treat jaundice, hepatitis,
neuritis and inflammation in Korea [12]. Several beneficial effects of M. tricuspidata extracts have been
reported including anticancer [13,14], anti-inflammatory [15], antioxidant [16,17], and antidiabetes
effects [18]. Various bioactive compounds such as prenylated xanthones, phenolic acids and flavonoids
have already been identified from its leaves, root, stem and fruit [19–21].
The ripe fruits of Maclura tricuspidata which have a bright red color are edible with a floral
aroma and sweet taste. They have traditionally been used to prepare fresh juice, jam, wine, vinegar
and fermented alcoholic beverages in Korea. Previous studies have reported that the extracts and
components of M. tricuspidata fruits have strong antioxidant and free radical-scavenging activities in
an in vitro system [22,23]. The antioxidant activity of M. tricuspidata fruit extract is associated with
the presence of phenolic compounds such as flavonoids and phenolic acids [17,24]. We have recently
identified 18 polyphenolic compounds among which five parishin derivatives (gastrodin, parishin
A, B, C, E) identified for the first time in the fruit and confirmed their anti-oxidant potentials [25].
Essential oil obtained from the fruit by microwave-assisted hydrodistillation has also been reported
to have antioxidant activity through 2,2-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide, hydroxy
and superoxide radical scavenging activities [26]. Recently, Bajpai and colleaques [26] identified 29
compounds as major constituents in the essential oil isolated from M. tricuspidata fruit. Although the
chemical compositions and their antioxidant activities of essential oils from the stem and root of M.
tricuspidata were elucidated [26,27], the information on the chemical composition and antioxidant
activity of the essential oil of M. tricuspidata fruit is still very poor. Furthermore, it is known that
some volatile compounds in plants are present either in a free form and glycosidically bound forms
to sugar moiety [28,29]. In some plants, glycosidically bound volatiles have shown a more potent
antioxidant activity than essential oils [30,31]. Nevertheless, little is known about chemical constituents
and their antioxidant potentials of glycosidically bound aglycones in M. tricuspidata fruit. Therefore,
the objective of this study was to elucidate the chemical composition of steam-distilled essential oils
(SDEO), aglycone fraction and major compounds of aglycone fraction liberated from glycosidically
bound volatiles (GBAF) in M. tricuspidata fruit and their antioxidant potentials.
2.1. Reagents
n-Decanol, n-decyl-β-d-glucopyranoside, Amberlite XAD-2 polymeric resin (20–60 mesh), butylated
hydroxyanisole (BHA), butylated hydroxy toluene (BHT), ascorbic acid, 2,2-diphenyl-1-picrylhydrazyl
(DPPH), 2,2 -azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 2,4,6-tri(2-pyridyl)-
s-triazine (TPTZ) and saturated n-alkanes mixture (C7 –C30 ), were purchased from Sigma-Aldrich
Corp. (St. Louis, MO, USA). Authentic volatile chemicals were purchased from commercial sources
(Sigma-Aldrich and Wako Pure Chemical Industries, Ltd., Osaka, Japan). The other reagents used were
of analytical grade and were purchased from commercial sources.
of Agricultural Life Science, Chonbuk National University. The fruit was freeze-dried for 4 day. The
samples were powdered and stored in a freezer (−20 ◦ C) until use.
(30 m × 0.32 mm, i.d., 0.25 μm film thickness), respectively. Both column temperatures were
programmed from 50 ◦ C to 230 ◦ C at 2 ◦ C per minute and then kept constant at 230 ◦ C for 20 min.
The injector and ion source temperatures were 250 ◦ C. The carrier gas was helium at a flow rate of
1.0 mL/min. Identification of the compounds was achieved by comparing their retention times with
those of authentic standards and mass spectral data in Wiley7n,1 database (Hewlett-Packard, Palo Alto,
CA, USA), and NIST (National Institute of Standards and Technology, USDA) Webbook, and reported
retention indices in the literatures [36]. Retention indices of each compound was calculated by a
homologous series of saturated n-alkanes (C7 –C30 ) (concentration of 1000 μg/mL in n-hexane) under
the same conditions [37]. All compounds identified based on comparisons of only mass spectral data
were listed as tentatively identified.
where A0 and A1 are absorbance values of the test sample and control, respectively.
Foods 2019, 8, 659
ABTS free radical scavenging activity was determined by the methods of Thaipong et al. [39] with
some modifications. Briefly, a mixture of ABTS (7.4 mM) solution and potassium persulfate (2.6 mM)
solution in 1:1 ratio was kept at room temperature for 12 h under dark condition to form ABTS cation.
The solution was diluted by adding methanol to obtain an absorbance of 1.1 ± 0.02 at 734 nm. All the
required solutions were freshly prepared for each assay. 100 μL of the samples and chemicals were
added to 1400 μL of the diluted ABTS solution and the mixture was incubated at room temperature for
2 h in a dark. After the reaction, its absorbance was measured at wavelength of 734 nm. The results
were expressed as RC50 value (μg/mL), and also ABTS radical scavenging activity (%) was calculated
with the following equation:
where A0 and A1 are absorbance values of the test sample and control, respectively.
SDEO GBAF
Alcohols
1 5.363 2-Methyl-1-butanol 737 1206 3.03 ± 0.25 1036.0 ± 124.6
5 7.735 trans-2-Hexen-1-ol 862 1405 7.33 ± 1.53 − 5)
8 10.318 5-Methyl-2-furfuryl alcohol 956 − 4) 3.17 ± 0.76 -
20 19.585 3,4-Dimethylcyclohexanol 6) 1109 - 15.67 ± 2.08 -
Aldehydes and ketones
3 6.644 Furfural 819 1459 53.67 ± 6.03 -
4 7.378 trans-2-Hexenal 848 1201 10.33 ± 3.06 -
2 6.284 n-Hexanal 804 1097 3.00 ± 0.80 -
7 8.777 2-Acetyl furan 903 1493 5.33 ± 1.53 -
9 10.513 5-Methylfufural 966 1508 4.13 ± 0.81 -
10 12.102 Benzaldehyde 971 1508 6.33 ± 1.53 -
11 12.491 6-Methyl-5-hepten-2-one 989 1326 6.33 ± 1.53 -
12 13.267 1-(2-Furanyl)-3-butanone 6) 1006 - 4.03 ± 0.55 -
16 15.179 Phenylacetaldehyde 1039 1629 44.33 ± 3.51 5.33 ± 1.04
18 18.958 n-Nonanal 1104 1388 140.3 ± 20.5 -
23 22.487 10-Undecenal 6) 1146 - 6.67 ± 2.52 -
24 23.306 2,4-Dimethylbenzaldehyde 6) 1158 1712 7.03 ± 1.55 -
44 41.734 Genanyl acetone 1451 1860 17.33 ± 2.52 -
52 44.505 2-Tridecanone 1493 - 23.67 ± 5.51 -
Terpenoids
36 35.657 Ylangene 1356 1464 10.93 ± 3.10 -
37 36.379 α-Copaene 1368 1477 62.33 ± 51.47 -
41 39.05 β-Caryophyllene 1409 1565 145.7 ± 10.5 -
43 39.533 α-Bergamotene 1416 1575 5.67 ± 0.58 -
45 41.982 β-Humulene 1454 - 10.33 ± 2.52 -
53 45.905 δ-Cadinene 1517 1754 147.7 ± 7.5 -
58 50.101 Caryophyllene oxide 1588 1968 56.33 ± 3.51 -
Table 1. Cont.
Carotenoid-derived compounds
14 15.079 2,2,6-Trimethylcyclohexanone 6) 1037 1300 5.57 ± 0.51 -
19 19.303 Isophorone 1119 1578 7.10 ± 1.85 -
22 21.727 4-Oxoisophorone 6) 1115 1674 5.33 ± 0.58 -
28 26.163 β-Cyclocitral 1214 1603 17.10 ± 1.85 -
29 28.870 β-Homocyclocitral 6) 1254 - 15.10 ± 0.85 -
31 31.253 Theaspirane A 1289 1482 121.3 ± 4.5 -
33 32.447 Theaspirane B 1306 1522 99.67 ± 9.02
42 39.454 7,8-Dihydro-α-ionone 6) 1415 1825 - 30.33 ± 2.52
48 43.389 β-Ionone 1480 1907 141.0 ± 4.4 -
49 43.637 β-Ionone epoxide 1483 1957 92.33 ± 9.71 -
55 46.692 Dihydroactinidiolide 6) 1530 2291 10.67 ± 5.51 -
59 56.486 3-Hydroxy-β-ionone 6) 1698 2646 - 160.7 ± 30.0
60 57.969 9-Hydroxymegastigma-4,6-dien-3-one (isomer #1) 6) 1705 2677 - 197.67 ± 9.45
61 58.525 4-Oxo-7,8-dihydro-β-ionol 1725 2694 - 76.00 ± 11.00
63 61.311 9-Hydroxymegastigma-4,6-dien-3-one (isomer #2) 6) 1786 2846 - 234.3 ± 24.5
Aromatic and phenolic compounds
15 15.292 Benzyl alcohol 1040 1864 - 883.7 ± 29.8
17 18.294 p-Cresol 1092 2074 393.5 ± 17.7 43.00 ± 7.55
21 19.694 2-Phenylethyl alcohol 1113 1892 - 58.85 ± 4.58
26 25.427 Pyrocatechol 7) 1203 2646 - 20.33 ± 5.51
30 31.225 Resorcinol 1288 - - 57.33 ± 10.50
32 31.523 Carvacrol 1293 2213 19.37 ± 3.46 -
34 34.006 α-Methoxy-p-cresol 7) 1331 2490 - 2783.0 ± 143.0
35 34.981 p-Vinylguaiacol 1346 2181 - 17.33 ± 3.51
25 24.925 Methyl chavicol 1171 1658 66.67 ± 9.02 -
38 37.539 2,4,6-Trihydroxybenzaldehyde 1386 - 9.33 ± 1.53 -
39 38.473 p-Hydroxybenzyl alcohol 7) 1400 2952 17.67 ± 3.06 468.1 ± 30.9
40 38.977 p-Hydroxybenzaldehyde 7) 1408 2964 - 170.0 ± 19.5
46 42.529 Tyrosol 7) 1463 2969 - 68.67 ± 4.51
47 43.524 p-Methylsalicylaldehyde 7) 1478 - 43.00 ± 10.82 4088.0 ± 147.8
50 44.116 Methyl p-hydroxybenzoate 7) 1487 1969 - 289.3 ± 12.5
51 44.439 Vanillyl alcohol 7) 1492 - - 30.67 ± 3.27
54 46.293 p-Hydroxybenzoic acid 7) 1523 - - 20.33 ± 4.51
Table 1. Cont.
Figure 2. Cont.
Foods 2019, 8, 659
Figure 2. Chemical structures of aromatic and phenolic compounds identified in glycosidically bound
aglycone fraction (GBAF) isolated from M. tricuspidata fruit. Numbers in brackets indicate peak
numbers as listed in Table 1.
Figure 3. Total phenol contents of fractions isolated from M. tricuspidata fruit. SDEO, steam-distilled
essential oil; FV, free volatile; GBAF, glycosidically bound aglycone fraction liberated from GBV by Asp.
niger cellulose; GBV, glycosidically bound volatile fraction.
extensively demonstrated in the literature, some of the volatile compounds exclusively detected in the
GBAF might also have greatly contributed to its considerable antioxidant capacity observed in this
study. It should also be noticed that the volatile aroma components detected in higher concentrations
in the GBAF including p-Hydroxybenzyl alcohol, p-hydroxybenzaldehyde and tyrosol are well known
to have strong biological activities [56–58]. However, while antioxidant activity estimations based
on synthetic radicals are indispensable tools, many people raise concerns about their substantiation
through in vivo and clinical trials which also have more safety issues [59].
Figure 4. Antioxidant activities of steam-distilled essential oil (SDEO), free volatile (FV) and glycosidically
bound aglycone fraction (GBAF) isolated from M. tricuspidata fruit. (a) 2,2-Diphenyl-1-Picrylhydrazyl
(DPPH) free radical scavenging activity, (b) 2,2 -Azino-Bis(3-Ethylbenzothiazoline-6- Sulfonic Acid (ABTS)
free radical scavenging activity; (c) Ferric reducing antioxidant power (FRAP). Samples, 1000 ug/mL;
* Butylated hydroxyltoluene BHA, Butylated hydroxyanisole (BHT), 200 ug/mL.
Foods 2019, 8, 659
Table 2. Antioxidant activity of SDEO, FV and GBAF isolated from M. tricuspidata fruit.
Even though antioxidant activity of the SDEO was found to be much lower than the other fractions,
it is suggested that its observed antioxidant property is related to the compounds detected in it.
Compounds such as palmitic acid, linoleic acid and p-cresol that were detected in relatively higher
concentrations in the SDEO are not important antioxidants [60,61]. Generally, the antioxidant capacity
of volatile compound fractions from M. triscuspidata fruit extracted with the SDE method and that of
GBAF are attributed to the individual components identified. The antioxidant activities expressed in
EC50 of some individual phenolic compounds evaluated in this study are also presented in Table 3.
Based on these results, it can be suggested that as most potent bioactive compounds are glycosidically
bound forms in M. triscuspidata fruit, enzymatic processing like fermentation can play an important
role in enhancing its biological activities.
EC50 (μg/mL)
Compounds
DPPH 1 ABTS 1 FRAP 2
Pyrocatechol 9.59 ± 1.22 e 67.68 ± 2.47 jk 74.45 ± 2.16 jk
α-Methoxy-p-cresol 1114.09 ± 114.45 d 59.55 ± 6.46 jk 3298.92 ± 126.20 f
p-Hydroxybenzyl alcohol 3357.55 ± 134.15 c 377.85 ± 4.78 f 2854.37 ± 43.04 g
p-Hydroxybenzaldehyde 1765.90 ± 364.23 d 1117.70 ± 7.01 c 7906.18 ± 60.96 c
Tyrosol 1331.74 ± 195.63 d 287.36 ± 3.70 g 92.64 ± 1.97 jk
p-Methylsalicylaldehyde 1644.14 ± 365.52 d 423.69 ± 3.13 e 19,365.27 ± 81.38 b
Methyl p-hydroxybenzoate 5241.03 ± 941.54 b 12,735.03 ± 47.26a 6789.61 ± 82.27 d
Vanillyl alcohol 27.96 ± 1.65 e 66.98 ± 1.99 jk 5928.60 ± 90.87 e
p-Hydroxybenzoic acid 10,906.51 ± 1103.69 a 6921.86 ± 50.48 b 1116.61 ± 11.69 h
Vanillic acid 48.58 ± 2.50 e 157.22 ± 4.83 h 161.18 ± 4.25 jk
Methyl caffeate 11.92 ± 0.48 e 11.91 ± 1.29 l 7.84 ± 0.28 k
Ferulic acid 24.47 ± 2.59 e 66.39 ± 2.11 jk 138.98 ± 3.73 jk
BHA 26.10 ± 0.42 e 89.27 ± 4.01 ij 129.46 ± 1.61 jk
BHT 33.71 ± 1.04 e 108.76 ± 3.93 i 331.26 ± 4.68 j
1 EC50 (μg/mL) values were calculated from the regression lines using six different concentrations (10–100 μg/mL) in
triplicate and data represent 50% scavenging activity. 2 FRAP were calculated from the regression lines curve using
six different concentrations (10–100 μg/mL) of authentic standards in triplicate and the values were presented by
sample concentration at 0.5 of absorbance at 517 nm. Different superscripts in the same column indicate significant
differences (p < 0.05).
antioxidants BHA and BHT. As can be seen from Table 3, several phenolic compounds including
pyrocatechol, vanillyl alcohol, methyl caffeate and ferulic acid have shown antioxidant potencies higher
than that of positive controls. Ferulic acid and methyl caffeate, the two compounds that showed the
highest DPPH-scavenging activities in this study, have been previously reported to have antioxidant
activities expressed in EC50 of DPPH scavenging activity of 22 and 10.64 μg/mL for ferulic acid methyl
caffeate, respectively [50,62].
Therefore, it can be assumed that these compounds have greatly contributed to the overall higher
antioxidant activity observed in the GBAF. As described above, only a few phenolic compounds were
detected in lower concentrations in the SDEO fraction. Considering this, proper processing techniques
are required before application of M. triscuspidata fruit for its biological activity. While processing
techniques such as specific enzymatic treatments can help release some compounds, processing
methods like fermentation with microorganisms may give more efficient results. A previous study has
demonstrated an increase in the levels of phenolic compounds such as kaempferol and quercetin after
lactobacillus-mediated fermentation of M. triscuspidata leaf [63].
4. Conclusions
This study explored the chemical compositions and antioxidant activities of steam-distilled
essential oil (SDEO) and glycosidically bound aglycone fraction (GBAF) extracts from fully ripe M.
triscuspidata fruit. Thirteen carotenoid-derived compounds are being isolated for the first time in M.
triscuspidata fruit. These compounds have been associated with a variety of organoleptic properties in
other plants. A number of bioactive compounds were exclusively identified in the GBAF. It can be
suggested that the relatively higher antioxidant activity observed in this particular fraction compared
to the SDEO fraction is mainly associated with these exclusive compounds. Therefore, enzymatic
treatments of fruits suh as M. triscuspidata can significantly enhance functional properties by releasing
glycosidically bound bioactive components.
References
1. Raut, J.S.; Karuppayil, S.M. A status review on the medicinal properties of essential oils. Ind. Crops Prod.
2014, 62, 250–264. [CrossRef]
2. Shaaban, H.A.E.; El-Ghorab, A.H.; Shibamoto, T. Bioactivity of essential oils and their volatile aroma
components: Review. J. Essent. Oil Res. 2012, 24, 203–212. [CrossRef]
3. Sendra, E. Essential Oils in Foods: From Ancient Times to the 21st Century. Foods 2016, 5, 43. [CrossRef]
4. Edris, A.E. Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents:
A review. Phyther. Res. 2007, 21, 308–323. [CrossRef]
5. Adorjan, B.; Buchbauer, G. Biological properties of essential oils: An updated review. Flavour Fragr. J. 2010,
25, 407–426. [CrossRef]
6. Wang, H.F.; Yih, K.H.; Yang, C.H.; Huang, K.F. Anti-oxidant activity and major chemical component analyses
of twenty-six commercially available essential oils. J. Food Drug Anal. 2017, 25, 881–889. [CrossRef]
Foods 2019, 8, 659
7. Alamed, J.; Chaiyasit, W.; McClements, D.J.; Decker, E.A. Relationships between Free Radical Scavenging
and Antioxidant Activity in Foods. J. Agric. Food Chem. 2009, 57, 2969–2976. [CrossRef]
8. Williams, G.M.; Iatropoulos, M.J.; Whysner, J. Safety assessment of butylated hydroxyanisole and butylated
hydroxytoluene as antioxidant food additives. Food Chem. Toxicol. 1999, 37, 1027–1038. [CrossRef]
9. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils—A review.
Food Chem. Toxicol. 2008, 46, 446–475. [CrossRef]
10. McClements, D.J.; Decker, E.A.; Weiss, J. Emulsion-Based Delivery Systems for Lipophilic Bioactive
Components. J. Food Sci. 2007, 72, R109–R124. [CrossRef]
11. Shahidi, F.; Ambigaipalan, P. Phenolics and polyphenolics in foods, beverages and spices: Antioxidant
activity and health effects—A review. J. Funct. Foods 2015, 18, 820–897. [CrossRef]
12. Hiep, N.T.; Kwon, J.; Kim, D.W.; Hong, S.; Guo, Y.; Hwang, B.Y.; Kim, N.; Mar, W.; Lee, D. Neuroprotective
constituents from the fruits of Maclura tricuspidata. Tetrahedron 2017, 73, 2747–2759. [CrossRef]
13. Seo, W.G.; Pae, H.O.; Oh, G.S.; Chai, K.Y.; Yun, Y.G.; Chung, H.T.; Jang, K.K.; Kwon, T.O. Ethyl acetate extract
of the stem bark of cudrania tricuspidata induces apoptosis in human leukemia HL-60 cells. Am. J. Chin.
Med. 2001, 29, 313–320. [CrossRef]
14. Kwon, S.-B.; Kim, M.-J.; Yang, J.M.; Lee, H.P.; Hong, J.T.; Jeong, H.S.; Kim, E.S.; Yoon, D.Y. Cudrania
tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells. PLoS
ONE 2016, 11, e0150235. [CrossRef]
15. Chang, S.H.; Jung, E.J.; Lim, D.G.; Oyungerel, B.; Lim, K.I.; Her, E.; Choi, W.S.; Jun, M.H.; Choi, K.D.;
Han, D.J.; et al. Anti-inflammatory action of Cudrania tricuspidata on spleen cell and T lymphocyte proliferation.
J. Pharm. Pharmacol. 2008, 60, 1221–1226. [CrossRef]
16. Kang, D.-H.; Kim, J.-W.; Youn, K.-S. Antioxidant Activities of Extracts from Fermented Mulberry (Cudrania
tricuspidata) Fruit and Inhibitory Actions on Elastase and Tyrosinase. Korean J. Food Preserv. 2011, 18, 236–243.
[CrossRef]
17. Jeong, C.-H.; Choi, G.-N.; Kim, J.-H.; Kwak, J.-H.; Heo, H.-J.; Shim, K.-H.; Cho, B.-R.; Bae, Y.-I.; Choi, J.-S.
In vitro Antioxidative Activities and Phenolic Composition of Hot Water Extract from Different Parts of
Cudrania tricuspidata. Prev. Nutr. Food Sci. 2009, 14, 283–289. [CrossRef]
18. Kim, D.H.; Lee, S.; Chung, Y.W.; Kim, B.M.; Kim, H.; Kim, K.; Yang, K.M. Antiobesity and Antidiabetes Effects of a
Cudrania tricuspidata Hydrophilic Extract Presenting PTP1B Inhibitory Potential. Biomed Res. Int. 2016. [CrossRef]
19. Han, X.H.; Hong, S.S.; Jin, Q.; Li, D.; Kim, H.K.; Lee, J.; Kwon, S.H.; Lee, D.; Lee, C.K.; Lee, M.K.; et al.
Prenylated and Benzylated Flavonoids from the Fruits of Cudrania tricuspidata. J. Nat. Prod. 2009, 72, 164–167.
[CrossRef]
20. Hwang, J.H.; Hong, S.S.; Han, X.H.; Hwang, J.S.; Lee, D.; Lee, H.; Yun, Y.P.; Kim, Y.; Ro, J.S.; Hwang, B.Y.
Prenylated Xanthones from the Root Bark of Cudrania tricuspidata. J. Nat. Prod. 2007, 70, 1207–1209. [CrossRef]
21. Xin, L.T.; Yue, S.J.; Fan, Y.C.; Wu, J.S.; Yan, D.; Guan, H.S.; Wang, C.Y. Cudrania tricuspidata: An updated
review on ethnomedicine, phytochemistry and pharmacology. RSC Adv. 2017, 7, 31807–31832. [CrossRef]
22. Lee, Y.J.; Kim, S.; Lee, S.J.; Ham, I.; Whang, W.K. Antioxidant activities of new flavonoids from Cudrania
tricuspidata root bark. Arch. Pharm. Res. 2009, 32, 195–200. [CrossRef]
23. Song, S.-H.; Ki, S.; Park, D.-H.; Moon, H.S.; Lee, C.D.; Yoon, I.S.; Cho, S.S. Quantitative Analysis, Extraction
Optimization, and Biological Evaluation of Cudrania tricuspidata Leaf and Fruit Extracts. Molecules 2017, 22, 1489.
[CrossRef]
24. Shin, G.R.; Lee, S.; Lee, S.; Do, S.G.; Shin, E.; Lee, C.H. Maturity stage-specific metabolite profiling of Cudrania
tricuspidata and its correlation with antioxidant activity. Ind. Crops Prod. 2015, 70, 322–331. [CrossRef]
25. Kim, D.-W.; Lee, W.-J.; Asmelash Gebru, Y.; Choi, H.S.; Yeo, S.H.; Jeong, Y.J.; Kim, S.; Kim, Y.H.; Kim, M.K.
Comparison of Bioactive Compounds and Antioxidant Activities of Maclura tricuspidata Fruit Extracts at
Different Maturity Stages. Molecules 2019, 24, 567. [CrossRef]
26. Bajpai, V.K.; Sharma, A.; Baek, K.H. Antibacterial mode of action of Cudrania tricuspidata fruit essential oil,
affecting membrane permeability and surface characteristics of food-borne pathogens. Food Control 2013, 32,
582–590. [CrossRef]
27. Bajpai, V.K.; Baek, K. Antioxidant efficacy, lipid peroxidation inhibition and phenolic content of essential oil
of fruits of cudrania tricuspidata. Bangladesh J. Bot. 2017, 46, 1015–102046.
28. Stahl-Biskup, E.; Intert, F.; Holthuijzen, J.; Stengele, M.; Schulz, G. Glycosidically bound volatiles—A review
1986–1991. Flavour Fragr. J. 1993, 8, 61–80. [CrossRef]
Foods 2019, 8, 659
29. Winterhalter, P.; Skouroumounis, G.K. Glycoconjugated aroma compounds: Occurrence, role and
biotechnological transformation. Adv. Biochem. Eng. Biotechnol. 1997, 55, 73–105. [CrossRef]
30. Politeo, O.; Jukic, M.; Milos, M. Chemical composition and antioxidant capacity of free volatile aglycones
from basil (Ocimum basilicum L.) compared with its essential oil. Food Chem. 2007, 101, 379–385. [CrossRef]
31. Maric, S.; Jukic, M.; Katalinic, V.; Milos, M. Comparison of Chemical Composition and Free Radical
Scavenging Ability of Glycosidically Bound and Free Volatiles from Bosnian Pine (Pinus heldreichii Christ.
var. leucodermis). Molecules 2007, 12, 283–289. [CrossRef]
32. Schultz, T.H.; Flath, R.A.; Mon, T.R.; Eggling, S.B.; Teranishi, R. Isolation of Volatile Components from a
Model System. J. Agric. Food Chem. 1977, 25, 446–449. [CrossRef]
33. Gunata, Y.Z.; Bayonove, C.L.; Baumes, R.L.; Cordonnier, R.E. The aroma of grapes I. Extraction and
determination of free and glycosidically bound fractions of some grape aroma components. J. Chromatogr. A
1985, 331, 83–90. [CrossRef]
34. Aubert, C.; Ambid, C.; Baumes, R.; Günata, Z. Investigation of Bound Aroma Constituents of Yellow-Fleshed
Nectarines (Prunus persica L. Cv. Springbright). Changes in Bound Aroma Profile during Maturation. J. Agric.
Food Chem. 2003, 51, 6280–6286. [CrossRef]
35. Aubert, C.; Günata, Z.; Ambid, C.; Baumes, R. Changes in Physicochemical Characteristics and Volatile
Constituents of Yellow- and White-Fleshed Nectarines during Maturation and Artificial Ripening. J. Agric.
Food Chem. 2003, 51, 3083–3091. [CrossRef]
36. Babushok, V.I.; Linstrom, P.J.; Zenkevich, I.G. Retention Indices for Frequently Reported Compounds of
Plant Essential Oils. J. Phys. Chem. Ref. Data 2011, 40. [CrossRef]
37. Van Den Dool, H.; Kratz, P.D. A generalization of the retention index system including linear temperature
programmed gas-liquid partition chromatography. J. Chromatogr. 1963, 11, 463–471. [CrossRef]
38. Assessment of total phenolic and flavonoid content, antioxidant properties, and yield of aeroponically
and conventionally grown leafy vegetables and fruit crops: A comparative study. Available online:
http://www.hindawin.com/journals/ecam/2014/253875/abs/ (accessed on 23 March 2014).
39. Thaipong, K.; Boonprakob, U.; Crosby, K.; Cisneros-Zevallos, L.; Hawkins Byrne, D. Comparison of ABTS,
DPPH, FRAP, and ORAC assays for estimating antioxidant activity from guava fruit extracts. J. Food Compos.
Anal. 2006, 19, 669–675. [CrossRef]
40. Benzie, I.F.F.; Strain, J.J. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”:
The FRAP assay. Anal. Biochem. 1996, 239, 70–76. [CrossRef]
41. Strauss, C.R.; Gooley, P.R.; Wilson, B.; Williams, P.J. Application of droplet countercurrent chromatography
to the analysis of conjugated forms of terpenoids, phenols, and other constituents of grape juice. J. Agric.
Food Chem. 1987, 35, 519–524. [CrossRef]
42. Gunata, Y.Z.; Dugelay, I.; Sapis, J.C.; Baumes, R.; Bayonove, C. Role of enzymes in the use of the flavor
potential from grape glycosides in winemaking. In Progress in Flavor Precursor Studies; 1994.
43. Synthesis and enantiodifferentiation of isomeric theaspiranes. Available online: https://doi.org/10.1021/
jf00019a022 (accessed on 1 July 1992).
44. Zelena, K.; Hardebusch, B.; Hülsdau, B.; Berger, R.G.; Zorn, H. Generation of Norisoprenoid Flavors from
Carotenoids by Fungal Peroxidases. J. Agric. Food Chem. 2009, 57, 9951–9955. [CrossRef]
45. Cai, Y.; Zheng, H.; Ding, S.; Kropachev, K.; Schwaid, A.G.; Tang, Y.; Mu, H.; Wang, S.; Geacintov, N.E.; Zhang, Y.;
et al. Free energy profiles of base flipping in intercalative polycyclic aromatic hydrocarbon-damaged DNA
duplexes: Energetic and structural relationships to nucleotide excision repair susceptibility. Chem. Res. Toxicol.
2013, 26, 1115–1125. [CrossRef]
46. Winterhalter, P.; Rouseff, R.L. (Eds.) Carotenoid-Derived Aroma Compounds; American Chemical Society:
Washington, DC, USA, 2001; Volume 802. [CrossRef]
47. Novruzov, E.N.; Agamirov, U.M. Carotinoids of Cudrania tricuspidata fruit. Chem. Nat. Compd. 2002, 38,
468–469. [CrossRef]
48. Schwab, W.; Davidovich-Rikanati, R.; Lewinsohn, E. Biosynthesis of plant-derived flavor compounds. Plant J.
2008, 54, 712–732. [CrossRef]
49. Adedeji, J.; Hartman, T.G.; Lech, J.; Ho, C.T. Characterization of glycosidically bound aroma compounds in
the African mango (Mangifera indica L.). J. Agric. Food Chem. 1992, 40, 659–661. [CrossRef]
50. Kicel, A.; Wolbiś, M. Study on the phenolic constituents of the flowers and leaves of Trifolium repens L.
Nat. Prod. Res. 2012, 26, 2050–2054. [CrossRef]
Foods 2019, 8, 659
51. Zhou, D.Y.; Sun, Y.X.; Shahidi, F. Preparation and antioxidant activity of tyrosol and hydroxytyrosol esters.
J. Funct. Foods. 2017, 37, 66–73. [CrossRef]
52. Cho, B.R.; Ryu, D.R.; Lee, K.S.; Lee, D.K.; Bae, S.; Kang, D.G.; Ke, Q.; Singh, S.S.; Ha, K.S.; Kwon, Y.G.; et al.
P-Hydroxybenzyl alcohol-containing biodegradable nanoparticle improves functional blood flow through
angiogenesis in a mouse model of hindlimb ischemia. Biomaterials 2015, 53, 679–687. [CrossRef]
53. Zhu, Y.P.; Li, X.; Du, Y.; Zhang, L.; Ran, L.; Zhou, N.N. Protective effect and mechanism of
p-hydroxybenzaldehyde on blood-brain barrier. Zhongguo Zhongyao Zazhi 2018, 43, 1021–1027. [CrossRef]
54. Chirinos, R.; Rogez, H.; Campos, D.; Pedreschi, R.; Larondelle, Y. Optimization of extraction conditions
of antioxidant phenolic compounds from mashua (Tropaeolum tuberosum Ruíz & Pavón) tubers.
Sep. Purif. Technol. 2007, 55, 217–225. [CrossRef]
55. Durazzo, A.; Lucarini, M.; Novellino, E.; Daliu, P.; Santini, A. Fruit-based juices: Focus on antioxidant
properties—Study approach and update. Phyther. Res. 2019, 33. [CrossRef]
56. Parada, F.; Duque, C.; Fujimoto, Y. Free and Bound Volatile Composition and Characterization of Some
Glucoconjugates as Aroma Precursors in Melón de Olor Fruit Pulp (Sicana o dorifera). J. Agric. Food Chem.
2000, 48, 6200–6204. [CrossRef]
57. Choi, J.; Yeo, S.; Kim, M.; Lee, H.; Kim, S. p-Hydroxybenzyl alcohol inhibits four obesity-related enzymes
in vitro. J. Biochem. Mol. Toxicol. 2018, 32, e22223. [CrossRef]
58. Coelho, E.; Genisheva, Z.; Oliveira, J.M.; Teixeira, J.A.; Domingues, L. Vinegar production from fruit
concentrates: Effect on volatile composition and antioxidant activity. J. Food Sci. Technol. 2017, 54, 4112–4122.
[CrossRef]
59. Daliu, P.; Santini, A.; Novellino, E. From pharmaceuticals to nutraceuticals: Bridging disease prevention and
management. Expert Rev. Clin. Pharmacol. 2019, 12, 1–7. [CrossRef]
60. Kashanian, S.; Ezzati Nazhad Dolatabadi, J. In vitro studies on calf thymus DNA interaction and
2-tert-butyl-4-methylphenol food additive. Eur. Food Res. Technol. 2010, 230, 821–825. [CrossRef]
61. Fagali, N.; Catalá, A. Antioxidant activity of conjugated linoleic acid isomers, linoleic acid and its methyl
ester determined by photoemission and DPPH{radical dot} techniques. Biophys. Chem. 2008, 137, 56–62.
[CrossRef]
62. Mishra, K.; Ojha, H.; Chaudhury, N.K. Estimation of antiradical properties of antioxidants using DPPH-assay:
A critical review and results. Food Chem. 2012, 130, 1036–1043. [CrossRef]
63. Lee, Y.; Oh, J.; Jeong, Y.S. Lactobacillus plantarum-mediated conversion of flavonoid glycosides into flavonols,
quercetin, and kaempferol in Cudrania tricuspidata leaves. Food Sci. Biotechnol. 2015, 24, 1817–1821. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Oleic Acid Is not the Only Relevant
Mono-Unsaturated Fatty Ester in Olive Oil
Archimede Rotondo 1, *, Giovanna Loredana La Torre 1 , Giacomo Dugo 1 , Nicola Cicero 1 ,
Antonello Santini 2 and Andrea Salvo 3
1 Department of Biomedical and Dental Sciences and Morpho-functional Imaging, University of Messina, Polo
Universitario Annunziata, Viale Annunziata, 98168 Messina, Italy; llatorre@unime.it (G.L.L.T.);
dugog@unime.it (G.D.); ncicero@unime.it (N.C.)
2 Department of Pharmacy, University of Napoli Federico II, via D. Montesano 49, 80131 Napoli, Italy;
asantini@unina.it
3 Department of Chemistry and Drug Technology, University of Roma La Sapienza, via P.le A. Moro 5, 00185
Roma, Italy; andrea.salvo@uniroma1.it
* Correspondence: arotondo@unime.it; Tel.: 39-090-676-6890
Abstract: (1) Background: Extra-virgin olive oil (EVOO) is a precious and universally studied
food matrix. Recently, the quantitative chemical composition was investigated by an innovative
processing method for the nuclear magnetic resonance (NMR) experiments called Multi-Assignment
Recovered Analysis (MARA)-NMR. (2) Methods: Any EVOO 13-carbon NMR (13 C-NMR) profile
displayed inconsistent signals. This mismatch was resolved by comparing NMR data to the official
gas-chromatographic flame ionization detection (GC-FID) experiments: the analyses concerned many
EVOOs but also the “exotic” Capparis spinosa oil (CSO). (3) Results: NMR and GC-FID evidenced
the overwhelming presence of cis-vaccenic esters in the CSO and, more importantly, cis-vaccenic
13 C-NMR resonances unequivocally matched the misunderstood 13 C-NMR signals of EVOOs. The
updated assignment revealed the unexpected relevant presence of cis-vaccenic ester (around 3%) in
EVOOs; it was neglected, so far, because routine and official GC-FID profiles did not resolve oleic
and cis-vaccenic signals leading to the total quantification of both monounsaturated fatty esters. (4)
Conclusions: The rebuilt MARA-NMR and GC-FID interpretations consistently show a meaningful
presence of cis-vaccenic esters in EVOOs, whose content could be a discrimination factor featuring
specific cultivar or geographical origin. The study paves the way toward new quantification panels
and scientific research concerning vegetable oils.
Keywords: cis-vaccenic; monounsaturated fatty; glycerols; NMR analysis; olive oil; Capparis spinosa;
13 C-NMR;
MARA-NMR
1. Introduction
Extra-virgin olive oil (EVOO) comes from the supernatant phase of juice obtained after cold
pressing of Olea europaea fruits and is the fundamental dressing of any Mediterranean dish. It is
considered the liquid gold in food trading because of its crucial role in the healthy way of life model
called “Mediterranean Diet” [1]. Many scientific studies reveal that the chemical composition of
EVOO is a perfect balance leading to countless benefits for humans [2–5]. The positive biological
activities are reasonably due to the suitable presence of vegetable sterols [6], liposoluble polyphenols [7]
and other anti-oxidant hydrocarbons [8] joined to the most abundant presence of mono-unsaturated
tri-acyl-glycerol esters among the vegetable oils. Albeit the oleic ester in EVOOs is considered
the overwhelming main mono-unsaturated fatty ester so far, this work casts another important
mono-unsaturated fat potentially playing important biological roles. The wide impact of EVOOs
composition accounts for the constantly updated European Regulation stating the chemical and taste
features, limits and official analytical techniques recognized for olive oil trade [9,10]. In the last decades,
the traditional food analysis was shocked by the nuclear magnetic resonance (NMR) as alternative
quantitative (qNMR) approach [11] flanking the officially recognized separation techniques. The
nondestructive NMR spectroscopy allows the in-situ detection of several chemical species without the
requirement of a real physical separation [8,12,13]; moreover qNMR is feasible directly or through a
clever data throughput [14,15]. The definite advantages of the NMR analyses are: a) minimal sample
treatment [8], b) simultaneous detection of a great amount of data [16], c) reduction of systematic
errors controlled by the intrinsic instrumental stability, d) constant and direct dependence between
signal integration and quantitative values because of the constant nuclear magnetic momentum for
the measured nuclei [17]. Criticism toward NMR concerned mainly sensitivity; however, it actually
depends on the machine, on sample type, on used solvent, on observed nuclei and on specific
experimental runs; this is the reason it should be evaluated from case to case [18]. After several years
of research on EVOOs composition, Rotondo et al. have developed a Multi-Assignment Recovered
Analysis (MARA-NMR) involving multi-nuclear 1 H and {1 H}13 C-NMR experiments processed by
an accustomed processing “MARA” algorithm [19]. This method successfully and quickly achieves
the quantification of many components in EVOOs samples through high-resolution spectroscopy
at 500 MHz (500 MHz HR-NMR). On the other hand, the “first” MARA-NMR scheme did not take
into account some 13 C-NMR resonances whose intensity was significant, but these were associated
to EVOO minor components (theoretically negligible and contributing for less than 1%) and, for
these studies, the best fitting goodness never reached the expected convergence. Since the official
method for the quantitative determination of glyceryl fatty esters consists in the gas-chromatographic
analysis of the corresponding methyl esters using the gas-chromatographic flame ionization detection
(GC-FID) [20], this work focused on the data comparison between NMR and GC-FID on oils in order to
solve inconsistent “leftovers” from literature. The paper evidences the neat importance of cis-vaccenic
fatty ester in EVOOs as its content is around 3%; however, it was neglected so far because, according
the official method, it is included in the level of oleic ester.
with a length of 30 m, internal diameter of 0.25 mm and film thickness of 0.25 μm. Helium was used
as a carrier gas at a column flow rate of 1.2 mL/min, with a split ratio of 1:100. The temperature
of the injector (split/splitless) and detector was of 220 ◦ C and 240 ◦ C, respectively. The oven was
programmed as follows: initial temperature at 130 ◦ C, final temperature at 200 ◦ C (10 min) with an
increase of 3 ◦ C/min. The fatty acid methyl esters were identified by comparing the retention times
with those of standard compounds. The relative percentage area of the fatty acids was obtained using
the following relationship: %FAX = [AX/AT] × 100, where FAX stands for fatty acids to quantify, AX is
the area of the methyl-esters and AT is the total area of the identified peaks in the chromatogram [21].
This analytical strategy is chosen for data comparison because it is officially recognized for the fatty
esters quantification, on another hand the reader should be aware that the hydrolysis-esterification
step is always tedious, laborious and time consuming, decreasing accuracy and precision. This is the
reason why, lately, alternative analytical chromatographic methods have also been proposed [22], still
showing limitations.
signal to (δH = 0.738 ppm) with the TMS always being (δ = 0.0 ± 0.005 ppm); for 13 C calibration of
experiment B the divinyl- methylene group of the linoleate glycerols (L11; δ13C = 25.6614 ppm) was
used always keeping the known TMS 13 C signal to δ13C = 0.0 ± 0.05 ppm. The TMS calibration would
not really change the results; here, the calibration over internal signals is preferred because these are
less dependent on random conditions as explained elsewhere [19].
The serial integration of 100 regions for all the A-type experiments, and of 90 regions for experiment
B profiles, provided a pretty big matrix whose columns were the 40 studied samples EVOO and
rows represented 190 homologous integrations (see Supplementary Materials). Every column of
this matrix was processed by the mentioned MARA algorithm [19]; this theoretical architecture is
modified according to the original knowledge and assignments concerning cis-vaccenic esters (V).
The experimental coherences simply confirm the presence of a relevant amount of V, also improving
consistency assessed by low best fitting goodness (ρ) values. The extended procedure outputs up to 20
quantitative parameters [7,8,19] (Table 1) but this manuscript focuses on the 11 quantitative parameters
showing sound precision and important significance (Table 2). The data validation and experimental
error is evaluated through reproducibility (several samplings) and repeatability (analyses in different
days of the same sample).
Table 2. Quantitative data and relative deviation for 11 main variables (whose code is reported in
Table 1), as measured through Multi-Assignment Recovered Analysis-Nuclear Magnetic Resonance
(MARA-NMR) processing method working on mono dimensional 1 H and 13 C-NMR experiments for 33
samples. Standard deviations were measured through 9 different experiments on 3 identical samples
analyzed on three different days.
xf n ◦ 2
γxj Ixj i=a N NUCi ∗Ci
ρ= ωxj − . (1)
xj=x1 Iref N◦ NUCref ∗Cref
The intensity of any signal in the spectrum Ixj respect to a reference signal Iref should even out the
relative concentration (Ci against Cref ) of the magnetically active nuclei NUCi actually assigned to that
Foods 2020, 9, 384
signal. Coefficients ω and γ are empirical parameters able to reduce experimental deviation improving
the algorithm; theoretically speaking the best fitting goodness ρ should be 0 but in the real world we
accept low values. The introduction of 18 new assignments for the cis-vaccenic ester, by enhancing just
one quantitative parameter referred to the “new” component greatly lowered the best fitting goodness
giving the proof of concept about the assignment. The 20 quantitative parameters are derived by 11
expressions derived from A experiments and 65 expressions derived from B experiments put together
in the same expression as equation (1) containing 76 xj members and 20 i compounds. In order to
preserve the quantitative proportion of 13 C integrations, despite the uneven nOe relayed on total
decoupled carbon nuclei, adopted equations in the sum (1) are divided in blocks of nuclei with the same
chemical environment (methyl terminal carbons, methylene inner chain carbons, vynil-methylene, etc.).
It is demonstrated that MARA-NMR keeps the quantitative information as reported in Supplementary
Materials and in Reference [19].
3. Results
Figure 1 shows the chemical moieties, related abbreviations and the adopted labelling scheme;
Figure 2 reports the GC-FID profile referring to the CSO extracted in our laboratory and Figure 3
represents the 13 C-NMR profile of EVOO and CSO in the unsaturated region (127–131 ppm) along
with the relative assignment witnessing the presence of the cis-vaccenic ester. As easily foreseeable,
other NMR spectral regions also clearly showed cis-vaccenic resonances; however, a total assignment
of 18 13 C carbon atoms was challenged by the many overlaps. Previous pioneering studies pointed out
the challenging quantitative decoding of the mono-unsaturated fatty esters mixture in EVOOs [23].
Specifically, other minor mono-unsaturated fatty esters (MUFE) were taken into account; beyond the
oleic (O) are also considered cis-vaccenic (V), eicosenoic (E) and palmitoleic (PO) [24,25]. On the other
hand, data coming from known EVOOs compositions, limit the quantitative contribution of E and PO
below 1% [9] and it is consistently witnessed by the lack of defined resonances in the regions where
these esters should not have overlap with other similar constructs. The Multiple Assignment Recovered
Analysis (MARA-NMR) takes advantage of any spectral section also overcoming the overlap issues
hampering, so far, the independent quantification of mono-unsaturated fatty esters. Specifically, in
this case, MARA-NMR processing definitely led to the detection and quantification of the V esters
(consistently all over the recorded spectral span). Among the 20 variables feed out from MARA-NMR
whose code is reported in Table 1, we herein have restricted our considerations to the most meaningful
11 variables reported in Table 2 along with the relative standard deviation.
With respect to the other studies [24,25] the new information remarkably smooths discrepancies
between 1 H and 13 C-NMR as the mono-unsaturated fatty esters contribution in 1 H-NMR matches the
contribution of O and V esters, which actually should be also somewhat enhanced by the minor PO
and E esters’ contribution. Because of the tricky GC-FID resolution between V and O, also referred to
in the European regulation (which suggests to report the whole V+O contribution), it is not always
possible to compare GC and NMR data. However, the new available data, display the best fitting so far
obtainable (Figure 4) concerning the measurements of mono-unsaturated (O + V + PO), saturated (P +
S), di-unsaturated (L) and tri-unsaturated (Ln) fatty esters. The average V contribution is around 3%
and it is consistent with previous NMR [23] and GC-FID [26] analyses; on the other hand, we think
that MARA-NMR is the most versatile method suitable for serial processing of several samples and
data. We think that this remarkable parameter in EVOOs cannot be ignored, since it is not constant by
shifting from sample to sample, therefore it could assess specific features of different food products.
The V quantification is not a marker for this study according to Table 2; however, it will trigger many
important statistical considerations.
Foods 2020, 9, 384
Figure 1. Chemical scheme of the fatty esters commonly found in olive oils with relative abbreviation.
Usually these acyl residues are esters of the glycerol moiety. The labelling scheme of carbon atoms is
adopted in this paper for assignments and discussion.
This enlightened an important piece of information concerning the cis-vaccenic ester as main
compound in CSO but also as relevant ester contributing to the EVOO mixture. This last element
was incredibly ignored so far. Table S1 (Supplementary Materials) reports the extended panel of 20
quantitative variables considered in the study for 33 samples (see details in Supplementary Materials).
These values are obtained by MARA-NMR—a post-processing algorithm working over the two
experiments A and B type.
Foods 2020, 9, 384
Figure 2. Expanded region of interest in the gas-chromatographic flame ionization detection (GC-FID)
profile for Capparis spinosa oil; oleic (O) and cis-vaccenic (V) methyl esters are resolved for the
quantification. In the case of extra-virgin oil the O peak is around 20 times more than V. Other labelled
signals are linolenic (Ln), linoleic (L) and stearic (S) esters
Figure 3. 13 C-NMR profiles for olive oil (EVOO) in gray and capparis seed oil (CSO) in black. All the
assignments for oleic (O), linoleic (L) linolenic (Ln) and cis-vaccenic (V), with the number representing
carbon atom position respect to the 1 carboxyl position, are pretty known and coherent with quantitative
and literature data.
Foods 2020, 9, 384
Figure 4. Comparison between MARA-NMR and GC-FID measured quantitative parameters referred
to: (A) mono-unsaturated (MUFA), (B) saturated (SFA), (C) Linoleic (L) and (D) Linolenic (Ln) esters in
relative percent ratio.
4. Discussion
The previously reported assignments for EVOOs 13 C-NMR definitely accounted for five fatty esters
in the following quantitative order: oleic (O), palmitic (P), linoleic (L), stearic (S) and linolenic (Ln) [27,28].
Some other tentative assignments concerned mono-unsaturated fatty esters like palmitoleic (PO) and
11-eicosenoic (E) constructs [29]. Despite the wide availability of NMR reports [30], none of these clearly
explained the systematic presence of unknown resonances (in our processing batch at 129.92, 129.82,
31.82, 22.69 ppm and others) which account for a relevant quantitative contribution (around 3%, Figure 3).
Scientific hesitancy probably owes to the general opinion that the total amount of other fatty esters is
limited to less than 1% of EVOOs. This idea was questioning the NMR technique itself as possible
analytical method but the serendipitous extraction of the Capparis spinosa oil (CSO) allowed us to solve
this inconsistency because of the remarkable presence of cis-vaccenic (V) esters. The comparison between
NMR and GC-FID analyses of CSO consistently confirmed the main presence of the V ester with a minor
contribution of the O ester. The analogous analytical approach executed over several EVOO samples
made us realize that the detected mono-unsaturated fatty esters were again O and V but in a reversed
quantitative proportion respect to the CSO. Against this background, the main NMR resonances attributed
to V in other peculiar food matter [31–33] (as also the reported CSO sample) were matching the EVOO
signals as reported in Figure 3. It definitely gave us the chance to include the V component in the EVOO
quantitative panel according to the 13 C-NMR resonances afore mentioned. The V remarkable presence
is not just a production side product as we did not observe the presence of trans isomers (resonances
downfield respect 5.40 ppm in the 1 H-NMR and relative other singlets in the 13 C-NMR). Once again these
results confirm the stability and sound presence of the cis form of unsaturated esters in spite of the minor
thermodynamic stability. In order to perform the updated comprehensive quantitative NMR analysis of
EVOO we have adopted an accustomed procedure based on MARA-NMR. Although it is not the first
analytical comparison between GC and NMR [34,35], the novel MARA-NMR strategy suitably refined
according to the new information led to a very good fitting (Figure 4). The whole outcome is reported
in Tables (Tables 1 and 2, and Tables S1 and S2 in Supplementary Data). In order to get consistent data,
we have chosen to compare the percent presence of L and Ln as detected, whereas the saturated fatty
esters (SFA%) were considered as the sum S+P and the mono-unsaturated fatty esters (MUFA) were
Foods 2020, 9, 384
considered as O+V+PO. We think it is actually an important parallel evaluation whose general trend shows
a very good fitting also kept with samples showing sensibly different proportions. Finally, by properly
considering all the mono-unsaturated fatty esters, the MUFA% estimation reached an unprecedented very
good matching. On the other hand, the slight systematic overestimation of GC-FID respect to the NMR
for L% and Ln% and underestimation of SFA% deserves to be elucidated with further studies requiring
standard mixtures similar to EVOO, which is a tri-acyl-glycerol mixture. At the moment, these substrates
are not available but work is in progress to develop further information. Although it is not the first
case of V detection and also quantification [36], the EVOOs routine quantifications barely evidence the
resolution for O-V peaks; this is clearly shown in the GC picture of the European Regulation 2013 [9]. Our
observations also demonstrated that new GC-FID columns keep a better (affordable) resolution, whereas
routine instruments adopted for serial records easily present the V peak as O shoulder. Fortunately,
recorded 13 C-NMR provide the missing information about the V fraction (not really taken into account so
far) for any EVOO sample (Figure 3). According to our opinion, future studies could take advantage from
a “powered” MARA-NMR working over sensitivity-enhanced 13 C-NMR profile (optimized scans); these
could push further the frontiers of quick qNMR in EVOOs by enabling the independent quantification of
fatty esters in the 2- internal position of glycerides but also the improved quantification of other minor
components (see Supplementary Materials). This contribution also opens the way toward new studies
concerning sensory attributes, geographical origin and beneficial effects [37] of EVOO as fundamental
functional food with the major presence of glycerol esters [38].
5. Conclusions
This study definitely assesses the constant and relevant presence in olive oils of a not-oleic
mono-unsaturated fatty ester called cis-vaccenic ester. It resolves the literature controversies concerning
the assignment of some 13 C-NMR resonances but, more importantly, it brings back the expected
coherency between NMR and chromatography data. The serendipitous comparison of GC-FID and
NMR profiles for the “exotic” Capparis spinosa oil evidenced the overwhelming amount of cis-vaccenic
ester in this matrix but also unambiguously confirmed 13 C-NMR assignments also validated in olive
oil. By reconsidering the NMR and GC-FID of olive oils, it turned out the surprising quantitative
contribution (around 3%) of cis-vaccenic ester. The official GC method does not always perform the
required resolution to resolve and quantify oleic and cis-vaccenic esters and this is leading to the
undistinguished quantification of both mono-unsaturated fatty esters. It opens up great potential
for any technique able to clearly resolve cis-vaccenic moieties (just like 13 C-NMR) in the study of
extra-virgin olive oils.
background, N.C. and A.S. (Antonello Santini). All authors have read and agreed to the published version of
the manuscript.
Funding: This research received no external funding.
Acknowledgments: Once again we thank the institution “University of Messina,” which, in spite of poor means
and the difficult situation of the south Italian research, does not give up.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Trichopolou, A.; Vasilopoulou, E. Mediterranean diet and longevity. Br. J. Nutr. 2000, 84, S205–S209.
[CrossRef] [PubMed]
2. Visioli, F.; Bernardini, E. Extra virgin olive oil’s polyphenols: Biological activities. Curr. Pharm. Des. 2011, 17,
786–804. [CrossRef] [PubMed]
3. Frankel, E.N. Nutritional and biological properties of extra virgin olive oil. J. Agric. Food Chem. 2011, 59,
785–792. [CrossRef] [PubMed]
4. Pérez-Jiménez, F.; Ruano, J.; Perez-Martinez, P.; Lopez-Segura, F.; Lopez-Miranda, J. The influence of olive oil
on human health: Not a question of fat alone. Mol. Nutr. Food Res. 2007, 51, 1199–1208. [CrossRef] [PubMed]
5. Schwingshackl, L.; Christoph, M.; Hoffmann, G. Effects of Olive Oil on Markers of Inflammation and Endothelial
Function—A Systematic Review and Meta-Analysis. Nutrients 2015, 7, 7651–7675. [CrossRef] [PubMed]
6. Azadmard-Damirchi, S.; Dutta, P.C. Phytosterol Classes in Olive Oils and their Analysis by Common
Chromatographic Method. In Olives and Olive Oil in Health and Disease Prevention; Victor, R., Preedy, V.R.,
Watson, R.R., Eds.; Academic Press: Cambridge, MA, USA, 2010; Chapter 27; pp. 249–257.
7. Klikarova, J.; Rotondo, A.; Cacciola, F.; Ceslova, L.; Dugo, P.; Mondello, L.; Rigano, F. The Phenolic Fraction
of Italian Extra Virgin Olive Oils: Elucidation through Combined Liquid Chromatography and NMR
Approaches. Food Anal. Methods 2019, 12, 1759–1770. [CrossRef]
8. Rotondo, A.; Salvo, A.; Gallo, V.; Rastrelli, L.; Dugo, G. Quick unreferenced NMR quantification of Squalene
in vegetable oils. Eur. J. Lipid Sci. Technol. 2019, 119, 1700151. [CrossRef]
9. EU. Commission Implementing Regulation (EU) No 1348/2013 of 16 December 2013 amending Regulation
(EEC) No 2568/91 on the characteristics of olive oil and olive-residue oil and on the relevant methods of
analysis. Off. J. Eur. Union 2013, L 338, 31–67.
10. EU. Commission Delegated Regulation (EU) No 2015/1830 of 8 July 2015 amending Regulation (EEC) No
2568/91 on the characteristics of olive oil and olive-residue oil and on the relevant methods of analysis. Off. J.
Eur. Union 2015, L 266, 9–13.
11. Mannina, L.; Sobolev, A.P.; Segre, A. NMR. Olive oil as seen by NMR and chemometrics. Spectroscopy 2003,
15, 6–14.
12. Simmler, C.; Napolitano, J.G.; Mc Alpine, J.B.; Chen, S.-N.; Pauli, G.F. Universal quantitative NMR analysis
of complex natural samples. Curr. Opin. Biotechnol. 2014, 25, 51–59. [CrossRef]
13. Salvo, A.; Rotondo, A.; La Torre, G.L.; Cicero, N.; Dugo, G. Determination of 1,2/1,3-diglycerides in Sicilian
extra-virgin olive oils by 1H-NMR over a one-year storage period. Nat. Prod. Res. 2017, 31, 822–828.
[CrossRef]
14. Bharti, S.K.; Roi, R. Quantitative 1H NMR spectroscopy. Trends Anal. Chem. 2012, 35, 5–26. [CrossRef]
15. Monakhova, Y.B.; Tsikin, A.M.; Kuballa, T.; Lachenmeiera, D.W.; Mushtakovab, S.P. Independent component
analysis (ICA) algorithms for improved spectral deconvolution of overlapped signals in 1 H NMR analysis:
Application to foods and related products. Magn. Reson. Chem. 2014, 52, 231–240. [CrossRef] [PubMed]
16. Ruiz-Aracama, A.; Goicoechea, E.; Guillén, M.D. Direct study of minor extra-virgin olive oil components
without any sample modification. 1 H NMR multisupression experiment: A powerful tool. Food Chem. 2017,
228, 301–314. [CrossRef] [PubMed]
17. Mannina, L.; Sobolev, A.P. High resolution NMR characterization of olive oils in terms of quality, authenticity
and geographical origin. Magn. Reson. Chem. 2011, 49, S3–S11. [CrossRef] [PubMed]
18. Salvo, A.; Rotondo, A.; Mangano, V.; Grimaldi, V.; Stillitano, I.; D’Ursi, A.M.; Dugo, G.; Rastrelli, L.
High-resolution magic angle spinning nuclear magnetic resonance (HR-MAS-NMR) as quick and direct
insight of almonds. Nat. Prod. Res. 2019, 34, 71–77. [CrossRef]
Foods 2020, 9, 384
19. Rotondo, A.; Mannina, L.; Salvo, A. Multiple Assignment Recovered Analysis (MARA) NMR for a Direct
Food Labeling, the Case Study of Olive Oils. Food Anal. Methods 2019, 12, 1238–1245. [CrossRef]
20. Christie, W.W. Preparation of Ester Derivatives of Fatty Acids for Chromatographic Analysis. Adv. Lipid
Methodol. 1993, 2, 69–111.
21. Naccari, C.; Rando, R.; Salvo, A.; Donato, D.; Bartolomeo, G.; Mangano, V.; Lo Turco, V.; Dugo, G. Study on
the composition and quality of several sicilian EVOOs (harvesting year 2015). Rivista Italiana Delle Sostanze
Grasse 2017, 94, 231–237.
22. Zhang, H.; Wang, Z.; Liu, O. Development and validation of a GC–FID method for quantitative analysis of
oleic acid and related fatty acids. J. Pharm. Anal. 2015, 5, 223–230. [CrossRef] [PubMed]
23. Scano, P.; Casu, M.; Lai, A.; Saba, G.; Dessi, M.A.; Deiana, M.; Corongiu, F.P.; Bandino, G. Recognition
and quantitation of cis-vaccenic and eicosenoic fatty acids in olive oils by 13C nuclear magnetic resonance
spectroscopy. Lipids 1999, 34, 757–759. [CrossRef] [PubMed]
24. Barison, A.; Pereira da Silva, C.W.; Ramos Campos, F.; Simonelli, F.; Lenz, C.A.; Ferreira, A.G. A simple
methodology for the determination of fatty acid composition in edible oils through 1 H NMR spectroscopy.
Magn. Reson. Chem. 2010, 48, 642–650. [CrossRef] [PubMed]
25. Knothe, G.; Kenar, J.A. Determination of the fatty acid profile by 1H-NMR spectroscopy. Eur. J. Lipid Sci.
Technol. 2004, 106, 88–96. [CrossRef]
26. Boudour-Benrachou, N.; Plard, J.; Pinatel, C.; Artaud, J.; Dupuy, N. Fatty acid compositions of olive oils
from six cultivars from East and South-Western Algeria. Adv. Food Technol. Nutr. Sci. Open J. 2017, 3, 1–5.
[CrossRef]
27. Retief, L.; McKenzie, J.M.; Koch, K.R. A novel approach to the rapid assignment of 13C NMR spectra of
major components of vegetable oils such as avocado, mango kernel andmacadamia nut oils. Magn. Reson.
Chem. 2009, 47, 771–781. [CrossRef]
28. Chira, N.A.; Nicolescu, A.; Stan, R.; Rosca, S. Fatty Acid Composition of Vegetable Oils Determined from
13C-NMR Spectra. Rev. Chim. 2016, 67, 1257–1263.
29. Vlahov, G.; Schiavone, C.; Simone, N. Quantitative 13 C NMR method using the DEPT pulse sequence for
the determination of the geographical origin (DOP) of olive oils. Magn. Reson. Chem. 2001, 39, 689–695.
[CrossRef]
30. Zamora, R.; Alba, V.; Hidalgo, F.J. Use of High-Resolution 13 C Nuclear Magnetic Resonance Spectroscopy for
the Screening of Virgin Olive Oils. J. Am. Oil Chem. Soc. 2001, 78, 89–94. [CrossRef]
31. Ng, S.; Koh, H.F. Detection of cis-Vaccenic Acid in Palm Oil by 13C NMR Spectroscopy. Lipids 1988, 23,
140–143. [CrossRef]
32. Kuznetsova, E.I.; Pchelkin, V.P.; Tsydendambaev, V.D.; Vereshchagin, A.G. Distribution of unusual fatty acids
in the mesocarp triacylglycerols of maturing sea buckthorn fruits. Russ. J. Plant Physiol. 2010, 57, 852–858.
[CrossRef]
33. Vlahov, G.; Chepkwony, P.K.; Ndalut, P.K. 13C NMR Characterization of Triacylglycerols of Moringa oleifera
Seed Oil: An “Oleic-Vaccenic Acid” Oil. J. Agric. Food Chem. 2002, 50, 970–975. [CrossRef] [PubMed]
34. Barding, G.A.; Béni, S.; Fukao, T.; Bailey-Serres, J.; Larive, C.K. Comparison of GC-MS and NMR for Metabolite
Profiling of Rice Subjected to Submergence Stress. J. Proteome Res. 2012, 12, 898–909. [CrossRef] [PubMed]
35. Romano, R.; Giordano, A.; Le Grottaglie, L.; Manzo, N.; Paduano, A.; Sacchi, R.; Santini, A. Volatile
compounds in intermittent frying by gas chromatography and nuclear magnetic resonance. Eur. J. Lipid Sci.
Technol. 2013, 115, 764–773. [CrossRef]
36. Shibaharaa, A.; Yamamoto, K.; Nakayama, T.; Kajimotoa, G. cis-Vaccenic Acid in Pulp Lipids of Commonly
Available Fruits. J. Am. Oil Chem. Soc. 1987, 64, 397–398. [CrossRef]
37. Circi, S.; Capitani, D.; Randazzo, A.; Ingallina, C.; Mannina, L.; Sobolev, A. Panel test and chemical analyses
of commercial olive oils: A comparative study. Chem. Biol. Technol. Agric. 2017, 4, 1–10. [CrossRef]
38. Naviglio, D.; Romano, R.; Pizzolongo, F.; Santini, A.; Vito, A.D.; Schiavo, L.; Nota, G.; Musso, S.S. Rapid
determination of esterified glycerol and glycerides in triglyceride fats and oils by means of periodate method
after transesterification. Food Chem. 2007, 102, 399–405. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Bioactivity-Guided Fractionation and NMR-Based
Identification of the Immunomodulatory Isoflavone
from the Roots of Uraria crinita (L.) Desv. ex DC
Ping-Chen Tu 1 , Chih-Ju Chan 2 , Yi-Chen Liu 3 , Yueh-Hsiung Kuo 2,4,5 , Ming-Kuem Lin 2, * and
Meng-Shiou Lee 2, *
1 Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica,
Taichung 404, Taiwan; pingchen.tu@gmail.com
2 Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University,
Taichung 404, Taiwan; ruby24301@gmail.com (C.-J.C.); kuoyh@mail.cmu.edu.tw (Y.-H.K.)
3 Institute of Biomedical Science and Rong Hsing Research Center for Translational Medicine, National
Chung-Hsing University, Taichung 402, Taiwan; sealioler@gmail.com
4 Department of Biotechnology, Asia University, Taichung 413, Taiwan
5 Chinese Medicine Research Center, China Medical University, Taichung 404, Taiwan
* Correspondence: linmk@mail.cmu.edu.tw (M.-K.L.); leemengshiou@mail.cmu.edu.tw (M.-S.L.);
Tel.: +886-4-2205-3366 (M.-K.L.); +886-4-2205-3366 (M.-S.L.)
Abstract: Uraria crinita is used as a functional food ingredient. Little is known about the association
between its immunomodulatory activity and its metabolites. We applied a precise strategy
for screening metabolites using immunomodulatory fractions from a U. crinata root methanolic
extract (UCME) in combination with bioactivity-guided fractionation and NMR-based identification.
The fractions from UCME were evaluated in terms of their inhibitory activity against the production
of pro-inflammatory cytokines (IL-6 and TNF-α) by lipopolysaccharide (LPS)-stimulated mouse
bone marrow-derived dendritic cells (BMDC). The role of the isoflavone genistein was indicated
by the 1 H NMR profiling of immunomodulatory subfractions (D-4 and D-5) and supported by the
result that genistein-knockout subfractions (D-4 w/o and D-5 w/o) had a lower inhibitory activity
compared to genistein-containing subfractions. This study suggests that genistein contributes to the
immunomodulatory activity of UCME and will help in the standardization of functional food.
1. Introduction
Uraria crinita (L.) Desv. ex DC. (UC) belongs to the family of Leguminosae. It is a popular
and commercially important medicinal plant, distributed widely in Taiwan and cultivated mostly
in Mingjian Township, Nantou (approximately 20–60 hectares per year). UC roots, also known as
“Taiwanese ginseng” due to the similar potency and aroma of its decoction and ginseng, have been
traditionally used to coordinate the gastrointestinal system, thanks to their detumescent and antipyretic
effects, indicating immunomodulatory activity [1]. UC roots are used as dietary supplements for
treating childhood skeletal dysplasia. UC roots have therefore been developed as valuable and
commercial functional food in Taiwan. This herb has been shown to have antioxidant [2] and
antidiabetic activities [3] and the potential to stimulate bone formation and regeneration [4]. Previous
phytochemical investigations on UC roots led to the isolation of fatty acids, steroids, triterpenoids,
phenolics, lignans, flavonoids, and isoflavonoids [2,4–6]. However, little is known about the association
between the immunomodulatory activity and the metabolites in this herb.
Dendritic cells (DCs), acting as antigen-presenting cells (APCs), are the major leukocytes, with a
critical role in regulating adaptive immune responses [7]. Immature DCs, characterized by a high
antigen uptake ability and poor antigen-presenting function, reside in the peripheral tissues, where
they regularly uptake and process self-antigens and maintain self-tolerance [7]. Upon activation,
immature DCs undergo maturation and migrate to adjacent lymph nodes or to the lymph organs,
after the recognition of pathogen-associated molecular patterns and damage-associated molecular
patterns by pattern recognition receptors, mostly Toll-like receptors (TLRs) [8]. This process is
accompanied by the upregulation of the expression of major histocompatibility complex (MHC) class
II molecules and several co-stimulatory molecules (CD40, CD80, and CD86) on the surface of cells [9].
Mature DCs generate more pro-inflammatory cytokines (TNF-α, IL-6, and IL-12) required for T cell
activation and have the ability to present antigens to T cells, linking the innate and adaptive immune
systems [9]. Therefore, targeting DCs is a promising strategy for immunomodulation. Medicinal herbs,
which modulate the function of DCs, can potentially be developed into botanical drugs for treating
immune disorders.
The promising potential of the herbal industry can only be achieved through the standardization
of the composition of herbal products and the assurance of proper quality control [10]. However,
the variable constituents of herbal products, owing to genetic, cultural, and environmental factors,
have made the quality of herbal medicines difficult to control. Nuclear magnetic resonance (NMR) has
been demonstrated as one of the best analytical approaches to identifying metabolites and providing
both qualitative and quantitative information [11]. While NMR suffers from a relatively poor sensitivity
compared to mass spectrometry (MS), it has some unique advantages over MS-based approaches,
including a non-destructive nature, high robustness, high reproducibility, high reliability, and powerful
ability to provide structural information for unknown metabolites [12]. NMR spectroscopy could offer
structural elucidation, achieved by the chemical shift, multiplicity, coupling constant, and integration
of (primary or secondary) metabolite signals in crude extracts. Additionally, the 1 H NMR signal
intensity, proportional to the relative number of protons, could provide useful information about the
quantity of the different metabolites in herbal extracts. Therefore, NMR has been successfully used for
fingerprinting and the metabolite discrimination of herbs [13,14]. Currently, NMR-based metabolomic
analysis is widely used in studies of nutrients, environment, plant physiology, drug metabolism,
toxicology, as well as for diagnoses and for the quality control of herbal products [10,15,16].
In this study, a combination of bioactivity-guided fractionation and NMR-based identification
led to the elucidation of the central role of the immunomodulatory isoflavone genistein present in
UC root methanolic extract (UCME) against the activation and maturation of lipopolysaccharide
(LPS)-stimulated DCs. This strategy could prevent unnecessary time-consuming isolation procedures
and provide a rapid tool for the identification of the active ingredients of herbs. Our findings suggest
that UC roots can be applied as an immunosuppressive functional food, of which genistein can be a
chemical marker for quality control. The standardization of UC roots could therefore be improved.
shown). In summary, our results revealed that the EtOAc-soluble fraction of UCME may contain
immunomodulatory phytochemicals which attenuate the activity of DCs.
Figure 1. The effects of UC methanolic extract and of its EtOAc-, n-BuOH-, H2 O-soluble fractions and
subfractions of the EtOAc-soluble fraction on pro-inflammatory cytokine production in LPS-stimulated
dendritic cells (DCs). DCs were untreated or treated with LPS (100 ng/mL, white bar). (A) Methanolic
extract and EtOAc, n-BuOH, and H2 O subfractions (25 μg/mL, gray bar, or 100 μg/mL, black bar) were
used. (B) EtOAc and Fr. A to I subfractions (50 μg/mL, black bar) were used. (C) Fr. D and D-1 to D-6
subfractions (10 μg/mL, hatch bar, 25 μg/mL, gray bar, or 50 μg/mL, black bar) were used. Supernatants
were collected 6 h after the treatment. The production of cytokines (TNF-α and IL-6) was measured by
ELISA. The data shown are the mean ± SD of three independent experiments; ### p < 0.001; * p < 0.05;
** p < 0.01; *** p < 0.001 (Scheffe’s test) for comparisons of the treated and untreated LPS-stimulated
DC samples.
2.2. Bioactivity-Guided Fractionation and NMR-Based Identification of the EtOAc-Soluble Fraction of UCME
The EtOAc-soluble fraction of UCME was subjected to silica gel column chromatography
(EtOAc/n-hexane/MeOH, gradient), and each collected fraction was analyzed by thin-layer
chromatography (TLC) and assign to one of nine main fractions (Fr. A to I, Figure 2).
Foods 2019, 8, 543
Figure 2. Bioactivity-guided fractionation and NMR-based identification of genistein from the roots of
Uraria crinita (UC). * indicates the most potent subfractions or constituents against pro-inflammatory
cytokine production in lipopolysaccharide (LPS)-stimulated DCs. UCME: UC root methanolic extract,
BMDCs: bone marrow-derived dendritic cells.
Foods 2019, 8, 543
Among them, fraction D significantly inhibited the production of TNF-α and IL-6 in BMDC
(Figure 1B). Furthermore, the subfractions D-4 and D-5 from fraction D indicated the most potent
inhibitory effects against DC activation (Figure 1C).
In order to elucidate the association between bioactivity and metabolites in subfractions D-1 to D-6,
1 H NMR spectroscopy was conducted (Figure 3). This could offer structural elucidation, achieved by
the chemical shift, multiplicity, coupling constant, and integration of metabolite signals in the mixtures.
Figure 3. Selected 1 H NMR profiling (acetone-d6 , 500 MHz) of subfractions D-1 to D-6. * indicates
the characteristic singlet signals, δH 8.13, of isoflavones; ↓ indicates the 1 H spectral data of genistein:
δH 7.44 (2H, d, J = 8.7 Hz), 6.88–6.94 (overlaps), 6.40 (1H, d, J = 2.2 Hz), and 6.28 (1H, d, J = 2.2 Hz).
According to the 1 H NMR profiling of subfractions D-1 to D-6, the characteristic singlet signals
(δH 8.13) indicated the presence of isoflavonoids in D-3, D-4, D-5, and D-6. The inhibitory activity
of subfractions D-4 and D-5 was then related to the additional signals [δH 7.44 (2H, d, J = 8.7 Hz),
6.88–6.94 (overlaps), 6.40 (1H, d, J = 2.2 Hz), and 6.28 (1H, d, J = 2.2 Hz)], which were not visible
for subfractions D-3 and D-6. A pair of aromatic protons with a meta coupling (J = 2.2 Hz) indicated
the presence of a 1,3,4,5-tetrasubstituted aromatic ring. An aromatic proton signal at δH 7.44 (2H, d,
J = 8.7 Hz) revealed that the other proton signal might be overlapping at δH 6.88–6.94 ppm, suggestive
of a 1,4-disubstituted aromatic ring. To determine the overlapping peaks at δH 6.88–6.94 ppm, the 13 C
NMR and 2D NMR experiments (Figures S1–S3), including heteronuclear single-quantum correlation
(HSQC) and heteronuclear multiple-bond correlation (HMBC), were then conducted. On the basis of
these results, genistein was identified [17] from the genistein-containing subfractions (D-4 and D-5).
Bioactive fractions, together with the active ingredient, were rapidly obtained from the combination of
bioactivity-guided fractionation and NMR-based identification of the UCME EtOAc-soluble fraction.
Foods 2019, 8, 543
Figure 4. The effects of the subfractions, containing or not containing genistein, on the production of
pro-inflammatory cytokines in LPS-stimulated DCs. (A) DCs were untreated or treated with LPS (100
ng/mL, white bar), LPS + genistein-containing subfractions, or LPS + genistein-knockout subfractions
(25 μg/mL, gray bar or 50 μg/mL, black bar), as indicated. Supernatants were collected 6 h after the
treatment. The production of cytokines (TNF-α and IL-6) was measured by ELISA. The data shown are
the mean ± SD of three independent experiments. ### p < 0.001; * p < 0.05; ** p < 0.01; *** p < 0.001
(Scheffe’s test) for comparisons of the treated and untreated LPS-stimulated DCs. (B) The inhibition
percentage (%) of the subfractions, with and without genistein, of cytokine production was derived
from the data in (A).
In addition to the identification of genistein, the fractionation and HPLC isolation of UCME
identified eight compounds, including an isoflavone (lupinalbin A [18]), three phenolic acids
(p-hydroxybenzoic acid [19], salicylic acid [20], and vanillic acid [19]), two fatty acids (monomethyl
succinate [21] and 1,10-decanedioic acid [22]), and two steroids (a mixture of β-sitosterol and
stigmasterol [23]). Their structures (Figure 5) were identified by comparing their spectroscopic
data with data in the literature. Among the isolates, lupinalbin A, p-hydroxybenzoic acid, vanillic
Foods 2019, 8, 543
acid, monomethyl succinate, and monomethyl succinate were isolated from this herb for the first time.
All isolates were also assessed in terms of their inhibitory effect on DC activation. However, only the
analogue of genistein, lupinalbin A, showed a moderate inhibitory activity against LPS-stimulated DC
activation (Figures S5 and S6).
1 H NMR signal intensity is absolutely proportional to the relative number of protons. Therefore,
the relative quantity of the different metabolites could easily be observed in the 1 H NMR spectra
(Figure 3). The major metabolites (identified by signals with a stronger intensity) in subfractions
D-4 and D-5 are shown in Table 1. Interestingly, the 1 H NMR profiling of subfractions D-4 and
D-5 revealed the presence of other unknown genistein derivatives, which might contribute slightly
to the immunomodulatory effects, because of their low abundance or poor activity. Additionally,
the well-known bioactive isoflavonoids, including daidzein, formononetin, equol, and glycitein, were
not present as major metabolites in fraction D. Therefore, genistein was suggested as having the central
role in the modulation by UCME of LPS-stimulated DC activation.
(TNF-α, IL-6, and IL-12) was suppressed by genistein below 20 μM, suggesting that genistein possesses
an immunosuppressive activity. Therefore, we selected concentrations below 20 μM of genistein
for further assessment of DC maturation. The complex process of DC maturation is accompanied
by the upregulation of the expression of MHC class II molecules and three major co-stimulatory
molecules (CD40, CD80, and CD86) on the surface of DCs. As shown in Figure 7, LPS stimulation
upregulated the expression of MHC class II and also of the co-stimulatory molecules (CD40, CD80,
and CD86) in DCs, while genistein treatment significantly decreased the expression levels of all these
molecules. These data indicated that genistein indeed impaired LPS-stimulated DC maturation at
non-cytotoxic concentrations.
Table 1. Chemical shifts (δH ) and assignment of major compounds present in the D-4 and
D-5 subfractions.
Figure 6. The effect of genistein on cell viability (A) and the production of pro-inflammatory cytokines
in LPS-stimulated DCs (B, C, and D). (A) DCs were treated with genistein at various concentrations for
24 hours, and then their viability was measured by the CCK-8 assay (Sigma). DCs were untreated or
treated with LPS (100 ng/mL) and LPS + genistein (2.5, 5, 10, 20, and 40 μM), as indicated. Supernatants
were collected 6 h after treatment. The production of the cytokines TNF-α (B), IL-6 (C), and IL-12p70
(D) was measured by ELISA. The data shown are the mean ± SD of three independent experiments.
### p < 0.001; * p < 0.05; ** p < 0.01; *** p < 0.001 (Scheffe’s test) for comparisons of the genistein-treated
Isoflavones, including genistein, daidzein, and glycitein, are generally found in leguminous plants
and have been reported as antioxidants and immunosuppressant agents, capable of suppressing the
allergic sensitization to peanuts by regulating human monocyte-derived dendritic cell function [24].
The majority of the dietary isoflavonoids are present in inactive glycosides forms (e.g., genistin) and then
converted to active aglycone forms (e.g., genistein) by the bacterial microbiote in the digestive tract. Thus,
DCs have direct access to dietary antigens and are therefore poised to uptake isoflavones directly from
the lumen [24]. Previously, genistein was shown to have promising activities, such as neuroprotective
effects by improving hippocampus neuronal cell viability and proliferation in vitro [25], antioxidant
capacity by regulating β-oxidation and energy metabolism in vivo [26], and anti-inflammatory effects by
inhibiting the ERK pathway [27] and NF-κB-dependent gene expression in TLR4-stimulated DCs [28].
In this study, the association between genistein and the immunomodulatory effect of UCME was
carefully elucidated through the combination of bioactivity-guided fractionation and NMR-based
identification. An 1 H NMR-based metabolomics approach was applied to partially purified
subfractions D-1 to D-6 from UCME. 1 H NMR profiling suggested the presence of genistein in
the D-4 and D-5 subfractions, which exhibited a stronger inhibitory activity against cytokine
production in LPS-stimulated DCs. Genistein was therefore supposed to be a possible marker
of the immunosuppressive activity of UCME. This suggestion was supported by the results of
the genistein-knockout subfractions, which showed a much lower inhibitory activity. Moreover,
HPLC isolation of the D-4 and D-5 subfractions provided other compounds with poor inhibitory
activity. On the basis of this evidence, genistein could be used as a chemical marker for the quality
control of the potentially immunosuppressive functional food UC roots. A literature survey disclosed
that the 1 H NMR-based metabolomics approach for screening bioactive secondary metabolites has not
been widely used [29,30]. Our study provides a powerful tool for discovering the active ingredients
in immunosuppressive functional foods. This approach can be applied for investigating the active
ingredients of herbal products.
Foods 2019, 8, 543
3.3. HPLC Conditions Used for the D-4 and D-5 Subfractions
D-4 and D-5 were isolated by semipreparative HPLC (dichloromethane/acetone = 85/15,
flow rate = 3 mL/min) to obtain the genistein-knockout subfractions D-4 w/o, D-5 w/o and genistein
(24.0 mg, tR = 8.0 min). The genistein-knockout subfractions D-4 w/o and D-5 w/o were further
isolated by semipreparative HPLC (n-hexane/acetone = 2/1, flowrate = 3 mL/min) to obtain salicylic
acid (tR = 8.3 min), lupinalbin A (tR = 11.0 min), 1,10-decanedioic acid (tR = 11.3 min), monomethyl
succinate (tR = 13.2 min), p-hydroxybenzoic acid (tR = 16.7 min), and vanillic acid (tR = 18.5 min).
and IL-4 (Peprotech). On day 3 and 5, a 2 mL/well fresh medium containing 10 ng/mL GM-CSF and
IL-4 was added. On day 7, BMDCs (> 80% CD11c+ cells) were harvested and used for all experiments.
4. Conclusions
In the present study, we assessed the effect of UC roots on the immune function of DCs and found
that the immunomodulatory effect of UCME was mainly associated with its EtOAc-soluble fraction.
After one-step chromatography, genistein was rapidly identified by the 1 H NMR profiling of the
immunomodulatory subfractions (D-4 and D-5). The central role of genistein in the immunomodulatory
activity of UC roots was supported by the result that the genistein-knockout subfractions (D-4 w/o and
D-5 w/o) had a lower inhibitory activity.
Importantly, this work elucidates a rapid strategy for identifying immunomodulatory
phytochemicals, distinguishing the chemical marker(s) for quality control and providing a rationale
for the traditional immunomodulatory use of UC roots. The findings indicated that UC roots can
potentially be used as an immunosuppressive functional food, of which genistein can be a chemical
marker for quality control. In conclusion, our strategy will help in the standardization of U. crinita
roots, a famous Taiwanese functional food.
Author Contributions: Conceptualization, M.-K.L. and M.-S.L.; methodology, Y.-H.K. and M.-K.L.; investigation,
P.-C.T., C.-J.C., and Y.-C.L.; resources, Y.-H.K., M.-S.L., and M.-K.L.; writing—original draft preparation, P.-C.T.
and C.-J.C.; writing—review and editing, P.-C.T., M.-K.L., and M.-S.L.; supervision, M.-K.L. and M.-S.L.
Funding: This research was funded by grants from China Medical University and the Ministry Science and
Technology of Taiwan, ROC (grant number, CMU 107-5-49 and MOST 107-2313-B-039-001).
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
CCK-8 Cell-Counting Kit-8
CD co-stimulatory molecules
ERK extracellular-regulated protein kinases
GM-CSF granulocyte-macrophage colony-stimulating factor
HSQC heteronuclear single-quantum correlation
HMBC heteronuclear multiple-bond correlation
IL interleukin
MHC major histocompatibility complex molecules
MS mass spectrometry
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
NMR nuclear magnetic resonance spectroscopy
TNF-α tumor necrosis factor alpha
TLRs Toll-like receptors
References
1. Liu, S.Y.; Liou, P.C.; Wang, J.Y.; Shyu, Y.T.; Hu, M.F.; Chang, Y.M.; Shieh, J.I. Production and electrophoretic
analysis of medical plants in Taiwan. In Proceeding of a Symposium on Development and Utilization of Resources of
Medicinal Plants in Taiwan; Tu, C.C., Lu, H.S., Liu, S.Y., Eds.; Taiwan Agricultural Research Institute: Taichung,
Taiwan, 1995; pp. 149–188.
2. Yen, G.C.; Lai, H.H.; Chou, H.Y. Nitric oxide-scavenging and antioxidant effects of Uraria crinita root.
Food Chem. 2001, 74, 471–478. [CrossRef]
3. Liu, X.P.; Cao, Y.; Kong, H.Y.; Zhu, W.F.; Wang, G.; Zhang, J.J.; Qiu, Y.C.; Pang, J.X. Antihyperglycemic and
antihyperlipidemic effect of Uraria crinita water extract in diabetic mice induced by STZ and food. J. Med.
Plants Res. 2010, 4, 370–374.
4. Mao, Y.W.; Lin, R.D.; Hung, H.C.; Lee, M.H. Stimulation of osteogenic activity in human osteoblast cells by
edible Uraria crinita. J. Agric. Food Chem. 2014, 62, 5581–5588. [CrossRef] [PubMed]
5. Okawa, M.; Akahoshi, R.; Kawasaki, K.; Nakano, D.; Tsuchihashi, R.; Kinjo, J.; Nohara, T. Two new triterpene
glycosides in the roots of Uraria crinita. Chem Pharm Bull. 2019, 67, 159–162. [CrossRef]
6. Wang, Y.Y.; Zhang, X.Q.; Gong, L.M.; Ruan, H.L.; Pi, H.F.; Zhang, Y.H. Studies on chemical constituents in
roots of Uraria crinita. Chin. Pharm. J. 2009, 44, 1217–1220.
7. Rossi, M.; Young, J.W. Human dendritic cells: Potent antigen-presenting cells at the crossroads of innate and
adaptive immunity. J. Immunol. 2005, 175, 1373–1381. [CrossRef]
8. Blanco, P.; Palucka, A.K.; Pascual, V.; Banchereau, J. Dendritic cells and cytokines in human inflammatory
and autoimmune diseases. Cytokine Growth Factor Rev. 2008, 19, 41–52. [CrossRef]
9. Kim, S.K.; Yun, C.H.; Han, S.H. Induction of dendritic cell maturation and activation by a potential adjuvant,
2-hydroxypropyl-β-Cyclodextrin. Front. Immunol. 2016, 7, 435. [CrossRef]
10. Heyman, H.M.; Meyer, J.J.M. NMR-based metabolomics as a quality control tool for herbal products. S. Afr.
J. Bot. 2012, 82, 21–32. [CrossRef]
11. van der Kooy, F.; Maltese, F.; Choi, Y.H.; Kim, H.K.; Verpoorte, R. Quality control of herbal material and
phytopharmaceuticals with MS and NMR based metabolic fingerprinting. Planta Med. 2009, 75, 763–775.
[CrossRef]
Foods 2019, 8, 543
12. Kumar Bharti, S.; Roy, R. Metabolite identification in NMR-based metabolomics. Curr. Metabol. 2014, 2,
163–173. [CrossRef]
13. Hussin, M.; Abdul Hamid, A.; Abas, F.; Ramli, N.S.; Jaafar, A.H.; Roowi, S.; Majid, N.A.; Pak Dek, M.S.
NMR-based metabolomics profiling for radical scavenging and anti-aging properties of selected herbs.
Molecules 2019, 24, 3208. [CrossRef] [PubMed]
14. Mediani, A.; Abas, F.; Maulidiani, M.; Khatib, A.; Tan, C.P.; Ismail, I.S.; Shaari, K.; Ismail, A. Characterization
of metabolite profile in Phyllanthus niruri and correlation with bioactivity elucidated by nuclear magnetic
resonance based metabolomics. Molecules 2017, 22, 902. [CrossRef] [PubMed]
15. Pontes, J.G.M.; Brasil, A.J.M.; Cruz, G.C.F.; de Souza, R.N.; Tasic, L. NMR-based metabolomics strategies:
Plants, animals and humans. Anal. Methods 2017, 9, 1078–1096. [CrossRef]
16. Zhang, L.; Hatzakis, E.; Patterson, A.D. NMR-based metabolomics and its application in drug metabolism
and cancer research. Curr. Pharmacol. Rep. 2016, 2, 231–240. [CrossRef]
17. Ma, Q.; Liu, Y.; Zhan, R.; Chen, Y. A new isoflavanone from the trunk of Horsfieldia pandurifolia. Nat. Prod.
Res. 2016, 30, 131–137. [CrossRef]
18. Tsukayama, M.; Oda, A.; Kawamura, Y.; Nishiuchi, M.; Yamashita, K. Facile synthesis
of polyhydroxycoumaronochromones with quinones: Synthesis of alkylpolyhydroxy- and
alkoxycoumaronochromones from 2 -hydroxyisoflavones. Tetrahedron Lett. 2001, 42, 6163–6166. [CrossRef]
19. Ni, J.C.; Shi, J.T.; Tan, Q.W.; Chen, Q.J. Phenylpropionamides, piperidine, and phenolic derivatives from the
fruit of Ailanthus altissima. Molecules 2017, 22, 2017. [CrossRef]
20. Zhang, Y.H.; Yu, J.Q. Pd(II)-catalyzed hydroxylation of arenes with 1 atm of O2 or air. J. Am. Chem. Soc. 2009,
131, 14654–14655. [CrossRef]
21. Wu, D.W.; Liang, Q.L.; Zhang, X.L.; Jiang, Z.; Fan, X.H.; Yue, W.; Wu, Q.N. New isocoumarin and stilbenoid
derivatives from the tubers of Sparganium stoloniferum (Buch.-Ham.). Nat. Prod. Res. 2017, 31, 131–137.
[CrossRef]
22. Schievano, E.; Morelato, E.; Facchin, C.; Mammi, S. Characterization of markers of botanical origin and other
compounds extracted from unifloral honeys. J. Agric. Food Chem. 2013, 61, 1747–1755. [CrossRef] [PubMed]
23. Liu, X.; Yin, C.; Cao, Y.; Zhou, J.; Wu, T.; Cheng, Z. Chemical constituents from Gueldenstaedtia verna and their
anti-inflammatory activity. Nat. Prod. Res. 2018, 32, 1145–1149. [CrossRef] [PubMed]
24. Masilamani, M.; Wei, J.; Bhatt, S.; Paul, M.; Yakir, S.; Sampson, H.A. Soybean isoflavones regulate dendritic
cell function and suppress allergic sensitization to peanut. J. Allergy Clin. Immunol. 2011, 128, 1242–1250.
[CrossRef] [PubMed]
25. Pan, M.; Han, H.; Zhong, C.; Geng, Q. Effects of genistein and daidzein on hippocampus neuronal cell
proliferation and BDNF expression in H19-7 neural cell line. J. Nutr. Health Aging 2012, 16, 389–394.
[CrossRef] [PubMed]
26. Lv, Z.; Xing, K.; Li, G.; Liu, D.; Guo, Y. Dietary genistein alleviates lipid metabolism disorder and inflammatory
response in laying hens with fatty liver syndrome. Front. Physiol. 2018, 9, 1493. [CrossRef]
27. Kim, D.H.; Jung, W.S.; Kim, M.E.; Lee, H.W.; Youn, H.Y.; Seon, J.K.; Lee, H.N.; Lee, J.S. Genistein inhibits
proinflammatory cytokines in human mast cell activation through the inhibition of the ERK pathway. Int. J.
Mol. Med. 2014, 34, 1669–1674. [CrossRef]
28. Dijsselbloem, N.; Goriely, S.; Albarani, V.; Gerlo, S.; Francoz, S.; Marine, J.C.; Goldman, M.; Haegeman, G.;
Vanden Berghe, W. A critical role for p53 in the control of NF-KB-dependent gene expression in
TLR4-stimulated dendritic cells exposed to genistein. J. Immunol. 2007, 178, 5048–5057. [CrossRef]
29. Graziani, V.; Scognamiglio, M.; Belli, V.; Esposito, A.; D’Abrosca, B.; Chambery, A.; Russo, R.; Panella, M.;
Russo, A.; Ciardiello, F.; et al. Metabolomic approach for a rapid identification of natural products with
cytotoxic activity against human colorectal cancer cells. Sci. Rep. 2018, 8, 5309. [CrossRef]
30. Freire, R.T.; Bero, J.; Beaufay, C.; Selegato, D.M.; Coqueiro, A.; Choi, Y.H.; Quetin-Leclercq, J. Identification of
antiplasmodial triterpenes from Keetia species using NMR-based metabolic profiling. Metabolomics 2019, 15,
27. [CrossRef]
Foods 2019, 8, 543
31. Lin, M.K.; Yu, Y.L.; Chen, K.C.; Chang, W.T.; Lee, M.S.; Yang, M.J.; Cheng, H.C.; Liu, C.H.; Chen Dz, C.;
Chu, C.L. Kaempferol from Semen cuscutae attenuates the immune function of dendritic cells. Immunobiology
2011, 216, 1103–1109. [CrossRef]
32. Lin, C.H.; Lin, S.H.; Lin, C.C.; Liu, Y.C.; Chen, C.J.; Chu, C.L.; Huang, H.C.; Lin, M.K. Inhibitory effect of
clove methanolic extract and eugenol on dendritic cell functions. J. Funct. Foods 2016, 27, 439–447. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
The Essential Oil and Hydrolats from Myristica
fragrans Seeds with Magnesium Aluminometasilicate
as Excipient: Antioxidant, Antibacterial, and
Anti-inflammatory Activity
Inga Matulyte 1,2 , Aiste Jekabsone 2 , Lina Jankauskaite 2,3 , Paulina Zavistanaviciute 4 ,
Vytaute Sakiene 4 , Elena Bartkiene 4 , Modestas Ruzauskas 5 , Dalia M. Kopustinskiene 2 ,
Antonello Santini 6, * and Jurga Bernatoniene 1,2
1 Department of Drug Technology and Social Pharmacy, Lithuanian University of Health Sciences,
LT-50161 Kaunas, Lithuania; inga.matulyte@lsmuni.lt (I.M.); jurga.bernatoniene@lsmuni.lt (J.B.)
2 Institute of Pharmaceutical Technologies, Medical Academy, Lithuanian University of Health Sciences,
LT-50161 Kaunas, Lithuania; aiste.jekabsone@lsmuni.lt (A.J.); lina.jankauskaite@lsmuni.lt (L.J.);
daliamarija.kopustinskiene@lsmuni.lt (D.M.K.)
3 Department of Pediatrics, Lithuanian University of Health Sciences Hospital Kauno Klinikos,
LT-50161 Kaunas, Lithuania
4 Department of Food Safety and Quality, Lithuanian University of Health Sciences, LT-47181 Kaunas,
Lithuania; paulina.zavistanaviciute@lsmuni.lt (P.Z.); vytaute.sakiene@lsmuni.lt (V.S.);
elena.bartkiene@lsmuni.lt (E.B.)
5 Institute of Microbiology and Virology, Lithuanian University of Health Sciences, LT-47181 Kaunas,
Lithuania; modestas.ruzauskas@lsmuni.lt
6 Department of Pharmacy, University of Napoli Federico II, Via D. Montesano 49, 80131 Napoli, Italy
* Correspondence: asantini@unina.it
Abstract: Nutmeg (Myristica fragrans) essential oil has antimicrobial, antiseptic, antiparasitic,
anti-inflammatory, and antioxidant properties. We have recently demonstrated that hydrodistillation
of nutmeg essential oil by applying magnesium aluminometasilicate as an excipient significantly
increases both the content and amount of bioactive substances in the oil and hydrolats. In this
study, we aimed to compare the antioxidant, antimicrobial, and anti-inflammatory activity of
hydrolats and essential oil obtained by hydrodistillation in the presence and absence of magnesium
aluminometasilicate as an excipient. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging
method revealed that magnesium aluminometasilicate did not significantly improved antioxidant
activity of both essential oil and hydrolat. Antibacterial efficiency was evaluated by monitoring growth
of 15 bacterial strains treated by a range of dilutions of the essential oil and the hydrolats. Essential oil
with an excipient completely inhibited the growth of E. faecalis, S. mutans (referent), and P. multocida,
whereas the pure oil was only efficient against the latter strain. Finally, the anti-inflammatory
properties of the substances were assessed in a fibroblast cell culture treated with viral dsRNR mimetic
Poly I:C. The essential oil with an excipient protected cells against Poly I:C-induced necrosis more
efficiently compared to pure essential oil. Also, both the oil and the hydrolats with aluminometasilicate
were more efficient in preventing IL-6 release in the presence of Poly I:C. Our results show that the
use of magnesium aluminometasilicate as an excipient might change and in some cases improve the
biological activities of nutmeg essential oil and hydrolats.
Keywords: nutmeg; essential oil; antioxidant activity; antibacterial activity; poly I:C-induced
inflammation; fibroblasts; magnesium aluminometasilicate
1. Introduction
Since ancient times, Myristica fragrans (nutmeg) seeds have been used as a food spice, flavoring
agent, a natural remedy for headaches and fever [1]. Nutmeg seeds have essential and fatty oils, resins,
wax, and other components [2]. Nutmeg’s essential oil has antimicrobial, antiseptic, antiparasitic,
anti-inflammatory, and antioxidant properties [1,3]. The concentration of essential oil in nutmeg seeds
is about 5–15% [4], and its major components are terpene hydrocarbons (sabinene, pinene, camphene,
p-cymene, phellandrene, terpinene, limonene, and myrcene altogether make up 60% to 80% of the oil),
oxygenated terpenes (linalool, geraniol, and terpineol, which make up approximately 5% to 15%) and
aromatic ethers (myristicin, elemicin, safrole, eugenol, and eugenol derivatives, together constituting
15 to 20%) [5–8]. The toxicity of nutmeg seeds at high doses has been reported, mainly due to myristicin
oil and elemicin, causing tachycardia, nausea, vomiting, agitation, and hallucinations. However, these
effects are related to the abuse of the spice and are not observed at usual low concentrations [9]. There
are many studies on the beneficial effects of nutmeg seed and various nutmeg seed extracts. One of the
most prominent biological activities of the nutmeg preparations is antibacterial. Nutmeg seed lignans
exert antimicrobial activity on Bacillus subtilis, Staphylococcus aureus, and Shigella dysenteriae [10]. Ethanol
and acetone extracts of nutmeg crust have strong antibacterial activity against gram-positive bacteria
Staphylococcus aureus [5]. Ethyl acetate extracts of flesh of the nutmeg fruit have inhibitory potential
against both gram-positive and gram-negative bacteria with a minimum inhibitory concentration (MIC)
ranging from 0.625 to 1.25 mg/mL [11]. Used for the preservation of sweets, nutmeg methanol extracts
inhibit growth of Staphylococcus aureus, Aspergillus niger, Saccharomyces cerevisiae, and Escherichia coli
at MIC between 250 and 300 mg/mL [12]. However, there are only a few studies on the biological
activity of nutmeg essential oil. Takikawa et al. showed a higher antibacterial effect of essential nutmeg
oil on pathogenic compared to non-pathogenic strains of Escherichia coli [13]. Furthermore, nutmeg
essential oil decreased the growth and survival of Yersinia enterocolitica and Listeria monocytogenes in
broth culture [14].
Nutmeg oil preparations are also known for their antioxidant capacity. Using the 2,2-diphenyl-1-
picrylhydrazyl (DPPH) free radical scavenging assay, Piaru et al. reported a significant antioxidant
activity of nutmeg oil [15]. The antioxidant properties are often related to the alleviation of inflammation.
Nutmeg oil diminished chronic inflammation and pain through the inhibition of COX-2 expression
and substance P release in vivo [16]. In another study, nutmeg oil suppressed reactive oxygen species
(ROS) production in human neutrophils stimulated by PMA (phorbol 12-myristate 13-acetate) [17] and
mildly inhibited phagocytosis in human neutrophils [18]. However, there is no published research on
the effect of nutmeg seed essential oil on virus-triggered inflammatory response.
Hydrodistillation is a popular method used for the preparation of essential oils. However,
hydrodistillation with excipients is not widely used—we have found just three studies applying this
method so far [19–21]. Therefore, we have applied magnesium aluminometasilicate in hydrodistillation
as the new excipient and have tested its effects on the nutmeg essential oil yield and its composition [22].
Aluminometasilicate is widely used as a disintegrator in the manufacturing of tablets. Furthermore,
this compound is non-toxic and inexpensive, as the price is ~300 eur for 25 kg. Magnesium
aluminometasilicate has significantly increased both the yield and composition of some chemical
compounds (sabinene, α-pinene, and limonene). The use of the excipient also increased the essential oil
yield by about 61% (hydrodistillation with water—the yield is 0.79 ± 0.04 g, using 1% excipient—1.29
± 0.05 g; the nutmeg quantity was 15 g, the water content was 300 mL) [22].
The increased amount of active substances suggests that oil preparations with aluminometasilicate
might have stronger biological activities. Therefore, in this study we compared the antioxidant,
antimicrobial, and anti-inflammatory properties of Myristica fragrans seed essential oil preparations
with and without aluminometasilicate.
Foods 2020, 9, 37
Acontrol − Asample
DPPH scavenging e f f ect % = × 100, (1)
Acontrol
where Acontrol and Asample are the absorbance of the control sample (0.1 mM DPPH solution, solvent is
96% ethanol) and the experiment sample.
3. Results
First, the antioxidant activity in essential oils was compared. The two samples of each category
were analyzed: the essential oil without excipient, or pure essential oil (EO1), and essential oil with 1%
of magnesium aluminometasilicate (EO2). The results are presented in Table 1. The range of essential
oil concentration in this examination was from 0.2 to 20%.
At small quantities of up to 0.3 mL, the antioxidant activities of both hydrolat preparations were
similar, but at 0.5 mL and 1 mL, the EOH1 antioxidant activity was significantly higher compared to
that of EOH2. EOH1 at 1 mL had an antioxidant activity greater than 50%, and this activity level was
similar to 5%–10% of EO1 activity. The results show that free radical scavenging activity of 0.2 mL of
hydrolat is higher than that of 1% or less concentrated essential oil.
Summarizing the antioxidant activity results, magnesium aluminometasilicate did not improve,
and even slightly decreased the antioxidant activity of nutmeg essential oil and its hydrolat.
Next in the study, antibacterial properties of nutmeg essential oil and hydrolats were investigated
on 15 pathogenic clinical isolate strains by using a dilution range assay. The results are presented in
Table 3.
Table 3. Antimicrobial study results of nutmeg essential oil and its hydrolats.
Microorganisms
Sample
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
EO1 + + + + + + + + + + + + + + 0.2
EO2 + + + + + + 0.5 + + ≤0.1 + + + + 0.2
EOH1 + + + + + + + + + + + + + + +
EOH2 + + + + + + + + + 0.5 + + + + +
+ means the pathogens growth. 1. Klebsiella pneumoniae, 2. Salmonella enterica 24 SPn06, 3. Pseudomonas
aeruginosa 17-331, 4. Acinetobacter baumanni 17-380, 5. Proteus mirabilis, 6. 6MRSA M87fox, 7. Enterococcus
faecalis 86, 8. Enterococcus faecium 103, 9. Bacillus cereus 18 01, 10. Streptococcus mutans (referent), 11. Enterobacter
cloacae, 12. Citrobacter freundii, 13. Staphylococcus epidermidis, 14. Staphylococcus haemolyticus, 15. Pasteurella
multocida. Where the growth of bacteria were inhibited, minimal inhibitory concentrations were provided in %.
EO1 only suppressed Pasteurella multocida growth, with the minimal concentration to achieve
this effect being 0.2%. However, nutmeg essential oil with 1% of magnesium aluminometasilicate
(EO2) had a broader effect. Next to P. multocida, it inhibited E. faecalis and S. mutans, and the efficient
concentrations were rather low. A mere 0.5% was enough to completely suppress E. faecalis, and
for the S. mutans strain even less than 0.1% was effective. In the case of EOH1 and EOH2, only the
hydrolat with aluminometasilicate suppressed the growth of S. mutans. Thus, the results indicate
that the excipient magnesium aluminometasilicate broadens the spectrum of antimicrobial activity of
nutmeg essential oil.
One of the most important pharmacological activities of plant essential oils is related to
anti-inflammatory properties. Nutmeg essential oil is also known for inflammation reducing
activity [24]. Therefore, next in the study, we have assessed nutmeg seed essential oil and hydrolat
Foods 2020, 9, 37
preparations in a virus mimetic Poly I:C-induced inflammation in vitro model by using human
fibroblast cell culture. Before starting the treatments, the general toxicity test of the oils and hydrolats
was performed and LD50 doses as well as safe concentrations were established.
As indicated in Figure 1a, there were no significant difference in cell viability detected after
treatment with both EO1 and EO2 essential oil solutions up to the dilution ratio 1:100. Further increases
in concentration up to the dilution ratio 1:40 significantly decreased viability of the fibroblasts. After
treatment with essential oil solutions at 1:40, the viability dropped from 97 ± 2% in control to 70 ± 12%
in the case of EO1, and to 42 ± 10% in the case of EO2. At the dilution ratio of 1:5, the percentage of
viable cells in the cultures was lower than 10% in the case of both essential oil preparations. The dilution
ratios corresponding to LD50 calculated for EO1, EO2, and 96% ethanol were 0.047, 0.022, and 0.055,
respectively. Thus, EO2 was significantly more toxic for the cells compared to EO1, and also to ethanol.
In contrast, the toxicity pattern of EO1 was very close to that of ethanol, indicating there were no or
very little toxic compounds in this essential oil preparation.
Figure 1. The effect of nutmeg essential oil ethanol solutions (a) and nutmeg essential oil hydrolats (b)
on viability of cultured human fibroblasts. EO1—essential oil without excipient solution, EO2—essential
oil with 1% magnesium aluminometasilicate solution, EOH1—hydrolat from EO1, and EOH2—hydrolat
from EO2. In addition, 96% ethanol was assessed as solvent control for the essential oil. Punctured
lines indicate the dilution ratios corresponding to LD50 . *—statistically significant difference compared
to untreated control, #—compared to EO1 in (a) or EOH1 in (b), respectively, when p < 0.05.
Evaluation of cell viability after 24 h treatment with nutmeg seed essential oil hydrolats revealed
that both EOH1 and EOH2 were not toxic up to a dilution of 1:20 (Figure 1b). After cell incubation with
1:10 EOH2, the percentage of viable cells in the cultures decreased to 57 ± 19%, making a significant
difference compared with the untreated control. A significant viability drop in EOH1 treatment series
was achieved when the dilution ratio 1:5 was applied. The level of viable cells in this treated cultures
was 44 ± 14%. After treatment with EOH1 and EOH2 at the ratio 1:2, nearly all cells in the cultures
were found to be necrotic. The dilution ratios corresponding to LD50 calculated for EOH1 and EOH2
were 0.160 and 0.105, respectively. Toxicity evaluation of the hydrolats indicated that EOH2 is slightly
more toxic compared to EOH1.
The next task in this work was to evaluate the efficiency of nutmeg seed essential oil and hydrolat
preparations to reduce toxicity and signaling in viral inflammation in vitro model. To stimulate
inflammatory response, human fibroblast cell culture was treated with 1 μg/mL virus double stranded
RNR mimetic polyinosinic: polycytidylic acid (Poly I:C) for 24 h, with or without nutmeg seed essential
oil solutions or hydrolats. After toxicity assessment, the dilution ratios selected for anti-inflammatory
property testing were 1:200 and 1:100 for the essential oil solutions, and 1:100 and 1:40 for the hydrolats.
Anti-inflammatory assessment results are presented in Figure 2.
Foods 2020, 9, 37
Figure 2. The effect of nutmeg seed essential oil ethanol solutions and the essential oil hydrolats on Poly
I:C-treated human fibroblast cell viability (a) and cytokine IL-6 release from the cells (b). EO1—essential
oil without the excipient solution, EO2—essential oil with 1% magnesium aluminometasilicate solution,
EOH1—hydrolat from EO1, and EOH2—hydrolat from EO2. *—statistically significant difference
compared to untreated control, #—compared to Poly I:C-only treatment, when p < 0.05; n = 5–7.
After fibroblast cell culture treatment with 1 mg/mL Poly I:C, the amount of viable cells decreased
by 59% (Figure 1a). Addition of nutmeg essential oil preparations to the cell culture medium increased
cell viability in the Poly I:C-affected cultures. Statistically significant differences compared with Poly
I:C samples were found after treatment with 1:200 EO1, 1:200 and 1:100 EO2, as well as 1:40 EOH1 and
1:40 EOH2. The percentages of viable nuclei in these samples were 81 ± 9%, 82 ± 16%, 76 ± 10%, 72 ±
14%, and 79 ± 12%, respectively. Thus, EO2 has demonstrated the highest cytoprotective capacity in a
virus mimetic inflammation model.
Evaluation of the release of IL-6 to the incubation medium revealed that after 24 h of Poly I:C
treatment, the level of this pro-inflammatory cytokine jumped from nearly a “zero” value to 883 ±
273 pg/mL (Figure 2b). Nutmeg essential oil preparations applied together with Poly I:C significantly
reduced the concentration of IL-6 in the medium. The significant drop in the IL-6 level was in the
samples incubated with 1:100 EO1, 1:200 and 1:100 EO2, 1:40 EOH1, and 1:100 and 1:40 EOH2. IL-6
concentration in these samples was found in the range between 162 ± 123 pg/mL (with 1:40 EOH2) and
206 ± 83 pg/mL (with 1:100 EO1). The assessment of IL-6 release indicates that both the solution of
nutmeg seed essential oil with magnesium aluminometasilicate and the hydrolat from this essential oil
are most efficient against Poly I:C-induced release of this inflammatory cytokine.
4. Discussion
The purpose of our study was to compare the biological activity of nutmeg seed essential oil
and hydrolat without excipient and using magnesium aluminometasilicate as the excipient. To our
knowledge, it is the first application of aluminometasilicate as an excipient in essential oil studies.
Essential oils have strong antioxidant activity, and some of them are used as preservation agents
protecting food or cosmetics from oxidation-induced spoilage [25,26]. Antioxidant activity studies
help to elucidate essential oil capacity to protect food from free radical damage [27]. The DPPH radical
scavenging method is widely used for this purpose because it is simple and cost-efficient, and gives
reliable results. Therefore, it was selected to evaluate the essential oil and hydrolat preparations in our
study. Our previous study [22] showed that magnesium aluminometasilicate had influence not only
on the yield of essential oil, but also on its chemical composition. Magnesium aluminometasilicate
significantly increased the quantity of sabinene, α-pinene, and limonene. Dai et al. (2013) study with
Wedella Prostrata essential oil (containing 11.38% limonene and 10.74% α-pinene) had a lower antioxidant
activity than 100 μg/mL limonene but a higher antioxidant activity than the pure α-pinene [28]. Such a
result suggests that limonene is a more prominent antioxidant compared to α-pinene. Our nutmeg seed
essential oil (EO2) had 11.66 ± 3.39% α-pinene and 4.91 ± 0.71% limonene [22]. Based on the results
of the study where the presence of limonenen together with α-pinene resulted in higher antioxidant
activity [28], we can predict that our EO2 has higher antioxidant activity than the pure α-pinene sample.
Foods 2020, 9, 37
The Juniperus scopulorum 10% essential oil had a 54.7% antioxidant activity (composition: sabinene
50.7%, α-pinene 3.23%, limonene 2.22%, cis sabinene hydrate 0.58%) [29]. Our study shows that 10%
essential oils EO1 and EO2 have 61.01 ± 0.26% and 62.11 ± 0.43% antioxidant activity, respectively.
Predominant compounds in EO2 were sabinene 61.42%, cis sabinene hydrate 0.3%, limonene 5.62%, and
α-pinene 15.05%. The EO1 essential oil had more β-pinene [22], which could increase its antioxidant
activity. Other authors have demonstrated nutmeg essential oil with higher antioxidant activity besides
α-pinene had also β-pinene [27]. Misharina et al. (2009) have also studied antioxidant properties of
nutmeg essential oil and found that 16.5% concentrated solution had approximately 50% antioxidant
activity [30]. Such differences may be due to the distinct technique of the research and the variation in
nutmeg seed material.
Hydrolats analyzed in our study had lower antioxidant activity compared to essential oils, most
likely because of the lower concentrations of volatile compounds. We have searched the literature data,
but could not find any studies about the antioxidant activity of nutmeg seed hydrolats so far. Hydrolats
prepared from other plant sources had different antioxidant properties. For example, Salvia officinalis
0.1 g/mL had about 30% radical scavenging activity. The same concentration of Rosmarinus officinalis
hydrolat had about 50% activity [31]. Our hydrolats (0.1 g/mL) had 31.43 ± 1.55% (EO1) and 27.24
± 1.63% (EO2) antioxidant activity—the same as Salvia officinalis. Nutmeg seeds hydrolats at the
highest concentration tested (0.5 g/mL) had 56.42% and 44.19% antioxidant activity (EOH1 and EOH2,
respectively).
Essential oils are known for bioactive compounds with antibacterial activity, therefore they are
used as antimicrobial agents in medicine, pharmacy, cosmetology, and other fields [18]. However,
different essential oils affect microorganisms in distinct ways—some suppress gram-positive effects,
others suppress gram-negative effects [19]. Also, the effective concentration of essential oils vary.
There are various methods for determining antibacterial activity (the agar disk-diffusion method,
antimicrobial gradient method, dilution methods, and other methods) [32]. Dilution methods are
the simplest methods used to determine whether the essential oil suppresses the growth of bacteria
or not [23]. There are many techniques and methods used for antimicrobial activity evaluation,
and therefore, it is difficult to compare the results obtained from the different studies. In our study,
the EO1 essential oil (0.2%) only suppressed Pasteurella multocida. The essential oil EO2 with a higher
quantity of sabinene, α-pinene, and limonene [22] had antimicrobial activity against three pathogens.
Next to P. multocida, it also prevented growth E. faecalis of and S. mutans. The increased efficiency
of EO2 against pathogenic strains can be explained by the higher quantity of volatile compounds.
Nurjanah et al.’s (2017) study showed (an in vitro disc diffusion antimicrobial activity method) that
Myristica fragrans essential oil (60% concentration was used) from Central Java inhibited the largest
areas [33]. The inhibition areas were from 12.96 mm to 16.79 mm, with the control at 0 mm (S. aureus,
S. dysenteriae, S. typhi, and S. epidermidis). In the essential oil used for the above-mentioned study,
sabinene, α-pinene, and β-pinene quantities were the highest out of all of the chemical compounds
(the concentrations were 18.82%, 16.54%, and 13.82, respectively). The essential oil EO2 investigated
in this study has a similar composition, meaning it could also be efficient against these pathogens
at higher concentrations. In another study, the nutmeg essential oil with similar quantity of volatile
compounds had a significant effect on the inhibition of the growth of E. coli and S. aureus [34]. In this
study, we found that essential oil EA2 (0.5%) inhibited E. faecalis. This bacteria resides in infected
canals of teeth and is often found in the oral cavity after tooth canal repair [35]. Repeated oral care
products with chlorhexidine promotes the development of E. faecalis resistance [36]. Since EA2 showed
activity against E. faecalis, nutmeg essential oil could be recommended as a safe protective component
for oral care products in the future.
The investigation of human fibroblast cell culture affected by virus mimetic Poly I:C showed
that nutmeg essential oils and hydrolats have an anti-inflammatory effect protecting cell viability
and significantly reducing the release of cytokine IL-6. EO2 had a higher effect on preventing Poly
I:C-induced necrosis and both EO2 and EOH2 more efficiently protected against IL-6 release compared
Foods 2020, 9, 37
to preparations without aluminometasilicate EO1 and EOH1. This is most likely due to the increased
amount and content of active substances (sabinene, α-pinene, and limonene) in the preparations that is
a result of the use of the excipient. α-Pinene significantly decreases the LPS-induced production of IL-6,
TNF-α and nitric oxide in bacterial lipopolysaccharide (LPS)-treated macrophages [37]. Sabinene from
Oenanthe crocata essential oil significantly inhibits nitric oxide production in LPS and IFNγ-treated
macrophages [38]. Limonene has a significantly decreased manifestation of inflammatory signals
in rat models of ulcerative colitis via regulation of iNOS, cyclooxygenase-2 (COX-2), PGE2, and
ERK [39]. However, there are not many studies about the anti-inflammatory effect of nutmeg essential
oil preparations. Zhang et al. have demonstrated the anti-inflammatory activity of nutmeg oil in
complete Freund’s adjuvant-injected rats [16]. Their study shows that nutmeg oil is effective in
inflammatory pain relief via inhibition of the COX-2 pathway and substance P release. Another in vivo
study exploring carrageenan-induced paw edema in rats have also confirmed the anti-inflammatory
properties of nutmeg oil [24]. To the best of our knowledge, there are no in vitro studies on virus-induced
anti-inflammatory activity of nutmeg oil. Dewi et al. have found that M. fragrans seed ethanolic extract
and pure quercetin extract from M. fragrans inhibited NO production and the release of inflammatory
cytokines, such as TNF-α, IL-6, and IL-1β from bacterial LPS-stimulated murine macrophages (RAW
264.7) in a dose-dependent manner. The essential oil of Monodora myristica was found to inhibit
inflammation-related lipoxygenase [40]. Because of the high content of bioactive volatile compounds,
which have been widely studied and characterized by gas chromatographic techniques [41] the
essential oils might be good candidates for inhalation treatment of respiratory tract infections. Most
common respiratory infections are induced by respiratory viruses, such as influenza or respiratory
syncytial virus [42]. As a result, we examined the anti-inflammatory efficiency of nutmeg essential oil
preparations in a virus mimetic Poly I:C mediated inflammation. Fibroblasts are multifunctional cells
that are responsible for support of other, more tissue-specific cell types, regeneration, wound healing,
extracellular matrix production, and inflammatory response [43]. They significantly contribute to the
response to infection by secreting cytokines for monocyte/macrophage attraction and their conversion
to inflammatory phenotype [44]. The release of IL-6 is one of the key inflammatory signals causing
activation of matrix metalloproteinases, macrophages, neutrophil production, and is also involved in
autoimmune responses in the condition such as chronic arthritis, osteoporosis, and psoriasis [41,45–48].
The results of our study indicate that nutmeg essential oil preparations have anti-inflammatory
properties that might be exploited further for treatment or prevention of viral inflammation-related
pathologies, taking the recent emerging nanotechnological and nutraceutical approaches in the field
into account [49–51]. However, to increase the applicability of these substances, more studies have to be
performed analyzing the mechanism of action of the essential compounds contained in the preparations.
5. Conclusions
Nutmeg essential oil prepared with and without magnesium aluminometasilicate as an excipient
has similar antioxidant activity. Nutmeg essential oil hydrolat prepared without excipient has a higher
antioxidant activity compared to that with magnesium aluminometasilicate as an excipient.
Nutmeg essential oil with aluminometasilicate has extended antibacterial properties compared to
the pure oil without additions. Both preparations prevent growth of P. multocida strain, but the oil with
aluminometasilicate also inhibits E. faecalis and S. mutans (referent).
Nutmeg essential oil preparations with aluminometasilicate have stronger anti-inflammatory
activity in Poly I:C-affected fibrolast cell culture. The oil with the excipient has a higher degree of
cytoprotection from Poly I:C-induced necrosis, and both the oil and hydrolats with excipient more
efficiently prevent IL-6 release compared to the preparations without aluminometasilicate.
The results show that the application of magnesium aluminometasilicate as an excipient in
hydrodistillation could help to increase the biological activity of essential oil and hydrolats.
Foods 2020, 9, 37
Author Contributions: Conceptualization, I.M. and J.B.; methodology, I.M., A.J., D.M.K., M.R., A.S. and
E.B.; validation, V.S., P.Z., J.B., A.S. and A.J.; investigation, I.M., L.J., P.Z., M.R. and V.S.; data curation, J.B.;
writing-original draft preparation, I.M., A.J., P.Z., D.M.K.; writing-review and editing, J.B. and I.M.; visualization,
L.J., I.M., G.L., A.S., V.S.; supervision, J.B. All authors have read and agreed to the published version of
the manuscript.
Funding: This research received no external funding.
Acknowledgments: The authors would like to thank Open Access Centre for the Advanced Pharmaceutical
and Health Technologies (Lithuanian University of Health Sciences) and for the opportunity to use modern
infrastructure and perform this research.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Muchtaridi; Subarnas, A.; Apriyantono, A.; Mustarichie, R. Identification of Compounds in the Essential Oil
of Nutmeg Seeds (Myristica Fragrans Houtt.) That Inhibit Locomotor Activity in Mice. Int. J. Mol. Sci. 2010,
11, 4771–4781. [CrossRef]
2. Barceloux, D.G. Nutmeg (Myristica Fragrans Houtt.). Disease-A-Month 2009, 55, 373–379. [CrossRef] [PubMed]
3. Baser, K.H.; Bunchbauer, G. Handbook of Essential Oils: Science, Technology, and Applications; CRC Press NW:
Boca Raton, FL, USA, 2010.
4. Djilani, A.; Dicko, A. The Therapeutic Benefits of Essential Oils. In Nutrition, Well-Being and Health; IntechOpen
Ltd.: London, UK, 2012; pp. 154–178. [CrossRef]
5. Gupta, A.D.; Bansal, V.K.; Babu, V.; Maithil, N. Chemistry, Antioxidant and Antimicrobial Potential of
Nutmeg (Myristica Fragrans Houtt). J. Genet. Eng. Biotechnol. 2013, 11, 25–31. [CrossRef]
6. Lanari, D.; Marcotullio, M.; Neri, A.A. Design of Experiment Approach for Ionic Liquid-Based Extraction of
Toxic Components-Minimized Essential Oil from Myristica Fragrans Houtt. Fruits. Molecules 2018, 23, 2817.
[CrossRef] [PubMed]
7. Morsy, S.; Nashwa, F. A Comparative Study of Nutmeg (Myristica Fragrans Houtt.) Oleoresins Obtained
by Conventional and Green Extraction Techniques. J. Food Sci. Technol. 2016, 53, 3770–3777. [CrossRef]
[PubMed]
8. Chatterjee, S.; Gupta, S.; Variyar, S. Comparison of Essential Oils Obtained from Different Extraction
Techniques as an Aid in Identifying Aroma Significant Compounds of Nutmeg (Myristica Fragrans).
Nat. Prod. Commun. 2015, 10, 1443–1446. [CrossRef] [PubMed]
9. Ehrenpreis, J.E.; Deslauriers, C.; Lank, P. Nutmeg Poisonings: A Retrospective Review of 10 Years Experience
from the Illinois Poison Center. J. Med. Toxicol. 2014, 10, 148–151. [CrossRef]
10. Abourashed, E.A.; El-Alfy, A.T. Chemical Diversity and Pharmacological Significance of the Secondary
Metabolites of Nutmeg (Myristica Fragrans Houtt). Phytochem. Rev. 2016, 15, 1035–1056. [CrossRef]
11. Shafiei, Z.; Shuhairi, N.N.; Fazly, N.; Yap, S.; Sibungkil, C.H.; Latip, J. Antibacterial Activity of Myristica
Fragrans against Oral Pathogens. Evid. Based Complement. Altern. Med. 2012. [CrossRef]
12. Sanghai-vaijwade, D.N.; Kulkarni, S.R.; Sanghai, N.N. Nutmeg: A promising antibacterial agent for stability
of sweets. Int. J. Res. Pharm. Chem. 2011, 1, 403–407.
13. Takikawa, A.; Abe, K.; Yamamoto, M.; Ishimaru, S.; Yasui, M.; Okubo, Y.; Yokoigawa, K. Antimicrobial
Activity of Nutmeg against Escherichia Coli O157. J. Biosci. Bioeng. 2002, 94, 315–320. [CrossRef]
14. Firouzi, R.; Shekarforoush, S.S.; Nazer, A.H.; Borumand, Z.; Jooyandeh, A.R. Effects of Essential Oils of
Oregano and Nutmeg on Growth and Survival of Yersinia Enterocolitica and Listeria Monocytogenes in
Barbecued Chicken. J. Food Prot. 2007, 70, 2626–2630. [CrossRef] [PubMed]
15. Piaru, S.P.; Mahmud, R.; Abdul Majid, A.M.; Ismail, S.; Man, C.N. Chemical Composition, Antioxidant and
Cytotoxicity Activities of the Essential Oils of Myristica Fragrans and Morinda Citrifolia. J. Sci. Food Agric.
2012, 92, 593–597. [CrossRef] [PubMed]
16. Zhang, W.K.; Tao, S.S.; Li, T.T.; Li, Y.S.; Li, X.J.; Tang, H.B.; Cong, R.H.; Ma, F.L.; Wan, C.J. Nutmeg Oil
Alleviates Chronic Inflammatory Pain through Inhibition of COX-2 Expression and Substance P Release in
Vivo. Food Nutr. Res. 2016, 60, 1–10. [CrossRef] [PubMed]
17. Perez-Roses, R.; Risco, E.; Vila, R.; Penalver, P.; Canigueral, S. Biological and Nonbiological Antioxidant
Activity of Some Essential Oils. J. Agric. Food Chem. 2016, 64, 4716–4724. [CrossRef]
Foods 2020, 9, 37
18. Perez-Roses, R.; Risco, E.; Vila, R.; Penalver, P.; Canigueral, S. Effect of Some Essential Oils on Phagocytosis
and Complement System Activity. J. Agric. Food Chem. 2015, 63, 1496–1504. [CrossRef]
19. Filly, A.; Fabiano-Tixier, A.S.; Louis, C.; Fernandez, X.; Chemat, F. Water as a Green Solvent Combined with
Different Techniques for Extraction of Essential Oil from Lavender Flowers. Comptes Rendus Chim. 2016, 19,
707–717. [CrossRef]
20. Kara, N.; Erbaş, S.; Baydar, H. The Effect of Seawater Used for Hydrodistillation on Essential Oil Yield and
Composition of Oil-Bearing Rose (Rosa Damascena Mill.). Int. J. Second. Metab. 2017, 4, 482–487. [CrossRef]
21. Charchari, S.; Abdelli, M. Enhanced Extraction by Hydrodistillation of Sage (Salvia Officinalis L.) Essential
Oil Using Water Solutions of Non-Ionic Surfactants. J. Essent. Oil-Bear. Plants 2014, 17, 1094–1099. [CrossRef]
22. Matulyte, I.; Marksa, M.; Ivanauskas, L.; Kalveniene, Z.; Lazauskas, R.; Bernatoniene, J. GC-MS Analysis
of the Composition of the Extracts and Essential Oil from Myristica Fragrans Seeds Using Magnesium
Aluminometasilicate as Excipient. Molecules 2019, 24, 1062. [CrossRef]
23. Canillac, N.; Mourey, A. Antibacterial Activity of the Essential Oil of Picea Excelsa on Listeria, Staphylococcus
Aureus and Coliform Bacteria. Food Microbiol. 2001, 18, 261–268. [CrossRef]
24. Olajide, O.A.; Ajayi, F.F.; Ekhelar, A.I.; Awe, S.O.; Makinde, J.M.; Alada, A.R.A. Biological Effects of Myristica
Fragrans (Nutmeg) Extract. Phytother. Res. 1999, 345, 344–345. [CrossRef]
25. Emami, S.A.; Abedindo, B.F.; Hassanzadeh-Khayyat, M. Antioxidant Activity of the Essential Oils of Different
Parts of Juniperus excelsa M. Bieb. subsp. excelsa and J. excelsa M. Bieb. subsp. polycarpos (K. Koch)
Takhtajan (Cupressaceae). Iran. J. Pharm. Res. 2011, 10, 799–810. [PubMed]
26. Kong, B.; Zhang, H.; Xiong, Y.L. Antioxidant Activity of Spice Extracts in a Liposome System and in Cooked
Pork Patties and the Possible Mode of Action. Meat Sci. 2010, 85, 772–778. [CrossRef] [PubMed]
27. Nishad, J.; Koley, T.K.; Varghese, E.; Kaur, C. Synergistic Effects of Nutmeg and Citrus Peel Extracts in
Imparting Oxidative Stability in Meat Balls. Food Res. Int. 2018. [CrossRef] [PubMed]
28. Dai, J.; Liang, Z.; Yang, L.; Qui, J. Chemical Composition, Antioxidant and Antimicrobial Activities of
Essential Oil from Wedelia Prostrata. EXCLI J. 2013, 12, 479–490. [CrossRef] [PubMed]
29. Zheljazkov, V.D.; Astatkie, T.; Jeliazkova, E.A.; Adrienne, O.; Schlegel, V.; Zheljazkov, V.D.; Astatkie, T.;
Jeliazkova, E.A. Distillation Time Alters Essential Oil Yield, Composition and Antioxidant Activity of Female
Juniperus Scopulorum Trees. J. Essent. Oil Res. 2013, 25, 62–69. [CrossRef]
30. Misharina, T.A.; Terenina, M.B.; Krikunova, N.I. Antioxidant Properties of Essential Oils. Prikl. Biokhim.
Mikrobiol. 2009, 45, 710–716. [CrossRef]
31. Aazza, S.; Lyoussi, B.; Miguel, M.G. Antioxidant Activity of Some Morrocan Hydrosols. J. Med. Plants Res.
2011, 5, 6688–6696. [CrossRef]
32. Balouiri, M.; Sadiki, M.; Ibnsouda, S.K. Methods for in Vitro Evaluating Antimicrobial Activity: A Review.
J. Pharm. Anal. 2016, 6, 71–79. [CrossRef]
33. Nurjanah, S.; Putri, I.L.; Sugiarti, D.P. Antibacterial Activity of Nutmeg Oil. KnE Life Sci. 2017, 2, 563.
[CrossRef]
34. Cui, H.; Zhang, X.; Zhou, H.; Zhao, C.; Xiao, Z.; Lin, L.; Changzhu, L. Antibacterial Properties of Nutmeg Oil
in Pork and Its Possible Mechanism. J. Food Saf. 2015, 35, 370–377. [CrossRef]
35. Funk, B.; Kirmayer, D.; Sahar-heft, S.; Gati, I.; Friedman, M.; Steinberg, D. Efficacy and Potential Use of
Novel Sustained Release Fillers as Intracanal Medicaments against Enterococcus Faecalis Biofilm in Vitro.
BMC Oral Health 2019, 19, 1–9. [CrossRef] [PubMed]
36. Kitagawa, H.; Izutani, N.; Kitagawa, R.; Maezono, H.; Yamaguchi, M.; Imazato, S. Evolution of Resistance to
Cationic Biocides in Streptococcus Mutans and Enterococcus Faecalis. J. Dent. 2016, 47, 18–22. [CrossRef]
37. Kim, D.S.; Lee, H.J.; Jeon, Y.D.; Han, Y.H.; Kee, J.Y.; Kim, H.J.; Shin, H.J.; Kang, J.; Lee, B.S.; Kim, S.H.; et al.
Alpha-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-KB
Pathway in Mouse Peritoneal Macrophages. Am. J. Chin. Med. 2015, 43, 731–742. [CrossRef]
38. Valente, J.; Zuzarte, M.; Gonçalves, M.J.; Lopes, M.C.; Cavaleiro, C.; Salgueiro, L.; Cruz, M.T. Antifungal,
Antioxidant and Anti-Inflammatory Activities of Oenanthe Crocata L. Essential Oil. Food Chem. Toxicol. 2013,
62, 349–354. [CrossRef]
39. Yu, L.; Yan, J.; Sun, Z. D-Limonene Exhibits Anti-Inflammatory and Antioxidant Properties in an Ulcerative
Colitis Rat Model via Regulation of INOS, COX-2, PGE2 and ERK Signaling Pathways. Mol. Med. Rep. 2017,
15, 2339–2346. [CrossRef]
Foods 2020, 9, 37
40. Akinwunmi, K.F.; Oyedapo, O.O. In Vitro Anti-Inflammatory Evaluation of African Nutmeg (Monodora
Myristica) Seeds. Eur. J. Med. Plants 2015, 8, 167–174. [CrossRef]
41. Romano, R.; Giordano, A.; Le Grottaglie, L.; Manzo, N.; Paduano, A.; Sacchi, R.; Santini, A. Volatile
compounds in intermittent frying by gas chromatography and nuclear magnetic resonance. Eur. J. Lipid
Sci. Technol. 2013, 115, 764–773. [CrossRef]
42. Crowe, J.E., Jr. Common Viral Respiratory Infections. In Harrison’s Principles of Internal Medicine, 20th ed.;
Jameson, J.L., Fauci, A.S., Kasper, D.L., Hauser, S.L., Longo, D.L., Loscalzo, J., Eds.; McGraw-Hill Education:
New York, NY, USA, 2018; Chapter 194.
43. Cells, S.; Smith, R.S.; Smith, T.J.; Blieden, T.M.; Phipps, R.P. Commentary Synthesis of Chemokines and
Regulation of Inflammation. Am. J. Pathol. 1997, 151, 317–322.
44. Richards, C.D. Innate Immune Cytokines, Fibroblast Phenotypes, and Regulation of Extracellular Matrix in
Lung. J. Interf. Cytokine Res. 2017, 37. [CrossRef] [PubMed]
45. Naik, S.P.; Mahesh, P.A.; Jayaraj, B.S.; Madhunapantula, S.V.; Jahromi, S.R.; Yadav, M.K. Evaluation of
Inflammatory Markers Interleukin-6 (IL-6) and Matrix Metalloproteinase-9 (MMP-9). J. Asthma 2017, 54,
584–593. [CrossRef] [PubMed]
46. Ishihara, K.; Hirano, T. IL-6 in Autoimmune Disease and Chronic Inflammatory Proliferative Disease.
Cytokine Growth Factor Rev. 2002, 13, 357–368. [CrossRef]
47. Sundararaj, K.P.; Samuvel, D.J.; Li, Y.; Sanders, J.J.; Lopes-Virella, M.F.; Huang, Y. Interleukin-6 Released from
Fibroblasts Is Essential for Up-Regulation of Matrix Metalloproteinase-1 Expression by U937 Macrophages
in Coculture: cross-talikng between fibroblast and U937 macrofages exposed high glucose. J. Biol. Chem.
2009, 284, 13714–13724. [CrossRef] [PubMed]
48. Fernandes, A.R.; Martins-Gomes, C.; Santini, A.; Silva, A.M.; Souto, E.B. Psoriasis vulgaris—Pathophysiology
of the disease and its classical treatment versus new drug delivery systems. In Design of Nanostructures for
Versatile Therapeutics Applications; Pharmaceutical Nanotechnology; Grumezescu, A.M., Ed.; Elsevier: Oxford,
UK, 2018; Chapter 9; pp. 379–406. ISBN 978-0-12-813667-6.
49. Daliu, P.; Santini, A.; Novellino, E. A decade of nutraceutical patents: where are we now in 2018? Expert Opin.
Ther. Pat. 2018, 28, 875–882. [CrossRef] [PubMed]
50. Campos, J.R.; Severino, P.; Ferreira, C.S.; Zielinska, A.; Santini, A.; Souto, S.B.; Souto, E.B. Linseed Essential
Oil—Source of Lipids as Active Ingredients for Pharmaceuticals and Nutraceuticals. Curr. Med. Chem. 2019,
26, 1–22. [CrossRef] [PubMed]
51. Severino, P.; Resende Diniz, F.; Cardoso Cordeiro, J.; do Céu Teixeira, M.; Santini, A.; Kovačević, A.B.;
Souto, E.B. Essential oils with antimicrobial properties formulated in lipid carriers—Review of the state of the
art. In Essential Oils and Nanotechnology for the Cure of Microbial Diseases; Rai, M., Derita, M., Zacchino, S., Eds.;
CRC Press: Boca Raton, FL, USA, 2017; Chapter 1; pp. 1–13. ISBN 978-1-1386-3072-7.
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Elderberry (Sambucus nigra L.) Fruit Extract Alleviates
Oxidative Stress, Insulin Resistance, and
Inflammation in Hypertrophied 3T3-L1 Adipocytes
and Activated RAW 264.7 Macrophages
Joanna Zielińska-Wasielica 1 , Anna Olejnik 1, *, Katarzyna Kowalska 1 , Mariola Olkowicz 2 and
Radosław Dembczyński 1
1 Department of Biotechnology and Food Microbiology, Poznan University of Life Sciences,
Wojska Polskiego 48, 60-627 Poznan, Poland
2 Department of Chemistry, University of Waterloo, 200 University Avenue West, Waterloo,
ON N2L 3G1, Canada
* Correspondence: anna.olejnik@up.poznan.pl; Tel.: +48-61-846-60-08
Abstract: Oxidative stress and inflammation in hypertrophied adipose tissue with excessive fat
accumulation play a crucial role in the development of obesity and accompanying metabolic
dysfunctions. This study demonstrated the capacity of elderberry fruit (EDB) extract to decrease the
elevated production of reactive oxygen species in hypertrophied 3T3-L1 adipocytes. Treatment with
the EDB extract resulted in modulation of mRNA expression and protein secretion of key adipokines
in hypertrophied adipocytes. Expression of leptin and adiponectin was, respectively, down- and
up-regulated. Moreover, glucose uptake stimulation was noticed in mature adipocytes, both sensitive
to insulin and insulin resistant. This may suggest a positive effect of EDB extract on insulin resistance
status. The extract was also found to alleviate the inflammatory response in activated RAW 264.7
macrophages by down-regulating the expression of proinflammatory genes (TNF-α, IL-6, COX-2,
iNOS) and suppressing the enhanced production of inflammatory mediators (TNF-α, IL-6, PGE2 ,
NO). In vitro experiments showed that the EDB extract could inhibit digestive enzymes, including
α-amylase, α-glucosidase, and pancreatic lipase, leading to reduced intestinal absorption of dietary
lipids and carbohydrates. Further in vivo studies could be postulated to support EDB as a functional
food component for the prevention and treatment of obesity and metabolic-immune comorbidities.
Keywords: elderberry polyphenols; functional food; obesity; digestive enzymes; fat cells; intracellular
reactive oxygen species; adipokines; glucose uptake; immune-metabolic effects
1. Introduction
Obesity is associated with excessive adipose tissue growth, which occurs through two possible
mechanisms: hypertrophy (expansion of existing adipocytes) and hyperplasia (recruitment of new
adipocytes). Hypertrophic adipose tissue growth is mainly considered to be related to insulin resistance
and other obesity metabolic comorbidities [1]. Abnormal expansion of adipose tissue is accompanied
by local hypoxia, adipocyte death, enhanced cytokine and chemokine secretion, dysfunctional fatty
acid metabolism and accumulation, and immune cell infiltration. Dysregulation of lipid metabolism in
adipose tissue leads to enhanced release of free fatty acids, which initiates inflammatory signaling
cascades in the infiltrating cell population. Chronic low-grade inflammation, found in abnormal fat
tissue, negatively affects the insulin signal transduction pathway, and promotes insulin resistance [2,3].
Recent scientific preclinical studies have shown that bioactive dietary compounds may specifically
influence hypertrophic adipose cells and mitigate the effects of extensive adipose tissue growth
After 3-h macrophage activation, the culture media and cells were harvested to analyze the protein
secretion and gene expression of pro-inflammatory mediators.
2.10. Determination of IL-6, TNF-α, and PGE2 Production in RAW 264.7 Macrophages
The secretion of IL-6 and TNF-α cytokines as well as generation of PGE2 by LPS-stimulated RAW
264.7 macrophages were determined with ELISA kits (R&D Systems, Inc, Minneapolis, MN, USA)
according to the manufacturer’s instructions. Protein concentrations were expressed in pg/mL of
culture supernatant, which was equivalent to the amount of protein per 1 × 106 cells.
at room temperature for 15 min. The absorbance was measured at 540 nm (Tecan M200 Infinite). The
standard curve plotted for sodium nitrite was used to calculate NO concentration.
The relative expression of each gene was calculated using the 2−ΔΔCT method. The mRNA levels
in the control cells were designated as 1, and the relative levels of the gene transcripts in the samples
were expressed as the fold change.
% non-inhibited enzyme activity = [(AInhibitor − AInhibitor blank )/(AControl − AControl blank )] × 100%
where AControl is the absorbance of the sample without EDB extract/reference inhibitor; AInhibitor is the
absorbance of the sample containing EDB extract/reference inhibitor; AInhibitor blank is the absorbance
of the sample with EDB extract/reference inhibitor, but without enzyme addition; AControl blank is the
absorbance of the sample without EDB extract/reference inhibitor and enzyme addition.
3. Results
Figure 1. Cont.
Foods 2019, 8, 326
Figure 1. HPLC-DAD chromatograms of elderberry (Sambucus nigra L.) fruit extract recorded at 520, 280, 325, and 355 nm, respectively. Peak numbers and retention
times refer to compounds indicated in Table 2.
Foods 2019, 8, 326
The polyphenolic compounds, described above, have been previously identified in berries
of Sambucus nigra [7,23,24]. However, the content of individual polyphenols in EDB fruits varies,
depending on the EDB genotypes as well as specific growth conditions. The total polyphenol content
in the extract analyzed was determined to 31.03 mg/g of EDB lyophilized powder, including 13.34 mg
of anthocyanins, 6.85 mg of flavan-3-ols, 4.98 mg of hydroxycinnamic acid derivatives, 4.26 mg of
flavonols, and 1.6 mg of hydroxybenzoic acid glucoside (Table 2).
Figure 2. The effect of elderberry fruit extract (EDBE) on the activity of digestive enzymes: α-glucosidase
(a), α-amylase (b), and lipase (c). Enzyme activity is expressed in relation to the negative control
(without extract addition). As positive controls, reference enzyme inhibitors, including acarbose (ACRB,
100 μg/mL) and orlistat (ORST, 5 μg/mL) were used in the experiment. The values represent the means
(n = 3) ± SD. * p < 0.05, *** p < 0.001 vs. control group.
Table 3. Inhibitory concentrations IC10 and IC50 (the inhibitor concentration required for 10% and 50%
inhibition of enzyme activity) of the elderberry fruit extract (EDBE), acarbose (ACRB), and orlistat
(ORST) as reference pharmacological inhibitors.
Lower potency of the extract was observed in inhibiting pancreatic lipase activity. The extract
concentrations reducing lipase activity by 10% and 50% were determined at 2.09 mg/mL and
10.98 mg/mL, respectively (Table 3). In inhibiting α-amylase and lipase activity, the drugs acarbose
(100 μg/mL) and orlistat (5 μg/mL) were more potent than the EDB extract (Figure 2b,c). However, in
α-glucosidase inhibition, the extract at concentrations of 5 mg/mL and 10 mg/mL evoked the stronger
effects than acarbose at a dose of 100 μg/mL.
level when applied at 5, 10, and 20 mg/mL, respectively, in comparison to untreated cells (p < 0.001)
(Figure 3c). Moreover, treatment with EDB extract led to down-regulation of NADPH oxidase 4 (NOX-4)
mRNA expression by approximately 49 ± 6%, independently of the extract dose. Treatment with the
extract at the maximum concentration (20 mg/mL) resulted in approximately 2-fold increased mRNA
expression of superoxide dismutase (SOD) and glutathione peroxidase (GPx). In contrast, the extract did
not influence the mRNA expression level of catalase (CAT) (Figure 3d).
Figure 3. Changes in cell viability (a), intracellular triglyceride content (b), reactive oxygen species
production (c), and mRNA expression of NOX4, SOD2, catalase (CAT), and GPx enzymes (d) as well
as leptin (LEP) (e) and adiponectin (ADIPOQ) (f) expression upon the treatment of3T3-L1 mature
adipocytes with the elderberry fruit extract (EDBE). The photos present 3T3-L1 preadipocytes (g),
fully differentiated 3T3-L1 adipocytes non-treated (h) and treated with EDBE at the concentration of
20 mg/mL (i). The cells were photographed at magnification of 100 ×. The results were expressed as
the means ± SD (n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control group.
Foods 2019, 8, 326
Supplementation of the fully differentiated adipocyte cultures with EDB extract considerably
affected the expression of key adipokines in treated adipocytes. The decrease in leptin (LEP) mRNA
levels between 78% and 94% was observed in mature adipocytes exposed to the extract at concentrations
ranging from 5 mg/mL to 20 mg/mL (p < 0.001) (Figure 3e). In contrast to leptin, the expression of
adiponectin was significantly up-regulated. The highest dose of EDB extract elevated adiponectin
(ADIPOQ) mRNA level by 77% compared to the control (p < 0.001) (Figure 3f). The exposure of mature
adipocytes to EDB extract resulted in a decrease of leptin secretion. The extract at concentrations
of 5 mg/mL and 10 mg/mL significantly reduced leptin synthesis (p < 0.05). Whereas, the highest
inhibitory effect with the reduction of leptin by 86% (p < 0.001) was observed in the cells treated
with the extract at maximum concentration. In contrast, EDB extract at the highest dose of 20 mg/mL
stimulated the adiponectin secretion in treated cells. The level of adiponectin was increased by 36%
respect to the control (p < 0.05) (Figure 3f).
3.4. The Effect of Elderberry Fruit Extract on Glucose Uptake in Mature 3T3-L1 Adipocytes
The effect of EDB extract on the glucose analogue (2-NBDG) uptake in mature 3T3-L1 adipocytes
was analyzed to determine whether the extract affects the glucose uptake by adipocytes. As shown in
Figure 4a, EDB extract caused a significant increase in 2-NBDG uptake at all assayed concentrations
(p < 0.001). The extract stimulated 2-NBDG uptake by 40%, 44%, and 62% tested at 5, 10, and 20 mg/mL,
respectively, in comparison to the control system. Unexpectedly, the stimulatory effect of the extract on
the glucose uptake in insulin-sensitive cells was more effective than that observed with rosiglitazone
(Figure 4a). Subsequently, the expression of glucose transporter type 4 (GLUT-4) gene in mature 3T3-L1
cells exposed to EDB extract was investigated. The results indicated no significant effect of EDB extract
on GLUT-4 mRNA level (Figure 4d).
Figure 4. Effect of the elderberry fruit extract (EDBE) on the glucose uptake (a–c) and glucose transporter
GLUT-4 mRNA expression (d–f) in mature 3T3-L1 adipocytes non-induced (a,d) and induced by TNF-α
(b–f) and non-treated (b,e) and treated (c,f) with insulin (INS). The cells were exposed to EDBE at
concentrations of 5, 10, and 20 mg/mL, and to rosiglitazone (RGZ). Data are mean values ± SD (n = 3).
The significance of the main effects of EDBE was determined by Tukey post hoc test; the control (INS,
RGZ) significance was analyzed by T-student test; * p < 0.05, ** p < 0.01, *** p < 0.001.
Foods 2019, 8, 326
In the parallel experiment, the influence of EDB extract on 2-NBDG incorporation into insulin
resistant adipocytes treated with TNF-α was determined. The cells were incubated with the extract
in the absence or presence of insulin at 100 nM. In the insulin-resistant adipocytes cultured without
insulin supplementation, the EDB extract at concentrations of 5, 10, and 20 mg/mL enhanced 2-NBDG
uptake by 40%, 38%, and 39%, respectively (Figure 4b). In this case, quantitative PCR analysis revealed
that treatment with EDB extract at doses from 5 mg/mL to 20 mg/mL significantly up-regulated the
mRNA expression of GLUT-4 with an increase ranging from 63% to 82% (Figure 4e).
In the experiments on insulin resistant adipocytes exposed to insulin, the EDB extract at the
highest concentration showed insulin-sensitizing properties, stimulating 2-NBDG incorporation by
34% (p < 0.01). Its efficacy was comparable to that of rosiglitazone, which enhanced the 2-NBDG
uptake by 36% (p < 0.01) (Figure 4c). In this study, the extract at a dose of 20 mg/mL up-regulated the
expression of GLUT-4 by 33% (p < 0.01), compared to control adipocytes (Figure 4f).
Figure 5. Effect of the elderberry fruit extract (EDBE) on mRNA expression of IL-6, TNF-α, COX-2, and
iNOS (a) and on the production of IL-6, TNF-α, PGE2 protein, and NO (b) in the lipopolysaccharide
(LPS)-activated RAW 264.7 macrophages. Data are mean values ± SD (n = 3). * p < 0.05, ** p < 0.01,
*** p < 0.001 when compared with control.
Foods 2019, 8, 326
The extract at a dose of 10 μg/mL also affected COX-2 expression, causing a 46% reduction of
COX-2 transcripts level in activated macrophages (p < 0.01) (Figure 5a). As a consequence, the decrease
in PGE2 production was detected after cell exposure to the extract. Namely, PGE2 level lowered by
33% and 47%, respectively, for a dose of 1 μg/mL and 10 μg/mL (Figure 5b).
Furthermore, the obtained results demonstrated the reduction in NO production as well as
down-regulation of inducible NO synthase (iNOS) expression in LPS-stimulated RAW 264.7 macrophages
in response to the EDB extract treatment. The extract reduced the NO synthesis by 35% (p < 0.05)
when assayed at 1 μg/mL and by 54% (p < 0.01) when applied at 10 μg/mL (Figure 5b). A significant
inhibitory effect of EDB extract on iNOS expression was noted only at the highest tested dose, which
decreased iNOS mRNA level by 30% (p < 0.01) (Figure 5a).
4. Discussion
Excessive fat accumulation in hypertrophic adipose tissue associated with obesity is responsible
for oxidative stress, chronic inflammation, and dysregulated adipokine secretion [25]. It is believed that
the therapeutic potential of natural dietary compounds against obesity and obesity-related disorders
should focus on improving the fat function in pathogenic hypertrophic adipocytes by reducing
oxidative stress, alleviating inflammation, and regulating underproduction or overproduction of
clinically relevant adipocyte factors. However, most bioactive compounds or extracts strongly affect
preadipocytes, their viability, proliferation, and differentiation into mature fat cells, without any
significant effects on the pathological status of hypertrophic adipocytes. Therefore, in this work, the
influence of the Sambucus nigra fruit extract on mature fully differentiated insulin-resistant 3T3-L1
adipocytes was investigated.
In our study, we found no reduction in cell viability and lipid content in hypertrophic 3T3-L1
adipocytes after exposure to EDB extract. However, as a result of the treatment, the intracellular ROS
generation was significantly down-regulated and probably, oxidative stress accompanying excessive
fat accumulation was also importantly reduced. Oxidative stress induced by enhanced lipid content is
reported to be involved in the pathogenesis of obesity-related comorbidities including insulin resistance
and diabetes, cardiovascular complications, and cancer [26]. It was found that ROS are intensively
generated in visceral adipose tissue by adipocytes during the metabolism of excess nutrients and also
by macrophages, which accumulate in adipose tissue in obesity state. The increased release of fatty
acids from overproduced fat accumulated in adipose tissue, activate NADPH oxidases (NOX) and
induce or aggravate ROS production. Other factors that also contribute oxidative stress to obesity
include hyperleptinemia, low antioxidant defense, or chronic inflammation [27]. Our results showed
that EDB extract could reduce ROS generation by lowering the expression of NOX4, the major NOX
isoform in adipocytes. Treatment of hypertrophied 3T3-L1 adipocytes with EDB extract caused a
significant decreasing in NOX4 mRNA expression. Furthermore, up-regulation of mRNA expression
of antioxidant enzymes, like SOD and GPx, could also contribute to enhancing adipocyte antioxidant
defense efficiency. Numerous studies have shown the high antioxidant capacity of Sambucus nigra
fruit [6,10]. However, the antioxidant effects of EDB on adipocytes have not yet been reported in the
literature. In the present study, we demonstrated that introduction of EDB extract to the culture of
hypertrophic adipocytes resulted in decreased ROS generation in cells. The antioxidant action of EDB
extract in adipocytes may be a potential protective mechanism against obesity-associated pathological
risk factors, including insulin resistance and chronic inflammation.
Additionally, EDB extract treatment modulated the leptin and adiponectin gene expression and
protein secretion in hypertrophic 3T3-L1 adipocytes. Leptin and adiponectin are adipocytokines, which
influence energy homeostasis, glucose and lipid metabolism, cardiovascular function, and immune
response [28]. Leptin is primarily secreted by fully differentiated adipocytes, and its crucial role is to
regulate energy intake and expenditure through controlling appetite and glucose metabolism. Reflecting
the increased amount of adipose tissue, obese individuals often have elevated leptin concentration
and the simultaneous apparent loss of efficacy of leptin, which is a result of leptin resistance, the
Foods 2019, 8, 326
state that leads to uncontrolled food intake, pro-inflammatory state, diabetes mellitus, and other
obesity-related complications [29]. In contrast to leptin, adiponectin is down-regulated in obesity, and
the circulating adiponectin levels are inversely correlated with body fat amount. Adiponectin enhances
energy metabolism and fatty acid oxidation, promotes insulin sensitivity, improves glucose tolerance,
and exerts anti-inflammatory effects [28]. Low serum adiponectin and high serum leptin levels are
considered as risk factors for developing type 2 diabetes (T2DM), obesity, dyslipidemia, hypertension,
and cardiovascular diseases. In this study, a remarkable decrease in leptin expression and secretion was
observed in response to EDB extract treatment of hypertrophied 3T3-L1 adipocytes, which may help
counteract the leptin resistance state. Whereas, adiponectin mRNA expression and protein secretion in
treated adipocytes were significantly increased. The effect of EDB extract on adiponectin production
may indicate anti-inflammatory potential and insulin-sensitizing activity of Sambucus nigra fruit.
The association of visceral obesity with T2DM is a long-recognized phenomenon. The primary
determinant of this correlation is the fact that central obesity is the critical factor in the emergence of
insulin resistance. The insulin-resistant state results in defective insulin-stimulated glucose uptake and
consequently in hyperglycemia, elevated circulating free fatty acids level, abnormal fat accumulation,
and dysregulation of hepatic glucose production, that, in combination with a paucity of insulin secretion
by pancreatic β-cells, leads to T2DM [30]. These metabolic abnormalities may arise from impairment
in insulin signaling pathways and subsequent defect in translocation of insulin-responsive glucose
transporter protein (GLUT-4) and in adipose tissue, also from down-regulation of GLUT-4 gene [31].
The effects of EDB extract on glucose uptake and GLUT-4 expression were evaluated in this
study. Experiments were performed both with mature 3T3-L1 adipocytes sensitive to insulin and
adipocytes treated with TNF-α to induce an inflammatory status and insulin resistance. Analysis
revealed that EDB extract stimulated the 2-NBDG uptake in both types of adipocytes and up-regulated
mRNA expression of GLUT-4 in insulin-resistant cells, suggesting insulin-like and insulin-sensitizing
activities of the extract. The signaling pathways involved in the development of these activities will
be further examined in future studies. This is the first study assessing the effects of EDB extract on
glucose uptake in 3T3-L1 cells. Although several recent reports have suggested the anti-diabetic and
hypoglycemic properties of elderberry, it has been found that EDB methanolic extracts markedly
stimulate glucose uptake in liver HepG2 cells and also exert inhibitory effect towards carbohydrate
hydrolyzing enzyme [32]. Furthermore, EDB extracts, EDB anthocyanins, mainly cyanidin-3-glucoside
and cyanidin-3-sambubioside, procyanidins, and their metabolites were found to enhance glucose
uptake in human skeletal muscle cells [33]. Whereas, EDB lipophilic and polar extracts were reported
to modulate glucose metabolism or lower insulin secretion contributing to the mitigation of insulin
resistance in T2DM rats [13].
Anti-obesity and anti-diabetic activity of EDB extract could be related to the inhibition of dietary
fat and sugar absorption from the intestinal tract. There is some evidence that polyphenols from
berry fruits, such as strawberry, raspberry, blueberry, bilberry, black and red currant, lingonberry, red
and green gooseberry, cranberry, and chokeberry, contribute to the inhibition of digestive enzymes
involved in the hydrolysis of dietary lipids and carbohydrates [34]. Based on our research, the Sambucus
nigra fruit may be included in the class of berries considered as effective inhibitors of α-amylase,
α-glucosidase, and pancreatic lipase activity.
Obesity is known to be accompanied by metaflammation—low-grade chronic inflammation
condition triggered by excess nutrients in metabolic cells [35]. An attribute of obesity-related
inflammation is enhanced infiltration of macrophages into expanding adipose tissue, activation
of specialized immune cells, and secretion of proinflammatory cytokines such as TNF-α, IL-6,
and MCP-1 leading to an unresolved inflammatory response, which affects normal metabolism
and insulin action [35]. Inhibition of obesity-induced inflammation could, thus, be a therapeutic
intervention against adipose tissue dysfunction and related co-morbidities. In recent years, the use of
anti-inflammatory nutrients provided through diet as a potential approach against obesity has been
extensively studied [36,37].
Foods 2019, 8, 326
pharmafoods should be evaluated in the clinical aspects regarding safety, side effects, bioavailability,
beneficial health effects, mechanisms of action and efficacy, and any possible interactions between
food and drugs assumed together with them [46,47]. Thus, the developing of clinical studies will
be of significant importance for clinically justified promotion of the Sambucus nigra fruit extract
as a safe nutraceutical with the capacity of prevention or treatment of obesity and obesity-related
immune-metabolic disorders.
Author Contributions: Conceptualization, J.Z.-W. and A.O.; methodology, J.Z.-W., A.O., M.O. and K.K.; formal
analysis, A.O. and R.D.; investigation, J.Z.-W. and M.O.; resources, R.D.; writing—original draft preparation,
J.Z.-W.; writing—review and editing, A.O.; project administration, A.O.; funding acquisition, A.O.
Funding: This research was funded by THE NATIONAL SCIENCE CENTRE, POLAND, grant number
2015/19/B/NZ9/01054.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Jo, J.; Gavrilova, O.; Pack, S.; Jou, W.; Mullen, S.; Sumner, A.E.; Cushman, S.W.; Periwal, V. Hypertrophy
and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput. Biol. 2009, e1000324. [CrossRef]
[PubMed]
2. Schuster, D.P. Obesity and the development of type 2 diabetes: The effects of fatty tissue inflammation.
Diabetes Metab. Syndr. Obes. 2010, 3, 253–262. [CrossRef] [PubMed]
3. Tateya, S.; Kim, F.; Tamori, Y. Recent advances in obesity-induced inflammation and insulin resistance.
Front. Endocrinol. 2013, 4, 93. [CrossRef] [PubMed]
4. Kowalska, K.; Olejnik, A. Current evidence on the health-beneficial effects of berry fruits in the prevention
and treatment of metabolic syndrome. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 446–452. [CrossRef]
[PubMed]
5. Veberic, R.; Jakopic, J.; Stampar, F.; Schmitzer, V. European elderberry (Sambucus nigra L.) rich in sugars,
organic acids, anthocyanins and selected polyphenols. Food Chem. 2009, 114, 511–515. [CrossRef]
6. Sidor, A.; Gramza-Michałowska, A. Advanced research on the antioxidant and health benefit of elderberry
(Sambucus nigra) in food—A review. J. Funct. Foods 2015, 18, 941–958. [CrossRef]
7. Olejnik, A.; Kowalska, K.; Olkowicz, M.; Rychlik, J.; Juzwa, W.; Myszka, K.; Dembczyński, R.; Białas, W.
Anti-inflammatory effects of gastrointestinal digested Sambucus nigra L. fruit extract analysed in co-cultured
intestinal epithelial cells and lipopolysaccharide-stimulated macrophages. J. Funct. Foods 2015, 19, 649–660.
[CrossRef]
8. Olejnik, A.; Olkowicz, M.; Kowalska, K.; Rychlik, J.; Dembczyński, R.; Myszka, K.; Juzwa, W.; Białas, W.;
Moyer, M.P. Gastrointestinal digested Sambucus nigra L. fruit extract protects in vitro cultured human colon
cells against oxidative stress. Food Chem. 2016, 197, 648–657. [CrossRef] [PubMed]
9. Młynarczyk, K.; Walkowiak-Tomczak, D.; Łysiak, G.P. Bioactive properties of Sambucus nigra L. as a functional
ingredient for food and pharmaceutical industry. J. Funct. Foods 2018, 40, 377–390. [CrossRef]
10. Neves, D.; Valentao, P.; Bernardo, J.; Oliveira, M.C.; Ferreira, J.M.G.; Pereira, D.M.; Andrade, P.B.; Videira, R.A.
A new insight on elderberry anthocyanins bioactivity: Modulation of mitochondrial redox chain functionality
and cell redox state. J. Funct. Foods 2019, 56, 145–155. [CrossRef]
11. Badescu, M.; Badulescu, O.; Badescu, L.; Ciocoiu, M. Effects of Sambucus nigra and Aronia melanocarpa extracts
on immune system disorders within diabetes mellitus. Pharm. Biol. 2015, 53, 533–539. [CrossRef] [PubMed]
12. Farrell, N.J.; Norris, G.H.; Ryan, J.; Porter, C.M.; Jiang, C.; Blesso, C.N. Black elderberry extract attenuates
inflammation and metabolic dysfunction in diet-induced obese mice. Br. J. Nutr. 2015, 114, 1123–1131.
[CrossRef] [PubMed]
13. Salvador, Â.C.; Król, E.; Lemos, V.C.; Santos, S.A.O.; Bento, F.P.M.S.; Costa, C.P.; Almeida, A.;
Szczepankiewicz, D.; Kulczyński, B.; Krejpcio, Z.; et al. Effect of Elderberry (Sambucus nigra L.) Extract
Supplementation in STZ-Induced Diabetic Rats Fed with a High-Fat Diet. Int. J. Mol. Sci. 2017, 18, 13.
[CrossRef] [PubMed]
Foods 2019, 8, 326
14. Farrell, N.; Norris, G.; Lee, S.G.; Porter, C.M.; Chun, O.K.; Blesso, C.N. Anthocyanin-rich black elderberry
extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice. Food Funct.
2015, 6, 1278–1287. [CrossRef] [PubMed]
15. Ho, G.T.; Wangensteen, H.; Barsett, H. Elderberry and elderflower extracts, phenolic compounds, and
metabolites and their effect on complement, RAW 264.7 macrophages and dendritic cells. Int. J. Mol. Sci.
2017, 18, 584. [CrossRef] [PubMed]
16. Simonyi, A.; Chen, Z.; Jiang, J.; Zong, Y.; Chuang, D.Y.; Gu, Z.; Lu, C.H.; Fritsche, K.L.; Greenlief, C.M.;
Rottinghaus, G.E.; et al. Inhibition of microglial activation by elderberry extracts and its phenolic components.
Life Sci. 2015, 128, 30–38. [CrossRef]
17. Kowalska, K.; Olejnik, A.; Zielińska-Wasielica, J.; Olkowicz, M. Inhibitory effects of lingonberry
(Vaccinium vitis-idaea L.) fruit extract on obesity-induced inflammation in 3T3-L1 adipocytes and RAW 264.7
macrophages. J. Funct. Foods 2019, 54, 371–380. [CrossRef]
18. Kowalska, K.; Olejnik, A.; Szwajgier, D.; Olkowicz, M. Inhibitory activity of chokeberry, bilberry, raspberry
and cranberry polyphenol-rich extract towards adipogenesis and oxidative stress in differentiated 3T3-L1
adipose cells. PLoS ONE 2017, 12, e0188583. [CrossRef]
19. Choi, H.S.; Kim, J.W.; Cha, Y.-N.; Kim, C. A quantitative nitroblue tetrazolium assay for determining
intracellular superoxide anion production in phagocytic cells. J. Immunoass. Immunoch. 2006, 27, 31–44.
[CrossRef]
20. Alonso-Castro, A.J.; Salazar-Olivo, L.A. The anti-diabetic properties of Guazuma ulmifolia Lam are mediated
by the stimulation of glucose uptake in normal and diabetic adipocytes without inducing adipogenesis.
J. Ethnopharmacol. 2008, 118, 252–256. [CrossRef]
21. Boath, A.S.; Grussu, D.; Stewart, D.; McDougall, G.J. Berry Polyphenols Inhibit Digestive Enzymes: A Source
of Potential Health Benefits? Food Dig. 2012, 3, 1–7. [CrossRef]
22. Tan, Y.; Chang, S.K.C.; Zhang, Y. Comparison of α-amylase, α-glucosidase and lipase inhibitory activity of
the phenolic substances in two black legumes of different genera. Food Chem. 2017, 214, 259–268. [CrossRef]
[PubMed]
23. Mikulic-Petkovsek, M.; Schmitzer, V.; Slatnar, A.; Stampar, F.; Veberic, R. Composition of sugars, organic
acids, and total phenolics in 25 wild or cultivated berry species. J. Food Sci. 2012, 77, C1064–C1070. [CrossRef]
[PubMed]
24. Mikulic-Petkovsek, M.; Schmitzer, V.; Slatnar, A.; Todorovic, B.; Veberic, R.; Stampar, F.; Ivancic, A.
Investigation of anthocyanin profile of four elderberry species and interspecific hybrids. J. Agric. Food Chem.
2014, 62, 5573–5580. [CrossRef] [PubMed]
25. Bays, H.E.; González-Campoy, J.M.; Bray, G.A.; Kitabchi, A.E.; Bergman, D.A.; Schorr, A.B.; Rodbard, H.W.;
Henry, R.R. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy
and increased visceral adiposity. Expert Rev. Cardiovasc. Ther. 2008, 6, 343–368. [CrossRef] [PubMed]
26. Manna, P.; Jain, S.K. Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks:
Causes and Therapeutic Strategies. Metab. Syndr. Relat. Disord. 2015, 13, 423–444. [CrossRef] [PubMed]
27. Matsuda, M.; Shimomura, I. Increased oxidative stress in obesity: Implications for metabolic syndrome,
diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes. Res. Clin. Pract. 2013, 7, e330–e341.
[CrossRef] [PubMed]
28. Meier, U.; Gressner, A.M. Endocrine regulation of energy metabolism: Review of pathobiochemical and
clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 2004, 50, 1511–1525.
[CrossRef] [PubMed]
29. Bravo, P.E.; Morse, S.; Borne, D.M.; Aguilar, E.A.; Reisin, E. Leptin and hypertension in obesity. Vasc. Health
Risk Manag. 2006, 2, 163–169. [CrossRef]
30. Zeyda, M.; Stulnig, T.M. Obesity, inflammation, and insulin resistance—A mini-review. Gerontology 2009, 55,
379–386. [CrossRef]
31. Kahn, B.B.; Flier, J.S. Obesity and insulin resistance. J. Clin. Investig. 2000, 106, 473–481. [CrossRef] [PubMed]
32. Ho, G.T.T.; Nguyen, T.K.Y.; Kase, E.T.; Tadesse, M.; Barsett, H.; Wangensteen, H. Enhanced Glucose Uptake
in Human Liver Cells and Inhibition of Carbohydrate Hydrolyzing Enzymes by Nordic Berry Extracts.
Molecules 2017, 22, 1806. [CrossRef] [PubMed]
Foods 2019, 8, 326
33. Ho, G.T.T.; Kase, E.T.; Wangensteen, H.; Barsett, H. Phenolic Elderberry Extracts, Anthocyanins, Procyanidins,
and Metabolites Influence Glucose and Fatty Acid Uptake in Human Skeletal Muscle Cells. J. Agric. Food Chem.
2017, 65, 2677–2685. [CrossRef] [PubMed]
34. Pods˛edek, A.; Majewska, I.; Redzynia, M.; Sosnowska, D.; Koziołkiewicz, M. In vitro inhibitory effect on
digestive enzymes and antioxidant potential of commonly consumed fruits. J. Agric. Food Chem. 2014, 62,
4610–4617. [CrossRef] [PubMed]
35. Hotamisligil, G.S. Inflammation and metabolic disorders. Nature 2006, 444, 860–867. [CrossRef] [PubMed]
36. Gregor, M.F.; Hotamisligil, G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29, 415–445.
[CrossRef]
37. Jayarathne, S.; Koboziev, I.; Park, O.-H.; Oldewage-Theron, W.; Shen, C.-L.; Moustaid-Moussa, N.
Anti-Inflammatory and Anti-Obesity Properties of Food Bioactive Components: Effects on Adipose Tissue.
Prev. Nutr. Food Sci. 2017, 22, 251–262. [CrossRef]
38. Aderem, A.; Ulevitch, R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000,
406, 782–787. [CrossRef]
39. Rodríguez-Hernández, H.; Simental-Mendía, L.E.; Rodríguez-Ramírez, G.; Reyes-Romero, M.A. Obesity
and Inflammation: Epidemiology, Risk Factors, and Markers of Inflammation. Int. J. Endocrinol. 2013, 2013,
678159. [CrossRef]
40. Suganami, T.; Nishida, J.; Ogawa, Y. A paracrine loop between adipocytes and macrophages aggravates
inflammatory changes: Role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc.
Biol. 2005, 25, 2062–2068. [CrossRef]
41. Popko, K.; Gorska, E.; Stelmaszczyk-Emmel, A.; Plywaczewski, R.; Stoklosa, A.; Gorecka, D.; Pyrzak, B.;
Demkow, U. Proinflammatory cytokines Il-6 and TNF-α and the development of inflammation in obese
subjects. Eur. J. Med. Res. 2010, 15, 120–122.
42. Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory responses and
inflammation-associated diseases in organs. Oncotarget 2018, 9, 7204–7218. [CrossRef]
43. García-Alonso, V.; Titos, E.; Alcaraz-Quiles, J.; Rius, B.; Lopategi, A.; López-Vicario, C.; Jakobsson, P.J.;
Delgado, S.; Lozano, J.; Clària, J. Prostaglandin E2 Exerts Multiple Regulatory Actions on Human Obese
Adipose Tissue Remodeling, Inflammation, Adaptive Thermogenesis and Lipolysis. PLoS ONE 2016, 11,
e0153751. [CrossRef]
44. Hsieh, P.-S.; Jin, J.-S.; Chiang, C.-F.; Chan, P.-C.; Chen, C.-H.; Shih, K.-C. COX-2-mediated inflammation in fat
is crucial for obesity-linked insulin resistance and fatty liver. Obesity 2009, 17, 1150–1157. [CrossRef]
45. Lin, H.-Y.; Juan, S.-H.; Shen, S.-C.; Hsu, F.-L.; Chen, Y.-C. Inhibition of lipopolysaccharide-induced nitric
oxide production by flavonoids in RAW264.7 macrophages involves heme oxygenase-1. Biochem. Pharmacol.
2003, 66, 1821–1832. [CrossRef]
46. Santini, A.; Novellino, E. Nutraceuticals: Shedding light on the grey area between pharmaceuticals and food.
Expert Rev. Clin. Pharmacol. 2018, 11, 545–547. [CrossRef]
47. Daliu, P.; Santini, A.; Novellino, E. From pharmaceuticals to nutraceuticals: Bridging disease prevention and
management. Expert Rev. Clin. Pharmacol. 2019, 12, 1–7. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Fermented Sea Tangle (Laminaria japonica Aresch)
Suppresses RANKL-Induced Osteoclastogenesis by
Scavenging ROS in RAW 264.7 Cells
Jin-Woo Jeong 1 , Seon Yeong Ji 2,3 , Hyesook Lee 2,3 , Su Hyun Hong 2,3 , Gi-Young Kim 4 ,
Cheol Park 5 , Bae-Jin Lee 6 , Eui Kyun Park 7 , Jin Won Hyun 8 , You-Jin Jeon 4 and
Yung Hyun Choi 2,3, *
1 Nakdonggang National Institute of Biological Resources, Sangju 37242, Korea
2 Department of Biochemistry, Dong-eui University College of Korean Medicine, Busan 47227, Korea
3 Anti-Aging Research Center, Dong-eui University, Busan 47227, Korea
4 Department of Marine Life Sciences, Jeju National University, Jeju 63243, Korea
5 Department of Molecular Biology, College of Natural Sciences, Dong-eui University, Busan 47340, Korea
6 Marine Bioprocess Co. Ltd., Busan 46048, Korea
7 Department of Oral Pathology and Regenerative Medicine, School of Dentistry,
Kyungpook National University, Daegu 41940, Korea
8 Department of Biochemistry, School of Medicine, Jeju National University, Jeju 63243, Korea
* Correspondence: choiyh@deu.ac.kr; Tel.: +82-51-850-7413
Abstract: Sea tangle (Laminaria japonica Aresch), a brown alga, has been used for many years as
a functional food ingredient in the Asia-Pacific region. In the present study, we investigated the
effects of fermented sea tangle extract (FST) on receptor activator of nuclear factor-κB (NF-κB) ligand
(RANKL)-stimulated osteoclast differentiation, using RAW 264.7 mouse macrophage cells. FST was
found to inhibit the RANKL-stimulated activation of tartrate-resistance acid phosphatase (TRAP) and
F-actin ring structure formation. FST also down-regulated the expression of osteoclast marker genes
like TRAP, matrix metalloproteinase-9, cathepsin K and osteoclast-associated receptor by blocking
RANKL-induced activation of NF-κB and expression of nuclear factor of activated T cells c1 (NFATc1),
a master transcription factor. In addition, FST significantly abolished RANKL-induced generation of
reactive oxygen species (ROS) by activation of nuclear factor-erythroid 2-related factor 2 (Nrf2) and
its transcriptional targets. Hence, it seems likely that FST may have anti-osteoclastogenic potential as
a result of its ability to inactivate the NF-κB-mediated NFATc1 signaling pathway and by reducing
ROS production through activation of the Nrf2 pathway. Although further studies are needed to
inquire its efficacy in vivo, FST appears to have potential use as an adjunctive or as a prophylactic
treatment for osteoclastic bone disease.
Keywords: fermented sea tangle; osteoclast differentiation; receptor of activator of nuclear factor
kappa-B ligand (RANKL); nuclear factor-κB (NF-κB); reactive oxygen species (ROS)
1. Introduction
Bone remodeling is an active physiological process involving bone deposition and bone resorption
by osteoblast and osteoclast, respectively. Imbalance of these processes in favor of resorption may
lead to the formation of osteolytic lesions and an increase in bone disease-related disorders and
morbidity [1–3]. Receptor activator of nuclear factor-κB (NF-κB) ligand (RANKL) and macrophage
colony-stimulating factor (M-CSF) are cytokines that play important roles in osteoclast differentiation
and maturation. RANKL belongs to the tumor necrosis factor (TNF) superfamily and is regarded
as the key promoter of osteoclastogenesis. M-CSF by contrast, is involved in the maintenance of
mature osteoclast survival and mobility [4,5]. The binding of RANKL to its receptor RANK results
in the activation of various signaling pathways, including the NF-κB pathway [6,7], which then
enhances the activation of nuclear factor of activated T cell c1 (NFATc1), which then in turn promotes
osteoclast formation by up-regulating the expression of osteoclast-specific genes [8,9]. In addition, a
number of previous studies have shown that reactive oxygen species (ROS) are also critical messengers
for osteoclast differentiation [10,11] and increased activity of the Nrf2 signaling system can block
this activation [12–14]. These findings suggest that suppression of ROS production in combination
with increasing activity of Nrf2 may provide a means to block osteoclast activity. Although various
drugs have been used clinically to inhibit bone resorption, all have severe side effects when used
long-term [15] and as a result, research into the prevention and treatment of osteolytic diseases using
natural products has greatly increased in recent years.
Many marine algae extract or components of these extracts have been shown to exhibit potential
for preventing and treating bone resorption related diseases [16,17] and fermented marine algal
extracts have attracted the attention of the food and medical care industries [17,18]. The sea tangle,
Laminaria japonica Aresch, is one of the most well-known edible brown seaweeds and has long been
used as an important food supplement in Pacific and Asian countries [19]. This seaweed is rich in
polysaccharides, dietary fiber, minerals, carbohydrates, polyphenols and proteins [20,21] and has
been reported to protect against obesity, inflammation and cancer [22–25]. Interestingly, Lee et al. [26]
developed a fermented form of sea tangle using Lactobacillus brevis with high antioxidant activity
and showed that a fermented sea tangle extract (FST) protected against liver damage better than a
non-fermented sea tangle extract [27,28]. They speculated that glutamate in the sea tangle which
converted to gamma-aminobutyric acid through the fermentation process, was the reason behind the
increased antioxidant capacity. It has been reported that FST supplementation reduce obesity and
improve stress management [29]. Furthermore, previous studies have shown that FST can protect
against age-associated short-term memory loss and reduced physical functioning [30–32]. However,
the effect of FST on bone has not previously been investigated and therefore we decided to investigate
whether FST had any inhibitory effect on RANKL-stimulated osteoclast differentiation using RAW
264.7 mouse macrophage cells.
3. Results
Figure 1. Effects of fermented sea tangle extract (FST) and receptor of activator of nuclear factor
kappa-B ligand (RANKL) on the viability of RAW 264.7 mouse macrophage-like cells. Cells were
treated with desired concentrations of FST in the absence (A) or presence (B) of 100 ng/mL RANKL
and/or 100 ng/mL OPG for 72 h. H2 O2 was used as a positive control. Cell viabilities were measured by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Relative cell viability is
expressed as percentages compared to treatment of naïve control cells. Results are presented as means
± SD of three independent experiments. * p < 0.05 and *** p < 0.005 indicates significant difference
compared to the untreated control cells. OPG: osteoprotegerin; +: cells treated the reagent; -: cells
untreated the reagent.
3.3. FST Disrupts RANKL-Induced Formation of F-Actin Rich Adhesive Structures in RAW 264.7 Mouse
Macrophage-Like Cells
Formation of the F-actin rich adhesive structures by osteoclasts is an essential step in bone
resorption [35,36]. Figure 3 indicated that staining with FITC-conjugated phalloidin showed
RANKL (100 ng/mL) stimulation increased well-defined F-actin sealing rings with a higher intensity
ring height. However, the size of rings formed by RANKL-treated cells was remarkably and
concentration-dependently reduced in cells co-treated with FST. Furthermore, OPG treatment
complementally inhibited the F-actin sealing ring formation in RANKL-stimulated cells.
Foods 2019, 8, 290
Figure 3. Suppression of F-actin ring formation by FST in RANKL-induced RAW 264.7 mouse
macrophage-like cells. The cells were co-treated with 100 ng/mL RANKL in the presence or absence
of FST or 100 ng/mL OPG for 5 days and stained for F-actin rich adhesive structures with fluorescein
isothiocyanate (FITC)-phalloidin and 4 ,6-diamidino-2-phenylindole (DAPI). The photographs are
representative of the morphological changes observed under a fluorescence microscope. RANKL:
receptor of activator of nuclear factor kappa-B ligand; FST: fermented sea tangle extract.
Foods 2019, 8, 290
3.4. FST Inhibits the RANKL-Induced Nuclear Translocation of NF-κB and IκBα Degradation in RAW
264.7 Cells
Activation of NF-κB through nuclear translocation by RANKL is an essential step for initiation of
osteoclast differentiation [6,7]. Therefore, we assessed whether FST affected the activation of NF-κB
induced by RANKL. As shown in Figure 4A,B, our immunoblotting results reveal that the expression
of NF-κB was markedly increased in the nuclei of RANKL treated cells but the expression of IκBα was
reduced in the cytoplasm, which suggested that RANKL stimulated activation of NF-κB. However,
FST suppressed the RANKL-mediated degradation of IκBα and the subsequent nuclear accumulation
of NF-κB. Furthermore, immunofluorescence studies produced similar results. More specifically,
phosphorylated NF-κB p65 was predominantly located in nuclei in RANKL-stimulated cells but not in
FST and RANKL co-treated cells (Figure 4C).
Figure 4. Effects of FST on the RANKL-induced activation of NF-κB in RAW 264.7 mouse
macrophage-like cells. (A) After co-treating cells with 100 ng/mL RANKL in the presence or absence of
FST for 1 h, nuclear and cytosolic proteins were isolated. The expression of NF-κB and IκB-α were
determined by Western blotting. Lamin B and β-actin were used as internal controls for the nuclear
and cytosolic fractions, respectively. (B) Densitometry quantifications of protein expressions were
measured by ImageJ. Statistical analyses were conducted using analysis of variances between groups.
*** p < 0.0001 when compared to control. (C) Cells grown on gelatin-coated glass coverslips were
co-treated with 800 μg/mL FST with or without 100 ng/mL RANKL. Localization of phospho-NF-κB
p65 was observed under a fluorescence microscope following staining with anti-phospho-NF-κB p65
antibody (red) and DAPI (nuclear stain; blue). Original magnification ×400. RANKL: receptor of
activator of nuclear factor kappa-B ligand; FST: fermented sea tangle extract; IκBα: inhibitory proteins
of kappa B, alpha; NF-κB: nuclear factor-kappa B; +: cells treated the reagent; -: cells untreated
the reagent.
3.5. FST Down-Regulates RANKL-Induced Osteoclast-Associated Gene Expression in RAW 264.7 Cells
NFATc1 is considered to be the most important regulator of the transcriptional activation
of osteoclast differentiation-associated genes by RANKL [8,9]. To examine in more detail the
mechanism of FST-mediated inhibition of osteoclastogenesis, we assessed the expression of NFATc1 in
RANKL-stimulated RAW 264.7 cells. Consistent with previous studies, the expression of NFATc1 was
significantly increased by RANKL but was down-regulated in a concentration-dependent manner by FST
(Figure 5). In addition, we investigated the effects of FST on the levels of specific marker for osteoclast
such as TRAP, cathepsin (CTSK), matrix metallopeptidase-9 (MMP-9) and osteoclast-associated receptor
Foods 2019, 8, 290
(OSCAR). Figure 5 showed that RANKL markedly up-regulated levels of these osteoclast-specific
markers, which were effectively attenuated by the addition of FST. Co-treatment with OPG also
completely prevented increases in these protein markers.
3.6. FST Attenuates RANKL-Induced Intracellular ROS Accumulation Associated with Activation of Nrf2 in
RAW 264.7 Mouse Macrophage-Like Cells
Overproduction of intracellular ROS plays a critical step in RANKL-mediated
osteoclastogenesis [12–14], thereby we examined whether FST inhibits the generation of ROS during
RANKL-mediated osteoclastogenesis using DCF-DA, a cell permeant redox-sensitive dye. We
demonstrated by flow cytometry that ROS levels were significantly increased by RANKL and that
these up-regulation were abolished by FST (Figure 6A,D). Moreover, this effect of FST was supported
by our fluorescence microscopic examination (Figure 6B) and further, co-treatment with N-acetyl
cysteine (NAC), an intensive ROS scavenger, completely alleviated RANKL-induced ROS generation
and F-actin ring formation (Figure 6C). In addition, Figure 6E,F shows that FST has the efficacy of
equivalence and/or superiority compared with NAC and it was suggested that FST is a powerful
anti-oxidant, thereby it has a suppressed RANKL-mediated ROS generation.
Foods 2019, 8, 290
Figure 6. Effect of FST on RANKL-induced reactive oxygen species (ROS) generation in RAW
264.7 mouse macrophage-like cells. Cells were co-treated with 100 ng/mL RANKL for 1 h in the
presence or absence of 800 μg/mL FST or 10 mM NAC. (A,D) Cells were stained with 5,6-carboxy-2 ,
7 -dichlorofluorescein diacetate (DCF-DA) and DCF fluorescence was measured by flow cytometry.
Results are means of two independent experiments. (B) After staining with DCF-DA, images were
obtained using a fluorescence microscope. Images are representative of at least three independent
experiments. (C) Cells cultured under the conditions used to induce osteoclast differentiation were fixed
and stained for F-actin ring with FITC-phalloidin solution and imaged under a fluorescence microscope.
Representative photographs of the morphological changes observed are presented. (E) Cellular proteins
were isolated from cells and the expression of NFATc1, phospho-NF-κB and phosphor-Nrf2 by Western
blot analysis. β-actin was used as the internal control. The results shown are representative of three
independent experiments. (F) Statistical analyses were conducted using analysis of variances. * p < 0.05
and *** p < 0.001 when compared to control. ### p < 0.0001 when compared to RANKL treatment.
RANKL: receptor of activator of nuclear factor kappa-B ligand; FST: fermented sea tangle extract;
NAC: N-acetyl cysteine osteoprotegerin; NFATc1: nuclear factor of activated T cells c1; p- NF-κB p65:
phosphorylated nuclear factor-kappa B p65; p-Nrf2: phosphorylated nuclear factor-erythroid 2-related
factor 2; +: cells treated the reagent; -: cells untreated the reagent.
Foods 2019, 8, 290
In addition, we show that FST increased the expression and phosphorylation of Nrf2
in RANKL-stimulated cells, which was associated with an increase in typical Nrf2-dependent
cytoprotective enzymes such as heme oxygenase-1 (HO-1) and NAD(P)H: Quinone oxidoreductase 1
(NQO-1) (Figure 7A,B). Furthermore, we observed that Nrf2 translocation to the nucleus was promoted
by FST treatment (Figure 7C,D).
Figure 7. Activation of Nrf2 signaling pathway by FST in RAW 264.7 mouse macrophage-like cells.
Cells were treated with FST with or without 100 ng/mL RANKL for 5 days. (A) Total cellular proteins
were isolated from cells and the expression levels of Nrf2 and its regulatory proteins were assessed
by Western blot analysis. β-actin was used as the internal control. (C) The expression of nuclear and
cytosol Nrf2 were determined by Western blotting. Lamin B and β-actin were used as internal controls
for the nuclear and cytosolic fractions, respectively. The results shown are representative of three
independent experiments. (B,D) Statistical analyses were conducted using analysis of variances between
groups. * p < 0.05 and *** p < 0.0001 when compared to control. # p < 0.05 and ### p < 0.0001 when
compared to RANKL treatment. RANKL: receptor of activator of nuclear factor kappa-B ligand; FST:
fermented sea tangle extract; Nrf2: nuclear factor-erythroid 2-related factor 2; p-Nrf2: phosphorylated
nuclear factor-erythroid 2-related factor 2; HO-1: heme oxygenase-1; NQO-1: NAD(P)H quinone
oxidoreductase 1; +: cells treated the reagent; -: cells untreated the reagent.
4. Discussion
Osteoclasts are multinucleated cells of hematopoietic origin which are derived from the
monocyte/macrophage in their ability to resorb bone, whereas osteoblast are derived from pluripotent
mesenchymal stem cells and are involved in bone formation [1,2]. Since excessive bone resorption
by osteoclasts causes an imbalance in bone regeneration and induces osteolytic diseases, osteoclasts
are considered prime targets for the management and treatment of bone diseases [2,3]. RANKL is a
pro-osteoclastogenic cytokine and plays a crucial role in promoting osteoclastogenesis from osteoclast
progenitor cells [4,5]. As has been well established in many earlier studies, RANKL binds to RANK
expressed on the plasma membrane of osteoclast precursors and activates complex signaling cascades
including NF-κB and NFATc1 for osteoclast differentiation [9,10]. Differentiation through activation
of these signal transduction systems by RANKL is characterized by the formation of multinucleated
giant cells [5,7]. This is a preliminary step in the maintenance, formation and function of the F-actin
Foods 2019, 8, 290
loop structure, which plays an important role in seal zone formation and resorption of bone mineral
matrix in osteoclasts by activated TRAP [37,38]. According to the present findings, FST effectively
inhibited RANKL-induced TRAP activation and F-actin ring formation without causing any significant
cytotoxicity in RAW 264.7 cells, implying that FST suppressed osteoclast differentiation from osteoclast
precursors at an early stage.
NF-κB, a transcription factor that plays a key role in inducing osteoclast differentiation, complexes
with cytoplasmic IκB-α in the absence of osteoclastogenic induction signals and keeps it in an inactive
form that tightly regulates its transcriptional activity for osteoclast differentiation [4,37]. However,
the interaction of RANKL and RANK promotes the activation of the IκB kinase (IKK) complex,
which phosphorylates IκB-α leading to ubiquitin-dependent degradation [6,7]. As a result, free NF-κB
translocates to the nucleus and activates transcription of various genes involved in osteoclastogenesis [5].
Our results demonstrated that RANKL promoted the degradation of IκB-α in the cytoplasm and
induced the translocation of NF-κB into the nucleus, both of which are essential for the activation of
NF-κB but that these changes were completely inhibited by FST.
In the early stages of NF-κB activation and osteoclast differentiation, NFATc1 acts as a master
regulator that enhances transcription of various osteoclast marker genes, which are highly expressed
in the terminal differentiation stage to promote bone resorption [5,39]. In addition to blocking
RANKL-induced NF-κB activation, FST inhibited NFATc1 expression in RANKL-treated cells.
OPG treatment also completely blocked the expression of NFATc1. As further proof that FST was
effectively inhibiting osteoclastogenesis, we showed that it attenuated RANKL-induced up-regulation
of osteoclast marker genes such as TRAP, MMP-9, CTSK and OSCAR to levels seen in the control and
OPG co-treated groups. Although further experiments are required to determine whether NFATc1
inhibition is the direct result of NF-κB inactivation, the present results indicate that inactivation of the
NF-κB signaling pathway and inhibition of the expression of osteoclast marker genes associated with a
decrease in NFATc1 expression are involved as important mechanisms in the anti-osteoclastogenic
effect of FST.
A number of previous studies have shown that ROS, as specific secondary messengers, play a
key role in the initiation of RANKL-stimulated osteoclast differentiation and bone resorption through
similar pathways involving the activation of NF-κB and NFATc1 [10,12]. However, the accumulation of
excessive ROS due to oxidative stress blocks osteoblast differentiation, suppresses osteoblast survival
and acts to promote bone loss [12,13]. It has also been reported that a variety of natural products with
antioxidant activity inhibit osteoclast differentiation by inhibiting ROS production [6,10,11]. Therefore,
ROS can be considered a potential target for inhibition of osteoclast differentiation and prevention
of bone loss. The present results showed that FST significantly suppressed ROS production by
RANKL. Moreover, consistent with the results of previous studies [12,40], RANKL-induced osteoclast
differentiation was completely inhibited when production of ROS was artificially blocked using NAC,
indicating that FST blocks osteoclast differentiation by acting as a scavenger or inhibitor of ROS. In order
to reduce the damage from oxidative stress in the face of excess production of ROS in cells, several
transcription factors are known to be activated to increase the expression of downstream antioxidant
enzymes [41,42]. One of these redox sensitive transcription factors, Nrf2 has recently been reported to
attenuate osteoclast differentiation through the regulation of ROS production [42,43]. For example,
Nrf2 deficiency improved RANKL-induced osteoclast differentiation [44], whereas local induction of
nuclear Nrf2 weakened RANKL-mediated osteoclastogenesis [45]. Under normal conditions, Nrf2 is
sequestered by Kelch-like ECH-associated protein 1 (Keap1) to the cytoplasm but becomes separated
from Keap1 by oxidative or electrophilic stress and translocated into the nucleus. In the nucleus,
Nrf2 binds to the antioxidant response elements to induce the transcription of target antioxidants and
detoxifying enzymes including HO-1 and NQO-1 [42,43]. In this study, FST significantly increased
expression of Nrf2 and its transcriptional targets, including HO-1 and NQO-1 in RANKL-treated RAW
264.7 cells. We also observed that FST increased phosphorylation and nuclear translocation of Nrf2
compared to the RANKL-alone stimulated group. The results presented, indicate that FST attenuates
Foods 2019, 8, 290
5. Conclusions
To assume the effect of FST on RANKL-mediated osteoclast differentiation, recombinant RANKL
protein was used to differentiate murine monocyte/macrophage RAW 264.7 cells as osteoclast
precursor cells into osteoclasts. Present results demonstrated that FST inhibited RANKL-induced
osteoclastogenesis and reduced the expression of several key osteoclast-regulatory genes through the
inactivation of NF-κB. In addition, FST blocked RANKL-induced oxidative stress, which was associated
with the activation of Nrf2 signaling pathway. Although the present study provides new insights
into the inhibition of osteoclastogenesis by FST, further investigation of the molecular mechanisms
underlying this process as well as identification of the bioactive constituents of FST are needed.
Author Contributions: Y.H.C., Y.-J.J., C.P. and B.-J.L. conceived and designed the experiments; J.-W.J., H.L.,
S.H.H. and C.P. performed the experiments; S.Y.J., H.L., G.-Y.K., E.K.P. and J.W.H. analyzed the data; J.-W.J. wrote
the paper and Y.H.C. edited the paper.
Funding: This research was a part of the project titled ‘Development of functional food products with natural
materials derived from marine resources (20170285)’, funded by the Ministry of Oceans and Fisheries.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Kikuta, J.; Ishii, M. Osteoclast migration, differentiation and function: Novel therapeutic targets for rheumatic
diseases. Rheumatology 2013, 52, 226–234. [CrossRef] [PubMed]
2. Teitelbaum, S.L.; Ross, F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 2003,
4, 638–649. [CrossRef] [PubMed]
3. Galson, D.L.; Roodman, G.D. Pathobiology of Paget’s disease of bone. J. Bone Metab. 2014, 21, 85–98.
[CrossRef] [PubMed]
4. Ono, T.; Nakashima, T. Recent advances in osteoclast biology. Histochem. Cell Biol. 2018, 149, 325–341.
[CrossRef] [PubMed]
5. Park, J.H.; Lee, N.K.; Lee, S.Y. Current understanding of RANK signaling in osteoclast differentiation and
maturation. Mol. Cells 2017, 40, 706–713. [PubMed]
6. Bi, H.; Chen, X.; Gao, S.; Yu, X.; Xiao, J.; Zhang, B.; Liu, X.; Dai, M. Key triggers of osteoclast-related diseases
and available strategies for targeted therapies: A review. Front. Med. 2017, 4, 234. [CrossRef] [PubMed]
7. Kuroda, Y.; Matsuo, K. Molecular mechanisms of triggering, amplifying and targeting RANK signaling in
osteoclasts. World J. Orthop. 2012, 3, 167–174. [CrossRef]
8. Sundaram, K.; Nishimura, R.; Senn, J.; Youssef, R.F.; London, S.D.; Reddy, S.V. RANK ligand signaling
modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp. Cell Res.
2007, 313, 168–178. [CrossRef]
9. Asagiri, M.; Sato, K.; Usami, T.; Ochi, S.; Nishina, H.; Yoshida, H.; Morita, I.; Wagner, E.F.; Mak, T.W.;
Serfling, E.; et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis.
J. Exp. Med. 2005, 202, 1261–1269. [CrossRef]
10. Lee, S.H.; Jang, H.D. Scoparone attenuates RANKL-induced osteoclastic differentiation through controlling
reactive oxygen species production and scavenging. Exp. Cell Res. 2015, 331, 267–277. [CrossRef]
11. Domazetovic, V.; Marcucci, G.; Iantomasi, T.; Brandi, M.L.; Vincenzini, M.T. Oxidative stress in bone
remodeling: Role of antioxidants. Clin. Cases Miner. Bone Metab. 2017, 14, 209–216. [CrossRef] [PubMed]
12. Li, Z.; Chen, C.; Zhu, X.; Li, Y.; Yu, R.; Xu, W. Glycyrrhizin suppresses RANKL-Induced osteoclastogenesis
and oxidative stress through inhibiting NF-κB and MAPK and activating AMPK/Nrf2. Calcif. Tissue Int.
2018, 103, 324–337. [CrossRef] [PubMed]
13. Thummuri, D.; Naidu, V.G.M.; Chaudhari, P. Carnosic acid attenuates RANKL-induced oxidative stress and
osteoclastogenesis via induction of Nrf2 and suppression of NF-κB and MAPK signalling. J. Mol. Med. 2017,
95, 1065–1076. [CrossRef] [PubMed]
Foods 2019, 8, 290
14. Kim, H.J.; Park, C.; Kim, G.Y.; Park, E.K.; Jeon, Y.J.; Kim, S.; Hwang, H.J.; Choi, Y.H. Sargassum serratifolium
attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and
activation of the Nrf2/HO-1 signaling pathway. Biosci. Trends 2018, 12, 257–265. [CrossRef] [PubMed]
15. Khan, M.; Cheung, A.M.; Khan, A.A. Drug-related adverse events of osteoporosis therapy. Endocrinol. Metab.
Clin. 2017, 46, 181–192. [CrossRef] [PubMed]
16. Koyama, T. Extracts of marine algae show inhibitory activity against osteoclast differentiation. Adv. Food
Nutr. Res. 2011, 64, 443–454. [PubMed]
17. Venkatesan, J.; Kim, S.K. Osteoporosis treatment: Marine algal compounds. Adv. Food Nutr. Res. 2011, 64,
417–427. [PubMed]
18. De Jesus Raposo, M.F.; De Morais, A.M.; De Morais, R.M. Emergent sources of prebiotics: Seaweeds and
microalgae. Mar. Drugs 2016, 14, E27. [CrossRef] [PubMed]
19. Shirosaki, M.; Koyama, T. Laminaria japonica as a food for the prevention of obesity and diabetes. Adv. Food
Nutr. Res. 2011, 64, 199–212.
20. Gao, J.; Lin, L.; Sun, B.; Zhao, M. A comparison study on polysaccharides extracted from Laminaria japonica
using different methods: Structural characterization and bile acid-binding capacity. Food Funct. 2017, 8,
3043–3052. [CrossRef]
21. Machu, L.; Misurcova, L.; Ambrozova, J.V.; Orsavova, J.; Mlcek, J.; Sochor, J.; Jurikova, T. Phenolic content
and antioxidant capacity in algal food products. Molecules 2015, 20, 1118–1133. [CrossRef] [PubMed]
22. Kim, Y.M.; Jang, M.S. Anti-obesity effects of Laminaria japonica fermentation on 3T3-L1 adipocytes are
mediated by the inhibition of C/EBP-α/β and PPAR-γ. Cell. Mol. Biol. 2018, 64, 71–77. [CrossRef] [PubMed]
23. Jang, E.J.; Kim, S.C.; Lee, J.H.; Lee, J.R.; Kim, I.K.; Baek, S.Y.; Kim, Y.W. Fucoxanthin, the constituent of
Laminaria japonica, triggers AMPK-mediated cytoprotection and autophagy in hepatocytes under oxidative
stress. BMC Complement. Altern. Med. 2018, 18, 97. [CrossRef] [PubMed]
24. Je, J.Y.; Park, S.Y.; Ahn, C.B. Antioxidant and cytoprotective activities of enzymatic extracts from Rhizoid of
Laminaria japonica. Prev. Nutr. Food Sci. 2017, 22, 312–319. [CrossRef] [PubMed]
25. Zeng, M.; Wu, X.; Li, F.; She, W.; Zhou, L.; Pi, B.; Xu, Z.; Huang, X. Laminaria Japonica polysaccharides
effectively inhibited the growth of nasopharyngeal carcinoma cells in vivo and in vitro study. Exp. Toxicol.
Pathol. 2017, 69, 527–532. [CrossRef] [PubMed]
26. Lee, B.J.; Senevirathne, M.; Kim, J.S.; Kim, Y.M.; Lee, M.S.; Jeong, M.H.; Kang, Y.M.; Kim, J.I.; Nam, B.H.;
Ahn, C.B.; et al. Protective effect of fermented sea tangle against ethanol and carbon tetrachloride-induced
hepatic damage in Sprague-Dawley rats. Food Chem. Toxicol. 2010, 48, 1123–1128. [CrossRef] [PubMed]
27. Kang, Y.M.; Lee, B.J.; Kim, J.I.; Nam, B.H.; Cha, J.Y.; Kim, Y.M.; Ahn, C.B.; Choi, J.S.; Choi, I.S.; Je, J.Y.
Antioxidant effects of fermented sea tangle (Laminaria japonica) by Lactobacillus brevis BJ20 in individuals
with high level of γ-GT: A randomized, double-blind, and placebo-controlled clinical study. Food Chem.
Toxicol. 2012, 50, 1166–1169. [CrossRef]
28. Cha, J.Y.; Jeong, J.J.; Yang, H.J.; Lee, B.J.; Cho, Y.S. Effect of fermented sea tangle on the alcohol dehydrogenase
and acetaldehyde dehydrogenase in Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 2011, 21, 791–795.
[CrossRef]
29. You, J.S.; Sung, M.J.; Chang, K.J. Evaluation of 8-week body weight control program including sea tangle
(Laminaria japonica) supplementation in Korean female college students. Nutr. Res. Pract. 2009, 3, 307–314.
[CrossRef]
30. Choi, W.C.; Reid, S.N.S.; Ryu, J.K.; Kim, Y.; Jo, Y.H.; Jeon, B.H. Effects of γ-aminobutyric acid-enriched
fermented sea tangle (Laminaria japonica) on brain derived neurotrophic factor-related muscle growth and
lipolysis in middle aged women. Algae 2016, 31, 175–187. [CrossRef]
31. Reid, S.N.S.; Ryu, J.K.; Kim, Y.; Jeon, B.H. GABA-enriched fermented Laminaria japonica improves cognitive
impairment and neuroplasticity in scopolamine- and ethanol-induced dementia model mice. Nutr. Res.
Pract. 2018, 12, 199–207. [CrossRef] [PubMed]
32. Reid, S.N.S.; Ryu, J.K.; Kim, Y.; Jeon, B.H. The effects of fermented Laminaria japonica on short-term working
memory and physical fitness in the elderly. Evid. Based Complement. Altern. Med. 2018, 2018, 8109621.
33. Khosla, S. Minireview: The OPG/RANKL/RANK system. Endocrinology 2001, 142, 5050–5055. [CrossRef]
[PubMed]
34. Hofbauer, L.C. Osteoprotegerin ligand and osteoprotegerin: Novel implications for osteoclast biology and
bone metabolism. Eur. J. Endocrinol. 1999, 141, 195–210. [CrossRef] [PubMed]
Foods 2019, 8, 290
35. Kong, X.; Yang, Y.; Wu, W.; Wan, H.; Li, X.; Zhong, M.; Su, X.; Jia, S.; Lin, N. Triterpenoid saponin W3 from
Anemone flaccida suppresses osteoclast differentiation through inhibiting activation of MAPKs and NF-κB
pathways. Int. J. Biol. Sci. 2015, 11, 1204–1214. [CrossRef]
36. Hong, S.; Huh, J.E.; Lee, S.Y.; Shim, J.K.; Rhee, S.G.; Jeong, W. TRP14 inhibits osteoclast differentiation via its
catalytic activity. Mol. Cell. Biol. 2014, 34, 3515–3524. [CrossRef] [PubMed]
37. Soysa, N.S.; Alles, N. Osteoclast function and bone-resorbing activity: An overview. Biochem. Biophys. Res.
Commun. 2016, 476, 115–120. [CrossRef]
38. Hayman, A.R. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy.
Autoimmunity 2008, 41, 218–223. [CrossRef]
39. Kim, Y.W.; Baek, S.H.; Lee, S.H.; Kim, T.H.; Kim, S.Y. Fucoidan, a sulfated polysaccharide, inhibits osteoclast
differentiation and function by modulating RANKL signaling. Int. J. Mol. Sci. 2014, 15, 18840–18855.
[CrossRef]
40. Zhang, Y.; Zhang, Y.; Kou, J.; Wang, C.; Wang, K. Role of reactive oxygen species in angiotensin II: Induced
receptor activator of nuclear factor-κB ligand expression in mouse osteoblastic cells. Mol. Cell. Biochem. 2014,
396, 249–255. [CrossRef]
41. Lee, N.K.; Choi, Y.G.; Baik, J.Y.; Han, S.Y.; Jeong, D.W.; Bae, Y.S.; Kim, N.; Lee, S.Y. A crucial role for reactive
oxygen species in RANKL-induced osteoclast differentiation. Blood 2005, 106, 852–859. [CrossRef] [PubMed]
42. Kang, K.A.; Hyun, J.W. Oxidative stress, Nrf2, and epigenetic modification contribute to anticancer drug
resistance. Toxicol. Res. 2017, 33, 1–5. [CrossRef] [PubMed]
43. Sun, Y.X.; Xu, A.H.; Yang, Y.; Li, J. Role of Nrf2 in bone metabolism. J. Biomed. Sci. 2015, 22, 101. [CrossRef]
[PubMed]
44. Hyeon, S.; Lee, H.; Yang, Y.; Jeong, W. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced
osteoclast differentiation. Free Radic. Biol. Med. 2013, 65, 789–799. [CrossRef] [PubMed]
45. Kanzaki, H.; Shinohara, F.; Kajiya, M.; Fukaya, S.; Miyamoto, Y.; Nakamura, Y. Nuclear Nrf2 induction by
protein transduction attenuates osteoclastogenesis. Free Radic. Biol. Med. 2014, 77, 239–248. [CrossRef]
[PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Antioxidant Activities of Solanum nigrum L. Leaf
Extracts Determined in In Vitro Cellular Models
Agata Campisi 1 , Rosaria Acquaviva 1 , Giuseppina Raciti 1 , Anna Duro 2 , Milena Rizzo 1, * and
Natale Alfredo Santagati 1
1 Department of Drug Science, University of Catania, Viale Andrea Doria 6, 95125 Catania, Italy;
agcampisi@gmail.com (A.C.); racquavi@unict.it (R.A.); racitigi@unict.it (G.R.); santagat@unict.it (N.A.S.)
2 Department of Biological, Geological and Environmental Sciences, University of Catania, Via A. Longo 19,
95125 Catania, Italy; annaduro@unict.it
* Correspondence: milena.rizzo@unict.it
Abstract: Several medicinal foods abound in traditional medicine with antioxidant potentials that
could be of importance for the management of several diseases but with little or no scientific
justification to substantiate their use. Thus, the objective of this study was the assessment of
the antioxidant effect of two leave extracts of Solanum nigrum L. (SN), which is a medicinal plant
member of the Solanaceae family, mainly used for soup preparation in different parts of the world.
Then methanolic/water (80:20) (SN1) and water (SN2) leaves extracts were prepared. The total
polyphenolic content and the concentration of phenolic acids and flavones compounds were
determined. In order to verify whether examined extracts were able to restore the oxidative status,
modified by glutamate in primary cultures of astrocytes, the study evaluated the glutathione levels,
the intracellular oxidative stress, and the cytotoxicity of SN1 and SN2 extracts. Both extracts were
able to quench the radical in an in vitro free cellular system and restore the oxidative status in in vitro
primary cultures of rat astroglial cells exposed to glutamate. These extracts prevented the increase in
glutamate uptake and inhibited glutamate excitotoxicity, which leads to cell damage and shows a
notable antioxidant property.
Keywords: Solanum nigrum L. leave extracts; natural products; antioxidant activity; functional food
1. Introduction
Several medicinal foods abound in traditional medicine with antioxidant activities. This could
be of important for the management of several diseases but has little or no scientific justification to
substantiate their use. In the tropics, as in Asia and in sub-Saharan Africa, green leafy vegetables are
used as one of the major components of local dishes.
Solanum nigrum L. (SN) belongs to the Solanaceae family to Europe, Asia, and North America and
was introduced in South America, Australia, and Africa. It represents one of the largest and most
variable species groups of the genus. SN, well known as “Black Nightshade” (the English name), is an
herbal plant widely distributed throughout the world, extending from tropical regions to temperate
regions [1].
In many developing countries, SN constitutes a minor food crop, with the shoots and berries not
only used as vegetables and fruits but also for various medicinal and local uses [2]. SN serves mainly
as vegetables for soup preparation in different parts of the world. Several studies have investigated
the nutritive value of the ‘vegetable black nightshade,’ which put forward evidence that this species
constitutes a nutritious vegetable [3]. This plant was chosen not only for being nutritive, but also
for their folkloric reports of medicinal properties [4]. Studies document potential health benefits of
different parts of this vegetable. SN leaves have been reportedly used in traditional medicine for the
management of several diseases including seizure and epilepsy, pain, ulcer, inflammation, diarrhea,
some eye infections, and jaundice [5,6].
In folklore medicine, the leaves are used to treat oral ulcers in India where an interesting
pharmacological investigation has been performed by using an aqueous extract of SN leaves [7].
More recently, many research studies have reported that SN showed anti-cancer activity for
hepatocellular carcinoma cells [8], human ovarian carcinoma cells [9], human colorectal carcinoma
cells [10], and human endometrial carcinoma cells [11]. The leaves can provide appreciable amounts of
protein and amino acids, minerals including calcium, iron, and phosphorus, vitamins A and C, fats and
fibers, and appreciable amounts of methionine, which is an amino acid scarce in other vegetables. Other
chemical constituents reported in leaves are steroidal glycosides [12]. Very recently, from the unripe
berries, a previously undescribed steroidal alkaloids [13] and steroidal glycosides [14] were isolated.
Those compounds showed a potent inhibitory activity against the lipopolysaccharide (LPS)-induced
nitric oxide (NO) production.
Because medicinal plants are gaining popularity for the production of reliable and safe medicines
suitable for human, many studies investigated the composition of extracts, their biological activities,
and optimization of extraction procedures [15,16].
The extracts of the SN contain many polyphenolic compounds. The leaves are rich in polyphenols,
including phenolic acids and flavones [17]. Zaidi et al. demonstrated that treatment of rats with SN
leaves extract was able to reduce oxidative stress, and, in particular, they showed the potential of
this extract in preventing/alleviating stress-induced diseases, involving oxidative damage to cellular
constituents especially the brain [18]. Antioxidant activity might be due to the presence of the
above-mentioned polyphenolic compounds on SN stems and leaves [19]. Sun et al. demonstrated that
oxidative stress has been associated with pathological conditions, including Central Nervous System
(CNS) diseases and physiological brain aging processes [20].
A very interesting study has shown that dietary inclusions of Solanum leaf could protect against
cognitive and neurochemical impairments induced by scopolamine, and, hence, this vegetable could
be used as a source of functional foods and nutraceuticals for the prevention and management of
cognitive impairment-associated diseases such as Alzheimer’s disease [21].
The formation and release of Radical Oxygen reactive Species (ROS) cause structural and
functional alterations of cell membranes. Free radicals attack polyunsaturated fatty acids in
bio-membranes and mitochondria begin the main source of ROS, when the mitochondrial respiratory
chain is impaired. In these cases, a compound possessing antioxidant properties can be useful in
stopping ROS production and limiting oxidative cell damages, which is particularly interesting if
this activity is produced by a functional food [22]. Experimentally, ROS is well determined by using
reduced glutathione (GSH), which is known as the most important scavengers of reactive species, and
a reduced glutathione/oxidized glutathione ratio is used as a marker of oxidative stress [23].
At the central level, the oxidative stress may activate several calcium-dependent enzymes, causing
mitochondria impairment, a decrease in adenosine triphosphate (ATP) levels, ROS production,
and subsequent neuronal cell death [24]. A brief exposure to glutamate, which is a major
excitatory neurotransmitter in the CNS, could determine several acute and chronic brain damages
on differentiated astrocytes, which then causes cell swelling, whereas a prolonged incubation
(excitotoxicity) induces cell damage [25,26]. This phenomenon causes alterations in glutamate
transport, GSH depletion, and macromolecular synthesis [27].
Herein, we prepared two SN polar leaf extracts and assessed the total polyphenolic content and
the concentration of phenolic acids and flavones compounds. Antioxidant activity in both an in vitro
cellular free system and in vitro cellular system was evaluated. To verify whether SN1 and SN2 extracts
were able to restore the oxidative status, which were modified by glutamate in primary cultures of
astrocytes, GSH, ROS levels and the cytotoxicity of both extracts has been assessed.
Foods 2019, 8, 63
2.1. Materials
Reference compounds (gallic acid, protocatechuic acid, chlorogenic acid, gentisic acid, caffeic
acid, luteolin, apigenin) were purchased from Sigma (St. Louis, MO, USA). Acetonitrile,
methanol, and water were chromatographic-grade and were bought from Carlo Erba (Milano,
Italy). STable 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical, 3(4,5-dimethyl-thiazol-2-yl)2,5-diphenyl-
tetrazolium bromide (MTT), 2 ,7 -dichlorofluorescein diacetate (DCFH-DA), 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (Trolox), dimethylsulfoxide (DMSO), GYKI 52466, phosphate
buffer solution (PBS), and other analytical chemicals were purchased from Sigma-Aldrich Chimica
(Milan, Italy). Distilled and deionized water was used for the preparation of all samples and solutions
and they were used after filtration through HA filters (0.45 μm Millipore, Bedford, MA, USA). All
standards were diluted to the appropriate obtained concentration and were stored at +4 ◦ C in amber
vials in a dark place until analysis. Dulbecco s modified Eagle s medium (DMEM) and heat-inactivated
Fetal Bovine Serum (FBS) were obtained from Invitrogen (Milan, Italy). The mouse monoclonal
antibody against glial fibrillary acidic protein (GFAP) and anti-IgG polyclonal antibody were from
Chemicon (Prodotti Gianni, Milan, Italy).
2.2. Methods
2.2.3. Chromatography
Chromatographic analysis was performed by using high-performance liquid chromatography
(HPLC) (Perkin Elmer, Norwalk, CT, USA) Series 200 pump equipped with an LC-235C Diode Array
Detector (DAD), auto-sampler, and column oven. Chromatographic data were processed by using a
Turbochrom Workstation software, version 6.1.2 (Perkin Elmer, Norwalk, CT, USA). Separation and
Foods 2019, 8, 63
determinations were accomplished on a 5 μm Hypersil ODS RP-18 column (250 × 4.6 mm, Supelco,
Bellefonte, PA, USA) fitted with a guard column (Hypersil ODS RP-18, 5 μm particles, 10 × 4.6 mm,
Supelco, Bellefonte, PA, USA). All the samples were filtered, through 0.45 μm membrane filter, and
degassed by an ultrasonic bath before the injection. The procedure was performed, as previously
described [17].
3. Results
Table 1. Extraction yields and concentration of total phenolic content of SN1 and SN2 extracts (n = 3).
The relative concentrations of phenolic acids and flavones in SN1 and SN2 were determined by
HPLC analysis, according to Huang et al. [29]. The values were expressed in mg/g of dry extract.
The results of the five phenolic acids determination (gallic, protocatechuic, chlorogenic, gentisic, and
caffeic) and two flavones (luteolin and apigenin) in studied extracts are summarized in Table 2 while
Figure 1 shows a representative chromatogram.
It was found that the major compound in both extracts was chlorogenic acid, whereas
gentisic acid is the second. Luteolin is more abundant than apigenin, and less amounts of caffeic
acid and protocatechuic acid were found. Gallic acid exists only in traces together with other
unknown compounds.
Table 2. Contents of phenolic acid and flavones (mg/g of dry weight) in SN1 and SN2 leave extracts
(n = 3).
Figure 1. Representative chromatogram of the dry extract reporting the retention time (RT) of gallic
acid (1, 0.65 min), protocatechuic acid (2, 13.85 min), chlorogenic acid (3, 20.5 min), gentisic acid (4,
25.1 min), caffeic acid (5, 27.5 min), luteolin (6, 52.9 min), and apigenin (7, 70.95 min). Axis: x label
minutes, y label absorbance unit.
Figure 2. Quenching of DPPH of SN1 and SN2 extracts at different concentrations (0.025-0.5-0.1-0.2-0.4
mg/mL), compared to Trolox (30 mM). Axis: x label: concentration, y label: quenching of DPPH
expressed as a percentage. (* p < 0.05 and ** p < 0.001).
(0.5 and 1 mg/mL) was able to restore, in a dose-dependent manner, GSH and ROS levels. In particular,
1 mg/mL of the extracts showed values similar to untreated control values.
Figure 3. GSH levels in primary rat astroglial cell cultures at 14 DIV: exposed to glutamate 500 μM for
24 h. Bar 1: control. Bar 2: cell culture exposed 500 μM. Bar 3: cell culture exposed 500 μM plus SN1
0.5 mg/mL. Bar 4: cell culture exposed 500 μM plus SN1 1 mg/mL. Bar 5: cell culture exposed 500 μM
plus SN2 0.5 mg/mL. Bar 6: cell culture exposed 500 μM plus SN2 1 mg/mL. Four replicates were
carried out for each sample. (* p < 0.05 and ** p < 0.001). Axis: x label: concentration, y label: nmoli of
GSH per mg of protein.
Figure 4. ROS levels in primary rat astroglial cell cultures at 14 DIV: exposed to glutamate 500 μM
for 24 h. Bar 1: control. Bar 2: cell culture exposed 500 μM. Bar 3: cell culture exposed 500 μM plus
SN1 0.5 mg/mL. Bar 4: cell culture exposed 500 μM plus SN1 1 mg/mL. Bar 5: cell culture exposed
500 μM plus SN2 0.5 mg/mL. Bar 6: cell culture exposed 500 μM plus SN2 1 mg/mL. Four replicates
were carried out for each sample. (* p < 0.05 and ** p < 0.001). Axis: x label: concentrations, y label:
percentage of fluorescence intensity per mg protein versus control.
4. Discussion
In this study, we assessed the antioxidant effect of SN1 and SN2 extracts of Solanum nigrum L.
leaves, both in an in vitro cellular free system and in vitro cellular models.
Foods 2019, 8, 63
Oxidative stress is the causative agent in a number of human diseases, such as atherosclerosis,
ischemic reperfusion injury, inflammation, carcinogenesis, aging, and neurodegenerative diseases.
Although there are many determinants in the development of these diseases, considerable experimental
evidence links the production of ROS to biological damage that can potentially provide a mechanistic
basis for their initiation and/or progression [36–39]. Moreover, because the ROS production is the
fatal consequence of aerobic life, it is also an important component of the signaling network of
plants [39], where polyphenols are the secondary metabolites produced as a defense mechanism
against stress factors.
In this study, we exploited the sources, composition, and mechanisms of action of two polar
Solanum nigrum L. leaf extracts natural products, and food, which represent a new frontier for therapy
and a valuable tool to reduce the costs of health care systems.
In recent years, there has been great interest in the health effects of various natural products and
in the in vivo protective function of natural antioxidants contained in dietary food against oxidative
damage caused by ROS [40–45].
The free radical-scavenging activity is measured by the ability to bleach the stable DPPH radical.
This assay provided information on the reactivity of test compounds with a stable free radical. SN1
and SN2 extracts were able to quench the DPPH-radical in a dose-dependent manner and showed
comparable capacity. In fact, the two polar extracts content of different level phenolic components, but
phenolic and flavones are not significantly different between SN1 and SN2. Only gentisic acid is more
abundant in SN2. In addition, their effect appeared similar to Trolox. Then, this set of experiments
demonstrate that SN1 and SN 2 possess comparable antioxidant properties.
Furthermore, we assessed the effect of the extracts in an in vitro cellular experimental model
of excitotoxicity. In our previous research studies, using an experimental model of excitotoxicity,
we demonstrated that glutamate exposure in primary cultures of astrocytes might be part of the
biochemical response to oxidative stress induced by a prolonged exposure of astrocyte cultures to the
neurotransmitter [46].
The antioxidant effect of the extracts SN1 and SN2 was also assessed in the cellular system using
primary rat astroglial cell cultures exposed to the astroglial cell cultures in the presence of 500 μM
glutamate for 24 hours. We used glutamate as a stressor because its high levels induce alterations in
glutamate transport, mitochondria impairment, decrease ATP levels, GSH depletion, ROS production,
macromolecular synthesis [35], and subsequent neuronal cell death [47,48].
Figure 2 shows the quenching of DPPH of SN1 and SN2 extracts at different concentrations,
compared to Trolox, which shows a stronger activity at a lower concentration (0.025–0.5 and
0.1 mg/mL). In fact, we found that the extracts SN1 and SN2 were able to counteract the effect of
glutamate, restoring, in a dose-dependent manner, the GSH and ROS levels similar to the control values.
The statistical analysis method in this study indicated high significance (* p < 0.05 and ** p < 0.001)
when compared with the control group, as reported in Figures 3 and 4, where SN1 and SN2 extracts
are compared with the cells exposed to glutamate 500 μM only.
The protective effect against glutamate toxicity of the extracts SN1 and SN2 appeared stronger
than that of the synthetic antioxidant compounds used in our previous research studies [46].
Thus, these findings show that the extracts SN1 and SN2 possess antioxidant properties.
Furthermore, it is possible to assume that the extracts of SN1 and SN2 of Solanum nigrum are able to
counteract glutamate uptake-induced impairment of cystine/glutamate antiporter, which leads to
depletion of the GSH content and biochemical alterations. This results in the delayed toxic effect for
primary astroglial cell cultures [35]. Moreover, in a previous study, we reported that a pre-incubation
with GYKI 52466, the selective inhibitor of AMPA/KA receptors, diminished glutamate effects, which
indicates the involvement of receptor-linked events in GSH decrease and ROS increase levels [49].
Spectrophotometric and chromatographic analytical methods applied for estimation of total
phenolic content and for determination of phenolic acids and flavones compounds in the examined
extracts showed that these constituents are present in a valuable amount. Our results strongly suggest
Foods 2019, 8, 63
that phenolic compounds are important components of SN, and some of their pharmacological effects
could be attributed to the presence of these compounds.
5. Conclusions
This study has provided some scientific rationale for these vegetables in the management of
diseases, as obtained in folklore.
SN leave extracts were able to reduce oxidative stress, and, in particular, they showed the
potential in quenching the radical in vitro free cellular system, and restoring the oxidative status
among in vitro primary rat astroglial cell cultures exposed to glutamate, which possesses notable
antioxidant properties and neuroprotective effects. Furthermore, preventing the increase in glutamate
uptake and inhibiting glutamate excitotoxicity, SN1 and SN2 leave polar extracts may represent a new
natural therapeutic strategy in the neuro-pathological conditions associated with excitotoxicity.
Therefore, these vegetables may serve as a potential source of natural phenolic antioxidants for
functional foods and nutraceuticals for the prevention and management of neurodegenerative diseases.
Author Contributions: The CRediT taxonomy is listed below to define author contributions to primary research
papers and the independent contributions of each author is provided, with the agreement of all co-authors.
Each author on the paper had more CRediT contribution roles, as listed below: conceptualization, A.C., N.A.S.;
methodology, A.C., R.A., M.R., N.A.S.; software, G.R.; validation, N.A.S., M.R.; formal analysis, M.R., G.R.;
investigation, G.R., R.A.; resources, A.C., R.A., N.A.S., A.D.; data curation, R.A.; G.R., writing—original draft
preparation, N.A.S., A.C., R.A.; writing—review and editing, M.R.; visualization, M.R.; supervision, A.C., N.A.S.,
R.A.; project administration, A.C., R.A., N.A.S.; funding acquisition, M.R.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest and the founder added the requested detail. The
funder M.R. had roles in methodology, validation, formal analysis, visualization and the decision to publish
the results.
Abbreviations
ATP Adenosine Triphosphate
DCF 2 ,7 -dichlorofluorescein
DCFH-DA 2 ,7 -dichlorofluorescein diacetate
DIV days in vitro
DMEM Dulbecco’s Modified Eagle’s medium
DPPH 1,1-Diphenyl-2-Picrylhydrazyl radical
EDTA ethylenediaminetetracetic acid
FBS Heat Inactivated Fetal Bovine Serum
FITC fluorescein isothiocyanate
GFAP Glial Fibrillary Acidic Protein
GSH reduced glutathione
HPLC High performance liquid chromatography
MTT 3(4,5-dimethyl-thiazol-2-yl)2,5-diphenyl-tetrazolium bromide
NADH β-Nicotinamide adenine dinucleotide
O2 • − superoxide anion
•OH hydroxyl radical
ROO• peroxyl radical
ROS reactive oxygen species
SOD Superoxide dismutase
SN Solanum Nigrum L
XO Xanthine oxidase
Foods 2019, 8, 63
References
1. Särkinen, T.; Poczai, P.; Barboza, G.E.; van der Weerden, G.M.; Baden, M.; Knapp, S. A revision of the Old
World Black Nightshades (Morelloid clade of Solanum L., Solanaceae). PhytoKeys 2018, 106, 1–223.
2. Jagatheeswari, D.; Bharathi, T.; Sheik Jahabar Ali, H. Black Night Shade (Solanum nigrum L.)-An Updated
Overview. Int. J. Pharm. Biol. Arch. 2013, 4, 288–295.
3. Akubugwo, I.E.; Obasi, A.N.; Ginika, S.C. Nutritional Potential of the Leaves and Seeds of Black
Nightshade-Solanum nigrum L. Var virginicum from Afikpo-Nigeria. Pak. J. Nutr. 2007, 6, 323–326. [CrossRef]
4. Leporatti, M.L.; Ghedira, K. Comparative analysis of medicinal plants used in traditional medicine in Italy
and Tunisia. J. Ethnobiol. Ethnomed. 2009, 5, 31. [CrossRef] [PubMed]
5. Jain, R.; Sharma, A.; Gupta, S.; Sarethy, I.P.; Gabrani, R. Solanum nigrum: Current perspectives on therapeutic
properties. Altern. Med. Rev. 2011, 16, 78–85. [PubMed]
6. Wang, Z.; Li, J.; Ji, Y.; An, P.; Zhang, S.; Li, Z. Traditional herbal medicine: A review of potential of inhibitory
hepatocellular carcinoma in basic research and clinical trial. Evid. Based Complement. Altern. Med. 2013, 2013,
268963. [CrossRef]
7. Patel, A.; Biswas, S.; Shoja, M.H.; Ramalingayya, G.V.; Nandakumar, K. Protective effects of aqueous extract
of Solanum nigrum Linn. leaves in rat models of oral mucositis. Sci. World J. 2014, 2014, 345939.
8. Wang, C.K.; Lin, Y.F.; Tai, C.J. Integrated treatment of aqueous extract of Solanum nigrum-potentiated cisplatin-
and doxorubicin-induced cytotoxicity in human hepatocellular carcinoma cells. Evid. Based Complement.
Alternat. Med. 2015, 2015, 675270.
9. Wang, C.W.; Chen, C.L.; Wang, C.K. Cisplatin-, doxorubicin-, and docetaxel-induced cell death promoted
by the aqueous extract of Solanum nigrum in human ovarian carcinoma cells. Integr. Cancer Ther. 2015, 14,
546–555. [CrossRef]
10. Tai, C.J.; Wang, C.K.; Chang, Y.J.; Lin, C.S.; Tai, C.J. Aqueous extract of Solanum nigrum leaf activates
autophagic cell death and enhances docetaxel-induced cytotoxicity in human endometrial carcinoma cells.
Evid. Based Complement. Alternat. Med. 2012, 2012, 859185.
11. Tai, C.J.; Wang, C.K.; Tai, C.J. Aqueous extract of Solanum nigrum leaves induces autophage and enhances
cytotoxicity of cisplatin, doxoorubicin, docetaxel, and 5-flurouracil in human colorectal carcinoma cells.
Evid. Based Complement. Alternat. Med. 2013, 2013, 514719.
12. Ikeda, T.; Tsumagari, H.; Nohara, T. Steroidal oligoglycosides from Solanum nigrum. Chem. Pharm. Bull.
2000, 48, 1062–1064. [CrossRef] [PubMed]
13. Gu, X.Y.; Shen, X.F.; Wang, L.; Wu, Z.W.; Li, F.; Chen, B.; Zhang, G.L.; Wang, M.K. Bioactive steroidal alkaloids
from the fruits of Solanum nigrum. Phytochemistry 2018, 147, 125–131. [CrossRef] [PubMed]
14. Xiang, L.; Wang, Y.; Yi, X.; He, X. Anti-inflammatory steroidal glycosides from the berries of Solanum nigrum
L. (European black nightshade). Phytochemistry 2018, 148, 87–96. [CrossRef] [PubMed]
15. Esmaeili, A.; Tahazadeh, A.R.; Ebrahimzadeh, M.A. Investigation of composition extracts, biological activities
and optimization of Solanum nigrum L. extraction growing in Iran. Pak. J. Pharm. Sci. 2017, 30, 473–480.
[PubMed]
16. Wang, H.C.; Chung, P.J.; Wu, C.H.; Lan, K.P.; Yang, M.Y.; Wang, C.J. Solanum nigrum L. polyphenolic extract
inhibits hepatocarcinoma cell growth by inducing G2/M phase arrest and apoptosis. J. Sci. Food Agric. 2011,
91, 178–185. [CrossRef] [PubMed]
17. Huang, H.C.; Syu, K.Y.; Lin, J.K. Chemical Composition of Solanum nigrum Linn Extract and Induction of
Autophagy by Leaf Water Extract and Its Major Flavonoids in AU565 Breast Cancer Cells. J. Agric. Food
Chem. 2010, 58, 8699–8708. [CrossRef]
18. Zaidi, S.K.; Hoda, M.N.; Tabrez, S.; Ansari, S.A.; Jafri, M.A.; Khan, M.S.; Hasan, S.; Alqahtani, M.H.;
Abuzenadah, A.M.; Banu, N. Protective Effect of Solanum nigrum Leaves Extract on Immobilization Stress
Induced Changes in Rat’s Brain. Evid. Based Complement. Altern. Med. 2014, 2014, 912450. [CrossRef]
19. Upadhyay, P.; Ara, S.; Prakash, P. Antibacterial and Antioxidant Activity of Solanum nigrum Stem and
Leaves. Chem. Sci. 2015, 4, 1013–1017.
20. Sun, A.Y.; Wang, Q.; Simonyi, A.; Sun, G.Y. Botanical Phenolics and Neurodegeneration. In Herbal Medicine
Biomolecular and Clinical Aspects, 2nd ed.; Benzie, I.F.F., Sissi Wachtel-Galor, S., Eds.; CRC Press Taylor &
Francis Group: Boca Raton, FL, USA, 2011; pp. 315–325.
Foods 2019, 8, 63
21. Ogunsuyi, O.B.; Ademiluyi, A.O.; Oboh, G.; Oyeleye, S.I.; Dada, A.F. Green leafy vegetables from two
Solanum spp. (Solanum nigrum L and Solanum macrocarpon L.) ameliorate scopolamine-induced cognitive
and neurochemical impairments in rats. Food Sci. Nutr. 2018, 6, 860–870. [CrossRef]
22. Lobo, V.; Patil, A.; Phatak, A.; Chndra, N. Free radicals, antioxidants and functional foods: Impact on human
health. Pharmacogn. Rev. 2010, 4, 118–126. [CrossRef] [PubMed]
23. Zitka, O.; Skalickova, S.; Gumulec, J.; Masarik, M.; Adam, V.; Hubalek, J.; Trnkova, L.; Kruseova, J.;
Eckschlager, T.; Kizek, R. Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in
paediatric tumour patients. Oncol Lett. 2012, 4, 1247–1253. [CrossRef] [PubMed]
24. Liu, W.; Duan, X.; Fang, X.; Shang, W.; Tong, C. Mitochondrial protein import regulates cytosolic protein
homeostasis and neuronal integrity. Autophagy 2018, 14, 1293–1309. [CrossRef] [PubMed]
25. Walls, A.B.; Waagepetersen, H.S.; Bak, L.K.; Schousboe, A.; Sonnewald, U. The glutamine glutamate/GABA
cycle: Function, regional differences in glutamate and GABA production and effects of interference with
GABA metabolism. Neurochem. Res. 2015, 40, 402–409. [CrossRef] [PubMed]
26. Devinsky, O.; Vezzani, A.; Najjar, S.; De Lanerolle, N.C.; Rogawski, M.A. Glia and epilepsy: Excitability and
inflammation. Trends Neurosci. 2013, 36, 174–184. [CrossRef] [PubMed]
27. Schousboe, A.; Bak, L.K.; Waagepetersen, H.S. Astrocytic control of biosynthesis and turnover of the
neurotransmitters glutamate and GABA. Front. Endocrinol. 2013, 4, 102. [CrossRef] [PubMed]
28. Agbor, G.A.; Vinson, J.A.; Donnelly, P.E. Folin-Ciocalteau Reagent for Polyphenolic Assay. Int. J. Food Sci.
Nutr. Diet. 2014, 3, 147–156. [CrossRef]
29. Sak, K. Dependence of DPPH radical scavenging activity of dietary flavonoid quercetin on reaction
environment. Mini-Rev. Med. Chem. 2014, 14, 494–504. [CrossRef] [PubMed]
30. Acquaviva, R.; Russo, A.; Galvano, F.; Galvano, G.; Barcellona, M.L.; Li Volti, G.; Vanella, A. Cyanidin and
cyanidin 3-O-beta-D -glucoside as DNA cleavage protectors and antioxidants. Cell Biol. Toxicol. 2003, 19,
243–252. [CrossRef] [PubMed]
31. Campisi, A.; Caccamo, D.; Raciti, G.; Cannavò, G.; Macaione, V.; Currò, M.; Macaione, S.; Vanella, A.;
Ientile, R. Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells.
Brain Res. 2003, 978, 24–30. [CrossRef]
32. Li Volti, G.; Ientile, R.; Abraham, N.G.; Vanella, A.; Cannavò, G.; Mazza, F.; Currò, M.; Raciti, G.; Avola, R.;
Campisi, A. Immunocytochemical localization and expression of heme oxygenase-1 in primary astroglial
cell cultures during differentiation: Effect of glutamate. Biochem. Biophys. Res. Commun. 2004, 315, 517–524.
[CrossRef]
33. Acquaviva, R.; Campisi, A.; Murabito, P.; Raciti, G.; Avola, R.; Mangiamel, S.; Musumeci, I.; Barcellona, M.L.;
Vanella, A.; Li Volti, G. Propofol attenuates peroxynitrite-mediated DNA damage and apoptosis in cultured
astrocytes: An alternative protective mechanism. Anesthesiology 2004, 101, 1363–1371. [CrossRef] [PubMed]
34. Murphy, T.H.; Baraban, J.M. Glutamate toxicity in immature cortical neurons precedes development of
glutamate receptor currents. Brain Res. Dev. Brain Res. 1990, 57, 146–150. [CrossRef]
35. Chen, Y.H.; Du, G.H.; Zhang, J.T. Salvianolic acid B protects brain against injuries caused by
ischemia-reperfusion in rats. Acta Pharmacol. Sin. 2000, 21, 463–466. [PubMed]
36. Moloney, J.N.; Cotter, T.G. ROS signalling in the biology of cancer. Semin. Cell Dev. Biol. 2018, 80, 50–64.
[CrossRef] [PubMed]
37. Schieber, M.; Chandel, N.S. ROS function in redox signaling and oxidative stress. Curr. Biol. 2014, 24, 453–462.
[CrossRef] [PubMed]
38. Nistico, S.; Ventrice, D.; Dagostino, C.; Lauro, F.; Ilari, S.; Gliozzi, M.; Strongoli, M.C.; Vecchio, I.; Rizzo, M.;
Mollace, V.; Muscoli, C.; et al. Effect of MN (III) tetrakis (4-benzoic acid) porphyrin by photodynamically
generated free radicals on SODs keratinocytes. J. Biol. Regul. Homeost. Agents 2013, 27, 781–790. [PubMed]
39. Del Río, L.A. ROS and RNS in plant physiology: An overview. J. Exp. Bot. 2015, 66, 2827–2837. [CrossRef]
[PubMed]
40. Carresi, C.; Musolino, V.; Gliozzi, M.; Maiuolo, J.; Mollace, R.; Nucera, S.; Maretta, A.; Sergi, D.; Muscoli, S.;
Gratteri, S.; et al. Anti-oxidant effect of bergamot polyphenolic fraction counteracts doxorubicin-induced
cardiomyopathy: Role of autophagy and c-kitposCD45negCD31neg cardiac stem cell activation. J. Mol. Cell.
Cardiol. 2018, 119, 10–18. [CrossRef] [PubMed]
41. Sharma, A.; Kaur, M.; Katnoria, J.K.; Nagpal, A.K. Polyphenols in Food: Cancer Prevention and Apoptosis
Induction. Curr. Med. Chem. 2018, 25, 4740–4757. [CrossRef]
Foods 2019, 8, 63
42. Loffredo, L.; Perri, L.; Nocella, C.; Violi, F. Antioxidant and antiplatelet activity by polyphenol-rich nutrients:
Focus on extra virgin olive oil and cocoa. Br. J. Clin. Pharmacol. 2017, 83, 96–102. [CrossRef] [PubMed]
43. Rizzo, M.; Ventrice, D.; Giannetto, F.; Cirinnà, S.; Santagati, N.A.; Procopio, A.; Mollace, V.; Muscoli, C.
Antioxidant activity of oleuropein and semisynthetic acetyl-derivatives determined by measuring
malondialdehyde in rat brain. J. Pharm. Pharmacol. 2017, 69, 1502–1512. [CrossRef] [PubMed]
44. Muscoli, C.; Lauro, F.; Dagostino, C.; Ilari, S.; Giancotti, L.A.; Gliozzi, M.; Costa, N.; Carresi, C.; Musolino, V.;
Casale, F.; et al. Olea Europea-derived phenolic products attenuate antinociceptive morphine tolerance:
An innovative strategic approach to treat cancer pain. J. Biol. Regul. Homeost. Agents 2014, 28, 105–116.
[PubMed]
45. Zhang, Y.; Li, X.; Wang, Z. Antioxidant activities of leaf extract of Salvia miltiorrhiza Bunge and related
phenolic constituents. Food Chem. Toxicol. 2010, 48, 2656–2662. [CrossRef] [PubMed]
46. Campisi, A.; Acquaviva, R.; Mastojeni, S.; Raciti, G.; Vanella, A.; De Pasquale, R.; Puglisi, S.; Iauk, L. Effect of
berberine and Berberis aetnensis C. Presl. alkaloid extract on glutamate-evoked tissue transglutaminase
up-regulation in astroglial cell cultures. Phytother. Res. 2001, 25, 816–820. [CrossRef]
47. Pierozan, P.; Biasibetti, H.; Schmitz, F.; Ávila, H.; Parisi, M.M.; Barbe-Tuana, F.; Wyse, A.T.; Pessoa-Pureur, R.
Quinolinic acid neurotoxicity: Differential roles of astrocytes and microglia via FGF-2-mediated signaling in
redox-linked cytoskeletal changes. Biochim. Biophys. Acta 2016, 1863, 3001–3014. [CrossRef] [PubMed]
48. Sandhu, J.K.; Pandey, S.; Ribecco-Lutkiewicz, M.; Monette, R.; Borowy-Borowski, H.; Walker, P.R.;
Sikorska, M. Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2-derived neurons
and astrocytes: Protective effects of coenzyme Q10. J. Neurosci. Res. 2003, 72, 691–703. [CrossRef] [PubMed]
49. Campisi, A.; Caccamo, D.; Li Volti, G.; Currò, M.; Parisi, G.; Avola, R.; Vanella, A.; Ientile, R. Glutamate-
evoked redox state alterations are involved in tissue transglutaminase upregulation in primary astrocyte
cultures. FEBS Lett. 2004, 578, 80–84. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Effect of a Milk-Based Fruit Beverage Enriched with
Plant Sterols and/or Galactooligosaccharides in a
Murine Chronic Colitis Model
Gabriel López-García 1 , Antonio Cilla 1, *, Reyes Barberá 1 , Amparo Alegría 1 and María C. Recio 2
1 Nutrition and Food Science Area, Faculty of Pharmacy, University of Valencia,
Avda. Vicente Andrés Estellés/n, 46100 Burjassot (Valencia), Spain; gabriel.lopez@uv.es (G.L.-G.);
reyes.barbera@uv.es (R.B.); amparo.alegria@uv.es (A.A.)
2 Department of Pharmacology, Faculty of Pharmacy, University of Valencia, Avda. Vicente Andrés Estellés/n,
46100 Burjassot (Valencia), Spain; maria.c.recio@uv.es
* Correspondence: antonio.cilla@uv.es; Tel.: +34-963-544-972
Abstract: The potential anti-inflammatory effect of plant sterols (PS) enriched milk-based fruit
beverages (PS, 1 g/100 mL) (MfB) with/without galactooligosaccharides (GOS, 2 g/100 mL) (MfB-G)
in an experimental mice model of chronic ulcerative colitis was evaluated. Beverages were orally
administered to mice every day by gavage to achieve PS and GOS doses of 35 and 90 mg/kg,
respectively, and experimental colitis was induced by giving mice drinking water ad libitum containing
2% (w/v) dextran sulphate sodium (DSS) for 7 days, alternating with periods without DSS up to the
end of the study (56 days). MfB beverage showed significant reduction of symptoms associated to
ulcerative colitis and improved the colon shortening and mucosal colonic damage, but it was not able
to reduce the increase of myeloperoxidase levels produced by DSS. MfB-G showed higher incidence of
bloody feces and loss of stool consistency than MfB, as well as high levels of immune cells infiltration
in colon tissue and myeloperoxidase. Therefore, PS-enriched milk-based fruit beverage could be an
interesting healthy food to extend the remission periods of the diseases and the need to evaluate, in a
pre-clinical model, the anti-inflammatory effect of the combination of bioactive compounds in the
context of a whole food matrix.
1. Introduction
Ulcerative colitis (UC) is a chronic inflammatory disease, within intestinal bowel diseases (IBD),
characterized by a tissue destruction of large intestine with relapsing phases followed by periods of
remission [1]. The most common treatment strategies used include pharmacological therapy (steroidal
and non-steroidal drugs) or, in the worst cases, removing portions of affected gastrointestinal tract
through surgery. Although, pharmacological therapy has shown efficacies in ameliorating the severity
and symptoms of IBD, typically does not lead to long periods of remission. Consequently, recent
investigations have focused on the study of the impact of diet and healthy foods as potential alternative,
and even the possible combination of nutraceuticals and healthy foods with pharmacological therapy
in cases when the patient is not eligible for conventional therapy which could help extend remission
periods and improve life quality of IBD patients [2–6].
A recent meta-analysis has associated a high intake of fruit and vegetables with a reduction
of UC in European population, suggesting that the intake of their bioactive compounds (fiber,
antioxidant vitamins and phytochemicals such as polyphenols, carotenoids, isoflavones) could
explain this inverse association [7]. In murine colitis models, which mimic human pathology,
it has been demonstrated the preventive effect on pro-inflammatory intestinal process associated
to the intake of mango [8] or pineapple [9] juices, polyphenols-rich extracts from orange [10] or its
sub-products [11], apple [12] and pomegranate [13]. Polyphenols seems to be the main bioactive
compounds involved in the anti-colitic action of fruits, due to its ability to inhibit some pivotal
pro-inflammatory mediators as nuclear transcriptional Factor-κB (NF-κB) and specific cytokines
(Tumor Necrosis Factor-α (TNF-α), and interleukin 1-β (IL-1β)) and the induction of antioxidant
defence systems. Furthermore, lipophilic compounds present in vegetables and fruits, such as
fat-soluble vitamins (pro-vitamin A) [14], carotenoids (β-carotene) [15] and plant sterols (PS) [16–21],
have displayed important anti-inflammatory and inmmunodulatory effects. In particular, PS could be
a good strategy to prevent IBD, because they show a very little absorption in the intestine (0.5–2%) and
reach the colon, where could exert anti-inflammatory effects. Moreover, the European Union authorized
PS addition into milk-based fruit beverages [22], among other foods, to achieve the necessary amount
of 1.5–3 g PS/day (not attainable with normal diet) for the well-known cholesterol-lowering effect [23].
PS have shown promising results in animal colitis models induced by trinitrobenzene sulfonic acid
(TNBS) [16,17], dextran sodium sulphate (DSS) [18–24] or high-fat diet (40–60%) [19–21]. Doses
between 20–150 mg/Kg/day help to mitigate some important parameters associated to UC such as
symptoms, colon shortening and presence of edema, histopathology and myeloperoxidase (MPO)
activity on colon tissue.
Other bioactive compounds that have gained attention are prebiotics, which stimulate selectively
beneficial intestinal bacteria, helping to maintain intestinal mucosal barrier and enhance defense
against pathogenic microorganism [25]. In this sense, galactooligosacharides (GOS) have been
proposed as an active ingredient to prevent or alleviate symptoms associated with IBD [26]. Human
clinical trials have demonstrated that consumption of GOS contained in chocolate or banana flavored
chews (3.5–7 g/day) [27] and sachets (5.5 g/day) [28,29], reduce different pro-inflammatory markers
such as calprotectin in feces, plasma C-reactive protein [28] and cytokines (IL-6, IL-1β and TNF-α) [29],
with a concomitant increase in levels of fecal secretory immunoglobulin A (sIgA) [28] and reduction of
common ulcerative colitis symptoms [27]. However, in animal studies the effect of GOS on colitis is
controversial. GOS (4 g/Kg/day) administration for 10 days increase bifidobacterial number in colon
in a TNBS colitis induced murine model, but it was not linked with a reduction of pro-inflammatory
markers as MPO activity and colon damage [30]. On the other hand, in mice smad-3 feed with GOS
(5 g/Kg/day) for 42 days an improvement of colitis severity and increase of natural killer activity were
observed after colitis induction by Helicobacter hepaticus [31].
Enrichment of healthy foods with bioactive compounds could be an effective strategy to help
mitigate the symptoms associated with IBD and extend remission periods [3]. In this sense, milk-based
fruit beverages could be a suitable nutritional matrix for this purpose due to its low-fat content and
good sources of bioactive compounds such as polyphenols, carotenoids and vitamins. Moreover,
previous studies of our research group have demonstrated the beneficial effect of PS enriched
milk-based fruit beverages on oxidative stress prevention and intestinal epithelia integrity maintenance
in Caco-2 cells [32], as well as, their systemic anti-inflammatory properties, in hypercholesterolemic
post-menopausal women, through the serum increase of anti-inflammatory cytokine IL-10 with
concomitant reduction of IL-1β, cytokine which play an important role on the development of IBD [33].
The present study investigates for the first time, the effect of the daily intake of a healthy food,
as milk-based fruit beverages, enriched with bioactive compounds (PS and/or GOS) on clinical
symptoms and inflammatory process of UC, using a pre-clinical chronic murine model induced by DSS.
The aim of this preliminary study is to evaluate if PS enriched milk-based fruit beverages with/without
GOS are a suitable dietetic strategy to help to mitigate the health problems associated with UC.
Foods 2019, 8, 114
Figure 1. Experimental design of the chronic colitis induction by dextran sulphate sodium (DSS) (2%,
w/v) and plant sterol enriched milk-based fruit beverages without (MfB) or with galactooligosacharides
(MfB-G) administration in the procedures.
Water intake was monitored three times a week to guarantee equitative DSS intake among different
colitis mice groups and the type of beverages did not affect drink behavior. No statistically significant
Foods 2019, 8, 114
differences (p > 0.05) in water intake was found among different mice group (ml/mouse/day); control
(4.3 ± 0.5), DSS (4.2 ± 0.8), DSS + MfB (4.5 ± 0.7), DSS+MfB-G (4.8 ± 1.1), MfB (4.6 ± 0.4) and MfB-G
(4.5 ± 0.5).
Table 1. Scoring system to calculate the disease activity index (DAI *).
Table 2. Scoring system used to calculate the histological score in dextran sulphate sodium
(DSS)-induced colitis.
Table 2. Cont.
3. Results
increase of blood presence in feces. This suggests that the higher acute diarrhea observed is related to
colonic epithelium erosion.
0
7 21 35 49 56
Days
(a)
(b)
ď
ď Ă
ď
6FRUHDUELWUDU\XQLWV
Ăď
Ă Ă
Ă Ă
Ă
Ă Ă
Ă
ď
ď
(c)
Figure 2. Effect of plant sterol enriched milk-based fruit beverages without (MfB) or with
galactooligosacharides (MfB-G) on clinical symptoms in DSS-induced chronic colitis model. (a) Disease
activity index (DAI) score after DSS (dextran sulphate sodium) administration in each cycle; (b) body
weight per mouse during all the experiments; (c) stool consistency loss (lines) and presence of blood
in feces (bars) at the end of each DSS administration cycle. Bars/markers show the mean ± standard
deviation (n = 8). Different lowercase letters (a–c) indicate statistically significant differences (p < 0.05)
among mice groups (DSS, DSS + MfB and DSS + MfB-G) within the same DSS cycle. (*) Denotes
statistically significant differences (p < 0.05), compared to the DSS group, at the same day.
Foods 2019, 8, 114
10
Ă Ă
9 Ă
8 Đ
Colon length (cm)
7 ď ď
6
5
4
3
2
1
0
Control DSS DSS + MfB DSS + MfB-G MfB MfB-G
(a)
70
Colon weight/length (mg/cm)
60 Đ
ďĐ
50
ď
40 Ă
Ă Ă
30
20
10
0
Control DSS DSS + MfB DSS + MfB-G MfB MfB-G
(b)
Figure 3. Evaluation of colon length (a) and presence of edema (b) after administration of plant
sterol enriched milk-based fruit beverages without (MfB) or with galactooligosacharides (MfB-G) for
56 days on dextran sulphate sodium (DSS)- chronic colitis induction. Bars show the mean ± standard
deviation (n = 8). Different lowercase letters (a–c) indicate statistically significant differences (p < 0.05)
among samples.
alteration compared to DSS group (b), with immune cell infiltration and distortion of crypts, although
the epithelial architecture was more preserved resulting in a significant (p < 0.05) lower histological
score (34 and 10%, respectively) values. However, DSS + MfB-G (Figure 4f) mice showed a higher
histological score (25%) and damage in the epithelial architecture, with distortion of crypts and high
presence of immune cell in comparison to the DSS + MfB group (Figure 4d).
ϭϬ Ă Đ
,ŝƐƚŽůŽŐŝĐĂůƐĐŽƌĞ
ϴ
ď
ϲ
Ϭ
^^ ^^нDĨ ^^нDĨͲ'
B
Figure 4. The representative photographs of hematoxylin and eosin staining (magnification ×200) (A)
and the corresponding score (B) of colon tissues obtained after administration of plant sterol enriched
milk-based fruit beverages without (MfB) or with galactooligosacharides (MfB-G) for 56 days on
dextran sulphate sodium (DSS)- chronic colitis induction. Data are expressed as the means ± standard
deviation of six mice in each group. Representative images of staining of colon tissues from each (n = 3)
p < 0.05 vs. normal control. Different lowercase letters (a–c) indicate statistically significant differences
(p < 0.05) among samples.
Foods 2019, 8, 114
Ϭ͘ϯϬ
ďĐ
DWKůĞǀĞůƐ;ĂƌďŝƚƌĂƌLJƵŶŝƚƐͿ
Ϭ͘Ϯϱ
Ϭ͘ϮϬ Đ
ď
Ϭ͘ϭϱ
Ă Ă
Ϭ͘ϭϬ
Ă
Ϭ͘Ϭϱ
Ϭ͘ϬϬ
ŽŶƚƌŽů ^^ ^^нDĨ ^^нDĨͲ' DĨ DĨͲ'
Figure 5. Presence of myeloperoxidase (MPO) levels in colonic tissue after administration of plant
sterol enriched milk-based fruit beverages without (MfB) or with galactooligosacharides (MfB-G) for
56 days on dextran sulphate sodium (DSS)- chronic colitis induction. Bars show the mean ± standard
deviation (n = 8). Different lowercase letters (a–c) indicate statistically significant differences (p < 0.05)
among samples.
4. Discussion
To investigate the potential anti-inflammatory effects of PS enriched milk-based fruit beverages
with or without GOS on UC, a model of chronic colitis induced by DSS in mice was selected. Although
colitis animal models do not represent the complexity of human disease, they provide valuable
information about factors involved in the inflammatory process and allow to evaluate different
therapeutic strategies to improve life quality of patients with IBD [38]. In particular, the DSS-induced
colitis model can easily reproduce the acute and chronic phases or the relapsing periods typical
of UC, depending on the concentration and cycles of exposition to DSS in drinking water. Moreover,
this model exhibits similar symptoms to those of human UC (diarrhea, bloody feces and body weight
loss) and histological features such as mononuclear leucocyte infiltration, crypt architectural disruption
and epithelial degeneration [39].
Our study showed that daily administration of MfB beverage resulted in a significant (p < 0.05)
reduction of symptoms associated to UC, mainly preventing the presence of diarrhea or alleviating
their increase during all experiment (vs. DSS group), as well as, protecting against presence of bloody
feces in the acute phase of the disease (first DSS cycle). Reduction of clinical symptoms led to partially
prevention of colon shortening induced by DSS cycles, showing longer colons (18%) compared to DSS
group. Histopathological analysis of the colon revealed a slight improvement in the architecture of
the colonic epithelium and a greater number of crypts compared to the DSS group, in agreement with
the previous parameters mentioned. However, the distribution and morphology of the crypts were
altered, as well as an increase of neutrophil infiltration and a high MPO level in the colonic tissue was
observed. Stimulation of neutrophil activity or its migration into colon tissue, could be related with the
Foods 2019, 8, 114
prevention of colon shortening observed after MfB treatment. Neutrophils are considered the first line
of defence against microorganisms and recently, it has been demonstrated that they can build a complex
formed by chromatin and neutrophil proteins that act as immunomodulator and activate immune
cells such as T cells, although their specific role on IBD has not been well described yet [40]. Beneficial
effect of MfB upon DSS-induced colitis can also be related with its cytoprotective effect at intestinal
level. In a previous in vitro study by our research group, it was demonstrated that milk-based fruit
beverages had several beneficial effects against oxidative stress and prevention of cell dead, inhibiting
some important pro-apoptotic events and preserving cell monolayer integrity in a differentiated colon
cancer (Caco-2) cell model [32]. This fact could be important because DSS is a toxic compound to
colonic epithelial cells that cause an increase of apoptotic cells and compromise the epithelial barrier
integrity through the loss of some important proteins present in the tight junctions [41].
It is important to note our study design does not allow knowing which bioactive compound/s
contained in the beverages has the anti-inflammatory effect on DSS-induced colitis. Nevertheless,
it may be possible that the specific combination of all of them produce the effect observed in our
study. The presence of mandarin juice (represents almost half of MfB composition), could contribute to
the anti-inflammatory effect since contains important quantities of antioxidant phytochemicals such
as flavonoids (mainly hesperidin, narirutin and vicenin-2) and β-cryptoxanthin (β-Cx) [42]. In this
sense, flavonoid-rich extracts (containing mainly hesperidin, narirutin and vicenin-2) obtained from
blood orange juice administrated (40 mg/kg/day) to CD1 mice with colitis-induced by dinitrobenzene
sulfonic acid, have shown preventive effects against the colonic pathological tissue damage. Flavonoids
acted mainly counteracting NF-κB signalling, decreasing expression of pro-apoptotic proteins (Bax) and
restoring the redox balance in colonic tissue [10]. Similar effects were observed in a recent study with
industrial orange by-products (citrus pectin and different sub-fractions obtained from orange after juice
extraction) in DSS-treated mice [11]. Byproducts with high polyphenol total content and antioxidant
capacity showed better anti-inflammatory effect in terms of clinical symptoms and reduction of
pro-inflammatory mediators’ expression (TNF-α, IL-1β, IL-6). On the other hand, the presence of β-Cx
could contribute to the beneficial effects of the MfB, although its specific role on UC has not been
studied yet. In steatohepatitis and insulin resistance murine models induced by high fat content diets,
β-Cx administration (~2.5–7.5 mg/kg/day) lead to attenuation of lipotoxicity-induced inflammation,
preventing hepatic tissue peroxidation (TBARS) and the macrophages activation [43], as well as the
stimulation of antioxidant enzymes (catalase, superoxide dismutase and glutathione peroxidase) and
inhibition of the expression of pro-inflammatory markers (NF-κB and TNFα) in liver [44]. Therefore,
β-Cx is able to reduce the pro-inflammatory process through a direct and indirect anti-oxidant
mechanism. Taking into account that oxidative stress has a pivotal role on UC, daily administration of
MfB containing β-Cx (0.02 mg/kg/day) could help to mitigate the pro-inflammatory process.
Additionally, it is important to note that enrichment of MfB with PS could be a remarkable factor
in its anti-colitic effect, since several studies using PS standard solutions (β-sitosterol, stigmasterol and
γ-oryzanol) added to feed and administered at doses between 20–50 mg/kg/day (similar to our study
35 mg/kg/day) for 3-56 days have shown a marked anti-inflammatory effect independently of the
colitis animal model used. In C57BL/6 mice, β-sitosterol (20 mg/kg/day) administration for 56 days
prevented the colon shortening (~8%) and reduced MPO activity in colon tissue (~35%), what led to a
lower level of pro-inflammatory cytokines (IL-1β, TNF-α and IL-6) after colitis induction by high fat
diet (60 Kcal% from fat) [16]. Similarly, β-sitosterol administration (10 or 20 mg/kg) during 3 days
to C57BL/6 mice with colon inflammation induced by TNBS prevented partially colon shortening
(~3.4%) and improved the pro-inflammatory status, reducing pro-inflammatory cytokine levels (IL-1β,
TNF-α and IL-6) and MPO activity in colon tissue (~42%), with a concomitant inhibition of NF-κB
translocation into the nucleus [17]. In UC models induced by DSS, administration to C57BL/6 mice of
γ-oryzanol (50 mg/Kg/day for 16 days), a mixture of phytosteryl ferulates derived from rice bran oil,
mitigated clinical symptoms associated to UC and partially prevented colon shortening (~9%) and
the pathophysiological activity during colonic inflammation through inhibition of NF-κB activation
Foods 2019, 8, 114
after 5 days of DSS at 3% (v/v) induction [24]. Differences observed in terms of MPO activity with
respect to our study, could be attributed to the fact that PS are added into the beverages as a food
ingredient composed of a complex mixture of PS (β-sitosterol, sitostanol, campesterol, campestanol
and stigmasterol). As far as we know, there are no studies that evaluate the anti-inflammatory
effect—in murine chronic colitis models—of some of the PS found in the food ingredient used
in the PS enrichment of our beverages (sitostanol, campesterol and campestanol), which suppose
20% of the total PS. The small molecular structural differences among sitostanol, campesterol or
campestanol, in comparison to β-sitosterol, could explain the lack of beneficial effect observed on the
pro-inflammatory process. Feng et al. [21] observed that β-sitosterol or stigmasterol administration
(0.4% w/w) in C57BL/6J mice similarly mitigate inflammation severity and macroscopic damage (colon
shortening and histopathology score) induced by DSS (1.5% w/v, for 5 days), but only stigmasterol was
able to reduce the expression of cyclooxygenase-2. Authors indicate that the presence of a double-bond
in the side chain in stigmasterol could be responsible for their additional anti-inflammatory effect
compared to β-sitosterol. In this sense, different behaviour of β-sitosterol, campesterol and stigmasterol
at the same concentration (24 μM for 48 h) and cell system (macrophages) have been observed.
Stigmasterol suppressed cytokine secretion into the supernatant, while β-sitosterol promoted it and
campesterol did not have any effect [45]. Moreover, it is also possible that some specific compounds
present in our beverages hidden the beneficial effects of PS on colitis. Llewellyn et al. [46] observed that
administration of a high casein diet (41% w/w) for 14 days promoted intestinal barrier damage and
increased colonic cytokines levels (IL-6 and TNF-α) in DSS induced model in mice (3% w/v for 7 days).
Although, the casein intake is around 850-fold higher than our study, the longer administration time
of beverage (14 vs. 56 days) and DSS (7 vs. 56 days) exposition could explain our results. Besides,
the potential impact of other compounds present in the beverage on the colitis process cannot be
ruled out.
Regarding the potential beneficial effect of GOS on DSS-induced colitis, results show that MfB-G
administration during all the experiment does not confer additional beneficial effects with respect
to MfB. DSS + MfB-G mice suffered a dramatic increase of clinical symptoms from the third DSS cycle,
remaining constant up to the end of the study. This fact could explain the absence of a beneficial
effect of MfB-G on colon shortening (12% shorter than MfB), the higher colonic mucosa alteration
(distortion of crypts and high immune cells infiltration) and MPO level compared to MfB. The effect of
GOS and mechanisms which could improve UC in murine colitis models have been poorly studied
and currently are controversial. Holma et al. [30] reported that administration to rats of two kinds
of GOS (whey and lactose derived from cow milk) at 4 g/kg/day for 10 days increased notably
bifidobacterial number in feces, which are high producers of anti-inflammatory compounds, such as
short-chain fatty acids. However, the increase of bifidobacterial number was not correlated with an
improvement of colonic damage and they did not prevent immune cell infiltration (MPO activity) and
edema induced by TNBS during 72 h. In contrast, in mice deficient in smad-3 (phenotype characterized
by colon moderate inflammatory response) infected by Helicobater hepaticus, GOS supplementation
(5 g/kg/day) for 42 days reduced colitis severity preserving colon architecture by modulating the
function and trafficking of natural killer cells [31]. The use of different animal species, agents of
induction of colitis, treatment times and type of GOS could explain the differences found between
the studies. However, it has been reported previously the harmful effect of fructooligosacharides
(FOS) administration (at 6 g/day), a kind of soluble fibre similar to GOS, in rats with colitis induced
by DSS (at 3% for seven days). Similar to our results, FOS slightly prevented symptoms associated
to UC (13–45%, DAI value) at the beginning of the study but quickly worsened without showing
differences with respect to DSS group up to the end of the study. FOS treatment did not prevent the
colon shortening and exacerbated colon histological damage severity and MPO activity, as well as
reduced crypt cell proliferation in the distal colon, which is an integral part of the colon repair process.
Authors indicated that FOS delayed the onset of repair, promoting the harmful effect of DSS on colon
epithelia [47]. Other possible hypothesis could be related with the bifidogenic effect of FOS, what lead
Foods 2019, 8, 114
to the increase of bifidobacterial genus in the colon. It has been indicated that a quick rate of FOS
fermentation in the cecum produce an overproduction of organic acids as lactic and acetic acids [48],
which can damage the intestinal epithelium, leading to an increase of colonic permeability [49]. Similar
to FOS, it has been indicated that GOS fermentation (72 h) lead to a quick increase and accumulation
of lactic and acetic acids in the colon, compared to propionic and butyric acids, in a dynamic in vitro
colon model (TIM-2). These increases were correlated with an increase of bifidobacteria and lactobacilli
genus [50]. Then, we hypothesized that MfB-G administration could produce a change in intestinal
microbiota by increasing the organic acids that produce bacteria, which could exacerbate the loss
of the epithelial barrier integrity and the colonic mucosal permeability induced by DSS. Moreover,
the potential inhibitory effect of GOS on the colonic repair mechanism cannot be ruled out.
In summary, PS-enriched milk-based fruit beverage (MfB) shows a moderate anti-inflammatory
effect, helping to alleviate the clinical symptoms associated to colitis, the colon shortening and colonic
damage in a DSS-induced mice model of chronic colitis. Neutrophil infiltration in colonic tissue
and MPO level remained higher after MfB treatment, suggesting that they could be involved in its
anti-inflammatory action as a compensatory mechanism trying to overcome the damage induced
by DSS. GOS addition to the MfB did not show any additional beneficial effects in comparison with
MfB and even exacerbated the pro-inflammatory action induced by DSS. The higher DAI value, colonic
mucosa damage, immune cell infiltration and MPO level, suggest that presence of GOS in colon
compromise colonic epithelial permeability or delay the reparation colonic mechanism, promoting the
cytotoxic effect of DSS on colon cells.
Our results demonstrate the importance to evaluate the biological effects of bioactive compounds
in the context of a complex food matrix. PS-enriched foods could be a suitable strategy to extend
remission periods and improve the quality of life of patients with UC, but further investigation is
needed to confirm the beneficial role of PS in a food matrix on the UC.
Author Contributions: Conceptualization and funding acquisition: A.C., R.B., and A.A.; methodology: M.C.R.;
analysis and experiments: G.L.-G., and M.C.R.; writing, review and editing: G. L-G., A.C., R.B., A.A., and M.C.R.
Funding: This research was funded by Spanish Ministry of Economy and Competitiveness, through National
Project AGL2015-68006-C2-1-R (MINECO-FEDER). G.L.-G. holds a grant (ACIF/2016/449) from the Generalitat
Valenciana (Spain).
Acknowledgments: The authors want to express their acknowledgement to the Central Service for Experimental
Research (SCSIE) of the University of Valencia, in particular to Animal Production and Microscopy sections,
for their support.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Vanga, R.; Long, M.D. Contemporary management of ulcerative colitis. Gastroenterol. Rep. 2018, 20, 12.
[CrossRef]
2. Charlebois, A.; Rosenfeld, G.; Bressler, B. The impact of dietary interventions on the symptoms of
inflammatory bowel disease: A systematic review. Crit. Rev. Food Sci. Nutr. 2016, 56, 1370–1378. [CrossRef]
[PubMed]
3. Al Mijan, M.; Lim, B.O. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory
bowel disease: Present status and future trends. World J. Gastroenterol. 2018, 24, 2673–2685. [CrossRef]
[PubMed]
4. Santini, A.; Novellino, E.; Armini, V.; Ritieni, A. State of the art of Ready-to Use Therapeutic Food: A tool for
nutraceuticals addition to foodstuff. Food Chem. 2013, 140, 843–849. [CrossRef] [PubMed]
5. Daliu, P.; Santini, A.; Novellino, E. From pharmaceuticals to nutraceuticals: Bridging disease prevention and
management. Expert Rev. Clin. Pharmacol. 2019, 12, 1–7. [CrossRef] [PubMed]
6. Santini, A.; Cammarata, S.M.; Capone, G.; Ianaro, A.; Tenore, G.C.; Pani, L.; Novellino, E. Nutraceuticals:
Opening the debate for a regulatory framework. Br. J. Clin. Pharmacol. 2018, 84, 659–672. [CrossRef]
7. Li, F.; Liu, X.; Wang, W.; Zhang, D. Consumption of vegetables and fruit and the risk of inflammatory bowel
disease: A meta-analysis. Eur. J. Gastroenterol. Hepatol. 2015, 27, 623–630. [CrossRef] [PubMed]
Foods 2019, 8, 114
8. Kim, H.; Banerjee, N.; Barnes, R.C.; Pfent, C.M.; Talcott, S.T.; Dashwood, R.H.; Mertens-Talcott, S.U. Mango
polyphenolics reduce inflammation in intestinal colitis—Involvement of the miR-126/PI3K/AKT/mTOR
axis in vitro and in vivo. Mol. Carcinog. 2017, 56, 197–207. [CrossRef] [PubMed]
9. Hale, L.P.; Chichlowski, M.; Trinh, C.T.; Greer, P.K. Dietary supplementation with fresh pineapple juice
decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitis. Inflamm. Bowel Dis. 2010,
16, 2012–2021. [CrossRef] [PubMed]
10. Fusco, R.; Cirmi, S.; Gugliandolo, E.; Di Paola, R.; Cuzzocrea, S.; Navarra, M. A flavonoid-rich extract of
orange juice reduced oxidative stress in an experimental model of inflammatory bowel disease. J. Funct. Foods
2017, 30, 168–178. [CrossRef]
11. Pacheco, M.T.; Vezza, T.; Diez-Echave, P.; Utrilla, P.; Villamiel, M.; Moreno, F.J. Anti-inflammatory bowel
effect of industrial orange by-products in DSS-treated mice. Food Funct. 2018, 9, 4888–4896. [CrossRef]
[PubMed]
12. D’Argenio, G.; Mazzone, G.; Tuccillo, C.; Ribecco, M.T.; Graziani, G.; Gravina, A.G.; Caserta, S.; Guido, S.;
Fogliano, V.; Caporaso, N.; et al. Apple polyphenols extract (APE) improves colon damage in a rat model of
colitis. Dig. Liver Dis. 2012, 44, 555–562. [CrossRef] [PubMed]
13. Rosillo, M.A.; Sánchez-Hidalgo, M.; Cárdeno, A.; Aparicio-Soto, M.; Sánchez-Fidalgo, S.; Villegas, I.;
de la Lastra, C.A. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates
chronic colonic inflammation in rats. Pharmacol. Res. 2012, 66, 235–242. [CrossRef] [PubMed]
14. Okayasu, I.; Hana, K.; Nemoto, N.; Yoshida, T.; Saegusa, M.; Yokota-Nakatsuma, A.; Song, S.Y.; Iwata, M.
Vitamin A inhibits development of dextran sulfate sodium-induced colitis and colon cancer in a mouse
model. Biomed. Res. Int. 2016. [CrossRef]
15. Trivedi, P.P.; Jena, G.B. Mechanistic insight into beta-carotene-mediated protection against ulcerative
colitis-associated local and systemic damage in mice. Eur. J. Nutr. 2015, 54, 639–652. [CrossRef]
16. Mencarelli, A.; Renga, B.; Palladino, G.; Distrutti, E.; Fiorucci, S. The plant sterol guggulsterone attenuates
inflammation and immune dysfunction in murine models of inflammatory bowel disease. Biochem. Pharmacol.
2009, 78, 1214–1223. [CrossRef] [PubMed]
17. Lee, I.A.; Kim, E.J.; Kim, D.H. Inhibitory effect of β-sitosterol on TNBS-induced colitis in mice. Planta Med.
2012, 78, 896–898. [CrossRef]
18. Aldini, R.; Micucci, M.; Cevenini, M.; Fato, R.; Bergamini, C.; Nanni, C.; Cont, M.; Camborata, C.; Spinozzi, S.;
Montagnani, M.; et al. Antiinflammatory effect of phytosterols in experimental murine colitis model:
Prevention, induction, remission study. PLoS ONE 2014, 9, e108112. [CrossRef]
19. Kim, K.A.; Lee, I.A.; Gu, W.; Hyam, S.R.; Kim, D.H. β-Sitosterol attenuates high-fat diet-induced intestinal
inflammation in mice by inhibiting the binding of lipopolysaccharide to toll-like receptor 4 in the NF-κB
pathway. Mol. Nutr. Food Res. 2014, 58, 963–972. [CrossRef]
20. Te Velde, A.A.; Brüll, F.; Heinsbroek, S.E.; Meijer, S.L.; Lütjohann, D.; Vreugdenhil, A.; Plat, J. Effects of dietary
plant sterols and stanol esters with low-and high-fat diets in chronic and acute models for experimental
colitis. Nutrients 2015, 7, 8518–8531. [CrossRef]
21. Feng, S.; Dai, Z.; Liu, A.; Wang, H.; Chen, J.; Luo, Z.; Yang, C.S. β-Sitosterol and stigmasterol ameliorate
dextran sulphate sodium-induced colitis in mice fed a high fat Western-style diet. Food Funct. 2017, 8,
4179–4186. [CrossRef]
22. European Commission. Decision 2004/336/EC of 31 March 2004 authorizing the placing on the market of
yellow fat spreads, milk based fruit drinks, yoghurt type products and cheese type products with added
phytosterols/phytostanols as novel foods or novel food ingredients under Regulation (EC) No 258/97 of the
European Parliament and of the Council. Off. J. Eur. Union 2004, L105, 49–51.
23. European Commission. Regulation (EU) No 686/2014 of 20 June 2014 amending Regulations (EC) No
983/2009 and (EU) No 384/2010 as regards the conditions of use of certain health claims related to the
lowering effect of plant sterols and plant stanols on blood LDL-cholesterol. Off. J. Eur. Union 2014, L182,
27–30.
24. Islam, M.S.; Murata, T.; Fujisawa, M.; Nagasaka, R.; Ushio, H.; Bari, A.M.; Hori, M.; Ozaki, H.
Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice.
Br. J. Pharmacol. 2008, 154, 812–824. [CrossRef] [PubMed]
25. Ioannidis, O.; Varnalidis, I.; Paraskevas, G.; Botsios, D. Nutritional modulation of the inflammatory bowel
response. Digestion 2011, 84, 89–101. [CrossRef] [PubMed]
Foods 2019, 8, 114
26. Laurell, A.; Sjöberg, K. Prebiotics and symbiotic in ulcerative colitis. Scand. J. Gastroenterol. 2017, 52, 477–485.
[CrossRef] [PubMed]
27. Silk, D.B.A.; Davis, A.; Vulevic, J.; Tzortzis, G.; Gibson, G.R. Clinical trial: The effects of a
trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.
Aliment. Pharmacol. Ther. 2009, 29, 508–518. [CrossRef] [PubMed]
28. Vulevic, J.; Juric, A.; Tzortzis, G.; Gibson, G.R. A Mixture of trans-galactooligosaccharides reduces markers of
metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr.
2013, 143, 324–331. [CrossRef] [PubMed]
29. Vulevic, J.; Drakoularakou, A.; Yaqoob, P.; Tzortzis, G.; Gibson, G.R. Modulation of the fecal microflora
profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly
volunteers. Am. J. Clin. Nutr. 2008, 88, 1438–1446.
30. Holma, R.; Juvonen, P.; Asmawi, M.Z.; Vapaatalo, H.; Korpela, R. Galacto-oligosaccharides stimulate
the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats.
Scand. J. Gastroenterol. 2002, 37, 1042–1047. [CrossRef]
31. Gopalakrishnan, A.; Clinthorne, J.F.; Rondini, E.A.; McCaskey, S.J.; Gurzell, E.A.; Langohr, I.M.;
Gardner, E.M.; Fenton, J.I. Supplementation with galacto-oligosaccharides increases the percentage of
NK cells and reduces colitis severity in smad3-deficient mice. J. Nutr. 2012, 142, 1336–1342. [CrossRef]
32. López-García, G.; Cilla, A.; Barberá, R.; Alegría, A. Protective effect of antioxidants contained in milk-based
fruit beverages against sterol oxidation products. J. Funct. Foods 2017, 30, 81–89. [CrossRef]
33. Alvarez-Sala, A.; Blanco-Morales, V.; Cilla, A.; Silvestre, R.A.; Hernández-Álvarez, E.; Granado-Lorencio, F.;
Barberá, R.; Garcia-Llatas, G. A positive impact on the serum lipid profile and cytokines after the consumption
of a plant sterol-enriched beverage with a milk fat globule membrane: A clinical study. Food Funct. 2018, 9,
5209–5219. [CrossRef] [PubMed]
34. Marín, M.; Giner, R.M.; Ríos, J.L.; Recio, M.C. Intestinal anti-inflammatory activity of ellagic acid in the acute
and chronic dextrane sulfate sodium models of mice colitis. J. Ethnopharmacol. 2013, 150, 925–934. [CrossRef]
[PubMed]
35. Giner, E.; Recio, M.C.; Ríos, J.L.; Cerdá-Nicolás, J.M.; Giner, R.M. Chemopreventive effect of oleuropein in
colitis-associated colorectal cancer in C57BL/6 mice. Mol. Nutr. Food Res. 2016, 60, 242–255. [CrossRef]
[PubMed]
36. Cooper, H.S.; Murthy, S.N.; Shah, R.S.; Sedergran, D.J. Clinicopathologic study of dextran sulfate sodium
experimental murine colitis. Lab. Investig. 1993, 69, 238–249. [PubMed]
37. Bradley, P.P.; Priebat, D.A.; Christensen, R.D.; Rothstein, G. Measurement of cutaneous inflammation:
Estimation of neutrophil content with an enzyme marker. J. Investig. Dermatol. 1982, 78, 206–209. [CrossRef]
[PubMed]
38. Almero, J. Modelos experimentales in vivo de enfermedad inflamatoria intestinal y cáncer colorrectal:
Conceptos, modelos actuales y aplicabilidad. Nutr. Hosp. 2007, 22, 178–189.
39. Perŝe, M.; Cerar, A. Dextran sodium sulphate colitis mouse model: Traps and tricks. J. Biomed. Biotechnol. 2012.
[CrossRef]
40. Gottlieb, Y.; Elhasid, R.; Berger-Achituv, S.; Brazowski, E.; Yerushalmy-Feler, A.; Cohen, S. Neutrophil
extracellular traps in paediatric inflammatory bowel disease. Pathol. Int. 2018, 68, 517–523. [CrossRef]
41. Eichele, D.D.; Kharbanda, K.K. Dextran sodium sulphate colitis murine model: An indispensable tool for
advancing our understanding of inflammatory bowel diseases pathogenesis. World J. Gastroenterol. 2017, 23,
6016–6029. [CrossRef]
42. Granado-Lorencio, F.; Largarda, M.J.; García-López, F.J.; Sánchez-Siles, L.M.; Blanco- Navarro, I.; Alegría, A.;
Pérez-Sacristán, B.; Garcia-Llatas, G.; Donoso-Navarro, E.; Silvestre-Mardomingo, R.A.; et al. Effect of
β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in postmenopausal
women: A randomized crossover trial. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 1090–1096. [CrossRef]
[PubMed]
43. Kobori, M.; Ni, Y.; Takahashi, Y.; Watanabe, N.; Sugiura, M.; Ogawa, K.; Nagashimada, M.; Kaneko, S.;
Naito, S.; Ota, T. β-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing
inflammatory gene expression in mice. PLoS ONE 2014, 9, e98294. [CrossRef] [PubMed]
Foods 2019, 8, 114
44. Sahin, K.; Orhan, C.; Akdemir, F.; Tuzcu, M.; Sahin, N.; Yılmaz, I.; Juturu, V. β-Cryptoxanthin ameliorates
metabolic risk factors by regulating NF-κB and Nrf2 pathways in insulin resistance induced by high-fat diet
in rodents. Food Chem. Toxicol. 2017, 107, 270–279. [CrossRef] [PubMed]
45. Sabeva, N.S.; McPhaul, C.M.; Li, X.; Cory, T.J.; Feola, D.J.; Graf, G.A. Phytosterols differentially influence
ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam
cells. J. Nutr. Biochem. 2011, 22, 777–783. [CrossRef] [PubMed]
46. Llewellyn, S.R.; Britton, G.J.; Contijoch, E.J.; Vennaro, O.H.; Mortha, A.; Colombel, J.F.; Grispan, A.;
Clemente, J.C.; Merad, M.; Faith, J.J. Interactions between diet and the intestinal microbiota alter intestinal
permeability and colitis severity in mice. Gastroenterology 2018, 154, 1037–1046. [CrossRef] [PubMed]
47. Geier, M.S.; Butler, R.N.; Giffard, P.M.; Howarth, G.S. Prebiotic and symbiotic fructooligosaccharide
administration fail to reduce the severity of experimental colitis in rats. Dis. Colon Rectum 2007, 50, 1061–1069.
[CrossRef]
48. Campbell, J.M.; Fahey, G.C., Jr.; Wolf, B.W. Selected indigestible oligosaccharides affect large bowel mass,
cecal and fecal short-chain fatty acids, pH and microflora in rats. J. Nutr. 1997, 127, 130–136. [CrossRef]
[PubMed]
49. Bruggencate, S.J.T.; Bovee-Oudenhoven, I.M.; Lettink-Wissink, M.L.; Van der Meer, R. Dietary
fructooligosaccharides increase intestinal permeability in rats. J. Nutr. 2005, 135, 837–842. [CrossRef]
50. Maathuis, A.J.; van den Heuvel, E.G.; Schoterman, M.H.; Venema, K. Galacto-oligosaccharides have prebiotic
activity in a dynamic in vitro colon model using a 13C-labeling technique. J. Nutr. 2012, 142, 1205–1212.
[CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Anti-Obesity Effect of Extract from Nelumbo Nucifera
L., Morus Alba L., and Raphanus Sativus Mixture in
3T3-L1 Adipocytes and C57BL/6J Obese Mice
Wan-Sup Sim 1 , Sun-Il Choi 1 , Bong-Yeon Cho 1 , Seung-Hyun Choi 1 , Xionggao Han 1 ,
Hyun-Duk Cho 2 , Seung-Hyung Kim 3 , Boo-Yong Lee 4 , Il-Jun Kang 5 , Ju-Hyun Cho 2, * and
Ok-Hwan Lee 1, *
1 Department of food science and biotechnology, Kangwon National University, Chuncheon 24341, Korea;
simws9197@naver.com (W.-S.S.); docgotack89@hanmail.net (S.-I.C.); bongyeon.cho92@gmail.com (B.-Y.C.);
zzaoszz@naver.com (S.-H.C.); xionggao414@hotmail.com (X.H.)
2 Haram Co. Ltd. Jeungpyeong 27914, Korea; hansol305@naver.com
3 Institute of Traditional Medicine and Bioscience, Daejeon University, Daejeon 34520, Korea; sksh518@dju.kr
4 Department of Food Science and Biotechnology, CHA University, Seongam, Gyeonggi 13488, Korea;
bylee@cha.ac.kr
5 Department of Food Science and Nutrition, Hallym University, Chuncheon 24252, Korea;
ijkang@hallym.ac.kr
* Correspondences: dusvnd608@hanmail.net (J.-H.C.); loh99@kangwon.ac.kr (O.-H.L.);
Tel: +82-43-217-1077 (J.-H.C.); +82-33-250-6454 (O.-H.L.); Fax: +82-43-217-1088 (J.-H.C.);
+82-33-259-5561 (O.-H.L.)
Abstract: The antioxidant and anti-adipogenic activities of a mixture of Nelumbo nucifera L.,
Morus alba L., and Raphanus sativus were investigated and their anti-obesity activities were established
in vitro and in vivo. Among the 26 different mixtures of extraction solvent and mixture ratios, ethanol
extract mixture no. 1 (EM01) showed the highest antioxidant (α,α-Diphenyl-β-picrylhydrazyl,
total phenolic contents) and anti-adipogenic (Oil-Red O staining) activities. EM01 inhibited lipid
accumulation in 3T3-L1 adipocytes compared to quercetin-3-O-glucuronide. Furthermore, body, liver,
and adipose tissue weights decreased in the high-fat diet (HFD)-EM01 group compared to in the
high-fat diet control group (HFD-CTL). EM01 lowered blood glucose levels elevated by the HFD.
Lipid profiles were improved following EM01 treatment. Serum adiponectin significantly increased,
while leptin, insulin growth factor-1, non-esterified fatty acid, and glucose significantly decreased
in the HFD-EM01 group. Adipogenesis and lipogenesis-related genes were suppressed, while fat
oxidation-related genes increased following EM01 administration. Thus, EM01 may be a natural
anti-obesity agent.
Keywords: anti-obesity; Nelumbo nucifera L., Morus alba L., Raphanus sativus; 3T3-L1 adipocyte;
C57BL/6J mice
1. Introduction
Obesity is defined as excessive weight gain, particularly inordinate fat accumulation in the
body [1]. Due to rapid economic growth and westernized diets, the number of patients with obesity
has increased [2], resulting in increased rates of diseases such as type 2 diabetes [3], hypertension [4],
hypercholesterolemia [5], and hyperlipidemia [6].
Obesity occurs because of a combination of overeating, lack of exercise, and neurotransmitters,
drugs, and genetic factors [7]. To improve obesity, pharmacological treatment has been applied.
However, because these treatments involve diverse side effects such as diarrhea and vomiting,
the development of anti-obesity materials from natural products with few side effects is required [8,9].
Nelumbo nucifera L contains several flavonoids and alkaloids and has recently been used as a plain
or blended tea to treat obesity in China [10]. Morus alba L is abundant in polyphenols such as rutin and
quercetin and has been used to treat dyslipidemia, diabetes, fatty liver disease, and hypertension [11].
Raphanus sativus is an annual herb belonging to the cruciferous family and has been reported to be
effective for treating hyperlipidemia by decreasing blood sugar level [12]. Some researchers evaluated
the anti-obesity effects of Eriobotrya japonica and N. nucifera in adipocytes and obese mice using a single
material or mixture, but few studies have examined mixtures of three natural materials [13]. Because
each material has a different physiological activity, it is necessary to confirm the physiological activities
of each according to the type and mixing ratio. These materials may exert synergistic effects, but there
might be also negative effects [14,15].
In this study, we blended N. nucifera L., M. alba L., and R. sativus in different mixing ratios
and selected the optimal mixed material based on antioxidant and anti-adipogenic experiments.
The anti-obesity effects of optimal mixed material were evaluated in 3T3-L1 adipocytes and C57BL/6J
obese mice.
3. Results
3.1. Effects of 26 Extracts by Mixture Ratio of N. Nucifera L., M. alba L., R. Sativus on the Antioxidant and
Anti-Adipogenic Activities
α,α-Diphenyl-β-picrylhydrazyl (DPPH) is a very stable free radical and representative reaction
substance used to measure antioxidant capacity. DPPH radical scavenging activity assay is a method
that utilizes the principle that a purple compound is discolored as yellow when radicals are eliminated
through hydrogen donation in a phenolic compound or flavonoid with a hydroxyl radical (-OH) [21].
For the extraction method, the radical scavenging activities of ethanol extracts were superior to those
of hot water extracts. For the mixing ratio, EM05 (84.30%), EM06 (83.00%), and EM01 (81.65%) were
superior in order, but there was no significant difference between these samples (Figure 1A).
(A)
(B)
Figure 1. Cont.
Foods 2019, 8, 170
(C)
(D)
Figure 1. Effects of 26 extracts by mixture ratio of Nelumbo nucifera L., Morus alba L., and Raphanus sativus
on antioxidant activity, cell viability, lipid accumulation. (A) DPPH radical scavenging activity. (B) Total
phenolic contents. (C) Post-confluent 3T3-L1 preadipocytes were differentiated along with the treatment of
each extracts for 6 days. XTT (2,3-bis(2-methoxy-4-nitro-5- sulfophenyl)-2H-tetrazolium-5-carboxanilide)
and PMS (N-methyl dibenzopyrazine methyl sulfate reagents) mixture was added to the medium. After
4 h of incubation, cell viability was found out by calculating the absorbance at 450 nm against 690 nm.
(D) Stained lipids were extracted and quantified by calculating the absorbance at 490 nm. Data are
presented as the mean ± SEM (n = 3). Means with different letters on bars indicate that there is a significant
difference at p < 0.05 by Duncan’s multiple range test.
The content of phenol, a representative antioxidant, was highest in EM03 (49.00 mg GAE/g), EM02
(48.40 mg GAE/g), and EM01 (47.90 mg GAE/g), with no significant difference between these samples
(Figure 1B).
Foods 2019, 8, 170
Figure 2. Effect of EM01 and its bioactive compound on lipid accumulation. Post-confluent 3T3-L1
preadipocytes were differentiated along with the treatment of each extracts and its bioactive compound
for 6 days. Stained lipids were eluted and quantified by calculating the absorbance at 490 nm. Data
are presented as the mean ± SEM (n = 3). Means with different letters on bars indicate that there is a
significant difference at p < 0.05 by Duncan’s multiple range test.
3.3. Effects of EM01 on Body Weight, Food Intake, FER, Organ Weight, and Adipose Tissue Weight in
HFD-Induced Obese Mice
There was no significant difference in the initial body weight between experimental groups,
but the final body weights in different groups were significantly different. The body weight increased
significantly in the HFD-CTL group compared to in the ND group, suggesting that obesity was induced
by the HFD. The HFD-EM01 group (100 μg/mL) showed a higher weight loss rate than the HFD-CTL
group (Figure 3A). Food intake was not significantly different between groups except for the ND group,
and the food efficiency ratio (FER) was significantly decreased in the HFD-EM01 group (100 μg/mL)
(Figure 3B,C).
Foods 2019, 8, 170
(A)G (B)G
(C)G (D)G
(E)G
Figure 3. Effects of EM01 on (A) body weight, (B) food intake, (C) FER, (D) organ weight, and (E)
adipose tissue fat weight in high-fat diet (HFD)-induced obese mice. GC, Garcinia cambogia extract;
HFD, mice were fed a high-fat diet (60% kcal fat); ND, mice were fed a normal diet (10% kcal fat); FER,
food efficiency ratio (total weight gain/total food intake × 100). Data are presented as the mean ± SEM
(n = 12); # p < 0.05, ## p < 0.01, ### p < 0.001 vs. ND; * p < 0.05, ** p < 0.01 and *** p < 0.001 vs. HFD-CTL.
The kidney and spleen weights were not significantly different among groups (Figure 3D). Liver
weight increased significantly in the HFD-CTL group compared to in the ND group, and weight
decreased significantly in the HFD-EM01 and HFD-Q3OG groups compared to in the HFD-CTL
group. According to Figure 3E, the weight of the kidney adipose tissue significantly increased in
the HFD-CTL group compared to in the ND group, but no significant inhibitory effect was observed
in any group. The weight of abdominal subcutaneous fat, epididymal, and intestine adipose tissue
Foods 2019, 8, 170
increased significantly in the HFD-CTL group compared to in the ND group, but there was an inhibitory
effect on fat accumulation in the HFD-EM01 and HFD-Q3OG group compared to the positive control
(HFD-GC group).
Figure 4. Effects of EM01 on glucose tolerance in HFD-induced obese mice. Data are presented as the
mean ± SEM (n = 12); # p < 0.05, ## p < 0.01, ### p < 0.001 vs. ND; * p < 0.05, ** p < 0.01 and *** p < 0.001
vs. HFD-CTL.
3.5. Effects of EM01 on the Serum Lipid Profile in HFD-Induced Obese Mice
The HFD-CTL group showed significant increases in all parameters of the serum lipid profile
compared to the ND group. The TC level was significantly decreased in the HFD-EM01 and HFD-Q3OG
groups compared to in the HFD-CTL group (Figure 5A). HDL-cholesterol was lowered by more than
LDL-cholesterol in these groups (Figure 5B,C). TC may decrease when LDL-cholesterol levels, often
referred to as bad hormones, are suppressed [23]. The TG level was higher in the HFD-CTL group
than in the ND group, but there was no significant difference between all groups compared to
HFD-CTL (Figure 5D). AST, ALT, and creatinine are used as liver toxicity marker [24] and their levels
were significantly lowered by EM01 administration (Figure 5E,F). This suggests that the 8-week oral
administration did not affect liver and kidney toxicity in obese mice.
Foods 2019, 8, 170
(A) (B)
(C) (D)
(E) (F)
Figure 5. Effects of EM01 on serum lipid profile in HFD-induced obese mice. (A) Total cholesterol.
(B) HDL cholesterol. (C) LDL cholesterol. (D) Triglyceride. (E) Creatinine. (F) AST & ALT. Data are
presented as the mean ± SEM (n = 12); # p < 0.05, ## p < 0.01, ### p < 0.001 vs. ND; * p < 0.05, ** p < 0.01
and *** p < 0.001 vs. HFD-CTL. AST, aspartate aminotransferase; ALT, alanine aminotransferase.
3.6. Effects of EM01 on the Energy Balancing Metabolism in HFD-Induced Obese Mice
Adipokine is a hormone specifically secreted from adipose tissue that affects endocrine system
function. We analyzed adiponectin, leptin, IGF-1, which plays an important role in normal growth and
Foods 2019, 8, 170
health maintenance, NEFA, and glucose, which is associated with energy homeostasis [25]. Adiponectin
levels in the serum were significantly decreased in the HFD-CTL group compared to in the ND group,
but there was a significant increase in the HFD-EM01 and HFD-Q3OG groups compared to in the
HFD-CTL group (Figure 6A). Leptin, IGF-1, NEFA, and glucose levels in the serum were significantly
increased in the HFD-CTL group compared to in the ND group, while HFD-EM01 and HFD-Q3OG
group were significantly decreased compared to the HFD-CTL group (Figure 6B–E).
(A) (B)
(C) (D)
(E)
Figure 6. Effects of EM01 on the energy balancing metabolism in HFD-induced obese mice.
(A) Adiponectin. (B) Leptin. (C) IGF-1. (D) NEFA. (E) Glucose. Data are presented as the mean ±
SEM (n = 12); # p < 0.05, ## p < 0.01, ### p < 0.001 vs. ND; * p < 0.05, ** p < 0.01 and *** p < 0.001 vs.
HFD-CTL. IGF-1, insulin-like growth factor-1; NEFA, non-esterified fatty acid.
Foods 2019, 8, 170
3.7. Effects of EM01 mRNA Expression Level of Lipid Metabolism-Related Genes in HFD-Induced Obese Mice
We analyzed the mRNA levels of adipogenesis, lipogenesis, and fatty acid oxidation-related
genes in the liver, epididymal adipose tissue, and abdominal subcutaneous fat after 8 weeks of EM01
administration (Figure 7).
As shown in Figure 7A, the mRNA levels of FAS, DGAT1, SCD-1, leptin, SREBP1c, PPARγ in
the liver were significantly increased in the HFD-CTL group but decreased in the HFD-EM01 and
HFD-Q3OG groups. The mRNA levels of COX1, adiponectin, UCP2, and PPARα increased in the
HFD-EM01 and HFD-Q3OG groups compared to in the HFD-CTL group.
As shown in Figure 7B, the mRNA levels of the FAS, leptin in the epididymal adipose tissue
increased in the HFD-CTL group, but markedly decreased in HFD-EM01 and HFD-Q3OG groups.
The mRNA levels of the ACS1, ACOX1, CPT1b, UCP2, adiponectin, PPARα increased in HFD-EM01
and HFD-Q3OG groups compared to those in the HFD-CTL group.
As shown in Figure 7C, the mRNA level of UCP1 in abdominal subcutaneous fat significantly
increased in the HFD-EM01 and HFD-Q3OG groups compared to in the HFD-CTL group.
(A)
Figure 7. Cont.
Foods 2019, 8, 170
(B)
Figure 7. Cont.
Foods 2019, 8, 170
(C)
Figure 7. Effects of EM01 on mRNA expression level of lipid metabolism-related genes in HFD-induced
obese mice. (A) Liver. (B) Epididymal adipose tissue. (C) Abdominal subcutaneous fat. Data are
presented as the mean ± SEM (n = 12); # p < 0.05, ## p < 0.01, ### p < 0.001 vs. ND; * p < 0.05, ** p < 0.01
and *** p < 0.001 vs. HFD-CTL. FAS, fatty acid synthase; SCD-1, stearoyl-CoA desaturase-1; SREBP-1c,
sterol regulatory element binding protein-1c; PPARγ, peroxisome proliferator-activated receptor γ;
DGAT1, diglyceride acyltransferase; UCP, mitochondrial uncoupling proteins; ACOX1, peroxisomal
acyl-coenzyme A oxidase 1; PPARα, peroxisome proliferator-activated receptor α; ACS1, acetyl CoA
synthetase 1; CPT1b, carnitine palmitoyltransferase 1b.
Foods 2019, 8, 170
4. Discussion
In recent years, many side effects have been reported for drugs used for therapeutic purposes,
and numerous clinical studies have examined natural products and natural product-derived
compounds [26,27]. In this study, we confirmed the anti-obesity effect of three natural materials.
In previous studies based on these materials, N. nucifera L was found to be a medicinal plant that is
not only useful for treating gastritis, bleeding, diarrhea, hemorrhoids, and enuresis, but also contains
various biologically active components such as polyphenolics, flavonoids, and tannic acid [28]. SOD,
CAT, GST played as defence means against the reactive oxygen species in biological systems. TBARS are
formed as a byproduct of lipid peroxidation. This material was reported to have anti-oxidative activity
by increasing the levels of SOD, CAT, GST and decreasing TBARS level in liver [29] and anti-obesity
activity in HFD-induced mice or anti-obesity activity for inducing apoptosis in 3T3-L1 adipocytes,
but few studies have examined these effects [30]. Morus alba L, which is prepared for medicinal use
such as treating headache, fever, and cough, shows pharmacological activities, particularly antidiabetic
effects on lowering blood sugar [31]. Raphanus sativus is an herbaceous plant belonging to the
cruciferous family and has been reported to have excellent anti-obesity efficacy [32]. Recent studies
have demonstrated the anti-obesity activity of a single material, but the mechanism action of this
material in a mixture has not been evaluated.
We selected EM01, which contains a high content of Nelumbo nucifera [16], among the 26 mixtures
(13 kinds of hot water extracts and 13 ethanol extracts) through the antioxidant and anti-obesity
experiments at in vitro model. EM01 treatment has an anti-obesity effect at in vivo model using
C57BL/6J obese mice. The weight of HFD-induced mice was effectively lower and the weight of the
adipose tissue was significantly decreased compared with the control.
Type 2 diabetes is one of the most common disabilities caused by obesity. Obesity directly affects
insulin function, which causes glucose to enter the cell membrane for energy metabolism, resulting in
insulin resistance and type 2 diabetes [33]. A glucose tolerance test was conducted to investigate the
glucose processing ability. EM01 effectively lowered the blood glucose level. This result was similar to
those of the glucose tolerance test using neferine an alkaloid compound extracted from N. nucifera
seed [34].
EM01 reduced the serum lipid profile (TC, HDL-cholesterol, LDL-cholesterol, TG) of HFD-induced
obese mice. It may be useful for preventing dyslipidemia induced by obesity [35]. AST, ALT,
and creatinine are toxicity indicators of the liver and kidney [24]. EM01 reduced the levels of these
markers in the serum and improved the function of each organ.
Adipocytes not only play a role as energy reservoirs but also regulate endocrine function.
Adipokine, a hormone specifically expressed and secreted from adipocytes such as adiponectin and
leptin, is involved in fatty acid and glucose metabolism. IGF-1 plays an important role in regulating
adipose tissue growth. These adipokines interact closely with each other and regulate the hormonal
system in the body [36]. EM01 significantly increased the adiponectin level and reduced leptin and
IGF-1 level in serum. According to a previous study [37], glucose and lipid metabolism are regulated
by insulin signaling. Glucose and fatty acid enter cells and are metabolized for glycogenesis and
β-oxidation, respectively. Based on these results, our study confirms that EM01 improves the process
of bringing glucose and fatty acid into the cells, resulting in anti-obesity and anti-diabetic effects.
Adipogenesis is the process of cell differentiation by which pre-adipocytes become adipocytes.
PPARγ is a key factor in adipogenic transcription [1]. In this study, it was found that mRNA expression
of PPARγ in the liver tissue was reduced by administration of EM01. Also, the expression levels of FAS,
DGAT1, SCD-1, leptin, SREBP1c were decreased, while the expression levels of UCP2, PPARα, ACOX1,
and adiponectin increased in the EM01, Q3OG treatment group in the liver. These results suggest
that EM01 treatment inhibits adipogenesis of 3T3-L1 adipocytes and improves fatty acid oxidation.
EM01 regulated lipid metabolism in epididymal adipose tissue and abdominal subcutaneous fat.
Our results demonstrate that EM01 has an anti-obesity effect in 3T3-L1 adipocytes and C57BL/6J
obese mice.
Foods 2019, 8, 170
5. Conclusions
In conclusion, we observed the anti-obesity activity of EM01, which is an optimal mixed material
containing N. nucifera L., M. alba L., and R. sativus in vitro and in vivo models. EM01 reduced lipid
accumulation and weight gain, fat mass, serum lipid concentration, and mRNA expression levels of
lipid-metabolism-related genes in HFD-induced obese mice. Therefore, our findings show that EM01
has potential as an effective material for anti-obesity treatment.
Author Contributions: W.-S.S., S.-I.C., B.-Y.C., S.-H.C., X.H., H.-D.C., J.-H.C., S.-H.K., B.-Y.L., I.-J.K. and O.-H.L.
designed research; W.-S.S., S.-H.K. performed research and analyzed the data; W.-S.S., O.-H.L. wrote the paper.
All authors read and approved the final manuscript.
Funding: This research was funded Technology Development Program (C1013823-01-01) funded by the Ministry
of SMEs and Startups (MSS, Korea).
Acknowledgments: This work was supported by the Technology Development Program (C1013823-01-01) funded
by the Ministry of SMEs and Startups (MSS, Korea); NRF (National Research Foundation of Korea) Grant funded
by the Korean Government (NRF-2018-Fostering Core Leaders of the Future Basic Science Program/Global Ph.D.
Fellowship Program); The basic Science Research Program through the National Research Foundation of Korea
(NRF) funded by the Ministry of Education (NRF-2017R1D1A3B06028469) and has been worked with the support
of a research grant from Kangwon National University in 2017.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Moon, J.; Do, H.J.; Kim, O.Y.; Shin, M.J. Antiobesity effects of quercetin-rich onion peel extract on the
differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food Chem. Toxicol. 2013,
58, 347–354. [CrossRef]
2. Mu, M.; Xu, L.-F.; Hu, D.; Wu, J.; Bai, M.-J. Dietary patterns and overweight/obesity: A review article. Iran J.
Public Health. 2017, 46, 869–876. [PubMed]
3. Kahn, S.E.; Hull, R.L.; Utzschneider, K.M. Mechanisms linking obesity to insulin resistance and type 2
diabetes. Nature 2006, 444, 840–847. [CrossRef] [PubMed]
4. Rahmouni, K.; Correia, M.L.; Haynes, W.G.; Mark, A.L. Obesity-associated hypertension: New insights into
mechanisms. Hypertension. 2005, 45, 9–14. [CrossRef] [PubMed]
5. Zahid, N.; Claussen, B.; Hussain, A. High prevalence of obesity, dyslipidemia and metabolic syndrome in a
rural area in Pakistan. Diabetes Metab. Syndr: Clinical Res. Rev. 2008, 2, 13–19. [CrossRef]
6. Lee, H.S.; Nam, Y.; Chung, Y.H.; Kim, H.R.; Park, E.S.; Chung, S.J.; Kim, J.H.; Sohn, U.D.; Kim, H.C.; Oh, K.W.;
et al. Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty
liver in mice. Life Sci. 2014, 118, 7–14. [CrossRef]
7. Kopelman, P.G. Obesity as a medical problem. Nature 2000, 404, 635–643. [CrossRef] [PubMed]
8. Padwal, R.S.; Majumdar, S.R. Drug treatments for obesity: Orlistat, sibutramine, and rimonabant. The Lancet
2007, 369, 71–77. [CrossRef]
9. Weigle, D.S. Pharmacological therapy of obesity: Past, present, and future. J. Clin. Endocrinol. Metab. 2003,
88, 2462–2469. [CrossRef] [PubMed]
10. Ono, Y.; Hattori, E.; Fukaya, Y.; Imai, S.; Ohizumi, Y. Anti-obesity effect of Nelumbo nucifera leaves extract in
mice and rats. J. Ethnopharmacol. 2006, 106, 238–244. [CrossRef]
11. Ann, J.Y.; Eo, H.; Lim, Y. Mulberry leaves (Morus alba L.) ameliorate obesity-induced hepatic lipogenesis,
fibrosis, and oxidative stress in high-fat diet-fed mice. Genes Nutr. 2015, 10, 46–59. [CrossRef]
12. Chaturvedi, P. Inhibitory response of Raphanus sativus on lipid peroxidation in albino rats. J. Evid. Based
Complementary Altern Med. 2008, 5, 55–59. [CrossRef] [PubMed]
13. Sharma, B.R.; Oh, J.; Kim, H.A.; Kim, Y.J.; Jeong, K.S.; Rhyu, D.Y. Anti-obesity effects of the mixture of
Eriobotrya japonica and Nelumbo nucifera in adipocytes and high-fat diet-induced obese mice. Am. J. Chin. Med.
2015, 43, 681–694. [CrossRef]
14. Zheng, G.; Sayama, K.; Okubo, T.; Juneja, L.R.; Oguni, I. Anti-obesity effects of three major components of
green tea, catechins, caffeine and theanine, in mice. In Vivo 2004, 18, 55–62.
Foods 2019, 8, 170
15. Nadeem, S. Synergistic effect of Commiphora mukul (gum resin) and Lagenaria siceraria (fruit) extracts in high
fat diet induced obese rats. Asian Pac. J. Trop. Dis. 2012, S883–S886. [CrossRef]
16. Jang, G.W.; Park, E.Y.; Choi, S.H.; Choi, S.I.; Cho, B.Y.; Sim, W.S.; Han, X.; Cho, H.D.; Lee, O.H. Development
and validation of analytical method for wogonin, quercetin, and quercetin-3-O-glucuronide in extracts of
Nelumbo nucifera, Morus alba L., and Raphanus sativus mixture. J. Food Hyg. Saf. 2018, 33, 289–295. [CrossRef]
17. Cho, M.; Ko, S.B.; Kim, J.M.; Lee, O.H.; Lee, D.W.; Kim, J.Y. Influence of extraction conditions on antioxidant
activities and catechin content from bark of Ulmus pumila L. Appl. Biol. Chem. 2016, 59, 329–336. [CrossRef]
18. Tawaha, K.; Alali, F.Q.; Gharaibeh, M.; Mohammad, M.; El-Elimat, T. Antioxidant activity and total phenolic
content of selected Jordanian plant species. Food Chem. 2007, 104, 1372–1378. [CrossRef]
19. Cho, B.Y.; Park, M.R.; Lee, J.H.; Ra, M.J.; Han, K.C.; Kang, I.J.; Lee, O.H. Standardized Cirsium setidens
Nakai ethanolic extract suppresses adipogenesis and regulates lipid metabolisms in 3T3-L1 adipocytes and
C57BL/6J mice fed high-fat diets. J. Med. Food. 2017, 20, 763–776. [CrossRef] [PubMed]
20. Lee, J.H.; Cho, B.Y.; Choi, S.H.; Jung, T.D.; Choi, S.I.; Lim, J.H.; Lee, O.H. Sulforaphane attenuates bisphenol
A-induced 3T3-L1 adipocyte differentiation through cell cycle arrest. J. Funct. Foods. 2018, 44, 17–23.
[CrossRef]
21. Bondet, V.; Brand-Williams, W.; Berset, C. Kinetics and mechanisms of antioxidant activity using the DPPH.
free radical method. LWT-Food Sci. Technol. 1997, 30, 609–615. [CrossRef]
22. Sinha, R.; Fisch, G.; Teague, B.; Tamborlane, W.V.; Banyas, B.; Allen, K.; Savoye, M.; Rieger, V.; Taksali, S.;
Barbetta, G.; et al. Prevalence of impaired glucose tolerance among children and adolescents with marked
obesity. N. Engl. J. Med. 2002, 346, 802–810. [CrossRef] [PubMed]
23. Barter, P.; Gotto, A.M.; LaRosa, J.C.; Maroni, J.; Szarek, M.; Grundy, S.M.; Kastelein, J.P.; Bittner, V.;
Fruchart, J.C. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N. Engl. J. Med.
2007, 357, 1301–1310. [CrossRef] [PubMed]
24. Xiong, Y.; Shen, L.; Liu, K.J.; Tso, P.; Xiong, Y.; Wang, G.; Woods, S.C.; Liu, M. Anti-obesity and
anti-hyperglycemic effects of ginsenoside Rb1 in rats. Diabetes 2010, 59, 2505–2512. [CrossRef] [PubMed]
25. Pardina, E.; Ferrer, R.; Baena-Fustegueras, J.A.; Lecube, A.; Fort, J.M.; Vargas, V.; Catalan, R.;
Peinado-Onsurbe, J. The relationships between IGF-1 and CRP, NO, leptin, and adiponectin during weight
loss in the morbidly obese. Obes. Surg. 2010, 20, 623–632. [CrossRef] [PubMed]
26. Butler, M.S. Natural products to drugs: Natural product-derived compounds in clinical trials. Nat. Prod. Rep.
2008, 25, 475–516. [CrossRef]
27. Pauwels, E.; Stoven, V.; Yamanishi, Y. Predicting drug side-effect profiles: A chemical fragment-based
approach. BMC bioinformatics. 2011, 12, 169–182. [CrossRef]
28. Choe, J.H.; Jang, A.; Choi, J.H.; Choi, Y.S.; Han, D.J.; Kim, H.Y.; Lee, M.A.; Kim, H.W.; Kim, C.J. Antioxidant
activities of lotus leaves (Nelumbo nucifera) and barley leaves (Hordeum vulgare) extracts. Food Sci. Biotechnol.
2010, 19, 831–836. [CrossRef]
29. Huang, B.; Ban, X.; He, J.; Tong, J.; Tian, J.; Wang, Y. Hepatoprotective and antioxidant activity of ethanolic
extracts of edible lotus (Nelumbo nucifera Gaertn.) leaves. Food Chem. 2010, 120, 873–878. [CrossRef]
30. Bin, X.; Jin, W.; Wenqing, W.; Chunyang, S.; Xiaolong, H.; Jianguo, F. Nelumbo nucifera alkaloid inhibits 3T3-L1
preadipocyte differentiation and improves high-fat diet-induced obesity and body fat accumulation in rats.
J. Med. Plant Res. 2011, 5, 2021–2028.
31. Hunyadi, A.; Martins, A.; Hsieh, T.J.; Seres, A.; Zupkó, I. Chlorogenic acid and rutin play a major role in the
in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats. PLOS One. 2012, 7, e50619.
[CrossRef] [PubMed]
32. Vivarelli, F.; Canistro, D.; Sapone, A.; De Nicola, G.R.; Marquillas, C.B.; Iori, R.; Antonazzo, I.C.; Gentilini, F.;
Paolini, M. Raphanus sativus cv. sango sprout juice decreases diet-induced obesity in Sprague Dawley rats
and ameliorates related disorders. PLoS ONE 2016, 11, e0150913. [CrossRef] [PubMed]
33. Kahn, B.B.; Flier, J.S. Obesity and insulin resistance. Clin. Investig. 2000, 106, 473–481. [CrossRef]
34. Pan, Y.; Cai, B.; Wang, K.; Wang, S.; Zhou, S.; Yu, X.; Xu, B.; Chen, L. Neferine enhances insulin sensitivity in
insulin resistant rats. J. Ethnopharmacol. 2009, 124, 98–102. [CrossRef]
35. Zhou, T.; Luo, D.; Li, X.; Luo, Y. Hypoglycemic and hypolipidemic effects of flavonoids from lotus (Nelumbo
nuficera Gaertn) leaf in diabetic mice. J. Med. Plant. Res. 2009, 3, 290–293.
Foods 2019, 8, 170
36. Winsz-Szczotka, K.; Kuźnik-Trocha, K.; Komosińska-Vassev, K.; Kucharz, E.; Kotulska, A.; Olczyk, K.
Relationship between adiponectin, leptin, IGF-1 and total lipid peroxides plasma concentrations in patients
with systemic sclerosis: Possible role in disease development. Int. J. Rheum Dis. 2016, 19, 706–714. [CrossRef]
37. Saltiel, A.R.; Kahn, C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001,
414, 799–806. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
Use of Phycobiliproteins from Atacama Cyanobacteria
as Food Colorants in a Dairy Beverage Prototype
Alexandra Galetović 1, *, Francisca Seura 2 , Valeska Gallardo 2 , Rocío Graves 2 , Juan Cortés 1 ,
Carolina Valdivia 3 , Javier Núñez 3 , Claudia Tapia 3 , Iván Neira 3 , Sigrid Sanzana 3 and
Benito Gómez-Silva 1
1 Departamento Biomédico, Laboratorio de Bioquímica, Facultad de Ciencias de la Salud and Centre for
Biotechnology and Bioengineering (CeBiB), Universidad de Antofagasta, Avenida Angamos N◦ 601,
Antofagasta 1270300, Chile; juancortesgonzalez.96@gmail.com (J.C.); benito.gomez@uantof.cl (B.G.-S.)
2 Departamento de Ciencias de los Alimentos y Nutrición, Universidad de Antofagasta, Avenida Angamos N◦
601, Antofagasta 1270300, Chile; fran.ncisca@hotmai.com (F.S.); nutricionistavale.gd@gmail.com (V.G.);
Rociograves@hotmail.com (R.G.)
3 Departamento de Tecnología Médica, Universidad de Antofagasta/Avenida Angamos N◦ 601,
Antofagasta 1270300, Chile; carovaldiviab@gmail.com (C.V.); javier.ignacio.ng@gmail.com (J.N.);
claudiafran.t@gmail.com (C.T.); ivan.neira@uantof.cl (I.N.); sigrid.sanzana@uantof.cl (S.S.)
* Correspondence: alexandra.galetovic@uantof.cl; Tel.: +56-55-2637054
Abstract: The interest of the food industry in replacing artificial dyes with natural pigments has
grown recently. Cyanobacterial phycobiliproteins (PBPs), phycoerythrin (PE) and phycocyanin
(PC), are colored water-soluble proteins that are used as natural pigments. Additionally, red PE
and blue PC have antioxidant capabilities. We have formulated a new food prototype based
on PBP-fortified skim milk. PBPs from Andean cyanobacteria were purified by ammonium
sulfate precipitation, ion-exchange chromatography, and freeze-drying. The stability of PE and
PC was evaluated by changes in their absorption spectra at various pH (1–14) and temperature
(0–80 ◦ C) values. Purified PBPs showed chemical stability under pH values of 5 to 8 and at
temperatures between 0 and 50 ◦ C. The antioxidant property of PBP was confirmed by ABTS
(2,2 -Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt radical ion scavenging,
and FRAP (Ferric Antioxidant Power) assays. The absence of PBP toxicity against Caenorhabditis
elegans was confirmed up to 1 mg PBP/mL. Skim milk fortified with PE obtained a higher score
after sensory tests. Thus, a functional food based on skim milk-containing cyanobacterial PBPs
can be considered an innovative beverage for the food industry. PBPs were stable at an ultra-high
temperature (138 ◦ C and 4 s). PBP stability improvements by changes at its primary structure and
the incorporation of freeze-dried PBPs into sachets should be considered as alternatives for their
future commercialization.
1. Introduction
Cyanobacteria are a large, diverse and ancient group of ubiquitous Gram-negative prokaryotes
that are found in terrestrial or aquatic habitats. They perform oxygenic photosynthesis and colonize
freshwater, marine and brackish waters and soils and rocks from drylands. They also are found
at extreme environments that are subjected to high ultraviolet radiation, high or low temperatures,
desiccation, and nutrient deficiencies [1,2]. Cyanobacteria can be found as free-living unicellular or
filamentous microorganisms and as photobionts in symbiotic association with fungi. Members of
some filamentous genera (e.g., Anabaena and Nostoc) have heterocysts—cells specialized in atmospheric
nitrogen fixation. Cyanobacteria are an important source of natural products with interest from
the pharmaceutical and biotechnological industries [3,4]. Particularly, cyanobacterial pigments have
attracted attention for their use in the food, textile and cosmetic industries [5,6].
Three types of cyanobacterial water-soluble phycobiliproteins (PBPs), C-allophycocyanin (APC),
phycocyanin (PC), and C-phycoerythrin (PE) are organized in phycobilisomes in the photosynthetic
apparatus. PE, PC and APC act as antennae pigments with absorption maxima at 562, 615, and 652 nm,
respectively [7]. PBPs contain linear tetrapyrrolic chromophores (bilins) that are covalently bound
to apoproteins via cysteine residues [7,8]. The ability of PBPs to act as free radical scavengers has
been demonstrated to be centered on their tetrapyrrolic systems, supporting their use in the food,
cosmetics and pharmaceutical industries, as well as their use as fluorochromes in biomedical research.
In addition, PBPs isolated from various cyanobacterial species also have beneficial effects as anticancer,
neuroprotective, anti-inflammatory, anti-allergic and hepatoprotective biomolecules [9–15].
Color in food has an important impact on consumers since it is one of the first characteristics
we perceive from a product. Additionally, colored food is attractive, and color allows for better
identification and selection among similar products. Coloration helps to relate water with food; for
example, yogurt, animal or vegetal milk (e.g., soybean, coconut, or almonds) with fruits such as
strawberries (reddish), blue berries (purple), and melon (green). Then, consumers would consider
ingesting these types of food as beneficial to their well-being even though they may not have fruits [16].
Artificial dyes are stable at different temperatures, pH and light regimes, maintaining their
coloration for long periods. Some synthetic dyes have been approved for their use in the food industry;
however, some of them have been reported to be neurotoxic, mutagenic, and genotoxic (lemon-yellow
tartrazine), damaging in the liver and the kidney (brilliant blue), and triggering biochemical changes
and cancer in the thyroid gland (cherry-red erythrosine) [17–19]. As such, the demand for natural
dyes in the food industry has grown in recent years due to the toxicity of artificial colorants [20].
There is great interest in finding non-harmful alternative pigments, especially blue pigments such
as PC, which has the capability to scavenge hydroxyl ions in order to avoid lipoperoxidation [21].
Natural dyes can be considered renewable and sustainable bioresources with minimal environmental
impact [22]. These eco-friendly, presumably mostly non-toxic, natural colorants could have applications
in other industrial sectors like the cosmetics or pharmacological industries [23–26]. Other studies have
shown that some natural colorants from plants have health-promoting properties in the human diet,
like natural carotenoids that provide beneficial biological effects such as antioxidant and anticancer
properties [27,28].
Cyanobacterial PBPs are natural pigments used as colorants in some food products; for example,
aqueous extracts of non-purified blue PC from Spirulina have been added in ice creams, yogurts, isotonic
beverages, confectionery, and jellies [29]. Particularly, bright blue PC has been selected over others
less-bright natural colorants such as gardenia blue and indigo in confectionery production [30–32]. Red
PE has been mostly used as a fluorescent probe in biomedical studies, rather than in the food industry.
Spirulina (Arthrospira platensis) has been used as a source of PBPs for additions to food products;
however, this microorganism mostly produces PC. The Andes wetlands in northern Chile are a source
of microbial communities that include PC and PE producing cyanobacteria. Isolated strains Nostoc
sp. Caquena (CAQ-15), LLA-10 and Nostoc sp. Llayta (LLC-10) from Andes wetlands, above 3000 m
of altitude, predominantly accumulate red PE, blue PC, and a purple fluorescent mixture of both,
respectively. In addition, the CAQ-15 strain modulates its PBP content by complementary chromatic
adaptation [33]. Here, we report the use of these isolated Nostocaceae strains for the purification of PBPs
and their application as colorants and antioxidant molecules in the formulation of dairy functional
prototypes. Additionally, we report results on the stability, antioxidant capabilities and toxicity of the
purified PBPs, as well as sensory tests of the final prototypes. This work represents the first step in the
use of PBPs from Andean cyanobacteria as ingredients for the food industry.
Foods 2020, 9, 244
the thermostable PC from the Synechococcus lividus PCC 6715 strain that was isolated from a hot spring
maintained 90% and 70% stability at 50 ◦ C for 5 h and two weeks, respectively [45]. Additionally, PC
from the thermophilic red algae Cyanidioschyzon merolae showed a midpoint denaturation at 83 ◦ C and
pH 5, with a half-life of 40 min [46].
Future work will consider the isolation of thermophilic cyanobacteria from a thermal spring
in the Atacama region and the purification of their phycobiliproteins. The biochemical properties
of these PBPs and relevant genetic studies would provide new unidentified protein resources for
biotechnological applications.
Figure 1. Effect of the temperature on the stability of phycocyanin (PC) and C-phycoerythrin (PE)
phycobiliproteins from the cyanobacterial Nostoc sp. Llayta (LLC-10) and Nostoc sp. Caquena (CAQ-15)
strains. The stability of the proteins was expressed as mg/mL of the remaining native phycobiliproteins
after 24 to 72 h of incubation. (*) significant, ns: no significant with respect to the reference group at 24 h.
Table 2. Antioxidant activity of purified phycobiliproteins and methanol extracts from the Atacama
native cyanobacterial strains CAQ-15, LLC-10 and LLA-10. The antioxidant capabilities were evaluated
by the ABTS and FRAP assays and expressed as TEAC (Trolox equivalent antioxidant capacity). TE:
Trolox equivalents; PE: Phycoerythrin; and PC: Phycocyanin. The assays were conducted in triplicate,
and the results are shown as the mean values with the corresponding standard deviation.
Figure 3. Toxicity of phycobiliproteins against the nematode Caenorhabditis elegans. Toxicity test of
a mixed solution of PE plus PC from the LLC-10 strain was evaluated at a phycobiliprotein (PBP)
concentration from 0.125 to 1.0 mg/mL. Ivermectin (0.3 mg/mL) was used as a nematicidal control drug.
The nematode M-9 buffer was used as a control without phycobiliproteins. Quadruplicate tests were
carried out for 24 h at 18 ◦ C.
Figure 4. Sensory test for a PBP-containing dairy product. (a) Three skim milk prototypes were fortified
with PE and PC: Prototype N◦ 1 (PC from the LLC-10 strain at 120 mg%); Prototype N◦ 2 (PE from the
CAQ-15 strain at 13 mg%; Prototype N◦ 3 (PE from the LLC-10 strain at 140 mg%). (b) Sensory test
by a volunteer team evaluating four sensory factors (appearance, smell, taste and texture) that used
a consumer acceptability 5-point hedonic scale: 1—dislike extremely; 2—dislike slightly; 3—neither
like nor dislike; 4—like slightly; and 5—like extremely) (c) Final sensory evaluation scores for four
attributes of prototypes P1, P2 and P3.
4. Conclusions
PBPs purified from two Andean cyanobacteria from northern Chile showed chemical stability at a
pH range from 5 to 8, and temperatures between 0 and 50 ◦ C. The pigmented proteins from the LLC-10
strain had no toxic effects against C. elegans. The highest score at the sensory test was obtained by skim
milk that was fortified with PE.
Colors are always attractive to children and induce consumption. The skim milk was selected to
incorporate blue PC and red PE because of its low-fat content and its contribution to human health
with vitamins, minerals and proteins, particularly to the overweight population.
We conclude that PBPs are natural proteins that can be used as colorants in the formulation
of functional food products based on skim milk in the replacement of added artificial colorants.
In addition, the native cyanobacterial PBPs have an appropriate level of antioxidant activity, and we
propose their potential use as an innovative source of pigments in the pharmaceutical, cosmetic and
food industries.
Finally, the UHT pasteurization (138 ◦ C, 4 s) of Atacama cyanobacterial PBPs induced a minor
denaturation of PE and PC; therefore, they can be added before the skim milk pasteurization process.
However, milk usually is heated over 50 ◦ C, and, in order to avoid the loss of added PBP coloration
Foods 2020, 9, 244
while maintaining bacteriological safety, we propose two alternatives for the use of cyanobacterial
PBPs at high temperatures in dairy products before pasteurization. One is the application of molecular
biology and genetic tools on PBP genes from mesophilic and thermophilic cyanobacteria in order to
increase their stability for biotechnological processes and the safety of new functional foods. The second
alternative is the use purified freeze-dried PBPs that are enclosed in sachets that can be added as
powder to already pasteurized dairy food before their consumption, avoiding protein denaturation
and the loss of antioxidant activity.
Author Contributions: Conceptualization, A.G.; methodology, A.G., I.N. and S.S.; investigation, A.G., F.S., V.G.,
R.G., C.V., J.N., C.T., I.N., J.C., S.S.; writing—original draft preparation A.G.; writing, reviewing and editing, A.G.,
I.N. and B.G.-S. All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by Semillero de Investigación, Universidad de Antofagasta (grant number:
SI-5305); CONICYT-Chile (grant number: CeBiB FB-0001); Financiamiento Asistente de Investigación, VRIIP,
Universidad de Antofagasta MINEDUC-UA (grant numbers: ANT1855 y ANT1856); Convenio Marco para
Universidades Estatales, Ministerio de Educación Chile (grant number: NEXER ANT 1756).
Acknowledgments: Special thanks to Milton Urrutia, Universidad de Antofagasta, for his assistance with the
statistics used in this work. We thank Catherine Lizama, Microbiology Laboratory, Universidad de Antofagasta
her support in the microbiological analyses.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Marsac, T.D.N.; Houmard, J. Adaptation of cyanobacteria to environmental stimuli: New steps towards
molecular mechanisms. FEMS Microb. 1993, 104, 119–189. [CrossRef]
2. Whitton, B.; Potts, M. Introduction of cyanobacteria. In The Ecology of Cyanobacteria. Their Diversity in Time
and Space; Kluwer Academic Publishers: Dordrecht, the Netherlands, 2012; pp. 1–10.
3. Abed, R.M.; Dobretsov, S.; Sudesh, K. Applications of cyanobacteria in biotechnology. J. Appl. Microbiol.
2009, 106, 1–12. [CrossRef]
4. Vijayakumar, S.; Menakha, M. Pharmaceutical applications of cyanobacteria—A review. J. Acute Med. 2015,
5, 15–23. [CrossRef]
5. Bermejo, R.; Talavera, E.; Alvarez-Pez, J.; Orte, J. Chromatographic purification of biliproteins from Spirulina
platensis. High-performance liquid chromatographic separation of their α and β subunits. J. Chromatogr.
1997, 778, 441–450. [CrossRef]
6. Saini, D.K.; Pabbi, S.; Shukla, P. Cyanobacterial pigments: Perspectives and biotechnological approaches.
Food Chem. Toxicol. 2018, 120, 616–624. [CrossRef] [PubMed]
7. Samsonoff, W.A.; MacColl, R. Biliproteins and phycobilisomes from cyanobacteria and red algae at the
extremes of habitat. Arch. Microbiol. 2001, 176, 400–405. [CrossRef] [PubMed]
8. Marín, J.; Pavón, N.; Llópiz, A.; Fernández, J.; Delgado, L.; Mendoza, Y. Pycocyanobilin promotes PC12 cell
survival and modulates immune and inflammatory genes and oxidative stress markers in acute hypoperfusion
in rats. Toxicol. Appl. Pharmacol. Rev. 2013, 104, 119–190.
9. Romay, C.H.; Armesto, J.; Remirez, D.; González, R.; Ledon, N.; García, I. Antioxidant and anti-inflammatory
properties of C-phycocyanin from blue-g.reen algae. Inflamm. Res. 1998, 47, 36–41. [CrossRef] [PubMed]
10. González, R.; Rodríguez, S.; Romay, C.; Ancheta, O.; González, A.; Armesto, J.; Remirez, D.; Merino, N.
Anti-inflammatory activity of phycocyanin extract in acetic acid-induced colitis in rats. Pharmacol. Res. 1999,
39, 55–59. [CrossRef]
11. Pleonsil, P.; Suwanwong, Y. An in vitro study of C-phycocyanin activity on protection of DNA and human
erythrocyte membrane from oxidative damage. J. Chem. Pharm. Res. 2012, 5, 332–336.
12. Liua, Q.; Wanga, Y.; Caoa, M.; Yang, T.; Maoa, H.; Suna, L.; Liu, G. Anti-allergic activity of R-phycocyanin
from Porphyra haitanensis in antigen-sensitized mice and mast cells. Int. Immunopharmacol. 2015, 25, 465–473.
[CrossRef]
13. Liu, Y.; Xu, L. Inhibitory effect of phycocyanin from Spirulina platensis on growth of human leukemia K562
cells. J. Appl. Phycol. 2000, 12, 125–130. [CrossRef]
14. Sonani, R.; Rastogi, R.; Madamwar, D. Antioxidant potential of phycobiliproteins: Role in anti-aging research.
Biochem. Anal. Biochem. 2015, 4, 2. [CrossRef]
Foods 2020, 9, 244
15. Munir, N.; Sharif, S.; Manzoor, S. Algae: A potent antioxidant source. Sky J. Microbiol. Res. 2013, 1, 22–31.
16. Griffiths, J.C. Coloring foods and beverages. Food Technol. 2005, 59, 38–44.
17. Borzelleca, J.F.; Capen, C.C.; Hallagan, J.B. Lifetime toxicity/carcinogenicity study of fd & c red no. 3
(erythrosine) in rats. Food Chem. Toxic. 1987, 10, 723–733.
18. Mahmoud, N. Toxic effects of the synthetic food dye brilliant blue on liver, kidney and testes functions in
rats. J. Egypt. Soc. Toxicol. 2006, 34, 77–84.
19. Mohammed, M.; Mohammed, Y.; Abo-EL-Sooud, K.; Eleiwa, M.M. Embryotoxic and teratogenic effects of
tartrazine in rats. Toxicol. Res. 2019, 35, 75–81.
20. Shetty, M.J.S.; Geethalekshmi, P.; Mini, C. Natural Pigments as Potential Food Colourants: A Review.
Trends Biosci. 2017, 10, 4057–4064.
21. Romay, C.H.; Remirez, D.; González, R. Actividad Antioxidante de la ficocianina frente a radicales peroxílicos
y la peroxidación microsomal. Rev. Cubana Investg. Biomed. 2001, 20, 38–41.
22. Selvam, R.M.; Athinarayanan, G.; Nanthini, A.U.R.; Singh, A.J.A.; Kalirajan, K.; Selvakumar, P.M. Extraction
of natural dyes from Curcuma longa, Trigonella foenum graecum and Nerium oleander, plants and their
application in antimicrobial fabric. Ind. Crops Prod. 2015, 70, 84–90. [CrossRef]
23. Mirjalili, M.; Nazarpoor, K.; Karimi, L. Eco-friendly dyeing of wool using natural dye from weld as co-partner
with synthetic dye. J. Clean. Prod. 2011, 19, 1045–1051. [CrossRef]
24. Frick, D. The coloration of food: Review of Progress in Coloration and Related Topics. Color. Technol. 2003,
33, 15–32. [CrossRef]
25. Dweck, A.C. Natural ingredients for coloring and styling. Int. J. Cosmet. Sci. 2002, 24, 287–302. [CrossRef]
[PubMed]
26. Yusuf, M.; Shabbir, M.; Mohammad, F. Natural Colorants: Historical, Processing and Sustainable Prospects.
Nat. Prod. Bioprospect. 2017, 7, 123–145. [CrossRef]
27. Chengaiah, B.; Rao, K.M.; Kumar, K.M.; Alagusundaram, M.; Chetty, C.M. Medicinal importance of natural
dyes, a review. Int. J. PharmTech Res. 2010, 2, 144–154.
28. Andriamanantena, M.; Danthu, P.; Cardon, D.; Fawbush, C.D.; Raonizafinimanana, B.; Razafintsalama, V.E.;
Rakotonandrasana, S.R.; Ethève, A.; Petit, T.; Caro, Y. Malagasy Dye Plant Species: A Promising Source
of Novel Natural Colorants with Potential Applications—A Review. Chem. Biodivers. 2019, 16, e1900442.
[CrossRef]
29. FDA. U.S. Food and Drug. Summary of Color Additives for Use in the United States in Foods, Drugs,
Cosmetics and Medical Devices. Available online: https://www.fda.gov/industry/color-additive-inventories/
summary-color-additives-use-united-states-foods-drugs-cosmetics-and-medical-devices (accessed on
14 January 2020).
30. Olsen, K.; Jespersen, L.; Strømdahl, L. Heat and light stability of three natural blue colorants for use in
confectionery and beverages. Eur. Food Res. Technol. 2005, 220, 261–266.
31. Pandey, V.D.; Pandey, A.; Sharma, V. Biotechnological applications of cyanobacterial phycobiliproteins. Int. J.
Curr. Microbiol. App. Sci. 2013, 2, 89–97.
32. Bermejo, R. Phycocianins. In Cyanobacteria an Economic Perspective; Sharma, N.K., Rai, A.K., Stal, L.J., Eds.;
Willey Blackwell, John Willey and Sons Ltd.: Hoboken, NJ, USA, 2014; pp. 209–225.
33. Galetović, A.; Gómez-Silva, B. Inmovilización de cianobacterias filamentosas en perlas de alginato.
Rev. Cienc. Salud. 1999, 3, 28–33.
34. Seibert, M.; Connolly, J.S. Fluorescence properties of C-phycocyanin isolated from a thermophilic
cyanobacterium. Photochem. Photobiol. 1984, 40, 267–271. [CrossRef]
35. Couteau, C.; Baudry, S.; Roussakis, C.; Coiffard, L.J.M. Study of thermodegradation of phycocyanin from
Spirulina platensis. Sci. Aliments 2004, 24, 415–421. [CrossRef]
36. Patel, A.; Pawar, R.; Mishra, S.; Sonawane, S.; Ghosh, P.K. Kinetic studies on thermal denaturation of
C-phycocyanin. Indian J. Biochem. Biophys. 2004, 41, 254–257. [PubMed]
37. Antelo, F.S.; Costa, J.A.V.; Kalil, S.J. Thermal degradation kinetics of the phycocyanin from Spirulina platensis.
Biochem. Eng. J. 2008, 41, 43–47. [CrossRef]
38. Zhao, J.; Brand, J.J. Specific bleaching of phycobiliproteins from cyanobacteria and red algae at high
temperature in vivo. Arch. Microbiol. 1989, 152, 447–452. [CrossRef]
Foods 2020, 9, 244
39. Tripathi, S.N.; Kapoor, S.; Shrivastava, A. Extraction and purification of an unusual phycoerythrin in
a terrestrial desiccation tolerant cyanobacterium Lyngbya arboricola. J. Appl. Phycol. 2007, 19, 441–447.
[CrossRef]
40. Kaur, S.; Khattar, J.I.S.; Singh, Y.; Singh, D.P.; Ahluwalia, A.S. Extraction, purification and characterisation
of phycocyanin from Anabaena fertilissima PUPCCC 410.5: As a natural and food grade stable pigment.
Appl. Phycol. 2019, 31, 1685–1696. [CrossRef]
41. Rastogi, R.P.; Sonani, R.R.; Madamwar, D. Physico-chemical factors affecting the in vitro stability of
phycobiliproteins from Phormidium rubidum A09DM. Bioresour. Technol. 2015, 190, 219–226. [CrossRef]
42. Munawaroh, H.S.H.; Darojatun, K.; Gumilar, G.G.; Aisyah, S.; Wulandari, A.P. Characterization of
phycocyanin from Spirulina fusiformis and its thermal stability. J. Phys. Conf. Ser. 2018, 1013, 012205.
[CrossRef]
43. Pumas, C.; Peerapornpisal, Y.; Vacharapiyasophon, P.; Leelapornpisid, P.; Boonchum, W.; Ishii, M.;
Khanongnuch, C. Purification and characterization of a thermostable phycoerythrin from hot spring
cyanobacterium Leptolyngbya sp. KC45. Int. J. Agric. Biol. 2012, 14, 121–125.
44. Leu, J.; Lin, T.; Selvamani, M.J.P.; Chen, H.; Liang, J.; Pan, K. Characterization of a novel thermophilic
cyanobacterial strain from taian hot springs in Taiwan for high CO2 mitigation and C-phycocyanin extraction.
Process Biochem. 2013, 48, 41–48. [CrossRef]
45. Liang, Y.; Kaczmarek, M.B.; Kasprzak, A.K.; Tang, J.; Shah, M.M.R.; Jin, P.; Daroch, M. Thermosynechococcaceae
as a source of thermostable C-phycocyanins: Properties and molecular insights. Algal Res. 2018, 35, 223–235.
[CrossRef]
46. Rahman, D.Y.; Sarian, F.D.; van Wijk, A.; Martinez-Garcia, M.; van der Maarel, M.J.E.C. Thermostable
phycocyanin from the red microalga Cyanidioschyzon merolae, a new natural blue food colorant. J. Appl. Phycol.
2017, 29, 1233–1239. [CrossRef] [PubMed]
47. Mishra, S.K.; Shrivastav, A.; Mishra, S. Effect of preservatives for food grade C-PC from Spirulina platensis.
Process Biochem. 2008, 43, 339–345. [CrossRef]
48. Mishra, S.K.; Shrivastav, A.; Pancha, I.; Jain, D.; Mishra, S. Effect of preservatives for food grade
C-phycoerythrin, isolated from marine cyanobacteria Pseudanabaena sp. Int. J. Biol. Macromol. 2010,
47, 597–602. [CrossRef] [PubMed]
49. Wu, H.; Wang, G.; Xiang, W.; Li, T.; He, H. Stability and antioxidant activity of food-grade phycocyanin
isolated from Spirulina platensis. Int. J. Food Prop. 2016, 19, 2349–2362. [CrossRef]
50. Martelli, G.; Folli, C.; Visai, L.; Daglia, M.; Ferrari, D. Thermal stability improvement of blue colorant
C-phycocyanin from Spirulina platensis for food industry applications. Process Biochem. 2014, 49, 154–159.
[CrossRef]
51. Romay, C.H.; González, R.; Ledón, N.; Remirez, D.; Rimbau, V. C-Phycocyanin: A biliprotein with antioxidant,
anti-Inflammatory and neuroprotective effects. Curr. Protein Pept. Sci. 2003, 4, 207–216. [CrossRef]
52. Patel, S.N.; Sonani, R.R.; Jakharia, K.; Bhastana, B.; Patel, H.M.; Chaubey, M.G.; Singh, N.K.; Madamwar, D.
Antioxidant activity and associated structural attributes of Halomicronema phycoerythrin. Int. J. Biol. Macromol.
2018, 111, 359–369. [CrossRef]
53. Soni, B.; Trivedi, U.; Madamwar, D. A novel method of single step hydrophobic interaction chromatography
for the purification of phycocyanin from Phormidium fragile and its characterization for antioxidant property.
Bioresour. Technol. 2008, 188, 194. [CrossRef]
54. Sonani, R.R.; Singh, N.K.; Kumar, J.; Thakar, D.; Madamwar, D. Concurrent purification and antioxidant
activity of phycobiliproteinsfrom Lyngbya sp. A09DM: An antioxidant and anti-aging potential of
phycoerythrin in Caenorhabditis elegans. Process Biochem. 2017, 49, 1757–1766. [CrossRef]
55. Kuskoski, E.M.; Asuero, A.G.; Ana, M.; Troncoso, A.M.; Mancini-Filho, J.; Fett, R. Aplicación de diversos
métodos químicos para determinar actividad antioxidante en pulpa de frutos. Ciênc. Tecnol. Aliment. Camp.
2005, 25, 726–732. [CrossRef]
56. Leung, M.C.K.; Williams, P.L.; Benedetto, A.; Au, C.; Helmcke, K.J.; Aschner, M.; Meyer, J.N. Caenorhabditis
elegans: An emerging model in biomedical and environmental toxicology. Toxicol. Sci. 2008, 106, 5–28.
[CrossRef] [PubMed]
57. Kaletta, T.; Hengartner, M.O. Finding function in novel targets: C. elegans as a model organism. Nat. Rev.
Drug Discov. 2006, 5, 387–398. [CrossRef]
Foods 2020, 9, 244
58. Ju, J.; Saul, N.; Kochan, C.; Putschew, A.; Pu, Y.; Yin, L.; Steinberg, C.E. Cyanobacterial xenobiotics as
evaluated by a Caenorhabditis elegans. Neurotoxicity screening test. Int. J. Environ. Res. Public Health 2014, 11,
4589–4606. [CrossRef]
59. Gouveia, L.; Batista, A.; Miranda, A.; Empis, J.; Raymundo, A. Chlorella vulgaris biomass used as coloring
source in traditional butter cookies. Innov. Food Sci. Emerg. Technol. 2007, 8, 433–436. [CrossRef]
60. Hossain, A.K.M.M.; Brennan, M.A.; Mason, S.L.; Guo, X.; Zeng, X.A.; Brennan, C.S. The Effect of
astaxanthin-rich microalgae “Haematococcus pluvialis” and wholemeal flours incorporation in improving the
physical and functional properties of cookies. Foods 2017, 6, 57. [CrossRef]
61. Caporgno, M.P.; Mathys, A. Trends in microalgae incorporation into innovative food products with potential
health benefits. Front. Nutr. 2018, 5, 58. [CrossRef]
62. Allen, M.; Arnon, D. Studies on nitrogen-fixing blue-green algae. I. Growth and nitrogen fixation by Anabaena
cylindrica. Plant Physiol. 1955, 30, 366–372. [CrossRef]
63. Ranjitha, K.; Kaushik, B.D. Purification of phycobiliproteins from Nostoc muscorum. J. Sci. Ind. Res. 2005, 64,
372–375.
64. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an
improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. [CrossRef]
65. Benzie, I.F.F.; Strain, J.J. The Ferric Reducing Ability of Plasma (FRAP) as a measure of “Antioxidant Power”:
The FRAP Assay. Anal. Biochem. 1996, 239, 70–76. [CrossRef] [PubMed]
66. Lewis, J.A.; Fleming, J.T. Basic culture methods. In Caenorhabditis Elegans: Modern Biological Analysis of an
Organism; Epstein, H.F., Shakes, D.C., Eds.; Academic Press: San Diego, CA, USA, 1995; pp. 4–27.
67. Brenner, S. The genetics of Caenorhabditis elegans. Genetics 1974, 77, 71–94. [PubMed]
68. Skantar, A.M.; Agama, K.; Meyer, S.L.F.; Carta, L.K.; Vinyard, B.T. Effects of geldanamycin on hatching
and juvenile motility in Caenorhabditis elegans and Heterodera glycines. J. Chem. Ecol. 2005, 31, 2481–2491.
[CrossRef]
69. BBL™ MacConkey II Agar (BD). Available online: http://legacy.bd.com/ds/technicalCenter/inserts/L007388(10)
.pdf (accessed on 15 January 2020).
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
foods
Article
A Microethnographic and Ethnobotanical Approach
to Llayta Consumption among Andes
Feeding Practices
Mailing Rivera 1 , Alexandra Galetović 2 , Romina Licuime 1 and Benito Gómez-Silva 2, *
1 Departamento de Educación, Facultad de Educación, Universidad de Antofagasta,
Antofagasta 124000, Chile; mailing.rivera@uantof.cl (M.R.); rlicuime1505@gmail.com (R.L.)
2 Departamento Biomédico, Facultad Ciencias de la Salud, and Centre for Biotechnology and Bioengineering,
CeBiB, Universidad de Antofagasta; Antofagasta 1240000, Chile; alexandra.galetovic@uantof.cl
* Correspondence: benito.gomez@uantof.cl; Tel.: +56-9-98297844
Abstract: Llayta is a dietary supplement that has been used by rural communities in Perú and
northern Chile since pre-Columbian days. Llayta is the biomass of colonies of a Nostoc cyanobacterium
grown in wetlands of the Andean highlands, harvested, sun-dried and sold as an ingredient for
human consumption. The biomass has a substantial content of essential amino acids (58% of total
amino acids) and polyunsaturated fatty acids (33% total fatty acids). This ancestral practice is
being lost and the causes were investigated by an ethnographic approach to register the social
representations of Llayta, to document how this Andean feeding practice is perceived and how
much the community knows about Llayta. Only 37% of the participants (mostly adults) have had
a direct experience with Llayta; other participants (mostly children) did not have any knowledge
about it. These social responses reflect anthropological and cultural tensions associated with a lack
of knowledge on Andean algae, sites where to find Llayta, where it is commercialized, how it is
cooked and on its nutritional benefits. The loss of this ancestral feeding practice, mostly in northern
Chile, is probably associated with cultural changes, migration of the rural communities, and very
limited access to the available information. We propose that Llayta consumption can be revitalized
by developing appropriate educational strategies and investigating potential new food derivatives
based on the biomass from the isolated Llayta cyanobacterium.
1. Introduction
The abundance and diversity of organisms in the Atacama Desert are severely limited by the
high levels of desiccation and ultraviolet light [1,2]. In the Andes Mountains highlands, biodiversity
is higher and plants have been used for centuries by local communities for feeding, foraging and
ethnomedicine [3–8]. Microalgae and cyanobacteria are part of the Andes biodiversity but seldom
acknowledged. Based on their nutritional and digestive benefits, microalgae and cyanobacteria
(i.e., Chlorella, Dunaliella, Arthrospira and Nostoc) have been part of the human diet in South America,
North America, Asia and Africa. Also, some species are natural resources for a variety of organic
molecules with high interest to the biotechnological industry (proteins, amino acids, vitamins,
polyunsaturated fatty acids, pigments) [3,4,9,10]. Edible members of the Nostoc genus are found
in China where Nostoc flagelliforme has been consumed as a delicacy for centuries but its collection is
prohibited today due to over-exploitation [11,12]. In South America, an indigenous foodstuff harvested
in the Andes wetlands, known as Llayta, is the dry biomass of macrocolonies of a cyanobacterium from
the genus Nostoc (Figure 1). Llayta consumption is a practice that can be traced back to pre-Columbian
times and it has been recorded in documents from the 17th century [13,14] and, in a more recent
botanical report [15].
TACNA Tropic of
Capricorn
PUTRE
ARICA
IQUIQUE
ANTOFAGAS
Figure 1. Locations, in southern Peru and northern Chile, where information on Llayta was acquired.
Thus, the genus Nostoc has been an old component of the human diet in South America, and it
continues to be used today as a food additive in northern Chile (Arica y Parinacota and Tarapacá
Regions) and in southern Peru (Tacna City) (Figure 2) [5,6,8,16–18]. However, and based on preliminary
interviews, this ancient culinary legacy is disappearing and it is already unknown by the urban
communities from other areas of the region; for example, at Antofagasta, the major coastal city in
northern Chile, nearly 400 km south of Iquique (Figure 2).
Figure 2. A dry colony of Llayta obtained at a major food market in Arica, Chile. (Bar: 1 cm).
Our report provides the results of a microethnographic study conducted to learn how much
people know about Llayta and their perception on this ancestral Andean ingredient, and is meant to
Foods 2018, 7, 202
be complementary to biochemical studies done on Llayta [4]. This work was based on the following
considerations: (i) Llayta consumption is a feeding practice transmitted through generations in the
rural Andean world of South America, without reports of adverse effects on human health; (ii) Llayta
consumption is an old culinary legacy that is disappearing in regions of South America; (iii) Llayta is a
nutritional ingredient containing essential amino acids (58% of total amino acids) and polyunsaturated
fatty acids (33% total fatty acids); (iv) the prevalence of undernourishment in South America; (iv) Llayta
consumption can be revitalized with appropriate educational strategies and new food derivatives can
be developed from the biomass of the isolated cyanobacterium from Llayta [4,9,18,19].
We propose that this microethnographic approach will help us to explore explanations for an
apparent decrease in Llayta consumption, and to provide arguments and suggestions for the revitalization
of this feeding practice.
3. Results
Table 1. The Llayta vocable: alternative names, their ethnic origins and meaning.
The extracts in Table 2 corroborate that 7 participants have had personal experience of Llayta, i.e., direct
knowledge. Only one teacher expressed indirect knowledge about Llayta since the information was
second-hand (Table 2). Compared with adult participants, the oral expression of knowledge used by
the fourth-grade students from Putre to refer to Llayta were few or absent. When asked to draw an
image of Llayta, 11 out of 12 students were willing to participate and their drawings were far from a
correct depiction of the colonies. As an exception, one student emphasized that his mother used to
cook Llayta and her drawing was the closest image to it. Another student said: “no, yo no” (No, I do
not (know Llayta)). A third student asked: “¿Esa es la Llayta? (Is this Llayta?), referring to a drawing
made by another student. Table 2 is a compilation of the representations of Llayta.
Table 2. Transcripts of interviews conducted to adult and students participants about their knowledge
on Llayta.
4. Discussion
activity of 17.4 μmoles (as equivalent to Trolox), and total fiber content was 56% of dry weight [4].
Galetovic et al. [4] inferred that Llayta biomass is a nutritious dietary ingredient.
One reason for the need for safety assessments of foods and food ingredients based on microalgae
and cyanobacteria biomasses to protect public health is the potential presence of cyanobacterial toxins
active at low doses (e.g., microcystin and nodularin). In particular, Arthrospira platensis (Spirulina)
is considered a safe food based on centuries of human consumption [23]. Comparatively, some
species of the Nostoc genus have toxic members that synthesize microcystine-like cyanotoxin [28].
However, the genome of the colony-forming Nostoc strain isolated from the Llayta biomass did not
show the presence of mycE, a key gene in the microcystine biosynthetic pathway, rendering it as a
non-toxic Nostoc strain [4,28]. In addition, the absence of epidemiological records associated with Llayta
consumption diminishes but does not remove the potential presence of toxic secondary metabolites in
this cyanobacterial biomass [4].
5. Conclusions
Llayta consumption is a feeding practice with a know-how that has been transmitted through
generations in the rural Andean world of South America, without untoward effects on human health.
Nevertheless, this ancestral feeding legacy is being lost in young generations from northern Chile.
New educational and anthropological strategies must be developed if there is interest in promoting
the preservation and value of this traditional feeding practice and cultural legacy.
Llayta is a nutritious dietary ingredient for human consumption. This is supported by the
absence of adverse epidemiological evidence, but also with interdisciplinary studies that complement
ethnographic records with biochemical information.
Caution on the amount of Llayta consumed daily, based on its arsenic content, must be stressed.
However, mass growth of the cyanobacterium isolated from Llayta under controlled conditions would
provide arsenic-free biomass for the formulation of new food products. This biotechnological approach
would revitalize the use of and add value to this ancestral food ingredient for the benefit of not only
Andean communities, but also the whole population of South America and the world.
Author Contributions: Conceptualization, B.G.-S. and M.R.; Data curation, M.R. and R.L. Funding acquisition,
B.G.-S. and A.G.; Investigation, A.G.; Methodology, M.R.; Supervision, B.G.-S. and A.G.; Validation, R.L.;
Writing—original draft, B.G.-S. and M.R.; Writing—review and editing, B.G.-S.
Funding: This research was funded by Universidad de Antofagasta, Chile, grant number SI-5305, and
CONICYT-CHILE, grant number CeBiB FB-0001.
Acknowledgments: The authors would like to thank Celedonio Maron Chura, Biblioteca de Antropología Andina
(Instituto para el Estudio de la Cultura y Tecnología Andina, Arica, Chile) for his useful comments.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to
publish the results.
References
1. Gómez-Silva, B. On the Limits Imposed to Life by the Hyperarid Atacama Desert in Northern Chile.
In Astrobiology: Emergence, Search and Detection of Life; Basiuk, V.A., Ed.; American Scientific Publishers: Los
Angeles, CA, USA, 2010; pp. 199–213.
2. Gómez-Silva, B. Lithobiontic life: Atacama rocks are well and alive. Anton Leeuwenhoek 2018, 111, 1333–1345.
[CrossRef] [PubMed]
3. Plaza, M.; Herrero, M.; Cifuentes, A.; Ibáñez, E. Innovative natural functional ingredients from microalgae.
J. Agric. Food Chem. 2009, 57, 7159–7170. [CrossRef] [PubMed]
4. Galetovic, A.; Araya, J.E.; Gómez-Silva, B. Composición bioquímica y toxicidad de colonias comestibles de la
cianobacteria andina Nostoc sp. Llayta. Rev. Chil. Nutr. 2017, 44, 360–370. [CrossRef]
Foods 2018, 7, 202
5. Villagrán, C.; Castro, V.; Sánchez, G.; Hinojosa, F.; Latorre, C. La tradición altiplánica: Estudio etnobotánico
en los Andes de Iquique, primera región, Chile. Chungara 1999, 31, 81–186.
6. Villagrán, C.; Castro, V. Ciencia Indígena de Los Andes del Norte de Chile; Editorial Universitaria: Santiago,
Chile, 2003.
7. Villagrán, C.; Romo, M.; Castro, V. Etnobotánica del sur de los Andes de la primera región de Chile: Un enlace
entre las culturas altiplánicas y las de quebradas altas del Loa Superior. Chungara 2003, 35, 73–124. [CrossRef]
8. Pardo, O.; Pizarro, J.L. Chile: Plantas Alimentarias Prehispánicas; Ediciones Parina: Arica, Chile, 2013;
ISBN 978-956-9120-02-2.
9. Gantar, M.; Svircev, Z. Microalgae and cyanobacteria: Food for the thought. J. Phycol. 2008, 44, 260–268.
[CrossRef] [PubMed]
10. Habib, M.; Ahsan, B.; Parvin, M.; Huntington, T.C.; Hasan, M.R. A Review on Culture, Production and Use
of Spirulina as Food for Humans and Feeds for Domestic Animals and Fish. FAO Fisheries and Aquaculture.
Circular No. 1034. 2008. Available online: http://www.fao.org/3/contents/b2d01d94-4707-54c1-9f65-
01f699fc6d07/i0424e00.htm (accessed on 19 October 2018).
11. Gao, K. Chinese studies on the edible blue-green alga, Nostoc flagelliforme: A review. J. Appl. Phycol. 1998,
10, 37–49. [CrossRef]
12. Qiu, B.; Liu, J.; Liu, Z.; Liu, S. distribution and Ecology of the edible cyanobacterium Ge-Xian-Mi (Nostoc) in
rice fields of Hefeng County in China. J. Appl. Phycol. 2002, 14, 423–429. [CrossRef]
13. Bertonio, L. Vocabulario de la Lengua Aymara. Colección Biblioteca Nacional de Chile: Impreso en la
Compañía de Jesús, Perú. Electronic Document. 1612. Available online: http://www.memoriachilena.cl/
602/w3-article-8656.html (accessed on 19 October 2018).
14. Mannheim, B. Poetic form in Guaman Poma’s Wariqsa Arawi. Amerindian 1986, 11, 41–67.
15. Lagerheim, M.G. La Yuyucha. La Nuova Notarisia 3:1376-1377. 1892. Available online: https://archive.org/
stream/lanotaristacomme7293levi/lanotarisiacomme7293levi_djvu.txt (accessed on 29 November 2018).
16. Aldave-Pajares, A. Cuschuro, algas azul-verde utilizadas como alimento en la región altoandina peruana.
Soc. Bot. Libertad 1969, 1, 9–22.
17. Aldave-Pajares, A. Algas andino peruanas como recurso hidrobiológico alimentario. Bol. Lima 1985, 7, 66–72.
18. Gómez-Silva, B.; Mendizabal, C.; Tapia, I.; Olivares, H. Microalgas del norte de Chile. IV. Composición
química de Nostoc commune Llaita [Microalgae from northern Chile: Chemical composition of Nostoc
commune Llaita]. Rev. Invest. Sci. Tecnol. 1994, 43, 19–25.
19. FAO. Food Security & Nutrition around the World. 2018. Available online: http://www.fao.org/state-of-
food-security-nutrition/en/ (accessed on 29 October 2018).
20. Pereira de Sá, C. The Central Nucleus Approach to Social Representations. Electronic Document.
1996. Available online: http://www.lse.ac.uk/methodology/pdf/QualPapers/CELSO-Core-periphery.pdf
(accessed on 29 November 2018).
21. Lam, M.R.; Gómez, W.C.; Vega, M.B.; Peña, R.A. Representaciones del monumento natural La Portada de
Antofagasta. Zona Próxima 2012, 17, 58–75.
22. Restrepo, B. Investigación en educación. In Especialización en Teoría, Métodos y Técnicas de Investigación Social;
ARFO Editores e Impresores Ltda.: Bogotá, Colombia, 2002.
23. Banchs, M.A. Concepto de representaciones sociales: Análisis comparativo. Rev. Costarric. Psicol. 1986, 5, 27–40.
24. Jodelet, D. La representación social: Fenómenos, concepto y teoría. In Psicología Social II. Pensamiento y Vida
Social; Moscovici, S., Ed.; Paidós: Barcelona, Spain, 1984.
25. Niccolai, A.; Bagagli, E.; Biondi, N.; Rodolfi, L.; Cinci, L.; Luceri, C.; Tredici, M.R. In vitro toxicity of
microalgal and cyanobacterial strains of interest as food source. J. Appl. Phycol. 2017, 29, 199–209. [CrossRef]
26. González, H.; Gundermann, H.; Rojas, R. Diagnóstico y Estrategia de Desarrollo Campesino en la I Región
de Tarapacá; Serie Documentos de Trabajo; Taller de Estudios Andinos; Corporación Norte Grande, Ed.;
Impresos Publicitarios: Arica, Chile, 1991; 246p.
Foods 2018, 7, 202
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
MDPI
St. Alban-Anlage 66
4052 Basel
Switzerland
Tel. +41 61 683 77 34
Fax +41 61 302 89 18
www.mdpi.com